{"id":"NCBIGene:12166","apiVersionInfo":"monarch-api-2014-12-19","xrefs":[{"ids":[{"id":"Ensembl:ENSMUSG00000021796"}],"source":"Ensembl"},{"ids":[{"id":"KEGG:mmu:12166"}],"source":"KEGG"},{"ids":[{"id":"MGI:1338938"},{"id":"MGI:2145761"},{"id":"MGI:1915998"},{"id":"MGI:88183"}],"source":"MGI"},{"ids":[{"id":"NCBIGene:12166"},{"id":"NCBIGene:ETG12166"}],"source":"NCBIGene"},{"ids":[{"id":"PRO:000000035"}],"source":"PRO"},{"ids":[{"id":"RefSeq:NM_009758"},{"id":"RefSeq:XM_006518469"},{"id":"RefSeq:XP_006518533"},{"id":"RefSeq:XM_006518470"},{"id":"RefSeq:XP_006518532"},{"id":"RefSeq:NP_033888"}],"source":"RefSeq"},{"ids":[{"id":"Swiss-Prot:P36895"}],"source":"Swiss-Prot"},{"ids":[{"id":"TrEMBL:Q53Z43"},{"id":"TrEMBL:Q3UP52"},{"id":"TrEMBL:E9PW65"},{"id":"TrEMBL:Q60607"},{"id":"TrEMBL:E9Q2G5"}],"source":"TrEMBL"},{"ids":[{"id":"Uniprot:P36895"}],"source":"Uniprot"},{"ids":[{"id":"Vega:OTTMUSG00000036087"}],"source":"Vega"}],"ncbi_id":12166,"label":"Bmpr1a","description":"Bone morphogenetic protein receptor, type 1A","taxon":{"id":"NCBITaxon:10090","label":"Mus musculus"},"references":[{"id":"NCBIGene:12166","source":"NCBIGene"}],"sources":[{"label":"MyGene"}],"location":"14 B|14 20.81 cM","synonyms":["1110037I22Rik"," ALK3"," AU045487"," BMPR-IA"," Bmpr"],"pathway_associations":[{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"pathway":{"id":"KEGG:path:map04550","label":"Signaling pathways regulating pluripotency of stem cells","source":{"id":"nlx_31015-3","label":"KEGG"}},"source":{"id":"nlx_31015-3","label":"KEGG"},"resource":{"id":"nlx_31015-3","label":"KEGG"}},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"pathway":{"id":"KEGG:path:map04390","label":"Hippo signaling pathway","source":{"id":"nlx_31015-3","label":"KEGG"}},"source":{"id":"nlx_31015-3","label":"KEGG"},"resource":{"id":"nlx_31015-3","label":"KEGG"}},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"pathway":{"id":"KEGG:path:map04350","label":"TGF-beta signaling pathway","source":{"id":"nlx_31015-3","label":"KEGG"}},"source":{"id":"nlx_31015-3","label":"KEGG"},"resource":{"id":"nlx_31015-3","label":"KEGG"}},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"pathway":{"id":"KEGG:path:map04060","label":"Cytokine-cytokine receptor interaction","source":{"id":"nlx_31015-3","label":"KEGG"}},"source":{"id":"nlx_31015-3","label":"KEGG"},"resource":{"id":"nlx_31015-3","label":"KEGG"}}],"type":"gene","phenotype_associations":[{"id":"monarch:disco/7be5cb09-2f4c-5f74-a82c-6b14ea779e1e","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3042225","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; Amhr2<tm3(cre)Bhr>/Amhr2<+> [involves: 129S/SvEv * C57BL/6]"},"phenotype":{"id":"MP:0002789","label":"male pseudohermaphroditism"},"references":[{"id":"PMID:12368913","label":"Jamin SP","url":"http://www.ncbi.nlm.nih.gov/pubmed/12368913"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/ab189386-e2e0-5823-8413-c89eb810a32b","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3042225","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; Amhr2<tm3(cre)Bhr>/Amhr2<+> [involves: 129S/SvEv * C57BL/6]"},"phenotype":{"id":"MP:0001939","label":"secondary sex reversal"},"references":[{"id":"PMID:12368913","label":"Jamin SP","url":"http://www.ncbi.nlm.nih.gov/pubmed/12368913"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/39dbdbc8-4fe8-5b4a-b462-b47167a4cdc0","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3713546","label":"Bmpr1a<Gt(pU21)17Imeg>/Bmpr1a<?> [involves: C57BL/6 * CBA]"},"phenotype":{"id":"MP:0003012","label":"no phenotypic analysis"},"references":[{"id":"J:109358","label":"Database for Exchangeable Gene Trap Clones","url":"http://www.informatics.jax.org/reference/J:109358"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/34d3287d-0d6e-5b39-8c62-1155d6634f46","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3578783","label":"<Tg(Gdf5-cre-ALPP)1Kng>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.2Bhr> [involves: 129 * C57BL/6 * FVB/N-Tg(Gdf5-cre-ALPP)1Kng]"},"phenotype":{"id":"MP:0008069","label":"abnormal joint mobility"},"references":[{"id":"PMID:15492776","label":"Rountree RB","url":"http://www.ncbi.nlm.nih.gov/pubmed/15492776"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/e348a63a-b0ee-513c-bd85-b204350d46c8","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046633","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre)40Smr>/<?> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0003875","label":"abnormal hair follicle regression"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/89e95823-d278-5159-8e49-853c6b8b8f49","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046633","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre)40Smr>/<?> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0000383","label":"abnormal hair follicle orientation"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/911a2a8b-18e6-553a-a4df-33cf231525bc","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046633","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre)40Smr>/<?> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0000377","label":"abnormal hair follicle morphology"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/83298e06-2788-565f-a3fc-e9ad22e2ef67","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046633","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre)40Smr>/<?> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0002073","label":"abnormal hair growth"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/2c2b3172-ffcf-5f80-8d2b-20578369039e","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046633","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre)40Smr>/<?> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0003809","label":"abnormal hair shaft morphology"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/18a01a6d-7530-5d26-8554-cf852decac37","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046633","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre)40Smr>/<?> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0000579","label":"abnormal nail morphology"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/fd9163b1-726f-5404-b6d4-416b589651b7","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046633","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre)40Smr>/<?> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0002100","label":"abnormal tooth morphology"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/669edff7-17ab-55a3-b500-2b78f627064a","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046633","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre)40Smr>/<?> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0000124","label":"absent teeth"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/f763e477-b0af-5819-ad77-9ef871236471","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046633","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre)40Smr>/<?> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0000414","label":"alopecia"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/2ed6316c-9386-5d78-adc8-ff8cc03b8876","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046633","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre)40Smr>/<?> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0002083","label":"premature death"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"},{"id":"PMID:23736260","label":"Wend P","url":"http://www.ncbi.nlm.nih.gov/pubmed/23736260"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/886f3637-a5e4-5c1b-9e6c-ba2235fc46bd","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046633","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre)40Smr>/<?> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0001265","label":"decreased body size"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/5620b8ff-8dfb-5680-a769-c3dd8cc8abca","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046633","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre)40Smr>/<?> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0000380","label":"small hair follicles"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/96122653-e14b-5349-b536-0537b821adde","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046634","label":"<Tg(KRT14-cre)43Smr>/<?>; Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0000452","label":"abnormal mouth morphology"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/86969129-efc7-5560-ac89-445345f1b4d4","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046634","label":"<Tg(KRT14-cre)43Smr>/<?>; Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0001436","label":"abnormal suckling behavior"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/f50ee466-f953-5d2f-a857-e8b84d5e94ac","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046634","label":"<Tg(KRT14-cre)43Smr>/<?>; Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0000116","label":"abnormal tooth development"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/e6153d5a-fcbf-5d47-abea-14b1a3497200","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046634","label":"<Tg(KRT14-cre)43Smr>/<?>; Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0000557","label":"absent hindlimb"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"},{"id":"PMID:11714671","label":"Ahn K","url":"http://www.ncbi.nlm.nih.gov/pubmed/11714671"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/1464a443-e554-5fbf-b44a-4764082aa7c5","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046634","label":"<Tg(KRT14-cre)43Smr>/<?>; Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0001302","label":"eyelids open at birth"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/78e3ca38-56e5-5d41-942f-36550e752c90","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046634","label":"<Tg(KRT14-cre)43Smr>/<?>; Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0011087","label":"complete neonatal lethality"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/6f2a2bad-feb9-5039-9ee8-3d03b566df60","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046635","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre)52Smr>/0 [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0011085","label":"complete postnatal lethality"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"},{"id":"PMID:16414041","label":"Eblaghie MC","url":"http://www.ncbi.nlm.nih.gov/pubmed/16414041"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/1a495aa8-cf8e-51f9-a939-b3748a785278","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046636","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre>/<?> [involves: 129S7/SvEvBrd * C57BL/6]"},"phenotype":{"id":"MP:0002009","label":"preneoplasia"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/3c3f24e3-0854-581b-a12c-5c723477a805","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046636","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre>/<?> [involves: 129S7/SvEvBrd * C57BL/6]"},"phenotype":{"id":"MP:0000416","label":"sparse hair"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/ab2f5ae8-bd9d-50ba-b0f9-112edfae4771","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0000164","label":"abnormal cartilage development"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"},{"id":"PMID:15492776","label":"Rountree RB","url":"http://www.ncbi.nlm.nih.gov/pubmed/15492776"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/5e5aa721-526d-57e1-87fb-6219c1403907","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0000166","label":"abnormal chondrocyte morphology"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/759ba938-84e2-560d-865d-7d2b92059bfc","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0006280","label":"abnormal digit development"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/22c52e1b-72a0-56eb-a231-b4c223b8c3b0","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0006395","label":"abnormal epiphyseal plate morphology"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/74e5331e-a9d7-57b7-a125-8d6916c27615","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0002825","label":"abnormal notochord morphology"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/df667f12-4f64-5d88-908b-2f2876f61f1a","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0000552","label":"abnormal radius morphology"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/780e5d25-a69e-5765-bb2f-f377db231d54","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0005108","label":"abnormal ulna morphology"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/14139923-cfe4-563c-95b9-27ad78a19a28","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0005225","label":"abnormal vertebrae development"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/ede60d64-ecef-5d50-8cc9-88795e5c8aee","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0004703","label":"abnormal vertebral column morphology"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/b26c1077-9d32-53f6-a2d9-3fbe8474388f","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0002657","label":"chondrodystrophy"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/a24808a1-8827-5fa0-90f2-d5a8a5e3fb89","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0008275","label":"failure of endochondral bone ossification"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/6c9fe7cf-147e-5001-bf6a-6fcbb999c15e","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0011099","label":"complete lethality throughout fetal growth and development"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/a38dbcbd-cd89-50c1-b08a-9e5878b8c027","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0004200","label":"decreased fetal size"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/c556b043-74dc-5d9a-b06d-f189aa1a21a5","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0000547","label":"short limbs"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/2f656dfb-94bf-51a7-8d73-730daab558a6","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0000445","label":"short snout"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/bb0f2193-4976-5b0d-93ae-fda9edd16532","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0000592","label":"short tail"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/a994f8e8-b391-537f-bbfe-23adf20448e7","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785772","label":"<Tg(Col2a1-cre)1Bhr>/<?>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0001954","label":"respiratory distress"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"},{"id":"PMID:16414041","label":"Eblaghie MC","url":"http://www.ncbi.nlm.nih.gov/pubmed/16414041"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/cb71d0b4-26d5-51ca-8106-d90969428aec","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785771","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Col2a1-cre)1Bhr>/<?> [involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0002113","label":"abnormal skeleton development"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"},{"id":"PMID:15492776","label":"Rountree RB","url":"http://www.ncbi.nlm.nih.gov/pubmed/15492776"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/6905ab3b-76de-51c6-a82b-cb05e9d46687","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785772","label":"<Tg(Col2a1-cre)1Bhr>/<?>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0010103","label":"small thoracic cage"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/ec714655-0ecc-523f-a9cb-216c7e7fe08b","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785772","label":"<Tg(Col2a1-cre)1Bhr>/<?>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0004686","label":"decreased length of long bones"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/e1572edc-b20e-58a4-ae29-fdfb2e622b6d","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785772","label":"<Tg(Col2a1-cre)1Bhr>/<?>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0000060","label":"delayed bone ossification"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/49ea126d-5466-5ede-9bfe-1d4d44eea56d","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785772","label":"<Tg(Col2a1-cre)1Bhr>/<?>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0002082","label":"postnatal lethality"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/f61e7563-3a2b-55cb-85f0-04534de426cb","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3811313","label":"<Tg(Sftpc-cre)1Blh>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; Bax<tm1Sjk>/Bax<tm1Sjk> [involves: 129 * C57BL/6 * DBA/2 * ICR]"},"phenotype":{"id":"MP:0001176","label":"abnormal lung development"},"references":[{"id":"PMID:16414041","label":"Eblaghie MC","url":"http://www.ncbi.nlm.nih.gov/pubmed/16414041"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/59653938-7065-50d2-b58a-7a5c3119adfb","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3811312","label":"<Tg(Sftpc-cre)1Blh>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * DBA/2 * ICR]"},"phenotype":{"id":"MP:0006382","label":"abnormal lung epithelium morphology"},"references":[{"id":"PMID:16414041","label":"Eblaghie MC","url":"http://www.ncbi.nlm.nih.gov/pubmed/16414041"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/a451f8a2-500a-50ff-8d1b-4ae1ebfa08cc","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3811312","label":"<Tg(Sftpc-cre)1Blh>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * DBA/2 * ICR]"},"phenotype":{"id":"MP:0001175","label":"abnormal lung morphology"},"references":[{"id":"PMID:16414041","label":"Eblaghie MC","url":"http://www.ncbi.nlm.nih.gov/pubmed/16414041"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/bb05f629-890f-5e1e-815f-c01cc95c8f5b","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3811312","label":"<Tg(Sftpc-cre)1Blh>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * DBA/2 * ICR]"},"phenotype":{"id":"MP:0002133","label":"abnormal respiratory system physiology"},"references":[{"id":"PMID:16414041","label":"Eblaghie MC","url":"http://www.ncbi.nlm.nih.gov/pubmed/16414041"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/5c4c1eb7-67d5-51da-9b5d-4e091986d95f","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3811312","label":"<Tg(Sftpc-cre)1Blh>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * DBA/2 * ICR]"},"phenotype":{"id":"MP:0010811","label":"decreased type II pneumocyte number"},"references":[{"id":"PMID:16414041","label":"Eblaghie MC","url":"http://www.ncbi.nlm.nih.gov/pubmed/16414041"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/c0dd14f1-f761-5336-a948-f220c1f66801","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3811312","label":"<Tg(Sftpc-cre)1Blh>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * DBA/2 * ICR]"},"phenotype":{"id":"MP:0005388","label":"respiratory system phenotype"},"references":[{"id":"PMID:16414041","label":"Eblaghie MC","url":"http://www.ncbi.nlm.nih.gov/pubmed/16414041"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/99daa0b2-66ed-58c3-bf34-180f37db0bf7","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3819176","label":"<Tg(Cga-cre)3Sac>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0003817","label":"abnormal pituitary diverticulum morphology"},"references":[{"id":"PMID:17359964","label":"Davis SW","url":"http://www.ncbi.nlm.nih.gov/pubmed/17359964"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/d5385aa0-fc8e-59e1-8e1e-acc50e01b002","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3819176","label":"<Tg(Cga-cre)3Sac>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0000266","label":"abnormal heart morphology"},"references":[{"id":"PMID:17359964","label":"Davis SW","url":"http://www.ncbi.nlm.nih.gov/pubmed/17359964"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/f04d2a95-335c-5082-8790-c5c83ffa28ed","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3819176","label":"<Tg(Cga-cre)3Sac>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0003816","label":"abnormal pituitary gland development"},"references":[{"id":"PMID:17359964","label":"Davis SW","url":"http://www.ncbi.nlm.nih.gov/pubmed/17359964"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/830f7599-21e8-5b00-93a5-7e1cebb88170","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3819176","label":"<Tg(Cga-cre)3Sac>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0011098","label":"complete embryonic lethality during organogenesis"},"references":[{"id":"PMID:17359964","label":"Davis SW","url":"http://www.ncbi.nlm.nih.gov/pubmed/17359964"},{"id":"PMID:16556916","label":"Yang L","url":"http://www.ncbi.nlm.nih.gov/pubmed/16556916"},{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/5ab08193-9eb7-5b57-9320-9ae870f91fb8","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3819176","label":"<Tg(Cga-cre)3Sac>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0001698","label":"decreased embryo size"},"references":[{"id":"PMID:17359964","label":"Davis SW","url":"http://www.ncbi.nlm.nih.gov/pubmed/17359964"},{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"},{"id":"PMID:8543149","label":"Mishina Y","url":"http://www.ncbi.nlm.nih.gov/pubmed/8543149"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/a4509408-4023-5183-83b7-9a3c3a27e735","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3829249","label":"<Tg(Col1a1-cre>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0002896","label":"abnormal bone mineralization"},"references":[{"id":"PMID:18927151","label":"Kamiya N","url":"http://www.ncbi.nlm.nih.gov/pubmed/18927151"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/d0cdcd83-1140-5503-80af-3c96b79d09fd","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3829249","label":"<Tg(Col1a1-cre>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0008271","label":"abnormal bone ossification"},"references":[{"id":"PMID:18927151","label":"Kamiya N","url":"http://www.ncbi.nlm.nih.gov/pubmed/18927151"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/239831af-b303-5f22-8b71-03f8622c39e2","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3829249","label":"<Tg(Col1a1-cre>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0003795","label":"abnormal bone structure"},"references":[{"id":"PMID:18927151","label":"Kamiya N","url":"http://www.ncbi.nlm.nih.gov/pubmed/18927151"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/6d2af507-9746-5a41-baad-c1d96ea685d4","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3829249","label":"<Tg(Col1a1-cre>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0008396","label":"abnormal osteoclast differentiation"},"references":[{"id":"PMID:18927151","label":"Kamiya N","url":"http://www.ncbi.nlm.nih.gov/pubmed/18927151"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/39944da7-47bb-5c06-8fb3-89c197740dea","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3829249","label":"<Tg(Col1a1-cre>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0001541","label":"abnormal osteoclast physiology"},"references":[{"id":"PMID:18927151","label":"Kamiya N","url":"http://www.ncbi.nlm.nih.gov/pubmed/18927151"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/ce824754-e7dd-503b-a499-d3ae25436fc0","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3829249","label":"<Tg(Col1a1-cre>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0004985","label":"decreased osteoclast cell number"},"references":[{"id":"PMID:18927151","label":"Kamiya N","url":"http://www.ncbi.nlm.nih.gov/pubmed/18927151"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/c0acd1f7-63a9-5717-84b3-92306b420416","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3829249","label":"<Tg(Col1a1-cre>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0004421","label":"enlarged parietal bone"},"references":[{"id":"PMID:18927151","label":"Kamiya N","url":"http://www.ncbi.nlm.nih.gov/pubmed/18927151"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/1fb509ff-1677-50b2-a893-5b0b8bbf6fab","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3829249","label":"<Tg(Col1a1-cre>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0005605","label":"increased bone mass"},"references":[{"id":"PMID:18927151","label":"Kamiya N","url":"http://www.ncbi.nlm.nih.gov/pubmed/18927151"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/94040598-195a-5a7b-8d90-dfc452b1eb4a","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3829249","label":"<Tg(Col1a1-cre>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0005508","label":"abnormal skeleton morphology"},"references":[{"id":"PMID:18927151","label":"Kamiya N","url":"http://www.ncbi.nlm.nih.gov/pubmed/18927151"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/4d72c34a-67bb-59cc-b9c3-841b60d29fa4","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3829249","label":"<Tg(Col1a1-cre>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0001533","label":"abnormal skeleton physiology"},"references":[{"id":"PMID:18927151","label":"Kamiya N","url":"http://www.ncbi.nlm.nih.gov/pubmed/18927151"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/1216465e-2383-5da4-99ef-ed304c54f5b3","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3625139","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.2Bhr>; Isl1<tm1(cre)Sev>/Isl1<+> [involves: 129S4/SvJae * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0002633","label":"persistent truncus arteriosis"},"references":[{"id":"PMID:16556916","label":"Yang L","url":"http://www.ncbi.nlm.nih.gov/pubmed/16556916"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/7608266b-afe5-549d-8ea6-ce09907904f0","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3625139","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.2Bhr>; Isl1<tm1(cre)Sev>/Isl1<+> [involves: 129S4/SvJae * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0003221","label":"abnormal cardiomyocyte apoptosis"},"references":[{"id":"PMID:16556916","label":"Yang L","url":"http://www.ncbi.nlm.nih.gov/pubmed/16556916"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/8103912f-ad74-5e76-a47d-4a1be676e115","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3625139","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.2Bhr>; Isl1<tm1(cre)Sev>/Isl1<+> [involves: 129S4/SvJae * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0003567","label":"abnormal fetal cardiomyocyte proliferation"},"references":[{"id":"PMID:16556916","label":"Yang L","url":"http://www.ncbi.nlm.nih.gov/pubmed/16556916"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/03ec7650-5725-5435-afe7-f571ec71bc68","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3625139","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.2Bhr>; Isl1<tm1(cre)Sev>/Isl1<+> [involves: 129S4/SvJae * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0000556","label":"abnormal hindlimb morphology"},"references":[{"id":"PMID:16556916","label":"Yang L","url":"http://www.ncbi.nlm.nih.gov/pubmed/16556916"},{"id":"PMID:11714671","label":"Ahn K","url":"http://www.ncbi.nlm.nih.gov/pubmed/11714671"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/b0f49fd6-61fa-56aa-8dc1-815f2be72825","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3625139","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.2Bhr>; Isl1<tm1(cre)Sev>/Isl1<+> [involves: 129S4/SvJae * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0000352","label":"decreased cell proliferation"},"references":[{"id":"PMID:16556916","label":"Yang L","url":"http://www.ncbi.nlm.nih.gov/pubmed/16556916"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/7a091c64-bcb1-5616-8d75-1d9a0cd886b6","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3663711","label":"<Tg(GATA6-cre)>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * FVB]"},"phenotype":{"id":"MP:0010512","label":"absent PR interval"},"references":[{"id":"PMID:16037571","label":"Gaussin V","url":"http://www.ncbi.nlm.nih.gov/pubmed/16037571"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/24367e10-53eb-57c9-8138-893853178047","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3663711","label":"<Tg(GATA6-cre)>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * FVB]"},"phenotype":{"id":"MP:0003137","label":"abnormal impulse conducting system conduction"},"references":[{"id":"PMID:16037571","label":"Gaussin V","url":"http://www.ncbi.nlm.nih.gov/pubmed/16037571"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/1c1b6613-54f6-5bc9-8027-ff9c90b5c53b","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3663711","label":"<Tg(GATA6-cre)>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * FVB]"},"phenotype":{"id":"MP:0010614","label":"abnormal mitral valve cusp morphology"},"references":[{"id":"PMID:16037571","label":"Gaussin V","url":"http://www.ncbi.nlm.nih.gov/pubmed/16037571"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/34b7a485-4ef3-51b9-a1fd-2ef96ac94997","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3663711","label":"<Tg(GATA6-cre)>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * FVB]"},"phenotype":{"id":"MP:0002624","label":"abnormal tricuspid valve morphology"},"references":[{"id":"PMID:16037571","label":"Gaussin V","url":"http://www.ncbi.nlm.nih.gov/pubmed/16037571"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/32f9fe0a-ff5a-5312-9784-c1d15969b3e8","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3663711","label":"<Tg(GATA6-cre)>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * FVB]"},"phenotype":{"id":"MP:0005140","label":"decreased cardiac muscle contractility"},"references":[{"id":"PMID:16037571","label":"Gaussin V","url":"http://www.ncbi.nlm.nih.gov/pubmed/16037571"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/0d6e5b07-cba7-5aab-b983-866265f18f81","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3663711","label":"<Tg(GATA6-cre)>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * FVB]"},"phenotype":{"id":"MP:0006045","label":"mitral valve regurgitation"},"references":[{"id":"PMID:16037571","label":"Gaussin V","url":"http://www.ncbi.nlm.nih.gov/pubmed/16037571"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/f2a1096a-ee2f-5f33-9248-ff9a3268a7e4","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3687380","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; Kdr<tm1(cre)Sato>/Kdr<+> [involves: 129S1/Sv * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0005312","label":"pericardial effusion"},"references":[{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/97974d96-f1d3-5b45-a3d3-19f56d18d132","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3687380","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; Kdr<tm1(cre)Sato>/Kdr<+> [involves: 129S1/Sv * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0000298","label":"absent atrioventricular cushions"},"references":[{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/093765cf-0c76-5709-9f10-405341751067","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3687380","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; Kdr<tm1(cre)Sato>/Kdr<+> [involves: 129S1/Sv * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0003227","label":"abnormal vascular branching morphogenesis"},"references":[{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/759547cf-74c4-5d9f-a1e0-79c91bedc867","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3687380","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; Kdr<tm1(cre)Sato>/Kdr<+> [involves: 129S1/Sv * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0000259","label":"abnormal vascular development"},"references":[{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/c7c2f4fb-f45b-5321-8cef-d94cfbdf63d0","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3687380","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; Kdr<tm1(cre)Sato>/Kdr<+> [involves: 129S1/Sv * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0002725","label":"abnormal vein morphology"},"references":[{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/5ed94534-ec7a-5f33-8f40-603d59066d52","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3687380","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; Kdr<tm1(cre)Sato>/Kdr<+> [involves: 129S1/Sv * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0003229","label":"abnormal vitelline vasculature morphology"},"references":[{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/d7fb4b73-a8b4-5200-a59d-ac2a4cb35c73","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3687380","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; Kdr<tm1(cre)Sato>/Kdr<+> [involves: 129S1/Sv * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0001730","label":"embryonic growth arrest"},"references":[{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/45c7a413-c499-50bc-8c9e-fec73c7c2c11","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3687380","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; Kdr<tm1(cre)Sato>/Kdr<+> [involves: 129S1/Sv * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0005397","label":"hematopoietic system phenotype"},"references":[{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/17d7ca9d-cb35-502c-a002-e6e33a7c7a63","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3687380","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; Kdr<tm1(cre)Sato>/Kdr<+> [involves: 129S1/Sv * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0001914","label":"hemorrhage"},"references":[{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/749a037c-c4db-5be6-a986-02fbe2e2bca4","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3687380","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; Kdr<tm1(cre)Sato>/Kdr<+> [involves: 129S1/Sv * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0001634","label":"internal hemorrhage"},"references":[{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/e0a72d53-7450-5c3e-b652-e16c9a0f53b9","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3687380","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; Kdr<tm1(cre)Sato>/Kdr<+> [involves: 129S1/Sv * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0001722","label":"pale yolk sac"},"references":[{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/2732e095-c7d5-5fa4-bffc-6bfdc1cf3b7c","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3687380","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; Kdr<tm1(cre)Sato>/Kdr<+> [involves: 129S1/Sv * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0003717","label":"pallor"},"references":[{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/8b00bd1e-07fd-5d13-9ff5-0963f0657d0b","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3687380","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; Kdr<tm1(cre)Sato>/Kdr<+> [involves: 129S1/Sv * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0002188","label":"small heart"},"references":[{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/152ea244-201a-5f2a-a88f-df68944a00a8","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3687380","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; Kdr<tm1(cre)Sato>/Kdr<+> [involves: 129S1/Sv * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0003814","label":"vascular smooth muscle cell hypoplasia"},"references":[{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/e200de83-a906-53a0-852d-979b708f01e2","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3687380","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; Kdr<tm1(cre)Sato>/Kdr<+> [involves: 129S1/Sv * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0001718","label":"abnormal visceral yolk sac morphology"},"references":[{"id":"PMID:16887829","label":"Park C","url":"http://www.ncbi.nlm.nih.gov/pubmed/16887829"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/e952be0d-f292-5296-a43e-489a09249eb9","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3785772","label":"<Tg(Col2a1-cre)1Bhr>/<?>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * SJL]"},"phenotype":{"id":"MP:0010099","label":"abnormal thoracic cage shape"},"references":[{"id":"PMID:15781876","label":"Yoon BS","url":"http://www.ncbi.nlm.nih.gov/pubmed/15781876"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/418715b5-ed03-5cdc-974e-f66d67d9ca57","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:2181286","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm1Bhr> [involves: 129S7/SvEvBrd * Swiss]"},"phenotype":{"id":"MP:0001693","label":"failure of primitive streak formation"},"references":[{"id":"PMID:8543149","label":"Mishina Y","url":"http://www.ncbi.nlm.nih.gov/pubmed/8543149"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/ba389e8f-2680-5a1c-bafc-301fdd64bea6","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3574975","label":"<Tg(Six3-cre)69Frty>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [Not Specified]"},"phenotype":{"id":"MP:0005391","label":"vision/eye phenotype"},"references":[{"id":"PMID:15673568","label":"Murali D","url":"http://www.ncbi.nlm.nih.gov/pubmed/15673568"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/04d27da8-a0ee-5a85-980a-7061d4365637","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3574976","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Six3-cre)69Frty>/0; Bmpr1b<tm1Kml>/Bmpr1b<+> [involves: 129S/SvEv]"},"phenotype":{"id":"MP:0008056","label":"abnormal retinal ganglion cell morphology"},"references":[{"id":"PMID:15673568","label":"Murali D","url":"http://www.ncbi.nlm.nih.gov/pubmed/15673568"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/93b24cc3-c9d2-55aa-8315-46a163fe2361","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3574977","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; <Tg(Six3-cre)69Frty>/0 [involves: 129S/SvEv]"},"phenotype":{"id":"MP:0001286","label":"abnormal eye development"},"references":[{"id":"PMID:15673568","label":"Murali D","url":"http://www.ncbi.nlm.nih.gov/pubmed/15673568"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/36cd9b04-e195-52cd-8314-6a1f75c9fa4a","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3574977","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; <Tg(Six3-cre)69Frty>/0 [involves: 129S/SvEv]"},"phenotype":{"id":"MP:0001325","label":"abnormal retina morphology"},"references":[{"id":"PMID:15673568","label":"Murali D","url":"http://www.ncbi.nlm.nih.gov/pubmed/15673568"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/a997e5f6-1b36-5b6f-8b21-b1cc1579be15","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3574977","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; <Tg(Six3-cre)69Frty>/0 [involves: 129S/SvEv]"},"phenotype":{"id":"MP:0006072","label":"abnormal retinal apoptosis"},"references":[{"id":"PMID:15673568","label":"Murali D","url":"http://www.ncbi.nlm.nih.gov/pubmed/15673568"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/1e664167-6769-5872-a708-1792b32b9fe8","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3574977","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; <Tg(Six3-cre)69Frty>/0 [involves: 129S/SvEv]"},"phenotype":{"id":"MP:0005201","label":"abnormal retinal pigment epithelium morphology"},"references":[{"id":"PMID:15673568","label":"Murali D","url":"http://www.ncbi.nlm.nih.gov/pubmed/15673568"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/c045ae39-ee62-5e8e-a8c1-b4f0af26bc41","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3574977","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; <Tg(Six3-cre)69Frty>/0 [involves: 129S/SvEv]"},"phenotype":{"id":"MP:0001293","label":"anophthalmia"},"references":[{"id":"PMID:15673568","label":"Murali D","url":"http://www.ncbi.nlm.nih.gov/pubmed/15673568"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/e3eaa4d2-7a95-5bc6-9d3d-9eb8d4692866","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:4830265","label":"Bmpr1a<tm1Bhr>/Bmpr1a<+> [involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6]"},"phenotype":{"id":"MP:0002151","label":"abnormal neural tube morphology/development"},"references":[{"id":"PMID:20730911","label":"Leung AW","url":"http://www.ncbi.nlm.nih.gov/pubmed/20730911"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/c7dd2a2b-8f29-5e55-951d-6df3b94eedc8","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:4830265","label":"Bmpr1a<tm1Bhr>/Bmpr1a<+> [involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6]"},"phenotype":{"id":"MP:0002111","label":"abnormal tail morphology"},"references":[{"id":"PMID:20730911","label":"Leung AW","url":"http://www.ncbi.nlm.nih.gov/pubmed/20730911"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/e9980782-8e1a-5355-bbf4-ff9c232664fd","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:4830264","label":"Col2a1<tm1.1Ksec>/Col2a1<+>; Bmpr1a<tm1Bhr>/Bmpr1a<+> [involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6]"},"phenotype":{"id":"MP:0006198","label":"enophthalmos"},"references":[{"id":"PMID:20730911","label":"Leung AW","url":"http://www.ncbi.nlm.nih.gov/pubmed/20730911"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/1c8672d5-24f8-5a91-a2d7-926294e6d500","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:4830263","label":"Col2a1<tm1.1Ksec>/Col2a1<tm1.1Ksec>; Bmpr1a<tm1Bhr>/Bmpr1a<+> [involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6]"},"phenotype":{"id":"MP:0012085","label":"midface hypoplasia"},"references":[{"id":"PMID:20730911","label":"Leung AW","url":"http://www.ncbi.nlm.nih.gov/pubmed/20730911"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/7ed49d59-b48a-5ccc-bc93-88ec9098c2ff","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:4830263","label":"Col2a1<tm1.1Ksec>/Col2a1<tm1.1Ksec>; Bmpr1a<tm1Bhr>/Bmpr1a<+> [involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6]"},"phenotype":{"id":"MP:0005163","label":"cyclopia"},"references":[{"id":"PMID:20730911","label":"Leung AW","url":"http://www.ncbi.nlm.nih.gov/pubmed/20730911"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/38447d66-6efd-50b7-bda5-dd903a93efa7","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:4830263","label":"Col2a1<tm1.1Ksec>/Col2a1<tm1.1Ksec>; Bmpr1a<tm1Bhr>/Bmpr1a<+> [involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6]"},"phenotype":{"id":"MP:0000433","label":"microcephaly"},"references":[{"id":"PMID:20730911","label":"Leung AW","url":"http://www.ncbi.nlm.nih.gov/pubmed/20730911"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/8cc1208b-1f87-53ba-bdc1-9ca39fefacce","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:4830263","label":"Col2a1<tm1.1Ksec>/Col2a1<tm1.1Ksec>; Bmpr1a<tm1Bhr>/Bmpr1a<+> [involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6]"},"phenotype":{"id":"MP:0011101","label":"partial prenatal lethality"},"references":[{"id":"PMID:20730911","label":"Leung AW","url":"http://www.ncbi.nlm.nih.gov/pubmed/20730911"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/a993a9e2-310a-56e4-a066-dd163b95c1bd","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3663711","label":"<Tg(GATA6-cre)>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * FVB]"},"phenotype":{"id":"MP:0010536","label":"Ebstein's malformation of tricuspid valve"},"references":[{"id":"PMID:16037571","label":"Gaussin V","url":"http://www.ncbi.nlm.nih.gov/pubmed/16037571"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/2a25217c-1826-5977-9736-d197f58c131d","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3663711","label":"<Tg(GATA6-cre)>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd * C57BL/6 * FVB]"},"phenotype":{"id":"MP:0010622","label":"abnormal tricuspid valve cusp morphology"},"references":[{"id":"PMID:16037571","label":"Gaussin V","url":"http://www.ncbi.nlm.nih.gov/pubmed/16037571"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/67adbdb4-cfb2-5269-87ef-30c685a54bee","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:2181287","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm1Bhr> [129S7/SvEvBrd-Bmpr1a<tm1Bhr>]"},"phenotype":{"id":"MP:0003890","label":"abnormal embryonic-extraembryonic boundary morphology"},"references":[{"id":"PMID:8543149","label":"Mishina Y","url":"http://www.ncbi.nlm.nih.gov/pubmed/8543149"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/4318d02f-4746-5f62-9f3c-18df52148e1f","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:2181287","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm1Bhr> [129S7/SvEvBrd-Bmpr1a<tm1Bhr>]"},"phenotype":{"id":"MP:0001683","label":"absent mesoderm"},"references":[{"id":"PMID:8543149","label":"Mishina Y","url":"http://www.ncbi.nlm.nih.gov/pubmed/8543149"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/74fef2bf-3d31-5ebf-a3b3-1e4811529e4e","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:2181287","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm1Bhr> [129S7/SvEvBrd-Bmpr1a<tm1Bhr>]"},"phenotype":{"id":"MP:0011096","label":"complete embryonic lethality between implantation and somite formation"},"references":[{"id":"PMID:8543149","label":"Mishina Y","url":"http://www.ncbi.nlm.nih.gov/pubmed/8543149"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/4a8efff8-2576-5ee4-96d4-6217ac5f967d","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:2181350","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Pou3f4-cre)32Cren>/0 [involves: 129S7/SvEvBrd * CD-1]"},"phenotype":{"id":"MP:0002110","label":"abnormal digit morphology"},"references":[{"id":"PMID:11714671","label":"Ahn K","url":"http://www.ncbi.nlm.nih.gov/pubmed/11714671"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/6f6f459a-a892-528c-94bd-dc79733b7e71","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:2181350","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Pou3f4-cre)32Cren>/0 [involves: 129S7/SvEvBrd * CD-1]"},"phenotype":{"id":"MP:0000568","label":"ectopic digits"},"references":[{"id":"PMID:11714671","label":"Ahn K","url":"http://www.ncbi.nlm.nih.gov/pubmed/11714671"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/708f5db6-0006-599c-971a-dc85eb7809bb","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:2181350","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Pou3f4-cre)32Cren>/0 [involves: 129S7/SvEvBrd * CD-1]"},"phenotype":{"id":"MP:0000562","label":"polydactyly"},"references":[{"id":"PMID:11714671","label":"Ahn K","url":"http://www.ncbi.nlm.nih.gov/pubmed/11714671"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/f9145914-c7d7-5ec2-9579-a42b0d2b12f1","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:2181350","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Pou3f4-cre)32Cren>/0 [involves: 129S7/SvEvBrd * CD-1]"},"phenotype":{"id":"MP:0000564","label":"syndactyly"},"references":[{"id":"PMID:11714671","label":"Ahn K","url":"http://www.ncbi.nlm.nih.gov/pubmed/11714671"},{"id":"PMID:15492776","label":"Rountree RB","url":"http://www.ncbi.nlm.nih.gov/pubmed/15492776"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/8c0fdd4a-d7c2-5f3f-ac97-36caf752d9ac","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:2181329","label":"Bmpr1a<tm2.2Bhr>/Bmpr1a<tm2.2Bhr> [involves: 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0002080","label":"prenatal lethality"},"references":[{"id":"PMID:11857780","label":"Mishina Y","url":"http://www.ncbi.nlm.nih.gov/pubmed/11857780"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/4f3a8583-b9c8-5660-a7df-3a9ee18a073c","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:2181351","label":"<Tg(Pou3f4-cre)32Cren>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<+> [involves: 129S7/SvEvBrd * CD-1]"},"phenotype":{"id":"MP:0002169","label":"no abnormal phenotype detected"},"references":[{"id":"PMID:11714671","label":"Ahn K","url":"http://www.ncbi.nlm.nih.gov/pubmed/11714671"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/206961e1-ea57-59a6-a6af-f8f9b1d64b85","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:4941477","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(CAG-cre>/0 [involves: 129S7/SvEvBrd * C57BL/6 * CBA]"},"phenotype":{"id":"MP:0005390","label":"skeleton phenotype"},"references":[{"id":"PMID:21303853","label":"Stafford DA","url":"http://www.ncbi.nlm.nih.gov/pubmed/21303853"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/d855d353-6012-5b63-8dbb-92fd501f31b4","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3578783","label":"<Tg(Gdf5-cre-ALPP)1Kng>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.2Bhr> [involves: 129 * C57BL/6 * FVB/N-Tg(Gdf5-cre-ALPP)1Kng]"},"phenotype":{"id":"MP:0000018","label":"small ears"},"references":[{"id":"PMID:15492776","label":"Rountree RB","url":"http://www.ncbi.nlm.nih.gov/pubmed/15492776"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/11c237b4-1ac0-5bfe-9bc7-0aa8c6577f13","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3578783","label":"<Tg(Gdf5-cre-ALPP)1Kng>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.2Bhr> [involves: 129 * C57BL/6 * FVB/N-Tg(Gdf5-cre-ALPP)1Kng]"},"phenotype":{"id":"MP:0006433","label":"abnormal articular cartilage morphology"},"references":[{"id":"PMID:15492776","label":"Rountree RB","url":"http://www.ncbi.nlm.nih.gov/pubmed/15492776"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/f10a121d-0cc0-57df-976f-1cbd6f3ed08e","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3578783","label":"<Tg(Gdf5-cre-ALPP)1Kng>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.2Bhr> [involves: 129 * C57BL/6 * FVB/N-Tg(Gdf5-cre-ALPP)1Kng]"},"phenotype":{"id":"MP:0000997","label":"abnormal joint capsule morphology"},"references":[{"id":"PMID:15492776","label":"Rountree RB","url":"http://www.ncbi.nlm.nih.gov/pubmed/15492776"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/0c25ca77-06ce-55b8-892d-a25ab5db5caa","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3578783","label":"<Tg(Gdf5-cre-ALPP)1Kng>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.2Bhr> [involves: 129 * C57BL/6 * FVB/N-Tg(Gdf5-cre-ALPP)1Kng]"},"phenotype":{"id":"MP:0003189","label":"fused joints"},"references":[{"id":"PMID:15492776","label":"Rountree RB","url":"http://www.ncbi.nlm.nih.gov/pubmed/15492776"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/2354f8dd-f7f8-5722-a137-8e87f1f3fdb1","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3578783","label":"<Tg(Gdf5-cre-ALPP)1Kng>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.2Bhr> [involves: 129 * C57BL/6 * FVB/N-Tg(Gdf5-cre-ALPP)1Kng]"},"phenotype":{"id":"MP:0003560","label":"osteoarthritis"},"references":[{"id":"PMID:15492776","label":"Rountree RB","url":"http://www.ncbi.nlm.nih.gov/pubmed/15492776"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/d132a3bc-f89b-5636-9c9e-a771c08caf4f","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3578783","label":"<Tg(Gdf5-cre-ALPP)1Kng>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.2Bhr> [involves: 129 * C57BL/6 * FVB/N-Tg(Gdf5-cre-ALPP)1Kng]"},"phenotype":{"id":"MP:0000131","label":"abnormal long bone epiphysis morphology"},"references":[{"id":"PMID:15492776","label":"Rountree RB","url":"http://www.ncbi.nlm.nih.gov/pubmed/15492776"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/2ea2d82b-d860-5c20-b825-a9a16e7b2916","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3578783","label":"<Tg(Gdf5-cre-ALPP)1Kng>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.2Bhr> [involves: 129 * C57BL/6 * FVB/N-Tg(Gdf5-cre-ALPP)1Kng]"},"phenotype":{"id":"MP:0010053","label":"decreased grip strength"},"references":[{"id":"PMID:15492776","label":"Rountree RB","url":"http://www.ncbi.nlm.nih.gov/pubmed/15492776"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/616a4fbd-4de1-5e30-a547-62c094936039","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3578783","label":"<Tg(Gdf5-cre-ALPP)1Kng>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.2Bhr> [involves: 129 * C57BL/6 * FVB/N-Tg(Gdf5-cre-ALPP)1Kng]"},"phenotype":{"id":"MP:0005422","label":"osteosclerosis"},"references":[{"id":"PMID:15492776","label":"Rountree RB","url":"http://www.ncbi.nlm.nih.gov/pubmed/15492776"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/7528157f-0740-56f4-b7bf-ec11b92ed0f3","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:3046633","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre)40Smr>/<?> [involves: 129S7/SvEvBrd * C57BL/6J * SJL/J]"},"phenotype":{"id":"MP:0003813","label":"abnormal hair follicle dermal papilla morphology"},"references":[{"id":"PMID:15102710","label":"Andl T","url":"http://www.ncbi.nlm.nih.gov/pubmed/15102710"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/378821b3-0ff5-558f-804c-4813dfc61e74","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:5508218","label":"Krt14<tm1.1(cre)Wbm>/Krt14<+>; Ctnnb1<tm1Mmt>/Ctnnb1<+>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129P2/OlaHsd * 129S7/SvEvBrd * 129X1/SvJ]"},"phenotype":{"id":"MP:0012110","label":"increased hair follicle number"},"references":[{"id":"PMID:23736260","label":"Wend P","url":"http://www.ncbi.nlm.nih.gov/pubmed/23736260"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/b2105c12-5405-5a08-80d6-dfea919920ed","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:5508218","label":"Krt14<tm1.1(cre)Wbm>/Krt14<+>; Ctnnb1<tm1Mmt>/Ctnnb1<+>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129P2/OlaHsd * 129S7/SvEvBrd * 129X1/SvJ]"},"phenotype":{"id":"MP:0010318","label":"increased salivary gland tumor incidence"},"references":[{"id":"PMID:23736260","label":"Wend P","url":"http://www.ncbi.nlm.nih.gov/pubmed/23736260"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/c8bce1e2-9b73-5a90-8bf1-f3a06477d3ee","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:5508218","label":"Krt14<tm1.1(cre)Wbm>/Krt14<+>; Ctnnb1<tm1Mmt>/Ctnnb1<+>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129P2/OlaHsd * 129S7/SvEvBrd * 129X1/SvJ]"},"phenotype":{"id":"MP:0004207","label":"increased squamous cell carcinoma incidence"},"references":[{"id":"PMID:23736260","label":"Wend P","url":"http://www.ncbi.nlm.nih.gov/pubmed/23736260"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/7fd5647c-233a-54cc-ab68-3541b0120546","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:5508225","label":"Krt14<tm1.1(cre)Wbm>/Krt14<+>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129P2/OlaHsd * 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0002006","label":"tumorigenesis"},"references":[{"id":"PMID:23736260","label":"Wend P","url":"http://www.ncbi.nlm.nih.gov/pubmed/23736260"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/d332260d-6a41-5b60-8d36-b0907d0e2639","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:2181284","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm1Bhr> [involves: 129S7/SvEvBrd * C57BL/6]"},"phenotype":{"id":"MP:0011186","label":"abnormal visceral endoderm morphology"},"references":[{"id":"PMID:8543149","label":"Mishina Y","url":"http://www.ncbi.nlm.nih.gov/pubmed/8543149"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/db00ee0a-3cf8-5a3f-9553-be85616bf498","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:2181284","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm1Bhr> [involves: 129S7/SvEvBrd * C57BL/6]"},"phenotype":{"id":"MP:0002085","label":"abnormal embryonic tissue morphology"},"references":[{"id":"PMID:8543149","label":"Mishina Y","url":"http://www.ncbi.nlm.nih.gov/pubmed/8543149"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/b44f52e4-e237-51d1-b25d-9939e9940f46","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:2181284","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm1Bhr> [involves: 129S7/SvEvBrd * C57BL/6]"},"phenotype":{"id":"MP:0011191","label":"increased embryonic epiblast cell apoptosis"},"references":[{"id":"PMID:8543149","label":"Mishina Y","url":"http://www.ncbi.nlm.nih.gov/pubmed/8543149"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/9d1be7c6-5050-5dd1-9b40-59a955bf1055","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:2181284","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm1Bhr> [involves: 129S7/SvEvBrd * C57BL/6]"},"phenotype":{"id":"MP:0011190","label":"thick embryonic epiblast"},"references":[{"id":"PMID:8543149","label":"Mishina Y","url":"http://www.ncbi.nlm.nih.gov/pubmed/8543149"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/630bb11b-4761-5d48-b7cb-68494ede5a57","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:2181284","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm1Bhr> [involves: 129S7/SvEvBrd * C57BL/6]"},"phenotype":{"id":"MP:0011192","label":"decreased embryonic epiblast cell proliferation"},"references":[{"id":"PMID:8543149","label":"Mishina Y","url":"http://www.ncbi.nlm.nih.gov/pubmed/8543149"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"},{"id":"monarch:disco/9539e5c8-108b-520d-a0dd-9d33b311f754","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"inferred_from":{"type":"effective_genotype","id":"MGI:5305710","label":"Shh<tm1(EGFP/cre)Cjt>/Shh<?>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr> [involves: 129S7/SvEvBrd]"},"phenotype":{"id":"MP:0011100","label":"complete preweaning lethality"},"references":[{"id":"PMID:21068065","label":"Rodriguez P","url":"http://www.ncbi.nlm.nih.gov/pubmed/21068065"}],"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"resource":"nif-0000-00096-6"}],"phenotype_list":[{"id":"MP:0002789","label":"male pseudohermaphroditism","observed":"positive"},{"id":"MP:0001939","label":"secondary sex reversal","observed":"positive"},{"id":"MP:0003012","label":"no phenotypic analysis","observed":"positive"},{"id":"MP:0008069","label":"abnormal joint mobility","observed":"positive"},{"id":"MP:0003875","label":"abnormal hair follicle regression","observed":"positive"},{"id":"MP:0000383","label":"abnormal hair follicle orientation","observed":"positive"},{"id":"MP:0000377","label":"abnormal hair follicle morphology","observed":"positive"},{"id":"MP:0002073","label":"abnormal hair growth","observed":"positive"},{"id":"MP:0003809","label":"abnormal hair shaft morphology","observed":"positive"},{"id":"MP:0000579","label":"abnormal nail morphology","observed":"positive"},{"id":"MP:0002100","label":"abnormal tooth morphology","observed":"positive"},{"id":"MP:0000124","label":"absent teeth","observed":"positive"},{"id":"MP:0000414","label":"alopecia","observed":"positive"},{"id":"MP:0002083","label":"premature death","observed":"positive"},{"id":"MP:0001265","label":"decreased body size","observed":"positive"},{"id":"MP:0000380","label":"small hair follicles","observed":"positive"},{"id":"MP:0000452","label":"abnormal mouth morphology","observed":"positive"},{"id":"MP:0001436","label":"abnormal suckling behavior","observed":"positive"},{"id":"MP:0000116","label":"abnormal tooth development","observed":"positive"},{"id":"MP:0000557","label":"absent hindlimb","observed":"positive"},{"id":"MP:0001302","label":"eyelids open at birth","observed":"positive"},{"id":"MP:0011087","label":"complete neonatal lethality","observed":"positive"},{"id":"MP:0011085","label":"complete postnatal lethality","observed":"positive"},{"id":"MP:0002009","label":"preneoplasia","observed":"positive"},{"id":"MP:0000416","label":"sparse hair","observed":"positive"},{"id":"MP:0000164","label":"abnormal cartilage development","observed":"positive"},{"id":"MP:0000166","label":"abnormal chondrocyte morphology","observed":"positive"},{"id":"MP:0006280","label":"abnormal digit development","observed":"positive"},{"id":"MP:0006395","label":"abnormal epiphyseal plate morphology","observed":"positive"},{"id":"MP:0002825","label":"abnormal notochord morphology","observed":"positive"},{"id":"MP:0000552","label":"abnormal radius morphology","observed":"positive"},{"id":"MP:0005108","label":"abnormal ulna morphology","observed":"positive"},{"id":"MP:0005225","label":"abnormal vertebrae development","observed":"positive"},{"id":"MP:0004703","label":"abnormal vertebral column morphology","observed":"positive"},{"id":"MP:0002657","label":"chondrodystrophy","observed":"positive"},{"id":"MP:0008275","label":"failure of endochondral bone ossification","observed":"positive"},{"id":"MP:0011099","label":"complete lethality throughout fetal growth and development","observed":"positive"},{"id":"MP:0004200","label":"decreased fetal size","observed":"positive"},{"id":"MP:0000547","label":"short limbs","observed":"positive"},{"id":"MP:0000445","label":"short snout","observed":"positive"},{"id":"MP:0000592","label":"short tail","observed":"positive"},{"id":"MP:0001954","label":"respiratory distress","observed":"positive"},{"id":"MP:0002113","label":"abnormal skeleton development","observed":"positive"},{"id":"MP:0010103","label":"small thoracic cage","observed":"positive"},{"id":"MP:0004686","label":"decreased length of long bones","observed":"positive"},{"id":"MP:0000060","label":"delayed bone ossification","observed":"positive"},{"id":"MP:0002082","label":"postnatal lethality","observed":"positive"},{"id":"MP:0001176","label":"abnormal lung development","observed":"positive"},{"id":"MP:0006382","label":"abnormal lung epithelium morphology","observed":"positive"},{"id":"MP:0001175","label":"abnormal lung morphology","observed":"positive"},{"id":"MP:0002133","label":"abnormal respiratory system physiology","observed":"positive"},{"id":"MP:0010811","label":"decreased type II pneumocyte number","observed":"positive"},{"id":"MP:0005388","label":"respiratory system phenotype","observed":"positive"},{"id":"MP:0003817","label":"abnormal pituitary diverticulum morphology","observed":"positive"},{"id":"MP:0000266","label":"abnormal heart morphology","observed":"positive"},{"id":"MP:0003816","label":"abnormal pituitary gland development","observed":"positive"},{"id":"MP:0011098","label":"complete embryonic lethality during organogenesis","observed":"positive"},{"id":"MP:0001698","label":"decreased embryo size","observed":"positive"},{"id":"MP:0002896","label":"abnormal bone mineralization","observed":"positive"},{"id":"MP:0008271","label":"abnormal bone ossification","observed":"positive"},{"id":"MP:0003795","label":"abnormal bone structure","observed":"positive"},{"id":"MP:0008396","label":"abnormal osteoclast differentiation","observed":"positive"},{"id":"MP:0001541","label":"abnormal osteoclast physiology","observed":"positive"},{"id":"MP:0004985","label":"decreased osteoclast cell number","observed":"positive"},{"id":"MP:0004421","label":"enlarged parietal bone","observed":"positive"},{"id":"MP:0005605","label":"increased bone mass","observed":"positive"},{"id":"MP:0005508","label":"abnormal skeleton morphology","observed":"positive"},{"id":"MP:0001533","label":"abnormal skeleton physiology","observed":"positive"},{"id":"MP:0002633","label":"persistent truncus arteriosis","observed":"positive"},{"id":"MP:0003221","label":"abnormal cardiomyocyte apoptosis","observed":"positive"},{"id":"MP:0003567","label":"abnormal fetal cardiomyocyte proliferation","observed":"positive"},{"id":"MP:0000556","label":"abnormal hindlimb morphology","observed":"positive"},{"id":"MP:0000352","label":"decreased cell proliferation","observed":"positive"},{"id":"MP:0010512","label":"absent PR interval","observed":"positive"},{"id":"MP:0003137","label":"abnormal impulse conducting system conduction","observed":"positive"},{"id":"MP:0010614","label":"abnormal mitral valve cusp morphology","observed":"positive"},{"id":"MP:0002624","label":"abnormal tricuspid valve morphology","observed":"positive"},{"id":"MP:0005140","label":"decreased cardiac muscle contractility","observed":"positive"},{"id":"MP:0006045","label":"mitral valve regurgitation","observed":"positive"},{"id":"MP:0005312","label":"pericardial effusion","observed":"positive"},{"id":"MP:0000298","label":"absent atrioventricular cushions","observed":"positive"},{"id":"MP:0003227","label":"abnormal vascular branching morphogenesis","observed":"positive"},{"id":"MP:0000259","label":"abnormal vascular development","observed":"positive"},{"id":"MP:0002725","label":"abnormal vein morphology","observed":"positive"},{"id":"MP:0003229","label":"abnormal vitelline vasculature morphology","observed":"positive"},{"id":"MP:0001730","label":"embryonic growth arrest","observed":"positive"},{"id":"MP:0005397","label":"hematopoietic system phenotype","observed":"positive"},{"id":"MP:0001914","label":"hemorrhage","observed":"positive"},{"id":"MP:0001634","label":"internal hemorrhage","observed":"positive"},{"id":"MP:0001722","label":"pale yolk sac","observed":"positive"},{"id":"MP:0003717","label":"pallor","observed":"positive"},{"id":"MP:0002188","label":"small heart","observed":"positive"},{"id":"MP:0003814","label":"vascular smooth muscle cell hypoplasia","observed":"positive"},{"id":"MP:0001718","label":"abnormal visceral yolk sac morphology","observed":"positive"},{"id":"MP:0010099","label":"abnormal thoracic cage shape","observed":"positive"},{"id":"MP:0001693","label":"failure of primitive streak formation","observed":"positive"},{"id":"MP:0005391","label":"vision/eye phenotype","observed":"positive"},{"id":"MP:0008056","label":"abnormal retinal ganglion cell morphology","observed":"positive"},{"id":"MP:0001286","label":"abnormal eye development","observed":"positive"},{"id":"MP:0001325","label":"abnormal retina morphology","observed":"positive"},{"id":"MP:0006072","label":"abnormal retinal apoptosis","observed":"positive"},{"id":"MP:0005201","label":"abnormal retinal pigment epithelium morphology","observed":"positive"},{"id":"MP:0001293","label":"anophthalmia","observed":"positive"},{"id":"MP:0002151","label":"abnormal neural tube morphology/development","observed":"positive"},{"id":"MP:0002111","label":"abnormal tail morphology","observed":"positive"},{"id":"MP:0006198","label":"enophthalmos","observed":"positive"},{"id":"MP:0012085","label":"midface hypoplasia","observed":"positive"},{"id":"MP:0005163","label":"cyclopia","observed":"positive"},{"id":"MP:0000433","label":"microcephaly","observed":"positive"},{"id":"MP:0011101","label":"partial prenatal lethality","observed":"positive"},{"id":"MP:0010536","label":"Ebstein's malformation of tricuspid valve","observed":"positive"},{"id":"MP:0010622","label":"abnormal tricuspid valve cusp morphology","observed":"positive"},{"id":"MP:0003890","label":"abnormal embryonic-extraembryonic boundary morphology","observed":"positive"},{"id":"MP:0001683","label":"absent mesoderm","observed":"positive"},{"id":"MP:0011096","label":"complete embryonic lethality between implantation and somite formation","observed":"positive"},{"id":"MP:0002110","label":"abnormal digit morphology","observed":"positive"},{"id":"MP:0000568","label":"ectopic digits","observed":"positive"},{"id":"MP:0000562","label":"polydactyly","observed":"positive"},{"id":"MP:0000564","label":"syndactyly","observed":"positive"},{"id":"MP:0002080","label":"prenatal lethality","observed":"positive"},{"id":"MP:0002169","label":"no abnormal phenotype detected","observed":"positive"},{"id":"MP:0005390","label":"skeleton phenotype","observed":"positive"},{"id":"MP:0000018","label":"small ears","observed":"positive"},{"id":"MP:0006433","label":"abnormal articular cartilage morphology","observed":"positive"},{"id":"MP:0000997","label":"abnormal joint capsule morphology","observed":"positive"},{"id":"MP:0003189","label":"fused joints","observed":"positive"},{"id":"MP:0003560","label":"osteoarthritis","observed":"positive"},{"id":"MP:0000131","label":"abnormal long bone epiphysis morphology","observed":"positive"},{"id":"MP:0010053","label":"decreased grip strength","observed":"positive"},{"id":"MP:0005422","label":"osteosclerosis","observed":"positive"},{"id":"MP:0003813","label":"abnormal hair follicle dermal papilla morphology","observed":"positive"},{"id":"MP:0012110","label":"increased hair follicle number","observed":"positive"},{"id":"MP:0010318","label":"increased salivary gland tumor incidence","observed":"positive"},{"id":"MP:0004207","label":"increased squamous cell carcinoma incidence","observed":"positive"},{"id":"MP:0002006","label":"tumorigenesis","observed":"positive"},{"id":"MP:0011186","label":"abnormal visceral endoderm morphology","observed":"positive"},{"id":"MP:0002085","label":"abnormal embryonic tissue morphology","observed":"positive"},{"id":"MP:0011191","label":"increased embryonic epiblast cell apoptosis","observed":"positive"},{"id":"MP:0011190","label":"thick embryonic epiblast","observed":"positive"},{"id":"MP:0011192","label":"decreased embryonic epiblast cell proliferation","observed":"positive"},{"id":"MP:0011100","label":"complete preweaning lethality","observed":"positive"}],"genotype_associations":[{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3713546","label":"Bmpr1a<Gt(pU21)17Imeg>/Bmpr1a<?>"},"background":"involves: C57BL/6 * CBA","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3785771","label":"<Tg(Col2a1-cre)1Bhr>/<?>; Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>"},"background":"involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * SJL","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3785772","label":"<Tg(Col2a1-cre)1Bhr>/<?>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>"},"background":"involves: 129S7/SvEvBrd * C57BL/6 * SJL","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3811312","label":"<Tg(Sftpc-cre)1Blh>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>"},"background":"involves: 129S7/SvEvBrd * C57BL/6 * DBA/2 * ICR","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3811313","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; Bax<tm1Sjk>/Bax<tm1Sjk>; <Tg(Sftpc-cre)1Blh>/0"},"background":"involves: 129 * C57BL/6 * DBA/2 * ICR","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3811314","label":"<Tg(Sftpc-cre)1Blh>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<+>"},"background":"involves: 129S7/SvEvBrd * C57BL/6 * DBA/2 * ICR","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3811322","label":"<Tg(Sftpc-cre)1Blh>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<+>"},"background":"involves: 129S7/SvEvBrd * C57BL/6 * DBA/2","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3819176","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Cga-cre)3Sac>/0"},"background":"involves: 129S7/SvEvBrd * C57BL/6 * SJL","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3829249","label":"<Tg(Col1a1-cre>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>"},"background":"involves: 129S7/SvEvBrd","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:4830263","label":"Col2a1<tm1.1Ksec>/Col2a1<tm1.1Ksec>; Bmpr1a<tm1Bhr>/Bmpr1a<+>"},"background":"involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:4830264","label":"Col2a1<tm1.1Ksec>/Col2a1<+>; Bmpr1a<tm1Bhr>/Bmpr1a<+>"},"background":"involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:4830265","label":"Bmpr1a<tm1Bhr>/Bmpr1a<+>"},"background":"involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:4941477","label":"<Tg(CAG-cre>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>"},"background":"involves: 129S7/SvEvBrd * C57BL/6 * CBA","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:5318396","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; <Tg(Pou3f4-cre)32Cren>/0"},"background":"involves: 129S/SvEv * 129S7/SvEvBrd","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:5305710","label":"Shh<tm1(EGFP/cre)Cjt>/Shh<?>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>"},"background":"involves: 129S7/SvEvBrd","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:2181284","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm1Bhr>"},"background":"involves: 129S7/SvEvBrd * C57BL/6","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:2181285","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm1Bhr>"},"background":"B6.129S7-Bmpr1a<tm1Bhr>","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:2181286","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm1Bhr>"},"background":"involves: 129S7/SvEvBrd * Swiss","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:2181287","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm1Bhr>"},"background":"129S7/SvEvBrd-Bmpr1a<tm1Bhr>","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:2181329","label":"Bmpr1a<tm2.2Bhr>/Bmpr1a<tm2.2Bhr>"},"background":"involves: 129S7/SvEvBrd","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:2181350","label":"<Tg(Pou3f4-cre)32Cren>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>"},"background":"involves: 129S7/SvEvBrd * CD-1","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:2181351","label":"<Tg(Pou3f4-cre)32Cren>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<+>"},"background":"involves: 129S7/SvEvBrd * CD-1","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3687380","label":"Kdr<tm1(cre)Sato>/Kdr<+>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>"},"background":"involves: 129S1/Sv * 129S7/SvEvBrd","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3042225","label":"Amhr2<tm3(cre)Bhr>/Amhr2<+>; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>"},"background":"involves: 129S/SvEv * C57BL/6","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3046633","label":"<Tg(KRT14-cre)40Smr>/<?>; Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>"},"background":"involves: 129S7/SvEvBrd * C57BL/6J * SJL/J","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3046634","label":"<Tg(KRT14-cre)43Smr>/<?>; Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>"},"background":"involves: 129S7/SvEvBrd * C57BL/6J * SJL/J","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3046635","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre)52Smr>/0"},"background":"involves: 129S7/SvEvBrd * C57BL/6J * SJL/J","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3046636","label":"Bmpr1a<tm2Bhr>/Bmpr1a<tm2Bhr>; <Tg(KRT14-cre>/<?>"},"background":"involves: 129S7/SvEvBrd * C57BL/6","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3046637","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2Bhr>; <Tg(Pou3f4-cre)32Cren>/<?>"},"background":"involves: 129S7/SvEvBrd * C57BL/6 * CD-1","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3511788","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm1Bhr>"},"background":"involves: 129S7/SvEvBrd","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3574975","label":"Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Six3-cre)69Frty>/0"},"background":"Not Specified","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3574976","label":"<Tg(Six3-cre)69Frty>/0; Bmpr1b<tm1Kml>/Bmpr1b<+>; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>"},"background":"involves: 129S/SvEv","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3574977","label":"Bmpr1b<tm1Kml>/Bmpr1b<tm1Kml>; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>; <Tg(Six3-cre)69Frty>/0"},"background":"involves: 129S/SvEv","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3578783","label":"<Tg(Gdf5-cre-ALPP)1Kng>/0; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.2Bhr>"},"background":"involves: 129 * C57BL/6 * FVB/N-Tg(Gdf5-cre-ALPP)1Kng","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3625139","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.2Bhr>; Isl1<tm1(cre)Sev>/Isl1<+>"},"background":"involves: 129S4/SvJae * 129S7/SvEvBrd","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:3663711","label":"<Tg(GATA6-cre)>/0; Bmpr1a<tm1Bhr>/Bmpr1a<tm2.1Bhr>"},"background":"involves: 129S7/SvEvBrd * C57BL/6 * FVB","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:5508218","label":"Krt14<tm1.1(cre)Wbm>/Krt14<+>; Ctnnb1<tm1Mmt>/Ctnnb1<+>; Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>"},"background":"involves: 129P2/OlaHsd * 129S7/SvEvBrd * 129X1/SvJ","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/undefined","type":"Association","genotype":{"id":"MGI:5508225","label":"Bmpr1a<tm2.1Bhr>/Bmpr1a<tm2.1Bhr>; Krt14<tm1.1(cre)Wbm>/Krt14<+>"},"background":"involves: 129P2/OlaHsd * 129S7/SvEvBrd","genes":"Bmpr1a","references":[{}],"source":{"id":"nif-0000-00096-5","label":"MGI"},"resource":"nif-0000-00096-5"}],"alleles":[{"id":"monarch:disco/ce89b8b8-fbfe-5a2f-b2f3-8fb35b7a7f1c","type":"Association","variant":{"id":"MGI:3630316","label":"Gt(pU21)17Imeg","variant_type":{"label":"Insertion of gene trap vector"},"coordinates":{}},"references":[],"source":{"id":"nif-0000-00096-5","label":"MGI","col":"sequence_alteration"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/7d6e6c55-8c50-5f26-9016-844a7dbff533","type":"Association","variant":{"id":"MGI:2158390","label":"tm2.1Bhr","variant_type":{"label":"Insertion"},"coordinates":{}},"references":[],"source":{"id":"nif-0000-00096-5","label":"MGI","col":"sequence_alteration"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/195877ce-e712-5e0b-85f4-2880f33990b9","type":"Association","variant":{"id":"MGI:2158342","label":"tm1Bhr","variant_type":{"label":"Insertion"},"coordinates":{}},"references":[],"source":{"id":"nif-0000-00096-5","label":"MGI","col":"sequence_alteration"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/5296eb39-3ee5-58c0-8504-c9585293da09","type":"Association","variant":{"id":"MGI:2181295","label":"tm2.2Bhr","variant_type":{"label":"Intragenic deletion"},"coordinates":{}},"references":[],"source":{"id":"nif-0000-00096-5","label":"MGI","col":"sequence_alteration"},"resource":"nif-0000-00096-5"},{"id":"monarch:disco/65da7c88-9f56-59fa-8c15-8aa19e7357e0","type":"Association","variant":{"id":"MGI:2158343","label":"tm2Bhr","variant_type":{"label":"Insertion"},"coordinates":{}},"references":[],"source":{"id":"nif-0000-00096-5","label":"MGI","col":"sequence_alteration"},"resource":"nif-0000-00096-5"}],"orthologs":[{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:100561841","label":"bmpr1a"},"organism":"Anolis carolinensis","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:489077","label":"BMPR1A"},"organism":"Canis lupus familiaris","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:58145","label":"bmpr1aa"},"organism":"Danio rerio","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:447846","label":"bmpr1ab"},"organism":"Danio rerio","orthology_class":"Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:33753","label":"tkv"},"organism":"Drosophila melanogaster","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:100064367","label":"BMPR1A"},"organism":"Equus caballus","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:396308","label":"BMPR1A"},"organism":"Gallus gallus","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:657","label":"BMPR1A"},"organism":"Homo sapiens","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:696898","label":"BMPR1A"},"organism":"Macaca mulatta","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:100026839","label":"BMPR1A"},"organism":"Monodelphis domestica","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:12167","label":"Bmpr1b"},"organism":"Mus musculus","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:11482","label":"Acvrl1"},"organism":"Mus musculus","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:11477","label":"Acvr1"},"organism":"Mus musculus","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:11479","label":"Acvr1b"},"organism":"Mus musculus","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:269275","label":"Acvr1c"},"organism":"Mus musculus","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:11481","label":"Acvr2b"},"organism":"Mus musculus","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:21812","label":"Tgfbr1"},"organism":"Mus musculus","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:21813","label":"Tgfbr2"},"organism":"Mus musculus","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:11480","label":"Acvr2a"},"organism":"Mus musculus","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:110542","label":"Amhr2"},"organism":"Mus musculus","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:12168","label":"Bmpr2"},"organism":"Mus musculus","orthology_class":"Paralog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:450572","label":"BMPR1A"},"organism":"Pan troglodytes","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:81507","label":"Bmpr1a"},"organism":"Rattus norvegicus","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"},{"id":"monarch:disco/undefined","type":"Association","gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"ortholog":{"id":"NCBIGene:100169652","label":"BMPR1A"},"organism":"Sus scrofa","orthology_class":"Least Diverged Ortholog","source":{"id":"PANTHER","label":"PANTHER"},"resource":"nlx_84521-1"}],"interactions":[{"genea":{"id":"NCBIGene:12166","label":"Bmpr1a","taxon":{"id":"NCBITaxon:10090","label":"Mus musculus"}},"geneb":{"id":"NCBIGene:12387","label":"Ctnnb1","taxon":{"id":"NCBITaxon:10090","label":"Mus musculus"}},"interaction_type":{"label":"additive genetic interaction defined by inequality"},"interaction_detection":"genetic interference","references":[{"id":"PMID:20043884"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:12166","label":"Bmpr1a","taxon":{"id":"NCBITaxon:10090","label":"Mus musculus"}},"geneb":{"id":"NCBIGene:657","label":"BMPR1A","taxon":{"id":"NCBITaxon:9606","label":"Homo sapiens"}},"interaction_type":{"label":"physical association"},"interaction_detection":"affinity chromatography technology","references":[{"id":"PMID:20360068"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:12166","label":"Bmpr1a","taxon":{"id":"NCBITaxon:10090","label":"Mus musculus"}},"geneb":{"id":"NCBIGene:17131","label":"Smad7","taxon":{"id":"NCBITaxon:10090","label":"Mus musculus"}},"interaction_type":{"label":"physical association"},"interaction_detection":"affinity chromatography technology","references":[{"id":"PMID:20663871"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"},{"genea":{"id":"NCBIGene:12166","label":"Bmpr1a","taxon":{"id":"NCBITaxon:10090","label":"Mus musculus"}},"geneb":{"id":"NCBIGene:17130","label":"Smad6","taxon":{"id":"NCBITaxon:10090","label":"Mus musculus"}},"interaction_type":{"label":"physical association"},"interaction_detection":"affinity chromatography technology","references":[{"id":"PMID:20663871"}],"sources":[{"id":"nif-0000-00432-1","label":"BioGrid"}],"resource":"nif-0000-00432-1"}],"disease_associations":[{"disease":{"id":"OMIM:174900","label":"Juvenile Polyposis Syndrome"},"gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"references":[],"source":[{"id":"nlx_151671-2","label":"ClinVar"},{"id":"nif-0000-03216-7","label":"OMIM"},{"id":"nlx_31015-2","label":"KEGG"},{"id":"nif-0000-02683-4","label":"CTD"}],"association_type":"putative - via ortholog","model_gene":{"id":"NCBIGene:657","label":"BMPR1A"},"model_species":"Homo sapiens"},{"disease":{"id":"OMIM:610069","label":"Polyposis Syndrome, Hereditary Mixed, 2"},"gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"references":[],"source":[{"id":"nlx_151671-2","label":"ClinVar"},{"id":"nif-0000-03216-7","label":"OMIM"},{"id":"nlx_31015-2","label":"KEGG"},{"id":"nif-0000-02683-4","label":"CTD"}],"association_type":"putative - via ortholog","model_gene":{"id":"NCBIGene:657","label":"BMPR1A"},"model_species":"Homo sapiens"},{"disease":{"id":"ORPHANET:329971","label":"Generalized juvenile polyposis/juvenile polyposis coli"},"gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"references":[],"source":[{"id":"nif-0000-21306-2","label":"ORPHANET"}],"association_type":"putative - via ortholog","model_gene":{"id":"NCBIGene:657","label":"BMPR1A"},"model_species":"Homo sapiens"},{"disease":{"id":"ORPHANET:144","label":"Hereditary nonpolyposis colon cancer"},"gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"references":[],"source":[{"id":"nif-0000-21306-2","label":"ORPHANET"}],"association_type":"putative - via ortholog","model_gene":{"id":"NCBIGene:657","label":"BMPR1A"},"model_species":"Homo sapiens"},{"disease":{"id":"ORPHANET:157794","label":"Hereditary mixed polyposis syndrome"},"gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"references":[],"source":[{"id":"nif-0000-21306-2","label":"ORPHANET"}],"association_type":"putative - via ortholog","model_gene":{"id":"NCBIGene:657","label":"BMPR1A"},"model_species":"Homo sapiens"},{"disease":{"id":"ORPHANET:79076","label":"Juvenile polyposis of infancy"},"gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"references":[],"source":[{"id":"nif-0000-21306-2","label":"ORPHANET"}],"association_type":"putative - via ortholog","model_gene":{"id":"NCBIGene:657","label":"BMPR1A"},"model_species":"Homo sapiens"},{"disease":{"id":"MESH:D019465","label":"Craniofacial Abnormalities"},"gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"references":[],"source":[{"id":"nif-0000-02683-4","label":"CTD"}],"association_type":"putative - via ortholog","model_gene":{"id":"NCBIGene:657","label":"BMPR1A"},"model_species":"Homo sapiens"},{"disease":{"id":"MESH:D006223","label":"Hamartoma Syndrome, Multiple"},"gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"references":[],"source":[{"id":"nif-0000-02683-4","label":"CTD"}],"association_type":"putative - via ortholog","model_gene":{"id":"NCBIGene:657","label":"BMPR1A"},"model_species":"Homo sapiens"},{"disease":{"id":"MESH:D005124","label":"Eye Abnormalities"},"gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"references":[],"source":[{"id":"nif-0000-02683-4","label":"CTD"}],"association_type":"putative - via ortholog","model_gene":{"id":"NCBIGene:657","label":"BMPR1A"},"model_species":"Homo sapiens"},{"disease":{"id":"MESH:D052776","label":"Female Urogenital Diseases"},"gene":{"id":"NCBIGene:12166","label":"Bmpr1a"},"references":[],"source":[{"id":"nif-0000-02683-4","label":"CTD"}],"association_type":"putative - via ortholog","model_gene":{"id":"NCBIGene:657","label":"BMPR1A"},"model_species":"Homo sapiens"}],"analyze_phenotypes":"/analyze/phenotypes/?input_items=MP:0002789+MP:0001939+MP:0003012+MP:0008069+MP:0003875+MP:0000383+MP:0000377+MP:0002073+MP:0003809+MP:0000579+MP:0002100+MP:0000124+MP:0000414+MP:0002083+MP:0001265+MP:0000380+MP:0000452+MP:0001436+MP:0000116+MP:0000557+MP:0001302+MP:0011087+MP:0011085+MP:0002009+MP:0000416+MP:0000164+MP:0000166+MP:0006280+MP:0006395+MP:0002825+MP:0000552+MP:0005108+MP:0005225+MP:0004703+MP:0002657+MP:0008275+MP:0011099+MP:0004200+MP:0000547+MP:0000445+MP:0000592+MP:0001954+MP:0002113+MP:0010103+MP:0004686+MP:0000060+MP:0002082+MP:0001176+MP:0006382+MP:0001175+MP:0002133+MP:0010811+MP:0005388+MP:0003817+MP:0000266+MP:0003816+MP:0011098+MP:0001698+MP:0002896+MP:0008271+MP:0003795+MP:0008396+MP:0001541+MP:0004985+MP:0004421+MP:0005605+MP:0005508+MP:0001533+MP:0002633+MP:0003221+MP:0003567+MP:0000556+MP:0000352+MP:0010512+MP:0003137+MP:0010614+MP:0002624+MP:0005140+MP:0006045+MP:0005312+MP:0000298+MP:0003227+MP:0000259+MP:0002725+MP:0003229+MP:0001730+MP:0005397+MP:0001914+MP:0001634+MP:0001722+MP:0003717+MP:0002188+MP:0003814+MP:0001718+MP:0010099+MP:0001693+MP:0005391+MP:0008056+MP:0001286+MP:0001325+MP:0006072+MP:0005201+MP:0001293+MP:0002151+MP:0002111+MP:0006198+MP:0012085+MP:0005163+MP:0000433+MP:0011101+MP:0010536+MP:0010622+MP:0003890+MP:0001683+MP:0011096+MP:0002110+MP:0000568+MP:0000562+MP:0000564+MP:0002080+MP:0002169+MP:0005390+MP:0000018+MP:0006433+MP:0000997+MP:0003189+MP:0003560+MP:0000131+MP:0010053+MP:0005422+MP:0003813+MP:0012110+MP:0010318+MP:0004207+MP:0002006+MP:0011186+MP:0002085+MP:0011191+MP:0011190+MP:0011192+MP:0011100&limit=100&target_species=Mus musculus","annotation_sufficiency":0.8645966666666668,"literature":[{"type":"phenotype","obj":{"id":"MP:0002789","label":"male pseudohermaphroditism"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"12368913"},{"type":"phenotype","obj":{"id":"MP:0001939","label":"secondary sex reversal"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"12368913"},{"type":"phenotype","obj":{"id":"MP:0008069","label":"abnormal joint mobility"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15492776"},{"type":"phenotype","obj":{"id":"MP:0003875","label":"abnormal hair follicle regression"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0000383","label":"abnormal hair follicle orientation"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0000377","label":"abnormal hair follicle morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0002073","label":"abnormal hair growth"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0003809","label":"abnormal hair shaft morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0000579","label":"abnormal nail morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0002100","label":"abnormal tooth morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0000124","label":"absent teeth"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0000414","label":"alopecia"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0002083","label":"premature death"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0002083","label":"premature death"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"23736260"},{"type":"phenotype","obj":{"id":"MP:0001265","label":"decreased body size"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0000380","label":"small hair follicles"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0000452","label":"abnormal mouth morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0001436","label":"abnormal suckling behavior"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0000116","label":"abnormal tooth development"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0000557","label":"absent hindlimb"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0000557","label":"absent hindlimb"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"11714671"},{"type":"phenotype","obj":{"id":"MP:0001302","label":"eyelids open at birth"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0011087","label":"complete neonatal lethality"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0011085","label":"complete postnatal lethality"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0011085","label":"complete postnatal lethality"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16414041"},{"type":"phenotype","obj":{"id":"MP:0002009","label":"preneoplasia"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0000416","label":"sparse hair"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0000164","label":"abnormal cartilage development"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0000164","label":"abnormal cartilage development"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15492776"},{"type":"phenotype","obj":{"id":"MP:0000166","label":"abnormal chondrocyte morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0006280","label":"abnormal digit development"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0006395","label":"abnormal epiphyseal plate morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0002825","label":"abnormal notochord morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0000552","label":"abnormal radius morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0005108","label":"abnormal ulna morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0005225","label":"abnormal vertebrae development"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0004703","label":"abnormal vertebral column morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0002657","label":"chondrodystrophy"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0008275","label":"failure of endochondral bone ossification"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0011099","label":"complete lethality throughout fetal growth and development"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0004200","label":"decreased fetal size"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0000547","label":"short limbs"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0000445","label":"short snout"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0000592","label":"short tail"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0001954","label":"respiratory distress"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0001954","label":"respiratory distress"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16414041"},{"type":"phenotype","obj":{"id":"MP:0002113","label":"abnormal skeleton development"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0002113","label":"abnormal skeleton development"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15492776"},{"type":"phenotype","obj":{"id":"MP:0010103","label":"small thoracic cage"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0004686","label":"decreased length of long bones"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0000060","label":"delayed bone ossification"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0002082","label":"postnatal lethality"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0001176","label":"abnormal lung development"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16414041"},{"type":"phenotype","obj":{"id":"MP:0006382","label":"abnormal lung epithelium morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16414041"},{"type":"phenotype","obj":{"id":"MP:0001175","label":"abnormal lung morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16414041"},{"type":"phenotype","obj":{"id":"MP:0002133","label":"abnormal respiratory system physiology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16414041"},{"type":"phenotype","obj":{"id":"MP:0010811","label":"decreased type II pneumocyte number"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16414041"},{"type":"phenotype","obj":{"id":"MP:0005388","label":"respiratory system phenotype"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16414041"},{"type":"phenotype","obj":{"id":"MP:0003817","label":"abnormal pituitary diverticulum morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"17359964"},{"type":"phenotype","obj":{"id":"MP:0000266","label":"abnormal heart morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"17359964"},{"type":"phenotype","obj":{"id":"MP:0003816","label":"abnormal pituitary gland development"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"17359964"},{"type":"phenotype","obj":{"id":"MP:0011098","label":"complete embryonic lethality during organogenesis"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"17359964"},{"type":"phenotype","obj":{"id":"MP:0011098","label":"complete embryonic lethality during organogenesis"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16556916"},{"type":"phenotype","obj":{"id":"MP:0011098","label":"complete embryonic lethality during organogenesis"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0001698","label":"decreased embryo size"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"17359964"},{"type":"phenotype","obj":{"id":"MP:0001698","label":"decreased embryo size"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0001698","label":"decreased embryo size"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"8543149"},{"type":"phenotype","obj":{"id":"MP:0002896","label":"abnormal bone mineralization"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"18927151"},{"type":"phenotype","obj":{"id":"MP:0008271","label":"abnormal bone ossification"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"18927151"},{"type":"phenotype","obj":{"id":"MP:0003795","label":"abnormal bone structure"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"18927151"},{"type":"phenotype","obj":{"id":"MP:0008396","label":"abnormal osteoclast differentiation"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"18927151"},{"type":"phenotype","obj":{"id":"MP:0001541","label":"abnormal osteoclast physiology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"18927151"},{"type":"phenotype","obj":{"id":"MP:0004985","label":"decreased osteoclast cell number"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"18927151"},{"type":"phenotype","obj":{"id":"MP:0004421","label":"enlarged parietal bone"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"18927151"},{"type":"phenotype","obj":{"id":"MP:0005605","label":"increased bone mass"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"18927151"},{"type":"phenotype","obj":{"id":"MP:0005508","label":"abnormal skeleton morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"18927151"},{"type":"phenotype","obj":{"id":"MP:0001533","label":"abnormal skeleton physiology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"18927151"},{"type":"phenotype","obj":{"id":"MP:0002633","label":"persistent truncus arteriosis"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16556916"},{"type":"phenotype","obj":{"id":"MP:0003221","label":"abnormal cardiomyocyte apoptosis"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16556916"},{"type":"phenotype","obj":{"id":"MP:0003567","label":"abnormal fetal cardiomyocyte proliferation"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16556916"},{"type":"phenotype","obj":{"id":"MP:0000556","label":"abnormal hindlimb morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16556916"},{"type":"phenotype","obj":{"id":"MP:0000556","label":"abnormal hindlimb morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"11714671"},{"type":"phenotype","obj":{"id":"MP:0000352","label":"decreased cell proliferation"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16556916"},{"type":"phenotype","obj":{"id":"MP:0010512","label":"absent PR interval"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16037571"},{"type":"phenotype","obj":{"id":"MP:0003137","label":"abnormal impulse conducting system conduction"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16037571"},{"type":"phenotype","obj":{"id":"MP:0010614","label":"abnormal mitral valve cusp morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16037571"},{"type":"phenotype","obj":{"id":"MP:0002624","label":"abnormal tricuspid valve morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16037571"},{"type":"phenotype","obj":{"id":"MP:0005140","label":"decreased cardiac muscle contractility"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16037571"},{"type":"phenotype","obj":{"id":"MP:0006045","label":"mitral valve regurgitation"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16037571"},{"type":"phenotype","obj":{"id":"MP:0005312","label":"pericardial effusion"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0000298","label":"absent atrioventricular cushions"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0003227","label":"abnormal vascular branching morphogenesis"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0000259","label":"abnormal vascular development"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0002725","label":"abnormal vein morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0003229","label":"abnormal vitelline vasculature morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0001730","label":"embryonic growth arrest"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0005397","label":"hematopoietic system phenotype"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0001914","label":"hemorrhage"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0001634","label":"internal hemorrhage"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0001722","label":"pale yolk sac"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0003717","label":"pallor"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0002188","label":"small heart"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0003814","label":"vascular smooth muscle cell hypoplasia"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0001718","label":"abnormal visceral yolk sac morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16887829"},{"type":"phenotype","obj":{"id":"MP:0010099","label":"abnormal thoracic cage shape"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15781876"},{"type":"phenotype","obj":{"id":"MP:0001693","label":"failure of primitive streak formation"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"8543149"},{"type":"phenotype","obj":{"id":"MP:0005391","label":"vision/eye phenotype"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15673568"},{"type":"phenotype","obj":{"id":"MP:0008056","label":"abnormal retinal ganglion cell morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15673568"},{"type":"phenotype","obj":{"id":"MP:0001286","label":"abnormal eye development"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15673568"},{"type":"phenotype","obj":{"id":"MP:0001325","label":"abnormal retina morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15673568"},{"type":"phenotype","obj":{"id":"MP:0006072","label":"abnormal retinal apoptosis"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15673568"},{"type":"phenotype","obj":{"id":"MP:0005201","label":"abnormal retinal pigment epithelium morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15673568"},{"type":"phenotype","obj":{"id":"MP:0001293","label":"anophthalmia"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15673568"},{"type":"phenotype","obj":{"id":"MP:0002151","label":"abnormal neural tube morphology/development"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"20730911"},{"type":"phenotype","obj":{"id":"MP:0002111","label":"abnormal tail morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"20730911"},{"type":"phenotype","obj":{"id":"MP:0006198","label":"enophthalmos"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"20730911"},{"type":"phenotype","obj":{"id":"MP:0012085","label":"midface hypoplasia"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"20730911"},{"type":"phenotype","obj":{"id":"MP:0005163","label":"cyclopia"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"20730911"},{"type":"phenotype","obj":{"id":"MP:0000433","label":"microcephaly"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"20730911"},{"type":"phenotype","obj":{"id":"MP:0011101","label":"partial prenatal lethality"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"20730911"},{"type":"phenotype","obj":{"id":"MP:0010536","label":"Ebstein's malformation of tricuspid valve"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16037571"},{"type":"phenotype","obj":{"id":"MP:0010622","label":"abnormal tricuspid valve cusp morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"16037571"},{"type":"phenotype","obj":{"id":"MP:0003890","label":"abnormal embryonic-extraembryonic boundary morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"8543149"},{"type":"phenotype","obj":{"id":"MP:0001683","label":"absent mesoderm"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"8543149"},{"type":"phenotype","obj":{"id":"MP:0011096","label":"complete embryonic lethality between implantation and somite formation"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"8543149"},{"type":"phenotype","obj":{"id":"MP:0002110","label":"abnormal digit morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"11714671"},{"type":"phenotype","obj":{"id":"MP:0000568","label":"ectopic digits"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"11714671"},{"type":"phenotype","obj":{"id":"MP:0000562","label":"polydactyly"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"11714671"},{"type":"phenotype","obj":{"id":"MP:0000564","label":"syndactyly"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"11714671"},{"type":"phenotype","obj":{"id":"MP:0000564","label":"syndactyly"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15492776"},{"type":"phenotype","obj":{"id":"MP:0002080","label":"prenatal lethality"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"11857780"},{"type":"phenotype","obj":{"id":"MP:0002169","label":"no abnormal phenotype detected"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"11714671"},{"type":"phenotype","obj":{"id":"MP:0005390","label":"skeleton phenotype"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"21303853"},{"type":"phenotype","obj":{"id":"MP:0000018","label":"small ears"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15492776"},{"type":"phenotype","obj":{"id":"MP:0006433","label":"abnormal articular cartilage morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15492776"},{"type":"phenotype","obj":{"id":"MP:0000997","label":"abnormal joint capsule morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15492776"},{"type":"phenotype","obj":{"id":"MP:0003189","label":"fused joints"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15492776"},{"type":"phenotype","obj":{"id":"MP:0003560","label":"osteoarthritis"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15492776"},{"type":"phenotype","obj":{"id":"MP:0000131","label":"abnormal long bone epiphysis morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15492776"},{"type":"phenotype","obj":{"id":"MP:0010053","label":"decreased grip strength"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15492776"},{"type":"phenotype","obj":{"id":"MP:0005422","label":"osteosclerosis"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15492776"},{"type":"phenotype","obj":{"id":"MP:0003813","label":"abnormal hair follicle dermal papilla morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"15102710"},{"type":"phenotype","obj":{"id":"MP:0012110","label":"increased hair follicle number"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"23736260"},{"type":"phenotype","obj":{"id":"MP:0010318","label":"increased salivary gland tumor incidence"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"23736260"},{"type":"phenotype","obj":{"id":"MP:0004207","label":"increased squamous cell carcinoma incidence"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"23736260"},{"type":"phenotype","obj":{"id":"MP:0002006","label":"tumorigenesis"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"23736260"},{"type":"phenotype","obj":{"id":"MP:0011186","label":"abnormal visceral endoderm morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"8543149"},{"type":"phenotype","obj":{"id":"MP:0002085","label":"abnormal embryonic tissue morphology"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"8543149"},{"type":"phenotype","obj":{"id":"MP:0011191","label":"increased embryonic epiblast cell apoptosis"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"8543149"},{"type":"phenotype","obj":{"id":"MP:0011190","label":"thick embryonic epiblast"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"8543149"},{"type":"phenotype","obj":{"id":"MP:0011192","label":"decreased embryonic epiblast cell proliferation"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"8543149"},{"type":"phenotype","obj":{"id":"MP:0011100","label":"complete preweaning lethality"},"source":{"id":"nif-0000-00096-6","label":"MGI","annotation_entity":"effective_genotype"},"pub":"21068065"},{"type":"gene","pub":"20043884"},{"type":"gene","pub":"20360068"},{"type":"gene","pub":"20663871"},{"type":"gene","pub":"20663871"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17391983"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"7671812"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23292934"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12805214"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"9876182"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"3268409"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"1793820"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"9851982"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"8605036"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"7937936"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"7750489"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"7818535"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"8592941"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"8065329"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"8543149"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"9547239"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"8889548"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"8674409"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"8707881"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"9303341"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"9207184"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"9268344"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12783783"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11701996"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11042159"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10631181"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10349636"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10512203"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10922068"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10725249"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"10749566"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11698278"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11217851"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11076861"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11171689"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11544199"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11401393"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11511541"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12666204"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12354394"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11857780"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11714671"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11854453"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12351174"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"11884477"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12141440"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12654290"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12421925"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12368913"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12399319"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12520002"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12466851"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12477932"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17359964"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15716346"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15102710"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"14633973"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"14574412"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12904583"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"12923052"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"14610273"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"14584896"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"14610062"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15090551"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"14701881"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"14656471"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"14681479"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15084466"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15064755"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15073157"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15673568"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15378062"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15136140"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15124223"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15136139"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15342483"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15289457"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15322331"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15582152"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15492776"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15469980"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15489334"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15558476"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15531373"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15556938"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17339028"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16414041"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15969004"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15840001"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15752764"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15781876"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15963767"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15897891"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"15913604"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16324690"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16127465"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16037571"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16049014"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16314491"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16141072"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16141073"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17301089"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16622178"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16537572"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16432712"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16481421"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16604073"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16556916"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16602821"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17065231"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16809539"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16630606"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16783635"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16959237"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16887829"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"16943278"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23197713"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20043884"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18498827"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17967808"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17605791"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17588538"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17537800"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17553962"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17928452"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17699604"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17626200"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17678919"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17913790"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17804727"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17823941"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18483623"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18233958"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18079409"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"17998461"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18000065"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18178801"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18087045"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18159948"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18449905"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18272594"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18243104"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18258849"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18322278"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18272846"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18287559"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19874086"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19246680"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18684091"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18579678"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18501628"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18543407"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18667463"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18594511"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18614674"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19224984"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18974875"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18799693"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"18927151"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19211807"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19141668"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19153163"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19812316"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19442313"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19358156"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19272526"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19327734"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19416967"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19369394"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19393343"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19804412"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19726563"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19592576"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19717734"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19793892"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19733164"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"19793887"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23103586"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21194568"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20522595"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20059955"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20360068"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20211162"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20130193"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20130285"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20493948"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20406889"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20363875"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20392740"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20445055"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20413717"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20417197"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21185278"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20730911"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20621052"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20534673"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20554972"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20724449"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20663871"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20689554"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21084449"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21034733"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20837004"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"20875817"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21068310"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21056086"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21068065"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23077214"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21786321"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21415412"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21273545"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21223962"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21394823"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21303850"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21303853"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21763800"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21571370"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21542012"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21571225"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21731673"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21613322"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21677750"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22872577"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22485132"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22036911"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21841161"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"21848994"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22306733"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22076636"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22170575"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22860096"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22729085"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22560297"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22698281"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22773757"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22729646"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"22761317"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23708139"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24680892"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23676271"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23485971"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23341776"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23360989"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23604909"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23560082"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23584254"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24657641"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24098149"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23776616"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23712751"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23736260"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24081330"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"23891934"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24048844"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24632946"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24398041"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24116187"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24163588"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24601881"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24491691"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24501215"},{"type":"gene","obj":{"id":"NCBIGene:12166","label":"Bmpr1a"},"source":{"id":"nif-0000-02801-2","label":"NCBI"},"pub":"24731097"}],"pmidinfo":[{"pmid":"15781876","pmcid":null,"title":"Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo.","authors":["Yoon BS","Ovchinnikov DA","Yoshii I","Mishina Y","Behringer RR","Lyons KM"],"grantIds":["AR42919","AR44528","NHLBI-T32-69766","R01 AR044528"],"grantAgencies":["NIAMS NIH HHS","NIAMS NIH HHS","NHLBI NIH HHS","NIAMS NIH HHS"],"retractions":[],"journal":"Proceedings of the National Academy of Sciences of the United States of America","journalShort":"Proc. Natl. Acad. Sci. U.S.A.","day":5,"month":4,"year":2005,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Cell Differentiation","Chondrocytes","Chondrogenesis","DNA-Binding Proteins","Extracellular Matrix","Gene Expression Regulation, Developmental","High Mobility Group Proteins","Mice","Mice, Knockout","Nuclear Proteins","Osteochondrodysplasias","Phenotype","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","SOX9 Transcription Factor","SOXD Transcription Factors","Signal Transduction","Transcription Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Previous studies have demonstrated the ability of bone morphogenetic proteins (BMPs) to promote chondrogenic differentiation in vitro. However, the in vivo role of BMP signaling during chondrogenesis has been unclear. We report here that BMP signaling is essential for multiple aspects of early chondrogenesis. Whereas mice deficient in type 1 receptors Bmpr1a or Bmpr1b in cartilage are able to form intact cartilaginous elements, double mutants develop a severe generalized chondrodysplasia. The majority of skeletal elements that form through endochondral ossification are absent, and the ones that form are rudimentary. The few cartilage condensations that form in double mutants are delayed in the prechondrocytic state and never form an organized growth plate. The reduced size of mutant condensations results from increased apoptosis and decreased proliferation. Moreover, the expression of cartilage-specific extracellular matrix proteins is severely reduced in mutant elements. We demonstrate that this defect in chondrocytic differentiation can be attributed to lack of Sox9, L-Sox5, and Sox6 expression in precartilaginous condensations in double mutants. In summary, our study demonstrates that BMPR1A and BMPR1B are functionally redundant during early chondrogenesis and that BMP signaling is required for chondrocyte proliferation, survival, and differentiation in vivo.","affiliation":[]},{"pmid":"15492776","pmcid":"523229","title":"BMP receptor signaling is required for postnatal maintenance of articular cartilage.","authors":["Rountree RB","Schoor M","Chen H","Marks ME","Harley V","Mishina Y","Kingsley DM"],"grantIds":["R37 AR042236"],"grantAgencies":["NIAMS NIH HHS"],"retractions":[],"journal":"PLoS biology","journalShort":"PLoS Biol.","day":19,"month":11,"year":2004,"meshHeadings":["Alleles","Animals","Apoptosis","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cartilage","Cartilage, Articular","Cell Proliferation","Chromosomes, Artificial, Bacterial","Gene Expression Regulation, Developmental","Genetic Variation","Growth Differentiation Factor 5","Inflammation","Integrases","Joints","Mice","Mice, Inbred C57BL","Mice, Transgenic","Molecular Sequence Data","Mutation","Osteoarthritis","Phenotype","Recombination, Genetic","Risk Factors","Signal Transduction","Synovial Membrane","Time Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Articular cartilage plays an essential role in health and mobility, but is frequently damaged or lost in millions of people that develop arthritis. The molecular mechanisms that create and maintain this thin layer of cartilage that covers the surface of bones in joint regions are poorly understood, in part because tools to manipulate gene expression specifically in this tissue have not been available. Here we use regulatory information from the mouse Gdf5 gene (a bone morphogenetic protein [BMP] family member) to develop new mouse lines that can be used to either activate or inactivate genes specifically in developing joints. Expression of Cre recombinase from Gdf5 bacterial artificial chromosome clones leads to specific activation or inactivation of floxed target genes in developing joints, including early joint interzones, adult articular cartilage, and the joint capsule. We have used this system to test the role of BMP receptor signaling in joint development. Mice with null mutations in Bmpr1a are known to die early in embryogenesis with multiple defects. However, combining a floxed Bmpr1a allele with the Gdf5-Cre driver bypasses this embryonic lethality, and leads to birth and postnatal development of mice missing the Bmpr1a gene in articular regions. Most joints in the body form normally in the absence of Bmpr1a receptor function. However, articular cartilage within the joints gradually wears away in receptor-deficient mice after birth in a process resembling human osteoarthritis. Gdf5-Cre mice provide a general system that can be used to test the role of genes in articular regions. BMP receptor signaling is required not only for early development and creation of multiple tissues, but also for ongoing maintenance of articular cartilage after birth. Genetic variation in the strength of BMP receptor signaling may be an important risk factor in human osteoarthritis, and treatments that mimic or augment BMP receptor signaling should be investigated as a possible therapeutic strategy for maintaining the health of joint linings.","affiliation":[]},{"pmid":"16414041","pmcid":null,"title":"Evidence that autocrine signaling through Bmpr1a regulates the proliferation, survival and morphogenetic behavior of distal lung epithelial cells.","authors":["Eblaghie MC","Reedy M","Oliver T","Mishina Y","Hogan BL"],"grantIds":["AR14317","HL080517"],"grantAgencies":["NIAMS NIH HHS","NHLBI NIH HHS","Intramural NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":1,"month":3,"year":2006,"meshHeadings":["Animals","Apoptosis","Autocrine Communication","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Differentiation","Cell Proliferation","Cell Survival","Endoderm","Fibroblast Growth Factors","Lung","Mice","Mice, Inbred C57BL","Mice, Inbred ICR","Mice, Mutant Strains","Morphogenesis","Mutation","Respiratory Mucosa","Tissue Culture Techniques","bcl-2-Associated X Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Lung development requires reciprocal epithelial/mesenchymal interactions, mediated by signaling factors such as Bmps made in both cell populations. To address the role of Bmp signaling in the epithelium, we have exploited the fact that Bmp receptor type Ia (Alk3) is expressed in the epithelium during branching morphogenesis. Deletion of Bmpr1a in the epithelium with an Sftpc-cre transgene leads to dramatic defects in lung development. There is reduced epithelial proliferation, extensive apoptosis, changes in cell morphology and extrusion of cells into the lumen. By E18.5, there are fewer Type II cells than normal, and the lung contains large fluid-filled spaces. If cell death is prevented by making embryos homozygous null for the proapoptotic gene, Bax, the epithelial cells that are rescued can apparently differentiate, but normal morphogenesis is not restored. To determine whether Bmps made by the epithelium can function in an autocrine manner, mesenchyme-free endoderm was cultured in Matrigel with Fgfs. Under these conditions, the mutant epithelium fails to undergo secondary budding. Abnormal development was also seen when Bmp4 was specifically deleted in the epithelium using the Sftpc-cre transgene. Our results support a model in which Bmp signaling primarily regulates the proliferation, survival and morphogenetic behavior of distal lung epithelial cells.","affiliation":[]},{"pmid":"17359964","pmcid":null,"title":"Noggin regulates Bmp4 activity during pituitary induction.","authors":["Davis SW","Camper SA"],"grantIds":["R01 HD034283","R01HD34283","R37 HD030428","R37HD30428","T32 HD07048"],"grantAgencies":["NICHD NIH HHS","NICHD NIH HHS","NICHD NIH HHS","NICHD NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":1,"month":5,"year":2007,"meshHeadings":["Animals","Bone Morphogenetic Protein 4","Bone Morphogenetic Proteins","Carrier Proteins","Cell Differentiation","Cell Proliferation","Embryonic Induction","Gene Expression Regulation, Developmental","Immunohistochemistry","Mice","Mice, Knockout","Pituitary Gland","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein (Bmp) signaling is critical for the development and patterning of the mouse pituitary from the initial induction of Rathke's pouch to cell specification in the anterior lobe. We examined the regulation of Bmp signaling during pituitary development by analyzing null embryos for noggin, a Bmp 2 and 4 antagonist. Noggin is expressed in the ventral diencephalon during Rathke's pouch induction, in the underlying cartilage plate during cell specification and in the adult anterior pituitary gland. Noggin null embryos have a variable pituitary phenotype, which ranges from a rostrally displaced Rathke's pouch to induction of secondary pituitary tissue. While cell specification in the anterior pituitary appears normal, patterning in the ventral diencephalon is disrupted; Bmp4 activity is expanded resulting in Fibroblast growth factor 10 repression and in a rostral shift in the boundary between the Bmp4 and Sonic hedgehog expression domains. The expanded domain of Bmp4 activity also results in additional invaginations of oral ectoderm and can shift the position of Rathke's pouch or create secondary pituitary tissue. This work demonstrates the importance of attenuating the activity of Bmp signaling during pituitary induction in order to maintain the proper balance of signaling factors necessary for pituitary organogenesis.","affiliation":[]},{"pmid":"16556916","pmcid":null,"title":"Isl1Cre reveals a common Bmp pathway in heart and limb development.","authors":["Yang L","Cai CL","Lin L","Qyang Y","Chung C","Monteiro RM","Mummery CL","Fishman GI","Cogen A","Evans S"],"grantIds":["R01 HL070867","R01 HL074066"],"grantAgencies":["NHLBI NIH HHS","NHLBI NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":24,"month":4,"year":2006,"meshHeadings":["Animals","Base Sequence","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Down-Regulation","Extremities","Heart","Heart Defects, Congenital","Homeodomain Proteins","LIM-Homeodomain Proteins","Mice","Mice, Knockout","Mice, Mutant Strains","Molecular Sequence Data","Nerve Tissue Proteins","Phenotype","Promoter Regions, Genetic","Signal Transduction","T-Box Domain Proteins","Transcription Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"A number of human congenital disorders present with both heart and limb defects, consistent with common genetic pathways. We have recently shown that the LIM homeodomain transcription factor islet 1 (Isl1) marks a subset of cardiac progenitors. Here, we perform lineage studies with an Isl1Cre mouse line to demonstrate that Isl1 also marks a subset of limb progenitors. In both cardiac and limb progenitors, Isl1 expression is downregulated as progenitors migrate in to form either heart or limb. To investigate common heart-limb pathways in Isl1-expressing progenitors, we ablated the Type I Bmp receptor, Bmpr1a utilizing Isl1Cre/+. Analysis of consequent heart and limb phenotypes has revealed novel requirements for Bmp signaling. Additionally, we find that Bmp signaling in Isl1-expressing progenitors is required for expression of T-box transcription factors Tbx2 and Tbx3 in heart and limb. Tbx3 is required for heart and limb formation, and is mutated in ulnar-mammary syndrome. We provide evidence that the Tbx3 promoter is directly regulated by Bmp Smads in vivo.","affiliation":[]},{"pmid":"23736260","pmcid":null,"title":"Wnt/-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours.","authors":["Wend P","Fang L","Zhu Q","Schipper JH","Loddenkemper C","Kosel F","Brinkmann V","Eckert K","Hindersin S","Holland JD","Lehr S","Kahn M","Ziebold U","Birchmeier W"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"The EMBO journal","journalShort":"EMBO J.","day":17,"month":7,"year":2013,"meshHeadings":["Animals","Bicyclo Compounds, Heterocyclic","Bone Morphogenetic Proteins","CREB-Binding Protein","Carcinoma, Squamous Cell","Cell Proliferation","Epigenesis, Genetic","Head and Neck Neoplasms","Histone-Lysine N-Methyltransferase","Humans","Mice","Mice, Inbred NOD","Mice, Mutant Strains","Mice, SCID","Mice, Transgenic","Mutation","Myeloid-Lymphoid Leukemia Protein","Neoplastic Stem Cells","Pyrimidinones","Salivary Gland Neoplasms","Transplantation, Heterologous","Wnt Signaling Pathway","beta Catenin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"We show that activation of Wnt/-catenin and attenuation of Bmp signals, by combined gain- and loss-of-function mutations of -catenin and Bmpr1a, respectively, results in rapidly growing, aggressive squamous cell carcinomas (SCC) in the salivary glands of mice. Tumours contain transplantable and hyperproliferative tumour propagating cells, which can be enriched by fluorescence activated cell sorting (FACS). Single mutations stimulate stem cells, but tumours are not formed. We show that -catenin, CBP and Mll promote self-renewal and H3K4 tri-methylation in tumour propagating cells. Blocking -catenin-CBP interaction with the small molecule ICG-001 and small-interfering RNAs against -catenin, CBP or Mll abrogate hyperproliferation and H3K4 tri-methylation, and induce differentiation of cultured tumour propagating cells into acini-like structures. ICG-001 decreases H3K4me3 at promoters of stem cell-associated genes in vitro and reduces tumour growth in vivo. Remarkably, high Wnt/-catenin and low Bmp signalling also characterize human salivary gland SCC and head and neck SCC in general. Our work defines mechanisms by which -catenin signals remodel chromatin and control induction and maintenance of tumour propagating cells. Further, it supports new strategies for the therapy of solid tumours.","affiliation":[]},{"pmid":"16887829","pmcid":null,"title":"Bone morphogenetic protein receptor 1A signaling is dispensable for hematopoietic development but essential for vessel and atrioventricular endocardial cushion formation.","authors":["Park C","Lavine K","Mishina Y","Deng CX","Ornitz DM","Choi K"],"grantIds":["HL55337","R01S HL63736"],"grantAgencies":["NHLBI NIH HHS","NHLBI NIH HHS","Intramural NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":15,"month":9,"year":2006,"meshHeadings":["Animals","Atrioventricular Node","Bone Morphogenetic Protein Receptors, Type I","DNA Primers","Endocardium","Hematopoiesis","Mice","Reverse Transcriptase Polymerase Chain Reaction","Signal Transduction","Transcription Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein 4 (BMP4) is crucial for the formation of FLK1-expressing (FLK1(+)) mesodermal cells. To further define the requirement for BMP signaling in the differentiation of blood, endothelial and smooth muscle cells from FLK1(+) mesoderm, we inactivated Alk3 (Bmpr1a) in FLK1(+) cells by crossing Alk3(floxed/floxed) and Flk1(+/Cre)Alk3(+/floxed) mice. Alk3 conditional knockout (CKO) mice died between E10.5 and E11.5. Unexpectedly, Alk3 CKO embryos did not show any hematopoietic defects. However, Alk3 CKO embryos displayed multiple abnormalities in vascular development, including vessel remodeling and maturation, which contributed to severe abdominal hemorrhage. Alk3 CKO embryos also displayed defects in atrioventricular canal (AVC) endocardial cushion formation in the heart. Collectively, our studies indicate a crucial role for ALK3 in vessel remodeling, vessel integrity and endocardial cushion formation during the development of the circulation system.","affiliation":[]},{"pmid":"12368913","pmcid":null,"title":"Requirement of Bmpr1a for Mllerian duct regression during male sexual development.","authors":["Jamin SP","Arango NA","Mishina Y","Hanks MC","Behringer RR"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Nature genetics","journalShort":"Nat. Genet.","day":31,"month":11,"year":2002,"meshHeadings":["Activin Receptors, Type I","Alleles","Animals","Bone Morphogenetic Protein Receptors, Type I","Exons","In Situ Hybridization","Ligands","Male","Mice","Mice, Transgenic","Models, Genetic","Mullerian Ducts","Mutation","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Recombination, Genetic","Sex Differentiation","Testis","Time Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Elimination of the developing female reproductive tract in male fetuses is an essential step in mammalian sexual differentiation. In males, the fetal testis produces the transforming growth factor beta (TGF-beta) family member anti-Mllerian hormone (Amh, also known as Mllerian-inhibiting substance (Mis)), which causes regression of the Mllerian ducts, the primordia of the oviducts, uterus and upper vagina. Amh induces regression by binding to a specific type II receptor (Amhr2) expressed in the mesenchyme surrounding the ductal epithelium. Mutations in AMH or AMHR2 in humans and mice disrupt signaling, producing male pseudohermaphrodites that possess oviducts and uteri. The type I receptor and Smad proteins that are required in vivo for Mllerian duct regression have not yet been identified. Here we show that targeted disruption of the widely expressed type I bone morphogenetic protein (BMP) receptor Bmpr1a (also known as Alk3) in the mesenchymal cells of the Mllerian ducts leads to retention of oviducts and uteri in males. These results identify Bmpr1a as a type I receptor for Amh-induced regression of Mllerian ducts. Because Bmpr1a is evolutionarily conserved, these findings indicate that a component of the BMP signaling pathway has been co-opted during evolution for male sexual development in amniotes.","affiliation":[]},{"pmid":"15102710","pmcid":null,"title":"Epithelial Bmpr1a regulates differentiation and proliferation in postnatal hair follicles and is essential for tooth development.","authors":["Andl T","Ahn K","Kairo A","Chu EY","Wine-Lee L","Reddy ST","Croft NJ","Cebra-Thomas JA","Metzger D","Chambon P","Lyons KM","Mishina Y","Seykora JT","Crenshaw EB","Millar SE"],"grantIds":["AR47709","DC03917","NS39159","R01 AR044528"],"grantAgencies":["NIAMS NIH HHS","NIDCD NIH HHS","NINDS NIH HHS","NIAMS NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":6,"month":5,"year":2004,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Cell Differentiation","Cell Division","Epidermis","Female","Hair","Hair Follicle","In Situ Hybridization","Integrases","Lactation","Mice","Mice, Inbred Strains","Mice, Transgenic","Morphogenesis","Osteogenesis","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Viral Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein (BMP) signaling is thought to perform multiple functions in the regulation of skin appendage morphogenesis and the postnatal growth of hair follicles. However, definitive genetic evidence for these roles has been lacking. Here, we show that Cre-mediated mutation of the gene encoding BMP receptor 1A in the surface epithelium and its derivatives causes arrest of tooth morphogenesis and lack of external hair. The hair shaft and hair follicle inner root sheath (IRS) fail to differentiate, and expression of the known transcriptional regulators of follicular differentiation Msx1, Msx2, Foxn1 and Gata3 is markedly downregulated or absent in mutant follicles. Lef1 expression is maintained, but nuclear beta-catenin is absent from the epithelium of severely affected mutant follicles, indicating that activation of the WNT pathway lies downstream of BMPR1A signaling in postnatal follicles. Mutant hair follicles fail to undergo programmed regression, and instead continue to proliferate, producing follicular cysts and matricomas. These results provide definitive genetic evidence that epithelial Bmpr1a is required for completion of tooth morphogenesis, and regulates terminal differentiation and proliferation in postnatal hair follicles.","affiliation":[]},{"pmid":"11714671","pmcid":null,"title":"BMPR-IA signaling is required for the formation of the apical ectodermal ridge and dorsal-ventral patterning of the limb.","authors":["Ahn K","Mishina Y","Hanks MC","Behringer RR","Crenshaw EB"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":20,"month":11,"year":2001,"meshHeadings":["Animals","Antigens, Differentiation","Body Patterning","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein 7","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Ectoderm","Epithelium","Extremities","Fibroblast Growth Factor 8","Fibroblast Growth Factors","Hindlimb","Homeodomain Proteins","Integrases","Limb Deformities, Congenital","Mesoderm","Mice","Mice, Knockout","Models, Biological","Organizers, Embryonic","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Signal Transduction","Transforming Growth Factor beta","Viral Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"We demonstrate that signaling via the bone morphogenetic protein receptor IA (BMPR-IA) is required to establish two of the three cardinal axes of the limb: the proximal-distal axis and the dorsal-ventral axis. We generated a conditional knockout of the gene encoding BMPR-IA (Bmpr) that disrupted BMP signaling in the limb ectoderm. In the most severely affected embryos, this conditional mutation resulted in gross malformations of the limbs with complete agenesis of the hindlimbs. The proximal-distal axis is specified by the apical ectodermal ridge (AER), which forms from limb ectoderm at the distal tip of the embryonic limb bud. Analyses of the expression of molecular markers, such as Fgf8, demonstrate that formation of the AER was disrupted in the Bmpr mutants. Along the dorsal/ventral axis, loss of engrailed 1 (En1) expression in the non-ridge ectoderm of the mutants resulted in a dorsal transformation of the ventral limb structures. The expression pattern of Bmp4 and Bmp7 suggest that these growth factors play an instructive role in specifying dorsoventral pattern in the limb. This study demonstrates that BMPR-IA signaling plays a crucial role in AER formation and in the establishment of the dorsal/ventral patterning during limb development.","affiliation":[]},{"pmid":"20043884","pmcid":null,"title":"Antagonistic crosstalk of Wnt/beta-catenin/Bmp signaling within the Apical Ectodermal Ridge (AER) regulates interdigit formation.","authors":["Villacorte M","Suzuki K","Hayashi K","de Sousa Lopes SC","Haraguchi R","Taketo MM","Nakagata N","Yamada G"],"grantIds":["R01 ES016597","R01 ES016597-01A1","R01-ES016597-01A1"],"grantAgencies":["NIEHS NIH HHS","NIEHS NIH HHS","NIEHS NIH HHS"],"retractions":[],"journal":"Biochemical and biophysical research communications","journalShort":"Biochem. Biophys. Res. Commun.","day":22,"month":1,"year":2010,"meshHeadings":["Animals","Apoptosis","Biological Markers","Bone Morphogenetic Protein Receptors","Ectoderm","Fibroblast Growth Factor 8","Limb Buds","Mice","Mice, Mutant Strains","Signal Transduction","Wnt Proteins","beta Catenin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Digit and interdigit (D/ID) development is one of the important research fields in molecular developmental biology. Interdigital cell death (ICD) is a morphogenetic event which has been considered as an essential process for D/ID formation. Although some growth factors including Bmp and Fgf signaling can modulate ICD, growth factor crosstalk regulating ICD is poorly understood. Wnt canonical pathway and Bmp signal crosstalk has been considered as the essential growth factor crosstalk in organogenesis. To elucidate the crosstalk to regulate the D/ID formation, we analyzed conditional mutant mice with limb bud ectoderm expressing constitutively activated beta-catenin signaling. We showed that modulation of Wnt/beta-catenin signal in the limb ectoderm including the AER regulates ID apoptosis. We also demonstrated that Wnt/beta-catenin signaling in the ectoderm can positively regulate Fgf8 possibly antagonizing the epithelial derived Bmp signaling. Human birth defects for digit abnormalities have been known to be affected by multiple parameters. Elucidation of the potential mechanisms underlying such D/ID development is an urgent medical issue to be solved. This work would be one of the first studies showing essential growth factor cascades in the D/ID formation.","affiliation":[]},{"pmid":"21303853","pmcid":null,"title":"Cooperative activity of noggin and gremlin 1 in axial skeleton development.","authors":["Stafford DA","Brunet LJ","Khokha MK","Economides AN","Harland RM"],"grantIds":["GM49346","R01 GM049346"],"grantAgencies":["NIGMS NIH HHS","NIGMS NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":9,"month":3,"year":2011,"meshHeadings":["Animals","Body Patterning","Bone Morphogenetic Proteins","Carrier Proteins","Embryo, Mammalian","Hedgehog Proteins","Intercellular Signaling Peptides and Proteins","Mice","Mice, Mutant Strains","Signal Transduction","Skeleton","Somites"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Inductive signals from adjacent tissues initiate differentiation within the somite. In this study, we used mouse embryos mutant for the BMP antagonists noggin (Nog) and gremlin 1 (Grem1) to characterize the effects of BMP signaling on the specification of the sclerotome. We confirmed reduction of Pax1 and Pax9 expression in Nog mutants, but found that Nog;Grem1 double mutants completely fail to initiate sclerotome development. Furthermore, Nog mutants that also lack one allele of Grem1 exhibit a dramatic reduction in axial skeleton relative to animals mutant for Nog alone. By contrast, Pax3, Myf5 and Lbx1 expression indicates that dermomyotome induction occurs in Nog;Grem1 double mutants. Neither conditional Bmpr1a mutation nor treatment with the BMP type I receptor inhibitor dorsomorphin expands sclerotome marker expression, suggesting that BMP antagonists do not have an instructive function in sclerotome specification. Instead, we hypothesize that Nog- and Grem1-mediated inhibition of BMP is permissive for hedgehog (Hh) signal-mediated sclerotome specification. In support of this model, we found that culturing Nog;Grem1 double-mutant embryos with dorsomorphin restores sclerotome, whereas Pax1 expression in smoothened (Smo) mutants is not rescued, suggesting that inhibition of BMP is insufficient to induce sclerotome in the absence of Hh signaling. Confirming the dominant inhibitory effect of BMP signaling, Pax1 expression cannot be rescued in Nog;Grem1 double mutants by forced activation of Smo. We conclude that Nog and Grem1 cooperate to maintain a BMP signaling-free zone that is a crucial prerequisite for Hh-mediated sclerotome induction.","affiliation":[]},{"pmid":"20730911","pmcid":null,"title":"Loss of procollagen IIA from the anterior mesendoderm disrupts the development of mouse embryonic forebrain.","authors":["Leung AW","Wong SY","Chan D","Tam PP","Cheah KS"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Developmental dynamics : an official publication of the American Association of Anatomists","journalShort":"Dev. Dyn.","day":14,"month":9,"year":2010,"meshHeadings":["Animals","Body Patterning","Bone Morphogenetic Protein Receptors, Type I","Collagen Type II","Endoderm","Head","Hedgehog Proteins","Mesoderm","Mice","Mice, Knockout","Nodal Protein","Procollagen","Prosencephalon","Protein Isoforms","RNA, Messenger","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Morphogenesis of the mammalian forebrain is influenced by the patterning activity of signals emanating from the anterior mesendoderm. In this study, we show that procollagen IIA (IIA), an isoform of the cartilage extracellular matrix protein encoded by an alternatively spliced transcript of Col2a1, is expressed in the prechordal plate and the anterior definitive endoderm. In the absence of IIA activity, the null mutants displayed a partially penetrant phenotype of loss of head tissues, holoprosencephaly, and loss of mid-facial structures, which is associated with reduced sonic hedgehog (Shh) expression in the prechordal mesoderm. Genetic interaction studies reveal that IIA function in forebrain and face development does not involve bone morphogenetic protein receptor 1A (BMPR1A)- or NODAL-mediated signaling activity.","affiliation":[]},{"pmid":"20360068","pmcid":null,"title":"Systematic analysis of human protein complexes identifies chromosome segregation proteins.","authors":["Hutchins JR","Toyoda Y","Hegemann B","Poser I","Hrich JK","Sykora MM","Augsburg M","Hudecz O","Buschhorn BA","Bulkescher J","Conrad C","Comartin D","Schleiffer A","Sarov M","Pozniakovsky A","Slabicki MM","Schloissnig S","Steinmacher I","Leuschner M","Ssykor A","Lawo S","Pelletier L","Stark H","Nasmyth K","Ellenberg J","Durbin R","Buchholz F","Mechtler K","Hyman AA","Peters JM"],"grantIds":["F 3407-B03"],"grantAgencies":["Austrian Science Fund FWF"],"retractions":[],"journal":"Science (New York, N.Y.)","journalShort":"Science","day":30,"month":4,"year":2010,"meshHeadings":["Anaphase-Promoting Complex-Cyclosome","Centrosome","Chromosome Segregation","Chromosomes, Artificial, Bacterial","Databases, Genetic","Genomics","Green Fluorescent Proteins","HeLa Cells","Humans","Mitosis","Multiprotein Complexes","Open Reading Frames","Protein Binding","Protein Interaction Mapping","Protein Subunits","RNA Interference","Spindle Apparatus","Tubulin","Ubiquitin-Protein Ligase Complexes"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Chromosome segregation and cell division are essential, highly ordered processes that depend on numerous protein complexes. Results from recent RNA interference screens indicate that the identity and composition of these protein complexes is incompletely understood. Using gene tagging on bacterial artificial chromosomes, protein localization, and tandem-affinity purification-mass spectrometry, the MitoCheck consortium has analyzed about 100 human protein complexes, many of which had not or had only incompletely been characterized. This work has led to the discovery of previously unknown, evolutionarily conserved subunits of the anaphase-promoting complex and the gamma-tubulin ring complex--large complexes that are essential for spindle assembly and chromosome segregation. The approaches we describe here are generally applicable to high-throughput follow-up analyses of phenotypic screens in mammalian cells.","affiliation":[]},{"pmid":"11857780","pmcid":null,"title":"Generation of Bmpr/Alk3 conditional knockout mice.","authors":["Mishina Y","Hanks MC","Miura S","Tallquist MD","Behringer RR"],"grantIds":["AR42919"],"grantAgencies":["NIAMS NIH HHS"],"retractions":[],"journal":"Genesis (New York, N.Y. : 2000)","journalShort":"Genesis","day":21,"month":2,"year":2002,"meshHeadings":["Alleles","Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Mice","Mice, Knockout","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Receptors, Transforming Growth Factor beta"],"hasAbstract":false,"score":0,"snippets":[],"abstract":null,"affiliation":[]},{"pmid":"21068065","pmcid":null,"title":"BMP signaling in the development of the mouse esophagus and forestomach.","authors":["Rodriguez P","Da Silva S","Oxburgh L","Wang F","Hogan BL","Que J"],"grantIds":["1K99DK082650-01A2","K99 DK082650","R01 DK078161"],"grantAgencies":["NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","Howard Hughes Medical Institute"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":24,"month":12,"year":2010,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Carrier Proteins","Epithelium","Esophagus","Gene Expression Regulation, Developmental","Hedgehog Proteins","Immunohistochemistry","In Situ Hybridization","Mice","Signal Transduction","Stomach"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The stratification and differentiation of the epidermis are known to involve the precise control of multiple signaling pathways. By contrast, little is known about the development of the mouse esophagus and forestomach, which are composed of a stratified squamous epithelium. Based on prior work in the skin, we hypothesized that bone morphogenetic protein (BMP) signaling is a central player. To test this hypothesis, we first used a BMP reporter mouse line harboring a BRE-lacZ allele, along with in situ hybridization to localize transcripts for BMP signaling components, including various antagonists. We then exploited a Shh-Cre allele that drives recombination in the embryonic foregut epithelium to generate gain- or loss-of-function models for the Bmpr1a (Alk3) receptor. In gain-of-function (Shh-Cre;Rosa26(CAG-loxpstoploxp-caBmprIa)) embryos, high levels of ectopic BMP signaling stall the transition from simple columnar to multilayered undifferentiated epithelium in the esophagus and forestomach. In loss-of-function experiments, conditional deletion of the BMP receptor in Shh-Cre;Bmpr1a(flox/flox) embryos allows the formation of a multilayered squamous epithelium but this fails to differentiate, as shown by the absence of expression of the suprabasal markers loricrin and involucrin. Together, these findings suggest multiple roles for BMP signaling in the developing esophagus and forestomach.","affiliation":[]},{"pmid":"8543149","pmcid":null,"title":"Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis.","authors":["Mishina Y","Suzuki A","Ueno N","Behringer RR"],"grantIds":["HD30284"],"grantAgencies":["NICHD NIH HHS"],"retractions":[],"journal":"Genes & development","journalShort":"Genes Dev.","day":15,"month":12,"year":1995,"meshHeadings":["Alleles","Animals","Base Sequence","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Differentiation","Cell Division","Embryonic Development","Embryonic and Fetal Development","Female","Gastrula","Gene Expression Regulation, Developmental","Genes, Lethal","Genes, Recessive","Germ-Line Mutation","Heterozygote","Homozygote","Male","Mice","Mice, Mutant Strains","Molecular Sequence Data","Pregnancy","Proteins","Testis"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (BMPs) are secreted proteins that interact with cell-surface receptors and are believed to play a variety of important roles during vertebrate embryogenesis. Bmpr, also known as ALK-3 and Brk-1, encodes a type I transforming growth factor-beta (TGF-beta) family receptor for BMP-2 and BMP-4. Bmpr is expressed ubiquitously during early mouse embryogenesis and in most adult mouse tissues. To study the function of Bmpr during mammalian development, we generated Bmpr-mutant mice. After embryonic day 9.5 (E9.5), no homozygous mutants were recovered from heterozygote matings. Homozygous mutants with morphological defects were first detected at E7.0 and were smaller than normal. Morphological and molecular examination demonstrated that no mesoderm had formed in the mutant embryos. The growth characteristics of homozygous mutant blastocysts cultured in vitro were indistinguishable from those of controls; however, embryonic ectoderm (epiblast) cell proliferation was reduced in all homozygous mutants at E6.5 before morphological abnormalities had become prominent. Teratomas arising from E7.0 mutant embryos contained derivatives from all three germ layers but were smaller and gave rise to fewer mesodermal cell types, such as muscle and cartilage, than controls. These results suggest that signaling through this type I BMP-2/4 receptor is not necessary for preimplantation or for initial postimplantation development but may be essential for the inductive events that lead to the formation of mesoderm during gastrulation and later for the differentiation of a subset of mesodermal cell types.","affiliation":[]},{"pmid":"16037571","pmcid":null,"title":"Alk3/Bmpr1a receptor is required for development of the atrioventricular canal into valves and annulus fibrosus.","authors":["Gaussin V","Morley GE","Cox L","Zwijsen A","Vance KM","Emile L","Tian Y","Liu J","Hong C","Myers D","Conway SJ","Depre C","Mishina Y","Behringer RR","Hanks MC","Schneider MD","Huylebroeck D","Fishman GI","Burch JB","Vatner SF"],"grantIds":["1P01HL69020","2P01HL59139","2R01AG14121","2R01HL33107","AR42919","HL55373","R01 HL064757","R01 HL064757-09","R01 HL076751","R01 HL076751-01A1","R01 HL076751-02","R01 HL076751-03","R01 HL076751-04"],"grantAgencies":["NHLBI NIH HHS","NHLBI NIH HHS","NIA NIH HHS","NHLBI NIH HHS","NIAMS NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS"],"retractions":[],"journal":"Circulation research","journalShort":"Circ. Res.","day":5,"month":8,"year":2005,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","DNA-Binding Proteins","GATA6 Transcription Factor","Heart","Heart Valves","Integrases","Mice","Mice, Transgenic","Myocytes, Cardiac","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Signal Transduction","Transcription Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Endocardial cushions are precursors of mature atrioventricular (AV) valves. Their formation is induced by signaling molecules originating from the AV myocardium, including bone morphogenetic proteins (BMPs). Here, we hypothesized that BMP signaling plays an important role in the AV myocardium during the maturation of AV valves from the cushions. To test our hypothesis, we used a unique Cre/lox system to target the deletion of a floxed Alk3 allele, the type IA receptor for BMPs, to cardiac myocytes of the AV canal (AVC). Lineage analysis indicated that cardiac myocytes of the AVC contributed to the tricuspid mural and posterior leaflets, the mitral septal leaflet, and the atrial border of the annulus fibrosus. When Alk3 was deleted in these cells, defects were seen in the same leaflets, ie, the tricuspid mural leaflet and mitral septal leaflet were longer, the tricuspid posterior leaflet was displaced and adherent to the ventricular wall, and the annulus fibrosus was disrupted resulting in ventricular preexcitation. The defects seen in mice with AVC-targeted deletion of Alk3 provide strong support for a role of Alk3 in human congenital heart diseases, such as Ebstein's anomaly. In conclusion, our mouse model demonstrated critical roles for Alk3 signaling in the AV myocardium during the development of AV valves and the annulus fibrosus.","affiliation":[]},{"pmid":"18927151","pmcid":null,"title":"BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway.","authors":["Kamiya N","Ye L","Kobayashi T","Mochida Y","Yamauchi M","Kronenberg HM","Feng JQ","Mishina Y"],"grantIds":["ES071003-11","K22 DE016977","K22 DE016977-03","P01 DK056246","P01 DK056246-090001","P01 DK56246","R01 AR051587","R01 AR051587","R01 AR051587-04","R21 AR052824","R21 AR052824","R21 AR052824-02","Z01 ES071003-10"],"grantAgencies":["NIEHS NIH HHS","NIDCR NIH HHS","NIDCR NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS","Intramural NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":27,"month":11,"year":2008,"meshHeadings":["Animals","Biological Markers","Bone Density","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Bone and Bones","Collagen Type I","Down-Regulation","Embryo, Mammalian","Gene Expression Regulation, Developmental","Genetic Markers","Glycoproteins","Integrases","Mice","Mice, Transgenic","Organ Size","Organ Specificity","Osteoprotegerin","RANK Ligand","Signal Transduction","Wnt Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (BMPs) are known to induce ectopic bone. However, it is largely unknown how BMP signaling in osteoblasts directly regulates endogenous bone. This study investigated the mechanism by which BMP signaling through the type IA receptor (BMPR1A) regulates endogenous bone mass using an inducible Cre-loxP system. When BMPR1A in osteoblasts was conditionally disrupted during embryonic bone development, bone mass surprisingly was increased with upregulation of canonical Wnt signaling. Although levels of bone formation markers were modestly reduced, levels of resorption markers representing osteoclastogenesis were severely reduced, resulting in a net increase in bone mass. The reduction of osteoclastogenesis was primarily caused by Bmpr1a-deficiency in osteoblasts, at least through the RANKL-OPG pathway. Sclerostin (Sost) expression was downregulated by about 90% and SOST protein was undetectable in osteoblasts and osteocytes, whereas the Wnt signaling was upregulated. Treatment of Bmpr1a-deficient calvariae with sclerostin repressed the Wnt signaling and restored normal bone morphology. By gain of Smad-dependent BMPR1A signaling in mice, Sost expression was upregulated and osteoclastogenesis was increased. Finally, the Bmpr1a-deficient bone phenotype was rescued by enhancing BMPR1A signaling, with restoration of osteoclastogenesis. These findings demonstrate that BMPR1A signaling in osteoblasts restrain endogenous bone mass directly by upregulating osteoclastogenesis through the RANKL-OPG pathway, or indirectly by downregulating canonical Wnt signaling through sclerostin, a Wnt inhibitor and a bone mass mediator.","affiliation":[]},{"pmid":"15673568","pmcid":null,"title":"Distinct developmental programs require different levels of Bmp signaling during mouse retinal development.","authors":["Murali D","Yoshikawa S","Corrigan RR","Plas DJ","Crair MC","Oliver G","Lyons KM","Mishina Y","Furuta Y"],"grantIds":["CA16672","EY13128"],"grantAgencies":["NCI NIH HHS","NEI NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":11,"month":3,"year":2005,"meshHeadings":["Animals","Body Patterning","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Proliferation","Chromosome Mapping","Fibroblast Growth Factors","Gene Expression Regulation, Developmental","Immunohistochemistry","In Situ Hybridization","Mice","Mice, Transgenic","Models, Biological","Models, Genetic","Mutation","Neurons","Optic Nerve","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Retina","Signal Transduction","Transgenes"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The Bmp family of secreted signaling molecules is implicated in multiple aspects of embryonic development. However, the cell-type-specific requirements for this signaling pathway are often obscure in the context of complex embryonic tissue interactions. To define the cell-autonomous requirements for Bmp signaling, we have used a Cre-loxP strategy to delete Bmp receptor function specifically within the developing mouse retina. Disruption of a Bmp type I receptor gene, Bmpr1a, leads to no detectable eye abnormality. Further reduction of Bmp receptor activity by removing one functional copy of another Bmp type I receptor gene, Bmpr1b, in the retina-specific Bmpr1a mutant background, results in abnormal retinal dorsoventral patterning. Double mutants completely lacking both of these genes exhibit severe eye defects characterized by reduced growth of embryonic retina and failure of retinal neurogenesis. These studies provide direct genetic evidence that Bmpr1a and Bmpr1b play redundant roles during retinal development, and that different threshold levels of Bmp signaling regulate distinct developmental programs such as patterning, growth and differentiation of the retina.","affiliation":[]},{"pmid":"9876182","pmcid":null,"title":"BMP signaling plays a role in visceral endoderm differentiation and cavitation in the early mouse embryo.","authors":["Coucouvanis E","Martin GR"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":4,"month":2,"year":1999,"meshHeadings":["Animals","Apoptosis","Basic Helix-Loop-Helix Leucine Zipper Transcription Factors","Blastocyst","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein 4","Bone Morphogenetic Proteins","Cell Differentiation","Cells, Cultured","DNA-Binding Proteins","Ectoderm","Endoderm","Hepatocyte Nuclear Factor 4","Mice","Phosphoproteins","Signal Transduction","Transcription Factors","Transforming Growth Factor beta","Transgenes","Viscera"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"At E4.0 the inner cell mass of the mouse blastocyst consists of a core of embryonic ectoderm cells surrounded by an outer layer of primitive (extraembryonic) endoderm, which subsequently gives rise to both visceral endoderm and parietal endoderm. Shortly after blastocyst implantation, the solid mass of ectoderm cells is converted by a process known as cavitation into a pseudostratified columnar epithelium surrounding a central cavity. We have previously used two cell lines, which form embryoid bodies that do (PSA1) or do not (S2) cavitate, as an in vitro model system for studying the mechanism of cavitation in the early embryo. We provided evidence that cavitation is the result of both programmed cell death and selective cell survival, and that the process depends on signals from visceral endoderm (Coucouvanis, E. and Martin, G. R. (1995) Cell 83, 279-287). Here we show that Bmp2 and Bmp4 are expressed in PSA1 embryoid bodies and embryos at the stages when visceral endoderm differentiation and cavitation are occurring, and that blocking BMP signaling via expression of a transgene encoding a dominant negative mutant form of BMP receptor IB inhibits expression of the visceral endoderm marker, Hnf4, and prevents cavitation in PSA1 embryoid bodies. Furthermore, we show that addition of BMP protein to cultures of S2 embryoid bodies induces expression of Hnf4 and other visceral endoderm markers and also cavitation. Taken together, these data indicate that BMP signaling is both capable of promoting, and required for differentiation of, visceral endoderm and cavitation of embryoid bodies. Based on these and other data, we propose a model for the role of BMP signaling during peri-implantation stages of mouse embryo development.","affiliation":[]},{"pmid":"8605036","pmcid":null,"title":"Vascular smooth muscle cells express multiple type I receptors for TGF-beta, activin, and bone morphogenetic proteins.","authors":["Agrotis A","Samuel M","Prapas G","Bobik A"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Biochemical and biophysical research communications","journalShort":"Biochem. Biophys. Res. Commun.","day":15,"month":2,"year":1996,"meshHeadings":["Activin Receptors, Type I","Amino Acid Sequence","Animals","Aorta, Thoracic","Base Sequence","Cells, Cultured","DNA Primers","DNA, Complementary","Gene Expression","Growth Substances","Molecular Sequence Data","Muscle, Smooth, Vascular","Polymerase Chain Reaction","Protein-Serine-Threonine Kinases","Rats","Rats, Inbred WKY","Receptors, Transforming Growth Factor beta","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Vascular smooth muscle cells (VSMCs) are known to produce activins, bone morphogenetic proteins and transforming growth factor-betas (TGF-betas). To determine whether these TGF-beta superfamily members exert autocrine effects on VSMCs we examined whether specific type I receptors (ALKs) for such peptides were expressed by the cells. RNA from both quiescent or growth-factor-activated VSMCs was reverse transcribed then cDNAs encoding ALK-2, ALK-3, ALK-5, and ALK-6 were amplified and characterised using specific PCR primers. All four ALK mRNAs were abundantly expressed. The ALK-5 fragment harbored a deletion of 12 nucleotides, removing 4 extracellular amino acids (Gly-Pro-Ser-Val) adjacent to its transmembrane domain. This deletion, which may arise from anomalous splicing of heteronuclear RNA, is likely to influence formation of the ALK-5:type II receptor complex through conformational changes associated with removal of a putative hinge region containing proline. Our finding that multiple ALKs are expressed by VSMCs would account for the multiplicity of effects TGF-beta peptides exert on these cells.","affiliation":[]},{"pmid":"3268409","pmcid":null,"title":"XY follicle cells in ovaries of XX----XY female mouse chimaeras.","authors":["Burgoyne PS","Buehr M","McLaren A"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":8,"month":12,"year":1988,"meshHeadings":["Animals","Bone Marrow Cells","Chimera","Disorders of Sex Development","Female","Genetic Markers","Metaphase","Mice","Mice, Inbred BALB C","Mice, Inbred CBA","Ovarian Follicle","Ovary","Sex Chromosomes","Translocation, Genetic"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Oocytes with adhering follicle cells were sampled from ovaries obtained from 11 GPI-1A----GPI-1B chimaeras, comprising 10 females and 1 hermaphrodite. GPI analysis of individual oocytes revealed a marked bias towards the GPI-1B component in the germ line of this chimaeric combination. GPI-1B XY oocytes were identified in the ovary from the hermaphrodite, the bias towards the GPI-1B germ line perhaps helping to counterbalance the normally severe selection against XY oocytes. GPI analysis of follicle cells revealed a much more balanced contribution of the two components to this ovarian cell type. Importantly, GPI-1A follicle cells were identified in more than half the follicles from an XX----XY female in which the GPI-1A component was XY, supporting an earlier conclusion of Ford et al. (1974) that XY cells can contribute to the follicles of XX----XY female mice. It is suggested that XY cells can be recruited to form follicle cells in XX----XY chimaeras when there is a developmental mismatch between the two components, such that an ovary-determining signal produced by the XX component pre-empts the testis-determining action of the Y.","affiliation":[]},{"pmid":"20663871","pmcid":null,"title":"Smad7 inhibits transforming growth factor-beta family type i receptors through two distinct modes of interaction.","authors":["Kamiya Y","Miyazono K","Miyazawa K"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"The Journal of biological chemistry","journalShort":"J. Biol. Chem.","day":1,"month":10,"year":2010,"meshHeadings":["Animals","COS Cells","Cercopithecus aethiops","Hep G2 Cells","Humans","Protein Structure, Tertiary","Protein-Serine-Threonine Kinases","Receptors, Transforming Growth Factor beta","Smad6 Protein","Smad7 Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The inhibitory Smads (I-Smads), i.e. Smad6 and Smad7, are negative regulators of transforming growth factor- (TGF-) family signaling. I-Smads inhibit TGF- family signaling principally through physical interaction with type I receptors (activin receptor-like kinases), so as to compete with receptor-regulated Smads (R-Smads) for activation. However, how I-Smads interact with type I receptors is not well understood. In the present study, we found that Smad7 has two modes of interaction with type I receptors. One is through a three-finger-like structure in the MH2 domain, consisting of residues 331-361, 379-387, and the L3 loop. The other is through a basic groove in the MH2 domain (Mochizuki, T., Miyazaki, H., Hara, T., Furuya, T., Imamura, T., Watabe, T., and Miyazono, K. (2004) J. Biol. Chem. 279, 31568-31574). We also found that Smad6 principally utilizes a basic groove in the MH2 domain for interaction with type I receptors. Smad7 thus has an additional mode of interaction with TGF- family type I receptors not possessed by Smad6, which may play roles in mediating the inhibitory effects unique to Smad7.","affiliation":[]},{"pmid":"1793820","pmcid":null,"title":"Expression of the dystrophin gene in mouse and rat brain.","authors":["Gorecki D","Geng Y","Thomas K","Hunt SP","Barnard EA","Barnard PJ"],"grantIds":[],"grantAgencies":["Wellcome Trust"],"retractions":[],"journal":"Neuroreport","journalShort":"Neuroreport","day":6,"month":12,"year":1991,"meshHeadings":["Animals","Brain","Dystrophin","Gene Expression","Mice","Nucleic Acid Hybridization","Oligonucleotide Probes","RNA, Messenger","Rats"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Duchenne muscular dystrophy is due to mutations in the dystrophin gene which is predominantly expressed in muscle and brain. Since the disease is associated with cognitive impairment, we sought to localize dystrophin mRNA in brain using in situ hybridization with oligonucleotide probes. We find the gene strongly expressed in the hippocampus and cerebral cortex, areas with an established cognitive function, and also in the Purkinje cells of the cerebellum, an area associated with motor coordination.","affiliation":[]},{"pmid":"12805214","pmcid":null,"title":"Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation.","authors":["Sharov AA","Weiner L","Sharova TY","Siebenhaar F","Atoyan R","Reginato AM","McNamara CA","Funa K","Gilchrest BA","Brissette JL","Botchkarev VA"],"grantIds":["AR45284","AR47414","AR48573","R01 AR049778"],"grantAgencies":["NIAMS NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS"],"retractions":[],"journal":"The EMBO journal","journalShort":"EMBO J.","day":16,"month":6,"year":2003,"meshHeadings":["Adenoviridae","Animals","Apoptosis","Biological Markers","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Proteins","Carrier Proteins","Cell Differentiation","Culture Techniques","DNA-Binding Proteins","Embryo, Mammalian","Epidermal Growth Factor","Epidermis","Eyelids","Genetic Vectors","Growth Differentiation Factor 5","Humans","In Situ Hybridization","In Situ Nick-End Labeling","Keratin-15","Keratin-5","Keratinocytes","Keratins","Mice","Mice, Transgenic","Morphogenesis","Neoplasm Proteins","Promoter Regions, Genetic","Proteins","Receptors, Growth Factor","Signal Transduction","Smad Proteins","Trans-Activators","Transforming Growth Factor alpha"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Contact of developing sensory organs with the external environment is established via the formation of openings in the skin. During eye development, eyelids first grow, fuse and finally reopen, thus providing access for visual information to the retina. Here, we show that eyelid opening is strongly inhibited in transgenic mice overexpressing the bone morphogenetic protein (BMP) antagonist noggin from the keratin 5 (K5) promoter in the epidermis. In wild-type mice, enhanced expression of the kinase-inactive form of BMPR-IB mediated by an adenovirus vector also inhibits eyelid opening. Noggin overexpression leads to reduction of apoptosis and retardation of cell differentiation in the eyelid epithelium, which is associated with downregulation of expression of the apoptotic receptors (Fas, p55 kDa TNFR), Id3 protein and keratinocyte differentiation markers (loricrin, involucrin). BMP-4, but not EGF or TGF-alpha, accelerates opening of the eyelid explants isolated from K5-Noggin transgenic mice when cultured ex vivo. These data suggest that the BMP signaling pathway plays an important role in regulation of genetic programs of eyelid opening and skin remodeling during the final steps of eye morphogenesis.","affiliation":[]},{"pmid":"7671812","pmcid":null,"title":"Isolation of novel tissue-specific genes from cDNA libraries representing the individual tissue constituents of the gastrulating mouse embryo.","authors":["Harrison SM","Dunwoodie SL","Arkell RM","Lehrach H","Beddington RS"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":13,"month":8,"year":1995,"meshHeadings":["Animals","Base Sequence","Blotting, Southern","Cloning, Molecular","DNA, Complementary","Ectoderm","Endoderm","Gastrula","Gene Expression","Gene Library","In Situ Hybridization","Mesoderm","Mice","Mice, Inbred C57BL","Mice, Inbred DBA","Molecular Sequence Data","Plasmids"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"A total of 5 conventional, directionally cloned plasmid cDNA libraries have been constructed from the entire embryonic region of the mid-gastrulation mouse embryo and from its four principal tissue constituents (ectoderm, mesoderm, endoderm and primitive streak). These libraries have been validated with respect to the number of independent clones, insert-size and appropriate representation of diagnostic marker genes. Subtractive hybridisation has been used to remove clones common to the Endoderm and Mesoderm cDNA libraries resulting in an Endoderm minus Mesoderm subtracted library. Probe prepared from this subtracted library has been hybridised to a grid containing approximately 18,500 Embryonic Region library clones. Three novel clones have been recovered as well as expected genes already known to be highly expressed in the primitive endoderm lineage at this stage of development. In situ hybridisation to early postimplantation embryos has revealed the expression patterns of these novel genes. One is highly expressed exclusively in visceral endoderm, one is expressed in ectodermal and endodermal tissues, and the third proves to be an early marker of prospective and differentiated surface ectoderm as well as being expressed in endoderm and its derivatives.","affiliation":[]},{"pmid":"17391983","pmcid":null,"title":"BMP signaling mutant mice exhibit glial cell maturation defects.","authors":["See J","Mamontov P","Ahn K","Wine-Lee L","Crenshaw EB","Grinspan JB"],"grantIds":["R01 NS043422-01","R01 NS043422-02","R01 NS043422-03","R01 NS39159","R01 NS43422"],"grantAgencies":["NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"Molecular and cellular neurosciences","journalShort":"Mol. Cell. Neurosci.","day":30,"month":5,"year":2007,"meshHeadings":["Animals","Animals, Newborn","Astrocytes","Bone Morphogenetic Protein 1","Bone Morphogenetic Proteins","Cell Death","Cell Division","Cell Lineage","Cervical Vertebrae","Female","Male","Metalloendopeptidases","Mice","Mice, Inbred Strains","Mice, Knockout","Myelin Proteins","Neural Tube Defects","Oligodendroglia","Pregnancy","Signal Transduction","Spinal Cord","Stem Cells"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins have been implicated in the development of oligodendrocytes and astrocytes, however, a role for endogenous BMP signaling in glial development has not been demonstrated in a genetic model. Using mice in which signaling via type I BMP receptors Bmpr1a and Bmpr1b have been inactivated in the neural tube, we demonstrate that BMP signaling contributes to the maturation of glial cells in vivo. At P0, mutant mice exhibited a 25-40% decrease in GFAP+ or S100beta+ astrocytes in the cervical spinal cord. The number of oligodendrocyte precursors and the timing of their emergence was unchanged in the mutant mice compared to the normals, however myelin protein expression and mature oligodendrocyte numbers were significantly reduced. These data indicate that BMP signaling promotes the generation of astrocytes and mature, myelinating oligodendrocytes in vivo but does not affect oligodendrocyte precursor development, thus suggesting tight regulation of BMP signaling to ensure proper gliogenesis.","affiliation":[]},{"pmid":"23292934","pmcid":null,"title":"Competitive balance of intrabulge BMP/Wnt signaling reveals a robust gene network ruling stem cell homeostasis and cyclic activation.","authors":["Kandyba E","Leung Y","Chen YB","Widelitz R","Chuong CM","Kobielak K"],"grantIds":["AR060306","R01 AR061552","R01-AR061552"],"grantAgencies":["NIAMS NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS"],"retractions":[],"journal":"Proceedings of the National Academy of Sciences of the United States of America","journalShort":"Proc. Natl. Acad. Sci. U.S.A.","day":22,"month":1,"year":2013,"meshHeadings":["Adult Stem Cells","Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Gene Regulatory Networks","Hair","Hair Follicle","Homeostasis","Keratin-15","Mice","Mice, Knockout","Mice, Transgenic","Models, Biological","Models, Genetic","Multipotent Stem Cells","Promoter Regions, Genetic","Transcriptome","Wnt Proteins","Wnt Signaling Pathway"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Hair follicles facilitate the study of stem cell behavior because stem cells in progressive activation stages, ordered within the follicle architecture, are capable of cyclic regeneration. To study the gene network governing the homeostasis of hair bulge stem cells, we developed a Keratin 15-driven genetic model to directly perturb molecular signaling in the stem cells. We visualize the behavior of these modified stem cells, evaluating their hair-regenerating ability and profile their molecular expression. Bone morphogenetic protein (BMP)-inactivated stem cells exhibit molecular profiles resembling those of hair germs, yet still possess multipotentiality in vivo. These cells also exhibit up-regulation of Wnt7a, Wnt7b, and Wnt16 ligands and Frizzled (Fzd) 10 receptor. We demonstrate direct transcriptional modulation of the Wnt7a promoter. These results highlight a previously unknown intra-stem cell antagonistic competition, between BMP and Wnt signaling, to balance stem cell activity. Reduced BMP signaling and increased Wnt signaling tilts each stem cell toward a hair germ fate and, vice versa, based on a continuous scale dependent on the ratio of BMP/Wnt activity. This work reveals one more hierarchical layer regulating stem cell homeostasis beneath the stem cell-dermal papilla-based epithelial-mesenchymal interaction layer and the hair follicle-intradermal adipocyte-based tissue interaction layer. Although hierarchical layers are all based on BMP/Wnt signaling, the multilayered control ensures that all information is taken into consideration and allows hair stem cells to sum up the total activators/inhibitors involved in making the decision of activation.","affiliation":[]},{"pmid":"9851982","pmcid":null,"title":"BMP4 is essential for lens induction in the mouse embryo.","authors":["Furuta Y","Hogan BL"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Genes & development","journalShort":"Genes Dev.","day":1,"month":12,"year":1998,"meshHeadings":["Animals","Antigens, Differentiation","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Proteins","DNA-Binding Proteins","Ectoderm","Embryonic Induction","Eye","Eye Proteins","Gene Expression Regulation, Developmental","Homeodomain Proteins","Homozygote","In Vitro Techniques","Lens, Crystalline","Mesoderm","Mice","Mice, Mutant Strains","Models, Biological","Nervous System","Paired Box Transcription Factors","Receptors, Cell Surface","Receptors, Growth Factor","Repressor Proteins","Tissue Transplantation"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Vertebrate lens development is a classical model system for studying embryonic tissue interactions. Little is known, however, about the molecules mediating such inductive events. Here, we show that Bmp4, which is expressed strongly in the optic vesicle and weakly in the surrounding mesenchyme and surface ectoderm, has crucial roles during lens induction. In Bmp4(tm1) homozygous null mutant embryos, lens induction is absent, but the process can be rescued by exogenous BMP4 protein applied into the optic vesicle in explant cultures. This is associated with rescue of ectodermal expression of Sox2, an early lens placode marker. Substituting the optic vesicle in explant cultures with BMP4-carrying beads, however, does not lead to lens induction, indicating that other factors produced by the optic vesicle are involved. BMP4 appears to regulate expression of a putative downstream gene, Msx2, in the optic vesicle. No change in Pax6 expression is seen in Bmp4(tm1) mutant eyes, and Bmp4 expression appears unaffected in the eyes of homozygous Pax6(Sey-1Neu), suggesting that PAX6 and BMP4 function independently. Based on these results we propose that BMP4 is required for the optic vesicle to manifest its lens-inducing activity, by regulating downstream genes and/or serving as one component of multiple inductive signals.","affiliation":[]},{"pmid":"9547239","pmcid":null,"title":"Development of bone morphogenetic protein receptors in the nervous system and possible roles in regulating trkC expression.","authors":["Zhang D","Mehler MF","Song Q","Kessler JA"],"grantIds":["NS20013","NS20778","NS35320","R01 MH066290"],"grantAgencies":["NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NIMH NIH HHS"],"retractions":[],"journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","journalShort":"J. Neurosci.","day":1,"month":5,"year":1998,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Protein Receptors, Type I","Brain","Embryonic and Fetal Development","Ganglia, Spinal","Ganglia, Sympathetic","In Situ Hybridization","Mice","Nerve Growth Factors","Nervous System","Nervous System Physiological Phenomena","Neurotrophin 3","Peptide Fragments","RNA, Messenger","Receptor Protein-Tyrosine Kinases","Receptor, trkC","Receptors, Cell Surface","Receptors, Growth Factor","Receptors, Nerve Growth Factor","Superior Cervical Ganglion"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Characterization of bone morphogenetic protein receptor (BMPR) expression during development is necessary for understanding the role of these factors during neural maturation. In this study, in situ hybridization analyses demonstrate that BMP-specific type I (BMPR-IA and BMPR-IB) and type II (BMPR-II) receptor mRNAs are expressed at significant levels in multiple regions of the CNS, cranial ganglia, and peripheral sensory and autonomic ganglia during the embryonic and neonatal periods. All three BMP receptor subunits are expressed within periventricular generative zones. BMPR-IA is more abundant than the other receptor subtypes, with widespread expression in the brain, cranial ganglia, and peripheral ganglia. By contrast, BMPR-IB mRNA displays significant expression within more restricted regions, including the anterior olfactory nuclei. BMPR-II mRNA exhibits peak expression within the cerebellar Purkinje cell layer and the hippocampus, as well as within cranial ganglia. The distribution of BMP receptors within large neurons in adult dorsal root ganglia suggested a possible role in regulating expression of the neurotrophin receptor trkC. This hypothesis was tested in explant cultures of embryonic day 15 (E15) and postnatal day 1 (P1) sympathetic superior cervical ganglia (SCG). Treatment of the E15 or the P1 SCG with BMP-2 induced expression of trkC mRNA and responsiveness of sympathetic neurons to NT3 as measured by neurite outgrowth. The pattern of expression of BMP receptors in embryonic brain suggests several potentially novel areas for further developmental analysis and supports numerous recent studies that indicate that BMPs have a broad range of cellular functions during neural development and in adult life.","affiliation":[]},{"pmid":"8065329","pmcid":null,"title":"Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells.","authors":["Koenig BB","Cook JS","Wolsing DH","Ting J","Tiesman JP","Correa PE","Olson CA","Pecquet AL","Ventura F","Grant RA"],"grantIds":["CA34610"],"grantAgencies":["NCI NIH HHS"],"retractions":[],"journal":"Molecular and cellular biology","journalShort":"Mol. Cell. Biol.","day":19,"month":9,"year":1994,"meshHeadings":["3T3 Cells","Amino Acid Sequence","Animals","Base Sequence","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Caenorhabditis elegans Proteins","Cloning, Molecular","Gene Expression","Helminth Proteins","Mice","Molecular Sequence Data","Oligonucleotide Probes","Protein-Serine-Threonine Kinases","Proteins","RNA, Messenger","Receptor Protein-Tyrosine Kinases","Receptors, Cell Surface","Receptors, Growth Factor","Receptors, Transforming Growth Factor beta","Recombinant Proteins","Sequence Alignment","Sequence Homology, Amino Acid","Tissue Distribution"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The bone morphogenetic proteins (BMPs) are a group of transforming growth factor beta (TGF-beta)-related factors whose only receptor identified to date is the product of the daf-4 gene from Caenorhabditis elegans. Mouse embryonic NIH 3T3 fibroblasts display high-affinity 125I-BMP-4 binding sites. Binding assays are not possible with the isoform 125I-BMP-2 unless the positively charged N-terminal sequence is removed to create a modified BMP-2, 125I-DR-BMP-2. Cross-competition experiments reveal that BMP-2 and BMP-4 interact with the same binding sites. Affinity cross-linking assays show that both BMPs interact with cell surface proteins corresponding in size to the type I (57- to 62-kDa) and type II (75- to 82-kDa) receptor components for TGF-beta and activin. Using a PCR approach, we have cloned a cDNA from NIH 3T3 cells which encodes a novel member of the transmembrane serine/threonine kinase family most closely resembling the cloned type I receptors for TGF-beta and activin. Transient expression of this receptor in COS-7 cells leads to an increase in specific 125I-BMP-4 binding and the appearance of a major affinity-labeled product of approximately 64 kDa that can be labeled by either tracer. This receptor has been named BRK-1 in recognition of its ability to bind BMP-2 and BMP-4 and its receptor kinase structure. Although BRK-1 does not require cotransfection of a type II receptor in order to bind ligand in COS cells, complex formation between BRK-1 and the BMP type II receptor DAF-4 can be demonstrated when the two receptors are coexpressed, affinity labeled, and immunoprecipitated with antibodies to either receptor subunit. We conclude that BRK-1 is a putative BMP type I receptor capable of interacting with a known type II receptor for BMPs.","affiliation":[]},{"pmid":"8707881","pmcid":null,"title":"Analysis of the native murine bone morphogenetic protein serine threonine kinase type I receptor (ALK-3).","authors":["Wu X","Robinson CE","Fong HW","Gimble JM"],"grantIds":["CA50898"],"grantAgencies":["NCI NIH HHS"],"retractions":[],"journal":"Journal of cellular physiology","journalShort":"J. Cell. Physiol.","day":12,"month":8,"year":1996,"meshHeadings":["Animals","Base Sequence","Blotting, Northern","Blotting, Western","Bone Marrow","Bone Marrow Cells","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Differentiation","Cell Line","Cell Membrane","Cloning, Molecular","Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase","Mice","Molecular Sequence Data","Muscle Fibers, Skeletal","Phenotype","Precipitin Tests","Protein-Serine-Threonine Kinases","Proteins","Receptors, Growth Factor","Stromal Cells","Uridine Monophosphate"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The bone morphogenetic proteins, members of the transforming growth factor-beta cytokine family, induce the osteoblast phenotype and promote osteogenesis in the bone marrow stroma. Simultaneously, these cytokines inhibit other mesodermal differentiation pathways, such as adipogenesis and myogenesis. The receptors for the bone morphogenetic proteins belong to a family of transmembrane serine/ threonine kinase TGF beta type I and type II receptor proteins. In man, these include the activin receptor like kinase-3 (ALK-3), a type I receptor protein. We have used a polyclonal antibody to examine the expression of the native murine ALK-3 protein in murine tissues and bone morphogenetic protein-responsive cell lines. On Western blot analyses, we found that the native 85 kDa native ALK-3 protein was expressed in a number of murine tissues; protein and mRNA levels did not necessarily correlate. Two bone morphogenetic protein-responsive cell lines, BMS2 bone marrow stromal cells and C2C12 myoblasts, expressed the ALK-3 protein constitutively. Cell differentiation was accompanied by modest changes in ALK-3 protein levels. Immunoprecipitation of the ALK-3 protein cross linked to [125I] BMP-4 revealed two major receptor complexes of approximately 90 kDa and 170 kDa in size. Biotin surface-labeling experiments revealed that the 85 kDa ALK-3 protein was constitutively associated with a novel 140 kDa surface glycoprotein. Deglycosylation reduced the protein's size to 116 kDa, comparable in size to that of the recently described BMP type II receptor. These findings support the current model that BMP interacts with a pre-existing complex consisting of a type I and type II receptor protein.","affiliation":[]},{"pmid":"8889548","pmcid":null,"title":"Normalization and subtraction: two approaches to facilitate gene discovery.","authors":["Bonaldo MF","Lennon G","Soares MB"],"grantIds":["R01 HG00980"],"grantAgencies":["NHGRI NIH HHS"],"retractions":[],"journal":"Genome research","journalShort":"Genome Res.","day":13,"month":9,"year":1996,"meshHeadings":["Adult","Animals","Base Sequence","Cloning, Molecular","DNA Primers","DNA, Complementary","Female","Gene Library","Genetic Techniques","Humans","Mice","Molecular Sequence Data","Multiple Sclerosis","Plasmids","Polymerase Chain Reaction","RNA, Messenger","Rats","Schistosoma mansoni"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Large-scale sequencing of cDNAs randomly picked from libraries has proven to be a very powerful approach to discover (putatively) expressed sequences that, in turn, once mapped, may greatly expedite the process involved in the identification and cloning of human disease genes. However, the integrity of the data and the pace at which novel sequences can be identified depends to a great extent on the cDNA libraries that are used. Because altogether, in a typical cell, the mRNAs of the prevalent and intermediate frequency classes comprise as much as 50-65% of the total mRNA mass, but represent no more than 1000-2000 different mRNAs, redundant identification of mRNAs of these two frequency classes is destined to become overwhelming relatively early in any such random gene discovery programs, thus seriously compromising their cost-effectiveness. With the goal of facilitating such efforts, previously we developed a method to construct directionally cloned normalized cDNA libraries and applied it to generate infant brain (INIB) and fetal liver/spleen (INFLS) libraries, from which a total of 45,192 and 86,088 expressed sequence tags, respectively, have been derived. While improving the representation of the longest cDNAs in our libraries, we developed three additional methods to normalize cDNA libraries and generated over 35 libraries, most of which have been contributed to our integrated Molecular Analysis of Genomes and Their Expression (IMAGE) Consortium and thus distributed widely and used for sequencing and mapping. In an attempt to facilitate the process of gene discovery further, we have also developed a subtractive hybridization approach designed specifically to eliminate (or reduce significantly the representation of) large pools of arrayed and (mostly) sequenced clones from normalized libraries yet to be (or just partly) surveyed. Here we present a detailed description and a comparative analysis of four methods that we developed and used to generate normalize cDNA libraries from human (15), mouse (3), rat (2), as well as the parasite Schistosoma mansoni (1). In addition, we describe the construction and preliminary characterization of a subtracted liver/spleen library (INFLS-SI) that resulted from the elimination (or reduction of representation) of -5000 INFLS-IMAGE clones from the INFLS library.","affiliation":[]},{"pmid":"7818535","pmcid":null,"title":"Genomic organization and chromosomal location of the mouse type I BMP-2/4 receptor.","authors":["Mishina Y","Suzuki A","Gilbert DJ","Copeland NG","Jenkins NA","Ueno N","Behringer RR"],"grantIds":["CA16672","HD30284","N01-CO-74101"],"grantAgencies":["NCI NIH HHS","NICHD NIH HHS","NCI NIH HHS"],"retractions":[],"journal":"Biochemical and biophysical research communications","journalShort":"Biochem. Biophys. Res. Commun.","day":5,"month":1,"year":1995,"meshHeadings":["Amino Acid Sequence","Animals","Base Sequence","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Proteins","Chromosome Mapping","Consensus Sequence","Crosses, Genetic","Exons","Female","Introns","Male","Mice","Mice, Inbred C57BL","Molecular Sequence Data","Muridae","Polymorphism, Restriction Fragment Length","Protein Biosynthesis","Proteins","Receptors, Cell Surface","Receptors, Growth Factor"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"We have characterized the structure of a mouse bone morphogenetic protein (BMP) type I receptor gene that can bind both BMP-2 and BMP-4. The mouse BMP-2/4 receptor gene is encoded by 11 exons and spans approximately 38-kb. Most of the intron/exon boundaries are not conserved compared to the kinase domain of the related, activin type II receptor. In addition, whereas the activin type II receptor gene contains large introns (> 40 kb), the largest intron of the BMP-2/4 receptor gene is only 6.4-kb. The BMP-2/4 receptor gene (Bmpr) was mapped to mouse chromosome 14. Bmpr is closely linked to Rbp3 in the region containing pugnose, a mutation that alters bone development. Knowledge of the genomic structure of Bmpr provides important information to create Bmpr-deficient mice.","affiliation":[]},{"pmid":"7937936","pmcid":null,"title":"A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo.","authors":["Suzuki A","Thies RS","Yamaji N","Song JJ","Wozney JM","Murakami K","Ueno N"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Proceedings of the National Academy of Sciences of the United States of America","journalShort":"Proc. Natl. Acad. Sci. U.S.A.","day":25,"month":10,"year":1994,"meshHeadings":["Amino Acid Sequence","Animals","Base Sequence","Blastomeres","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Proteins","Cloning, Molecular","DNA Primers","Embryo, Nonmammalian","Embryonic and Fetal Development","Growth Substances","Humans","In Situ Hybridization","Mice","Molecular Sequence Data","Polymerase Chain Reaction","Protein-Serine-Threonine Kinases","Proteins","RNA, Messenger","Receptors, Cell Surface","Receptors, Growth Factor","Recombinant Proteins","Sequence Homology, Amino Acid","Signal Transduction","Transforming Growth Factor beta","Xenopus laevis"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (BMPs), which are members of the transforming growth factor beta (TGF-beta) superfamily, have been implicated in bone formation and the regulation of early development. To better understand the roles of BMPs in Xenopus laevis embryogenesis, we have cloned a cDNA coding for a serine/threonine kinase receptor that binds BMP-2 and BMP-4. To analyze its function, we attempted to block the BMP signaling pathway in Xenopus embryos by using a dominant-negative mutant of the BMP receptor. When the mutant receptor lacking the putative serine/threonine kinase domain was expressed in ventral blastomeres of Xenopus embryos, these blastomeres were respecified to dorsal mesoderm, eventually resulting in the formation of a secondary body axis. These findings suggest that endogenous BMP-2 and BMP-4 are involved in the dorsal-ventral specification in the embryo and that ventral fate requires induction rather than resulting from an absence of dorsal specification.","affiliation":[]},{"pmid":"8674409","pmcid":null,"title":"Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis.","authors":["Bellusci S","Henderson R","Winnier G","Oikawa T","Hogan BL"],"grantIds":["AR41943","HD28955","ST32HL07256"],"grantAgencies":["NIAMS NIH HHS","NICHD NIH HHS","OHS HRSA HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":12,"month":6,"year":1996,"meshHeadings":["Animals","Base Sequence","Bone Morphogenetic Protein 7","Bone Morphogenetic Proteins","Cell Death","Cell Division","DNA Primers","DNA-Binding Proteins","Epithelial Cells","Gene Expression","Hedgehog Proteins","Hepatocyte Nuclear Factor 3-beta","Humans","Lung","Mesoderm","Mice","Mice, Inbred C57BL","Mice, Inbred DBA","Mice, Transgenic","Molecular Sequence Data","Morphogenesis","Nuclear Proteins","Protein Biosynthesis","Proteins","Proteolipids","Proto-Oncogene Proteins","Pulmonary Surfactants","Rats","Recombinant Fusion Proteins","Trans-Activators","Transcription Factors","Transforming Growth Factor beta","Wnt2 Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Epithelial-mesenchymal interactions are critical for the branching and differentiation of the lung, but the mechanisms involved are still unclear. To investigate this problem in mouse embryonic lung, we have studied the temporal and spatial expression of genes implicated in the morphogenesis of other organs. At 11.5 days p.c., hepatocyte nuclear factor-3beta (Hnf-3beta) is expressed uniformly throughout the epithelium, while Wnt-2 expression is confined to the distal mesenchyme. Sonic hedgehog (Shh) transcripts are found throughout the epithelium, with high levels in the distal tips of the terminal buds, while bone morphogenetic protein-4 (Bmp-4) transcripts are localized at high levels in the distal tips of the epithelium, with lower levels in the adjacent mesenchyme. Epithelial expression is also seen for Bmp-7, but transcripts are less dramatically upregulated at the distal tips. The Type I Bone morphogenetic protein receptor gene (Bmpr/Tfr-11/Brk-1) is expressed at low levels in the epithelium and in the distal mesenchyme. To investigate the role of Bmp-4 in lung development, we have misexpressed the gene throughout the distal epithelium of transgenic lungs using a surfactant protein C enhancer/promoter. From 15.5 days p.c., transgenic lungs are smaller than normal, with grossly distended terminal buds and, at birth, contain large air-filled sacs which do not support normal lung function. Labeling with BrdU reveals an inhibition of epithelia] proliferation in 15.5 days p.c. transgenic lungs. A small but significant stimulation of proliferation of mesenchymal cells is also observed, but this is accompanied by an increase in cell death. In situ hybridization with riboprobes for the proximal airway marker, CC10, and the distal airway marker, SP-C, shows normal differentiation of bronchiolar Clara cells but a reduction in the number of differentiated Type II cells in transgenic lungs. A model is proposed for the role of BMP4 and other signalling molecules in embryonic lung morphogenesis.","affiliation":[]},{"pmid":"7750489","pmcid":null,"title":"Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis.","authors":["Dewulf N","Verschueren K","Lonnoy O","Morn A","Grimsby S","Vande Spiegle K","Miyazono K","Huylebroeck D","Ten Dijke P"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Endocrinology","journalShort":"Endocrinology","day":19,"month":6,"year":1995,"meshHeadings":["Activin Receptors","Amino Acid Sequence","Animals","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Protein Receptors, Type I","Cloning, Molecular","Embryonic and Fetal Development","Gene Expression Regulation, Developmental","Humans","Mice","Molecular Sequence Data","Protein-Serine-Threonine Kinases","RNA, Messenger","Receptors, Cell Surface","Receptors, Growth Factor","Sequence Homology, Amino Acid","Tissue Distribution"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (BMPs) are multifunctional proteins structurally related to transforming growth factor-beta (TGF beta) and activin that can induce cartilage and bone growth in vivo. Members of the TGF beta superfamily exert their biological effects via heteromeric serine/threonine kinase complexes of type I and type II receptors. We previously obtained six different type I receptors, termed activin receptor-like kinase-1 (ALK-1) to -6. ALK-5 is a TGF beta type I receptor, ALK-2 and ALK-4 are activin type I receptors, and ALK-3 and ALK-6 are type I receptors for osteogenic protein-1 (OP-1)/bone morphogenetic protein-7 (BMP-7) and BMP-4. Here we report the complementary DNA cloning of the mouse homolog of ALK-3, which is highly conserved between mouse and man. ALK-3 messenger RNA (mRNA) is ubiquitously expressed in various adult mouse tissues, whereas ALK-6 mRNA is only found in brain and lung. The distribution of ALK-3 and ALK-6 mRNA in the postimplantation mouse embryo [6.5-15.5 days postcoitum (pc)] was studied by in situ hybridization. ALK-3 was nearly ubiquitously expressed throughout these stages of development, but was notably absent in the liver. In contrast, ALK-6 showed a more restricted expression pattern. ALK-6 mRNA was absent in early postimplantation embryos, was detected first in 9.5 days pc embryos, and persisted until 15.5 days pc. In midgestation embryos, ALK-6 transcripts were detected in mesenchymal precartilage condensations, premuscle masses, blood vessels, central nervous system, parts of the developing ear and eye, and epithelium. The expression in sites of developing cartilage and bone supports the idea that ALK-3 and -6 are receptors for BMPs in vivo. In addition, the expression of these genes in many soft tissues suggests broader functions for BMPs in embryogenesis.","affiliation":[]},{"pmid":"8592941","pmcid":null,"title":"Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation.","authors":["Ishidou Y","Kitajima I","Obama H","Maruyama I","Murata F","Imamura T","Yamada N","ten Dijke P","Miyazono K","Sakou T"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","journalShort":"J. Bone Miner. Res.","day":3,"month":11,"year":1995,"meshHeadings":["Animals","Antibodies","Bone Development","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Femoral Fractures","Fibroblasts","Growth Substances","Immunohistochemistry","Mice","Mice, Inbred C57BL","Osteoblasts","Proteins","Rats","Rats, Wistar","Receptors, Cell Surface","Receptors, Growth Factor","Tissue Fixation"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Type I receptors for bone morphogenetic proteins (BMPs), i.e., BMPR-IA and BMPR-IB, are transmembrane serine/threonine kinases, that bind osteogenic protein-1 (OP-1, also termed BMP-7) and BMP-4. Using antibodies specific to BMPR-IA and -IB, we have studied the expression of BMP type I receptors in the bone formation process during embryonic development and fracture healing. In the mouse embryo, both BMPR-IA and -IB were expressed in condensing mesenchymal cells at 13.5 days post coitum (p.c.). At 15.5 days p.c., expression of BMPR-IB, but not of BMPR-IA, was observed in the cells in perichondrium of developing cartilage. At 17.5 and 19.5 days p.c., expression of both receptors was observed in chondrocytes and in osteoblasts. In normal rat adult bone, expression of BMPR-IA, but not of BMPR-IB, was observed in osteoblasts in the periosteum. Three days after the femoral fracture, expression of BMPR-IA and -IB was up-regulated in cells at the proliferating osteogenic layer of the periosteum. On day 7, both receptors were found in fibroblast-like spindle cells and chondrocytes in the endochondral ossification sites, and osteoblasts in the newly formed trabecular bone. Expression of BMPR-IA was higher than that BMPR-IB in osteogenic layer on day 3 and in osteoblasts in the trabecular bone on day 7. On day 14, expression of BMP type I receptors was observed at similar sites, albeit with lower expression levels than were observed on day 7. The present data suggest that expression of BMP type I receptors is up-regulated during bone formation, and that they may play important roles in bone morphogenesis.","affiliation":[]},{"pmid":"9303341","pmcid":null,"title":"Differential expression of BMP receptors in early mouse development.","authors":["Roelen BA","Goumans MJ","van Rooijen MA","Mummery CL"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"The International journal of developmental biology","journalShort":"Int. J. Dev. Biol.","day":9,"month":8,"year":1997,"meshHeadings":["Animals","Blastocyst","Bone Morphogenetic Protein Receptors","Carcinoma, Embryonal","Cells, Cultured","DNA Probes","Embryo, Mammalian","Embryonic and Fetal Development","Gene Expression Regulation, Developmental","In Situ Hybridization","Mice","Morula","Polymerase Chain Reaction","RNA, Messenger","Receptors, Cell Surface","Receptors, Growth Factor","Stem Cells","Transcription, Genetic","Tumor Cells, Cultured","Uridine Monophosphate"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-beta family of polypeptide signaling molecules. They function via binding to two types of transmembrane serine/threonine kinase receptors, type I and type II receptors, that are both necessary for signaling. The expression patterns of the type II BMP receptor (BMPR-II) and three type I BMP receptors (ActR-I, BMPR-IA and BMPR-IB) were examined in preimplantation embryos by means of heminested reverse transcription-polymerase chain reaction (RT-PCR). BMPR-II mRNA was detected in one-cell, two-cell and blastocyst stage embryos. ActR-I exhibited a similar expression pattern. BMPR-IA mRNA however was only detected in blastocysts, whereas BMPR-IB transcripts were detected at all stages from the one-cell zygote to the uncompacted morula, but not in the compacted morula and blastocyst. If translated into proteins, this suggests that different receptor complexes can be formed at different developmental stages. Transcripts for BMPs were not detected in preimplantation embryos, but were detected in the maternal tissues surrounding the embryos. BMPR-II, BMPR-IA and BMPR-IB mRNAs were also detected in undifferentiated and differentiated embryonal carcinoma and embryonic stem cells. In postimplantation embryos BMPR-II transcripts were first detected from 6.0 days post coitum. In situ hybridization analysis revealed that BMPR-II mRNA is ubiquitously expressed in the entire embryo at least until midgestation.","affiliation":[]},{"pmid":"10631181","pmcid":null,"title":"Combinatorial signaling through BMP receptor IB and GDF5: shaping of the distal mouse limb and the genetics of distal limb diversity.","authors":["Baur ST","Mai JJ","Dymecki SM"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":9,"month":2,"year":2000,"meshHeadings":["Animals","Apoptosis","Body Patterning","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Bone and Bones","Cartilage, Articular","Chromosome Mapping","Extremities","Gene Expression Regulation, Developmental","Genotype","Growth Differentiation Factor 5","Growth Substances","Mice","Mice, Transgenic","Osteogenesis","Promoter Regions, Genetic","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Toes","Transcription, Genetic"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"In this study, we use a mouse insertional mutant to delineate gene activities that shape the distal limb skeleton. A recessive mutation that results in brachydactyly was found in a lineage of transgenic mice. Sequences flanking the transgene insertion site were cloned, mapped to chromosome 3, and used to identify the brachydactyly gene as the type IB bone morphogenetic protein receptor, BmprIB (ALK6). Expression analyses in wild-type mice revealed two major classes of BmprIB transcripts. Rather than representing unique coding RNAs generated by alternative splicing of a single pro-mRNA transcribed from one promoter, the distinct isoforms reflect evolution of two BmprIB promoters: one located distally, driving expression in the developing limb skeleton, and one situated proximally, initiating transcription in neural epithelium. The distal promoter is deleted in the insertional mutant, resulting in a regulatory allele (BmprIB(Tg)) lacking cis-sequences necessary for limb BmprIB expression. Mutants fail to generate digit cartilage, indicating that BMPRIB is the physiologic transducer for the formation of digit cartilage from the skeletal blastema. Expansion of BmprIB expression into the limb through acquisition of these distal cis-regulatory sequences appears, therefore, to be an important genetic component driving morphological diversity in distal extremities. GDF5 is a BMP-related signal, which is also required for proper digit formation. Analyses incorporating both Gdf5 and BmprIB(Tg) alleles revealed that BMPRIB regulates chondrogenesis and segmentation through both GDF5-dependent and -independent processes, and that, reciprocally, GDF5 acts through both IB and other type I receptors. Together, these findings provide in vivo support for the concept of combinatorial BMP signaling, in which distinct outcomes result both from a single receptor being triggered by different ligands and from a single ligand binding to different receptors.","affiliation":[]},{"pmid":"10725249","pmcid":null,"title":"Large-scale cDNA analysis reveals phased gene expression patterns during preimplantation mouse development.","authors":["Ko MS","Kitchen JR","Wang X","Threat TA","Wang X","Hasegawa A","Sun T","Grahovac MJ","Kargul GJ","Lim MK","Cui Y","Sano Y","Tanaka T","Liang Y","Mason S","Paonessa PD","Sauls AD","DePalma GE","Sharara R","Rowe LB","Eppig J","Morrell C","Doi H"],"grantIds":["R01HD32243"],"grantAgencies":["NICHD NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":30,"month":4,"year":2000,"meshHeadings":["Animals","Chromosome Mapping","DNA, Complementary","Embryonic Development","Expressed Sequence Tags","Female","Gene Expression","Gene Library","Humans","Male","Mice","Mice, Inbred C57BL","Pregnancy"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Little is known about gene action in the preimplantation events that initiate mammalian development. Based on cDNA collections made from each stage from egg to blastocyst, 25438 3'-ESTs were derived, and represent 9718 genes, half of them novel. Thus, a considerable fraction of mammalian genes is dedicated to embryonic expression. This study reveals profound changes in gene expression that include the transient induction of transcripts at each stage. These results raise the possibility that development is driven by the action of a series of stage-specific expressed genes. The new genes, 798 of them placed on the mouse genetic map, provide entry points for analyses of human and mouse developmental disorders.","affiliation":[]},{"pmid":"11701996","pmcid":null,"title":"Expression of bone morphogenetic protein receptors in the developing mouse metanephros.","authors":["Martinez G","Loveland KL","Clark AT","Dziadek M","Bertram JF"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Experimental nephrology","journalShort":"Exp. Nephrol.","day":9,"month":11,"year":2001,"meshHeadings":["Activin Receptors, Type I","Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Protein Receptors, Type II","Embryo, Mammalian","Embryonic and Fetal Development","Histocytochemistry","In Situ Hybridization","Kidney","Mice","Mice, Inbred BALB C","Protein-Serine-Threonine Kinases","RNA, Messenger","Receptors, Growth Factor","Reverse Transcriptase Polymerase Chain Reaction","Tissue Distribution"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"While bone morphogenetic proteins (BMPs) 2, 4 and 7 have recently been implicated in aspects of metanephric development, and expression patterns of these ligands have been described in the developing metanephros, the distribution of BMP receptors in developing metanephroi remains unknown. In the present study, in situ hybridisation histochemistry was used to localise mRNAs for BMP type-I receptors (BMPR-IA and BMPR-IB) and the BMP type-II receptor (BMPR-II) in developing mouse metanephroi. At embryonic day 12.5 (E12.5) and E14.5 transcripts for BMP type-I receptors were localised to the tips and body of the branching ureter as well as mesenchymal condensates, developing vesicles and comma-shaped bodies. Localisation of BMPR-II transcripts was similar although expression was not observed in the body of the ureter. At E17.5, transcripts for all three receptors were localised in the nephrogenic zone including ureteric tips, vesicles, comma- and S-shaped bodies as well the body of the ureter and in tubules. BMP type-I and type-II receptor transcripts co-localised with each other, in agreement with the well-documented evidence that BMPs signal via heterotetrameric complexes of type-I and type-II receptors and with the previously reported metanephric expression pattern of BMPs. These patterns of receptor expression suggest that these molecules are important regulators of epithelial-mesenchymal interactions, nephron development and ureteric branching morphogenesis.","affiliation":[]},{"pmid":"11042159","pmcid":null,"title":"Normalization and subtraction of cap-trapper-selected cDNAs to prepare full-length cDNA libraries for rapid discovery of new genes.","authors":["Carninci P","Shibata Y","Hayatsu N","Sugahara Y","Shibata K","Itoh M","Konno H","Okazaki Y","Muramatsu M","Hayashizaki Y"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Genome research","journalShort":"Genome Res.","day":15,"month":10,"year":2000,"meshHeadings":["Animals","Cloning, Molecular","Cricetinae","DNA, Complementary","Female","Gene Library","Male","Mice","Pregnancy","RNA Caps","Reproducibility of Results","Sensitivity and Specificity"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"In the effort to prepare the mouse full-length cDNA encyclopedia, we previously developed several techniques to prepare and select full-length cDNAs. To increase the number of different cDNAs, we introduce here a strategy to prepare normalized and subtracted cDNA libraries in a single step. The method is based on hybridization of the first-strand, full-length cDNA with several RNA drivers, including starting mRNA as the normalizing driver and run-off transcripts from minilibraries containing highly expressed genes, rearrayed clones, and previously sequenced cDNAs as subtracting drivers. Our method keeps the proportion of full-length cDNAs in the subtracted/normalized library high. Moreover, our method dramatically enhances the discovery of new genes as compared to results obtained by using standard, full-length cDNA libraries. This procedure can be extended to the preparation of full-length cDNA encyclopedias from other organisms.","affiliation":[]},{"pmid":"12783783","pmcid":null,"title":"Loss of Bmp7 and Fgf8 signaling in Hoxa13-mutant mice causes hypospadia.","authors":["Morgan EA","Nguyen SB","Scott V","Stadler HS"],"grantIds":["5R01DK5915-01"],"grantAgencies":["NIDDK NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":4,"month":7,"year":2003,"meshHeadings":["Animals","Antigens, CD31","Apoptosis","Bone Morphogenetic Protein 7","Bone Morphogenetic Proteins","Cell Division","Fibroblast Growth Factor 8","Fibroblast Growth Factors","Heterozygote","Homeodomain Proteins","Homozygote","Humans","Hypospadias","Immunohistochemistry","In Situ Hybridization","In Situ Nick-End Labeling","Male","Mice","Mice, Mutant Strains","Microscopy, Fluorescence","Mitosis","Models, Biological","Mutation","Penis","Phenotype","RNA","Signal Transduction","Time Factors","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"In humans and mice, mutations in Hoxa13 cause malformation of limb and genitourinary (GU) regions. In males, one of the most common GU malformations associated with loss of Hoxa13 function is hypospadia, a condition defined by the poor growth and closure of the urethra and glans penis. By examining early signaling in the developing mouse genital tubercle, we show that Hoxa13 is essential for normal expression of Fgf8 and Bmp7 in the urethral plate epithelium. In Hoxa13(GFP)-mutant mice, hypospadias occur as a result of the combined loss of Fgf8 and Bmp7 expression in the urethral plate epithelium, as well as the ectopic expression of noggin (Nog) in the flanking mesenchyme. In vitro supplementation with Fgf8 restored proliferation in homozygous mutants to wild-type levels, suggesting that Fgf8 is sufficient to direct early proliferation of the developing genital tubercle. However, the closure defects of the distal urethra and glans can be attributed to a loss of apoptosis in the urethra, which is consistent with reduced Bmp7 expression in this region. Mice mutant for Hoxa13 also exhibit changes in androgen receptor expression, providing a developmental link between Hoxa13-associated hypospadias and those produced by antagonists to androgen signaling. Finally, a novel role for Hoxa13 in the vascularization of the glans penis is also identified.","affiliation":[]},{"pmid":"10512203","pmcid":null,"title":"Exchangeable gene trap using the Cre/mutated lox system.","authors":["Araki K","Imaizumi T","Sekimoto T","Yoshinobu K","Yoshimuta J","Akizuki M","Miura K","Araki M","Yamamura K"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Cellular and molecular biology (Noisy-le-Grand, France)","journalShort":"Cell. Mol. Biol. (Noisy-le-grand)","day":24,"month":7,"year":1999,"meshHeadings":["Animals","Clone Cells","Genetic Techniques","Genetic Vectors","Green Fluorescent Proteins","Integrases","Luminescent Proteins","Mice","Mutagenesis","Mutation","Plasmids","Stem Cells","Viral Proteins","beta-Galactosidase"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The gene trap technique is a powerful approach for characterizing and mutating genes involved in mouse development. However, one shortcoming of gene trapping is the relative inability to induce subtle mutations. This problem can be overcome by introducing a knock-in system into the gene trap strategy. Here, we have constructed a new gene trap vector, pU-Hachi, employing the Cre-mutated lox system (Araki et al., 1997), in which a pair of mutant lox, lox71 and lox66, was used to promote targeted integrative reaction by Cre recombinase. The pU-Hachi carries splicing acceptor (SA)-lox71-internal ribosomal entry site (IRES)-beta-geo-pA-loxP-pA-pUC. By using this vector, we can carry out random insertional mutagenesis as the first step, and then we can replace the beta-geo gene with any gene of interest through Cre-mediated integration. We have isolated 109 trap clones electroporated with pU-Hachi, and analyzed their integration patterns by Southern blotting to select those carrying a single copy of the trap vector. By use of some of these clones, we have succeeded in exchanging the reporter gene at high efficiency, ranging between 20-80%. This integration system is also quite useful for plasmid rescue to recover flanking genomic sequences, because a plasmid vector sequence can be introduced even when the pUC sequence of the trap vector is lost through integration into the genome. Thus, this method, termed exchangeable gene trapping, has many advantages as the trapped clones can be utilized to express genes with any type of mutation.","affiliation":[]},{"pmid":"10349636","pmcid":null,"title":"High-efficiency full-length cDNA cloning.","authors":["Carninci P","Hayashizaki Y"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Methods in enzymology","journalShort":"Meth. Enzymol.","day":22,"month":7,"year":1999,"meshHeadings":["Animals","Bacteriophage lambda","Base Sequence","Cloning, Molecular","DNA, Complementary","DNA, Viral","Gene Library","Genetic Vectors","Indicators and Reagents","Mice"],"hasAbstract":false,"score":0,"snippets":[],"abstract":null,"affiliation":[]},{"pmid":"9268344","pmcid":null,"title":"A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts.","authors":["Namiki M","Akiyama S","Katagiri T","Suzuki A","Ueno N","Yamaji N","Rosen V","Wozney JM","Suda T"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"The Journal of biological chemistry","journalShort":"J. Biol. Chem.","day":29,"month":8,"year":1997,"meshHeadings":["Affinity Labels","Animals","Binding Sites","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","CHO Cells","Cell Differentiation","Cricetinae","Humans","Muscle Fibers, Skeletal","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Recombinant Proteins","Signal Transduction","Transfection","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Members of the transforming growth factor (TGF)-beta superfamily bind the transmembrane serine/threonine kinase complex consisting of type I and type II receptors. Their intracellular signals are propagated via respective type I receptors. Bone morphogenetic protein (BMP)-2, a member of the TGF-beta superfamily, induces ectopic bone formation when implanted into muscular tissues. Two type I receptors (BMPR-IA and BMPR-IB) have been identified for BMP-2. We have reported that BMP-2 inhibits the terminal differentiation of C2C12 myoblasts and converts their differentiation pathway into that of osteoblast lineage cells (Katagiri, T., Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikeda, T., Rosen, V., Wozney, J. M., Fujisawa-Sehara, A. and Suda, T. (1994) J. Cell Biol. 127, 1755-1766). In the present study, we examined the involvement of functional BMP-2 type I receptors in signal transduction in C2C12 cells, which expressed mRNA for BMPR-IA, but not for BMPR-IB in Northern blotting. TGF-beta type I receptor (TbetaR-I) mRNA was also expressed in C2C12 cells. Subclonal cell lines of C2C12 that stably expressed a kinase domain-truncated BMPR-IA (DeltaBMPR-IA) differentiated into myosin heavy chain-expressing myotubes but not into alkaline phosphatase (ALP)-positive cells, even in the presence of BMP-2. In contrast, the differentiation of the DeltaBMPR-IA-transfected C2C12 cells into myotubes was suppressed by TGF-beta1, as in the parental C2C12 cells. BMP-2 did not efficiently suppress the mRNA expression of muscle-specific genes such as muscle creatine kinase, MyoD, and myogenin, nor did it induce the expression of ALP mRNA in the DeltaBMPR-IA-transfected C2C12 cells. In contrast, TGF-beta1 inhibited mRNA expression of the muscle-specific genes in those cells. When wild-type BMPR-IA was transiently transfected into the DeltaBMPR-IA-transfected C2C12 cells, a number of ALP-positive cells appeared in the presence of BMP-2. Transfection of wild-type BMPR-IB or TbetaR-I failed to increase the number of ALP-positive cells. These results suggest that the BMP-2-induced signals, which inhibit myogenic differentiation and induce osteoblast differentiation, are transduced via BMPR-IA in C2C12 myoblasts.","affiliation":[]},{"pmid":"9207184","pmcid":null,"title":"cDNA cloning and genomic organization of the mouse BMP type II receptor.","authors":["Beppu H","Minowa O","Miyazono K","Kawabata M"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Biochemical and biophysical research communications","journalShort":"Biochem. Biophys. Res. Commun.","day":27,"month":6,"year":1997,"meshHeadings":["Alternative Splicing","Amino Acid Sequence","Animals","Base Sequence","Bone Morphogenetic Protein Receptors, Type II","Cell Line","Cloning, Molecular","Consensus Sequence","DNA, Complementary","Exons","Humans","Introns","Mice","Molecular Sequence Data","Protein-Serine-Threonine Kinases","RNA, Messenger","Receptors, Cell Surface","Recombinant Proteins","Sequence Homology, Amino Acid","Sequence Homology, Nucleic Acid"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The cDNA for the mouse bone morphogenetic protein type II receptor (BMPR-II) was isolated using the human counterpart as a probe and its genomic structure was determined. The cDNA encodes a protein of 1,038 amino acids with a single transmembrane domain, a serine/threonine kinase domain, and a long carboxy-terminal tail. The overall amino acid sequence identity between the mouse and the human BMPR-II is 96.6%. mRNA is widely distributed in various adult tissues. The gene is encoded by 13 exons spanning over 80 kb. Two large introns (intron 1 and 3) contribute to the majority of the gene size, as in the mouse activin type II receptor gene. The intron/exon boundaries were sequenced. The results suggest that alternative splicing can yield a shorter form of BMPR-II of 530 amino acids, as reported previously. Knowledge of the structure of the BMPR-II gene is essential for the understanding of the role of bone morphogenetic proteins in the developmental and physiological processes of animals.","affiliation":[]},{"pmid":"10922068","pmcid":null,"title":"Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray.","authors":["Tanaka TS","Jaradat SA","Lim MK","Kargul GJ","Wang X","Grahovac MJ","Pantano S","Sano Y","Piao Y","Nagaraja R","Doi H","Wood WH","Becker KG","Ko MS"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Proceedings of the National Academy of Sciences of the United States of America","journalShort":"Proc. Natl. Acad. Sci. U.S.A.","day":1,"month":8,"year":2000,"meshHeadings":["Amino Acid Sequence","Animals","Base Sequence","DNA Primers","DNA, Complementary","Embryo, Mammalian","Female","Gene Expression Regulation, Developmental","Genome","Mice","Mice, Inbred C57BL","Molecular Sequence Data","Nucleic Acid Hybridization","Placenta","Pregnancy","Pregnancy Proteins","Sequence Homology, Amino Acid"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"cDNA microarray technology has been increasingly used to monitor global gene expression patterns in various tissues and cell types. However, applications to mammalian development have been hampered by the lack of appropriate cDNA collections, particularly for early developmental stages. To overcome this problem, a PCR-based cDNA library construction method was used to derive 52,374 expressed sequence tags from pre- and peri-implantation embryos, embryonic day (E) 12.5 female gonad/mesonephros, and newborn ovary. From these cDNA collections, a microarray representing 15,264 unique genes (78% novel and 22% known) was assembled. In initial applications, the divergence of placental and embryonic gene expression profiles was assessed. At stage E12.5 of development, based on triplicate experiments, 720 genes (6.5%) displayed statistically significant differences in expression between placenta and embryo. Among 289 more highly expressed in placenta, 61 placenta-specific genes encoded, for example, a novel prolactin-like protein. The number of genes highly expressed (and frequently specific) for placenta has thereby been increased 5-fold over the total previously reported, illustrating the potential of the microarrays for tissue-specific gene discovery and analysis of mammalian developmental programs.","affiliation":[]},{"pmid":"10749566","pmcid":null,"title":"Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter.","authors":["Miyazaki Y","Oshima K","Fogo A","Hogan BL","Ichikawa I"],"grantIds":["DK37868","DK44757"],"grantAgencies":["NIDDK NIH HHS","NIDDK NIH HHS"],"retractions":[],"journal":"The Journal of clinical investigation","journalShort":"J. Clin. Invest.","day":22,"month":4,"year":2000,"meshHeadings":["Animals","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Count","Female","Gene Expression","Humans","Kidney","Male","Mice","Mice, Inbred C57BL","Mice, Knockout","Mutation","Organ Culture Techniques","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Stromal Cells","Ureter","Urinary Tract"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"In the normal mouse embryo, Bmp4 is expressed in mesenchymal cells surrounding the Wolffian duct (WD) and ureter stalk, whereas bone morphogenetic protein (BMP) type I receptor genes are transcribed either ubiquitously (Alk3) or exclusively in the WD and ureter epithelium (Alk6). Bmp4 heterozygous null mutant mice display, with high penetrance, abnormalities that mimic human congenital anomalies of the kidney and urinary tract (CAKUT), including hypo/dysplastic kidneys, hydroureter, ectopic ureterovesical (UV) junction, and double collecting system. Analysis of mutant embryos suggests that the kidney hypo/dysplasia results from reduced branching of the ureter, whereas the ectopic UV junction and double collecting system are due to ectopic ureteral budding from the WD and accessory budding from the main ureter, respectively. In the cultured metanephros deprived of sulfated glycosaminoglycans (S-GAGs), BMP4-loaded beads partially rescue growth and elongation of the ureter. By contrast, when S-GAGs synthesis is not inhibited, BMP4 beads inhibit ureter branching and expression of Wnt 11, a target of glial cell-derived neurotrophic factor signaling. Thus, Bmp4 has 2 functions in the early morphogenesis of the kidney and urinary tract. One is to inhibit ectopic budding from the WD or the ureter stalk by antagonizing inductive signals from the metanephric mesenchyme to the illegitimate sites on the WD. The other is to promote the elongation of the branching ureter within the metanephros, thereby promoting kidney morphogenesis.","affiliation":[]},{"pmid":"11401393","pmcid":null,"title":"Mesenchymal factor bone morphogenetic protein 4 restricts ductal budding and branching morphogenesis in the developing prostate.","authors":["Lamm ML","Podlasek CA","Barnett DH","Lee J","Clemens JQ","Hebner CM","Bushman W"],"grantIds":["DK 02426","DK 52687","P01 ES10549"],"grantAgencies":["NIDDK NIH HHS","NIDDK NIH HHS","NIEHS NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":15,"month":4,"year":2001,"meshHeadings":["Animals","Base Sequence","Bone Morphogenetic Protein 4","Bone Morphogenetic Proteins","Cell Division","DNA Primers","Epithelial Cells","Gene Expression Regulation, Developmental","Heterozygote","In Situ Hybridization","In Vitro Techniques","Male","Mesoderm","Mice","Mice, Inbred BALB C","Mice, Knockout","Mice, Mutant Strains","Morphogenesis","Prostate"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The budding of the urogenital sinus epithelium into the surrounding mesenchyme signals the onset of prostate morphogenesis. The epithelial and mesenchymal factors that regulate ductal budding and the ensuing process of ductal growth and branching are not fully known. We provide evidence that bone morphogenetic protein 4 (BMP4) is a mesenchymal factor that regulates ductal morphogenesis. The Bmp4 gene was most highly expressed in the male urogenital sinus from embryonic day 14 through birth, a period marked by formation of main prostatic ducts and initiation of ductal branching. From an initial wide distribution throughout the prostatic anlage of the urogenital sinus, Bmp4 expression became progressively restricted to the mesenchyme immediately surrounding the nascent prostatic ducts and branches. Exogenous BMP4 inhibited epithelial cell proliferation and exhibited a dose-dependent inhibition of ductal budding in urogenital sinus tissues cultured in vitro. Adult Bmp4 haploinsufficient mice exhibited an increased number of duct tips in both the ventral prostate and coagulating gland. Taken together, our data indicate that BMP4 is a urogenital sinus mesenchymal factor that restricts prostate ductal budding and branching morphogenesis.","affiliation":[]},{"pmid":"12354394","pmcid":null,"title":"BMP signaling is required locally to pattern the dorsal telencephalic midline.","authors":["Hbert JM","Mishina Y","McConnell SK"],"grantIds":["MH51864","NS12151"],"grantAgencies":["NIMH NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"Neuron","journalShort":"Neuron","day":12,"month":9,"year":2002,"meshHeadings":["Animals","Body Patterning","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Differentiation","Choroid Plexus","DNA-Binding Proteins","Female","Fetus","Forkhead Transcription Factors","Gene Expression Regulation, Developmental","Integrases","Mice","Mice, Knockout","Nerve Tissue Proteins","Neurons","Pregnancy","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Receptors, Transforming Growth Factor beta","Signal Transduction","Stem Cells","Telencephalon","Viral Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BMPs have been proposed to pattern the medial-lateral axis of the telencephalon in a concentration-dependent manner, thus helping to subdivide the embryonic telencephalon into distinct forebrain regions. Using a CRE/loxP genetic approach, we tested this hypothesis by disrupting the Bmpr1a gene in the telencephalon. In mutants, BMP signaling was compromised throughout the dorsal telencephalon, but only the most dorsalmedial derivative, the choroid plexus, failed to be specified or differentiate. Choroid plexus precursors remained proliferative and did not adopt the fate of their lateral telencephalic neighbors. These results demonstrate that BMP signaling is required for the formation of the most dorsal telencephalic derivative, the choroid plexus, and that BMP signaling plays an essential role in locally patterning the dorsal midline. Our data fail to support a more global, concentration-dependent role in specifying telencephalic cell fates.","affiliation":[]},{"pmid":"11511541","pmcid":null,"title":"Sequential actions of BMP receptors control neural precursor cell production and fate.","authors":["Panchision DM","Pickel JM","Studer L","Lee SH","Turner PA","Hazel TG","McKay RD"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Genes & development","journalShort":"Genes Dev.","day":15,"month":8,"year":2001,"meshHeadings":["Animals","Apoptosis","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Count","Cell Differentiation","Embryo, Mammalian","Epithelial Cells","Female","Hedgehog Proteins","Male","Mice","Mice, Inbred C3H","Mice, Inbred C57BL","Mice, Transgenic","Neurons","Protein-Serine-Threonine Kinases","Proteins","Receptor Cross-Talk","Receptors, Cell Surface","Receptors, Growth Factor","Signal Transduction","Trans-Activators"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (BMPs) have diverse and sometimes paradoxical effects during embryonic development. To determine the mechanisms underlying BMP actions, we analyzed the expression and function of two BMP receptors, BMPR-IA and BMPR-IB, in neural precursor cells in vitro and in vivo. Neural precursor cells always express Bmpr-1a, but Bmpr-1b is not expressed until embryonic day 9 and is restricted to the dorsal neural tube surrounding the source of BMP ligands. BMPR-IA activation induces (and Sonic hedgehog prevents) expression of Bmpr-1b along with dorsal identity genes in precursor cells and promotes their proliferation. When BMPR-IB is activated, it limits precursor cell numbers by causing mitotic arrest. This results in apoptosis in early gestation embryos and terminal differentiation in mid-gestation embryos. Thus, BMP actions are first inducing (through BMPR-IA) and then terminating (through BMPR-IB), based on the accumulation of BMPR-IB relative to BMPR-IA. We describe a feed-forward mechanism to explain how the sequential actions of these receptors control the production and fate of dorsal precursor cells from neural stem cells.","affiliation":[]},{"pmid":"12666204","pmcid":null,"title":"Expression and misexpression of members of the FGF and TGFbeta families of growth factors in the developing mouse pancreas.","authors":["Dichmann DS","Miller CP","Jensen J","Scott Heller R","Serup P"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Developmental dynamics : an official publication of the American Association of Anatomists","journalShort":"Dev. Dyn.","day":31,"month":4,"year":2003,"meshHeadings":["Animals","Bone Morphogenetic Proteins","Female","Fibroblast Growth Factor 1","Fibroblast Growth Factor 10","Fibroblast Growth Factor 7","Fibroblast Growth Factor 9","Fibroblast Growth Factors","Gene Expression Regulation, Developmental","Inhibin-beta Subunits","Inhibins","Mice","Mice, Inbred Strains","Mice, Transgenic","Pancreas","Pregnancy","Transforming Growth Factor beta","Transforming Growth Factor beta1","Transforming Growth Factor beta2","Transforming Growth Factor beta3"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"We have performed a high-capacity, semiquantitative, reverse transcriptase-polymerase chain reaction screen for expression of fibroblast growth factor (FGF) and transforming growth factor beta (TGFbeta) family genes as well as their cognate receptors. By using cDNA prepared from embryonic day 12 to postnatal day 0 embryonic mouse pancreas, we have identified several factors potentially involved in the development of the endocrine pancreas. We find high-level early expression of TGFbeta-1 and -2, and constitutive expression of TGFbeta-3 and their receptors. Of the Inhibin/Activin members, we found exclusively Inhibin-alpha and Activin-betaB to be expressed, and the BMP family was represented by BMP4, BMP5, and BMP7. The predominant forms of the BMP and Activin type II receptors were ActR-IIB and BMPR-II and of the type I receptors, BMPR-1A and -1B were the highest expressed. FGF1, FGF7, FGF9, FGF10, FGF11, and FGF18 were also expressed in the pancreas at varying time points and levels, as well as FGF receptor forms FGFR1b, FGFR1c, FGFR2b, FGFR2c, FGFR3b, and FGFR4. To gain insight into the biological function, we misexpressed members of these families in the pancreas by using the early pancreas promoter Pdx1. Misexpression of FGF4 results in disruption of the pancreas morphology with epithelial structures interspersed in stroma tissue. The endocrine compartment was reduced to scattered single cells, and the exocrine consisted of unbranched ductal epithelia with acinar structures budding off. In contrast, misexpression of BMP-6 resulted in complete agenesis of the pancreas and reduced the size of the stomach and spleen dramatically and caused fusion of the liver and duodenum.","affiliation":[]},{"pmid":"11544199","pmcid":null,"title":"Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.","authors":["Piao Y","Ko NT","Lim MK","Ko MS"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Genome research","journalShort":"Genome Res.","day":6,"month":9,"year":2001,"meshHeadings":["Animals","DNA, Complementary","Gene Amplification","Gene Library","Mice","Mice, Inbred C57BL","Molecular Sequence Data","Polymerase Chain Reaction","RNA"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Here we report a novel design of linker primer that allows one to differentially amplify long tracts (average 3.0 kb with size ranges of 1-7 kb) or short DNAs (average 1.5 kb with size ranges of 0.5-3 kb) from a complex mixture. The method allows one to generate cDNA libraries enriched for long transcripts without size selection of insert DNAs. One representative library from newborn kidney includes 70% of clones bearing ATG start codons. A comparable library has been generated from 20 mouse blastocysts, containing only approximately 40 ng of total RNA. This universal PCR amplification scheme can provide a route to isolate very large cDNAs, even if they are expressed at very low levels.","affiliation":[]},{"pmid":"11171689","pmcid":null,"title":"Inactivation of one allele of the type II collagen gene alters the collagen network in murine articular cartilage and makes cartilage softer.","authors":["Hyttinen MM","Tyrs J","Lapvetelinen T","Lindblom J","Prockop DJ","Li SW","Arita M","Jurvelin JS","Helminen HJ"],"grantIds":["AR3970"],"grantAgencies":["NIAMS NIH HHS"],"retractions":[],"journal":"Annals of the rheumatic diseases","journalShort":"Ann. Rheum. Dis.","day":22,"month":3,"year":2001,"meshHeadings":["Animals","Biomechanical Phenomena","Birefringence","Cartilage, Articular","Collagen","Densitometry","Loss of Heterozygosity","Mice","Mice, Inbred C57BL","Mice, Knockout","Microscopy, Polarization","Proteoglycans","Statistics, Nonparametric"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"OBJECTIVE: To evaluate the influence of inactivation of one allele (\"heterozygous knockout\" or \"heterozygous inactivation\") of the type II procollagen gene (Col2a1) on the biomechanical properties and structure of the articular cartilage and subchondral bone in 15 month old mice. METHODS: Indentation stiffness of the humerus head articular cartilage was measured by a microindentation method. Cartilage and subchondral bone were prepared for digital densitometry of proteoglycans (PGs), polarised light microscopy (PLM) of collagen, and osteoarthrosis (OA) grading. RESULTS: Heterozygous inactivation of the Col2a1 gene softened articular cartilage (p=0.002) as measured by indentation stiffness ((mean (SEM) 0.50 (0.07) MPa v 0.94 (0.13) MPa in controls). Fibrillar collagen network exhibited lower birefringence in the intermediate (p=0.04) and deep zones (p=0.01) of cartilage by PLM, indicating either decreased collagen content or a lower degree of fibril parallelism in the knockout mice. The total and zonal thicknesses of articular cartilage were unchanged. Zonal PG contents did not differ significantly. In knockout mice, the prevalence of superficial fibrillation-that is, a sign of OA, was higher than in controls (73% v 21%, p=0.002). The collagen induced birefringence of the superficial zone was not reduced. The subchondral bone volume fraction was lower in knockout mice than in controls, 31% v 43% (p=0.01), and optical retardation values in PLM of bone collagen were slightly but significantly lower (p=0.01). CONCLUSION: Heterozygous inactivation of the Col2a1 gene made articular cartilage softer, altered the collagenous network, reduced subchondral bone volume, and altered its microstructure. Changes in the cartilage collagen network probably contributed to increased susceptibility to OA.","affiliation":[]},{"pmid":"11217851","pmcid":null,"title":"Functional annotation of a full-length mouse cDNA collection.","authors":["Kawai J","Shinagawa A","Shibata K","Yoshino M","Itoh M","Ishii Y","Arakawa T","Hara A","Fukunishi Y","Konno H","Adachi J","Fukuda S","Aizawa K","Izawa M","Nishi K","Kiyosawa H","Kondo S","Yamanaka I","Saito T","Okazaki Y","Gojobori T","Bono H","Kasukawa T","Saito R","Kadota K","Matsuda H","Ashburner M","Batalov S","Casavant T","Fleischmann W","Gaasterland T","Gissi C","King B","Kochiwa H","Kuehl P","Lewis S","Matsuo Y","Nikaido I","Pesole G","Quackenbush J","Schriml LM","Staubli F","Suzuki R","Tomita M","Wagner L","Washio T","Sakai K","Okido T","Furuno M","Aono H","Baldarelli R","Barsh G","Blake J","Boffelli D","Bojunga N","Carninci P","de Bonaldo MF","Brownstein MJ","Bult C","Fletcher C","Fujita M","Gariboldi M","Gustincich S","Hill D","Hofmann M","Hume DA","Kamiya M","Lee NH","Lyons P","Marchionni L","Mashima J","Mazzarelli J","Mombaerts P","Nordone P","Ring B","Ringwald M","Rodriguez I","Sakamoto N","Sasaki H","Sato K","Schnbach C","Seya T","Shibata Y","Storch KF","Suzuki H","Toyo-oka K","Wang KH","Weitz C","Whittaker C","Wilming L","Wynshaw-Boris A","Yoshida K","Hasegawa Y","Kawaji H","Kohtsuki S","Hayashizaki Y","RIKEN Genome Exploration Research Group Phase II Team and the FANTOM Consortium"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Nature","journalShort":"Nature","day":8,"month":2,"year":2001,"meshHeadings":["Animals","Chromosome Mapping","Computational Biology","DNA, Complementary","Enzymes","Gene Library","Genome","Humans","Mice","Mice, Inbred C57BL","Protein Biosynthesis","Protein Structure, Tertiary","RNA, Messenger","Sequence Analysis, DNA"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The RIKEN Mouse Gene Encyclopaedia Project, a systematic approach to determining the full coding potential of the mouse genome, involves collection and sequencing of full-length complementary DNAs and physical mapping of the corresponding genes to the mouse genome. We organized an international functional annotation meeting (FANTOM) to annotate the first 21,076 cDNAs to be analysed in this project. Here we describe the first RIKEN clone collection, which is one of the largest described for any organism. Analysis of these cDNAs extends known gene families and identifies new ones.","affiliation":[]},{"pmid":"11076861","pmcid":null,"title":"RIKEN integrated sequence analysis (RISA) system--384-format sequencing pipeline with 384 multicapillary sequencer.","authors":["Shibata K","Itoh M","Aizawa K","Nagaoka S","Sasaki N","Carninci P","Konno H","Akiyama J","Nishi K","Kitsunai T","Tashiro H","Itoh M","Sumi N","Ishii Y","Nakamura S","Hazama M","Nishine T","Harada A","Yamamoto R","Matsumoto H","Sakaguchi S","Ikegami T","Kashiwagi K","Fujiwake S","Inoue K","Togawa Y"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Genome research","journalShort":"Genome Res.","day":8,"month":11,"year":2000,"meshHeadings":["Animals","Base Sequence","DNA","Electrophoresis, Capillary","Electrophoresis, Polyacrylamide Gel","Genome","Image Cytometry","Mice","Molecular Sequence Data","Polymerase Chain Reaction","Reproducibility of Results","Sensitivity and Specificity","Sequence Analysis, DNA","Templates, Genetic"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The RIKEN high-throughput 384-format sequencing pipeline (RISA system) including a 384-multicapillary sequencer (the so-called RISA sequencer) was developed for the RIKEN mouse encyclopedia project. The RISA system consists of colony picking, template preparation, sequencing reaction, and the sequencing process. A novel high-throughput 384-format capillary sequencer system (RISA sequencer system) was developed for the sequencing process. This system consists of a 384-multicapillary auto sequencer (RISA sequencer), a 384-multicapillary array assembler (CAS), and a 384-multicapillary casting device. The RISA sequencer can simultaneously analyze 384 independent sequencing products. The optical system is a scanning system chosen after careful comparison with an image detection system for the simultaneous detection of the 384-capillary array. This scanning system can be used with any fluorescent-labeled sequencing reaction (chain termination reaction), including transcriptional sequencing based on RNA polymerase, which was originally developed by us, and cycle sequencing based on thermostable DNA polymerase. For long-read sequencing, 380 out of 384 sequences (99.2%) were successfully analyzed and the average read length, with more than 99% accuracy, was 654.4 bp. A single RISA sequencer can analyze 216 kb with >99% accuracy in 2.7 h (90 kb/h). For short-read sequencing to cluster the 3' end and 5' end sequencing by reading 350 bp, 384 samples can be analyzed in 1.5 h. We have also developed a RISA inoculator, RISA filtrator and densitometer, RISA plasmid preparator which can handle throughput of 40,000 samples in 17.5 h, and a high-throughput RISA thermal cycler which has four 384-well sites. The combination of these technologies allowed us to construct the RISA system consisting of 16 RISA sequencers, which can process 50,000 DNA samples per day. One haploid genome shotgun sequence of a higher organism, such as human, mouse, rat, domestic animals, and plants, can be revealed by seven RISA systems within one month.","affiliation":[]},{"pmid":"11698278","pmcid":null,"title":"Age- and stage-specific regulation patterns in the hematopoietic stem cell hierarchy.","authors":["Geiger H","True JM","de Haan G","Van Zant G"],"grantIds":["AG16653"],"grantAgencies":["NIA NIH HHS"],"retractions":[],"journal":"Blood","journalShort":"Blood","day":15,"month":11,"year":2001,"meshHeadings":["Aging","Animals","Cell Differentiation","Cell Lineage","Chromosome Mapping","Crosses, Genetic","Female","Gene Expression Regulation, Developmental","Genetic Linkage","Hematopoiesis","Hematopoietic Stem Cells","Mice","Mice, Congenic","Mice, Inbred C57BL","Mice, Inbred DBA","Mice, Inbred Strains"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The molecular mechanisms that regulate self-renewal and differentiation of very primitive hematopoietic stem and progenitor cells in vivo are still poorly understood. Despite the clinical relevance, even less is known about the mechanisms that regulate these cells in old animals. In a forward genetic approach, using quantitative trait linkage analysis in the mouse BXD recombinant inbred set, this study identified loci that regulate the genetic variation in the size of primitive hematopoietic cell compartments of young and old C57BL6 and DBA/2 animals. Linked loci were confirmed through the generation and analysis of congenic animals. In addition, a comparative linkage analysis revealed that the number of primitive hematopoietic cells and hematopoietic stem cells are regulated in a stage-specific and an age-specific manner.","affiliation":[]},{"pmid":"11854453","pmcid":null,"title":"Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3.","authors":["Gaussin V","Van de Putte T","Mishina Y","Hanks MC","Zwijsen A","Huylebroeck D","Behringer RR","Schneider MD"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Proceedings of the National Academy of Sciences of the United States of America","journalShort":"Proc. Natl. Acad. Sci. U.S.A.","day":5,"month":3,"year":2002,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Line","Female","Gene Expression","Heart","Male","Mice","Morphogenesis","Mutagenesis","Myocardium","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Receptors, Transforming Growth Factor beta","Transforming Growth Factor beta","Transforming Growth Factor beta2"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Receptors for bone morphogenetic proteins (BMPs), members of the transforming growth factor-beta (TGFbeta) superfamily, are persistently expressed during cardiac development, yet mice lacking type II or type IA BMP receptors die at gastrulation and cannot be used to assess potential later roles in creation of the heart. Here, we used a Cre/lox system for cardiac myocyte-specific deletion of the type IA BMP receptor, ALK3. ALK3 was specifically required at mid-gestation for normal development of the trabeculae, compact myocardium, interventricular septum, and endocardial cushion. Cardiac muscle lacking ALK3 was specifically deficient in expressing TGFbeta2, an established paracrine mediator of cushion morphogenesis. Hence, ALK3 is essential, beyond just the egg cylinder stage, for myocyte-dependent functions and signals in cardiac organogenesis.","affiliation":[]},{"pmid":"12520002","pmcid":null,"title":"BayGenomics: a resource of insertional mutations in mouse embryonic stem cells.","authors":["Stryke D","Kawamoto M","Huang CC","Johns SJ","King LA","Harper CA","Meng EC","Lee RE","Yee A","L'Italien L","Chuang PT","Young SG","Skarnes WC","Babbitt PC","Ferrin TE"],"grantIds":["P41 RR01081","U01 HL66621"],"grantAgencies":["NCRR NIH HHS","NHLBI NIH HHS"],"retractions":[],"journal":"Nucleic acids research","journalShort":"Nucleic Acids Res.","day":1,"month":1,"year":2003,"meshHeadings":["Animals","Cell Line","Databases, Nucleic Acid","Embryo, Mammalian","Genomics","Internet","Mice","Mice, Knockout","Mutagenesis, Insertional","Mutation","Stem Cells","User-Computer Interface"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The BayGenomics gene-trap resource (http://baygenomics.ucsf.edu) provides researchers with access to thousands of mouse embryonic stem (ES) cell lines harboring characterized insertional mutations in both known and novel genes. Each cell line contains an insertional mutation in a specific gene. The identity of the gene that has been interrupted can be determined from a DNA sequence tag. Approximately 75% of our cell lines contain insertional mutations in known mouse genes or genes that share strong sequence similarities with genes that have been identified in other organisms. These cell lines readily transmit the mutation to the germline of mice and many mutant lines of mice have already been generated from this resource. BayGenomics provides facile access to our entire database, including sequence tags for each mutant ES cell line, through the World Wide Web. Investigators can browse our resource, search for specific entries, download any portion of our database and BLAST sequences of interest against our entire set of cell line sequence tags. They can then obtain the mutant ES cell line for the purpose of generating knockout mice.","affiliation":[]},{"pmid":"11884477","pmcid":null,"title":"A novel susceptibility locus on chromosome 2 in the (New Zealand Black x New Zealand White)F1 hybrid mouse model of systemic lupus erythematosus.","authors":["Rahman ZS","Tin SK","Buenaventura PN","Ho CH","Yap EP","Yong RY","Koh DR"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Journal of immunology (Baltimore, Md. : 1950)","journalShort":"J. Immunol.","day":15,"month":3,"year":2002,"meshHeadings":["Alleles","Animals","Autoantibodies","Chromosome Mapping","Crosses, Genetic","Disease Models, Animal","Female","Genetic Linkage","Genetic Markers","Genetic Predisposition to Disease","Genotype","Hybridization, Genetic","Lupus Erythematosus, Systemic","Lupus Nephritis","Mice","Mice, Inbred NZB","Proteinuria","Urea"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Systemic lupus erythematosus (SLE) is inherited as a complex polygenic trait. (New Zealand Black (NZB) x New Zealand White (NZW)) F(1) hybrid mice develop symptoms that remarkably resemble human SLE, but (NZB x PL/J)F(1) hybrids do not develop lupus. Our study was conducted using (NZW x PL/J)F(1) x NZB (BWP) mice to determine the effects of the PL/J and the NZW genome on disease. Forty-five percent of BWP female mice had significant proteinuria and 25% died before 12 mo of age compared with (NZB x NZW)F(1) mice in which >90% developed severe renal disease and died before 12 mo. The analysis of BWP mice revealed a novel locus (chi(2) = 25.0; p < 1 x 10(-6); log of likelihood = 6.6 for mortality) designated Wbw1 on chromosome 2, which apparently plays an important role in the development of the disease. We also observed that both H-2 class II (the u haplotype) and TNF-alpha (TNF(z) allele) appear to contribute to the disease. A suggestive linkage to proteinuria and death was found for an NZW allele (designated Wbw2) telomeric to the H-2 locus. The NZW allele that overlaps with the previously described locus Sle1c at the telomeric part of chromosome 1 was associated with antinuclear autoantibody production in the present study. Furthermore, the previously identified Sle and Lbw susceptibility loci were associated with an increased incidence of disease. Thus, multiple NZW alleles including the Wbw1 allele discovered in this study contribute to disease induction, in conjunction with the NZB genome, and the PL/J genome appears to be protective.","affiliation":[]},{"pmid":"12141440","pmcid":null,"title":"BMPs and BMP receptors in mouse metanephric development: in vivo and in vitro studies.","authors":["Martinez G","Mishina Y","Bertram JF"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"The International journal of developmental biology","journalShort":"Int. J. Dev. Biol.","day":26,"month":7,"year":2002,"meshHeadings":["Animals","Biotinylation","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein 4","Bone Morphogenetic Proteins","Carrier Proteins","Dolichos","Dose-Response Relationship, Drug","Gene Expression Regulation, Developmental","Genotype","Homozygote","Immunohistochemistry","Kidney","Mice","Microscopy, Phase-Contrast","Mutation","Protein Biosynthesis","Proteins","RNA, Messenger","Time Factors","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BMPs have recently emerged as likely regulators of development of the permanent kidney (metanephros). Transcripts for BMPs and their receptors have been localised in the developing metanephros. In vitro, BMPs 2, 4 and 7 have direct or indirect roles in regulation of ureteric branching morphogenesis and branch formation. In vivo, renal phenotypes have been reported in BMP7 homozygous null mutant mice and BMP4 heterozygous null mutant mice. In the present study, in vivo and in vitro roles of BMPs and BMP receptors in metanephric development were further analysed. Stereology and histology were used to analyse kidneys from mice heterozygous for mutations in either BMP2, BMPR-IA or ActR-IA. Roles of BMPs 2 and 4 in mouse metanephric development in vitro were analysed by culturing whole metanephroi in the presence of BMP2, BMP4, the BMP inhibitor noggin, and BMP4 plus noggin. Ureteric branching morphogenesis and nephrogenesis were analysed. By qualitative histology, kidneys from BMP2, BMPR-IA and ActR-IA heterozygous null mutant mice were found to be the same as those from wild type mice. The kidneys of the heterozygous mice contained the normal complement of nephrons. In vitro, high concentrations of BMP4 inhibited branching of the ureteric epithelium and changed its morphology, while nephrogenesis was inhibited by 50%. A range of concentrations of BMP2 did not alter ureteric or mesenchyme morphology, or the number of glomeruli formed. Noggin did not alter metanephric development in vitro, but did block the effect of BMP4. The experiments described in this study have shown that BMP4 has distinct roles from BMP2 in metanephric development.","affiliation":[]},{"pmid":"12421925","pmcid":null,"title":"Bone morphogenetic protein 2/4 signaling regulates early thymocyte differentiation.","authors":["Hager-Theodorides AL","Outram SV","Shah DK","Sacedon R","Shrimpton RE","Vicente A","Varas A","Crompton T"],"grantIds":["WT061000"],"grantAgencies":["Wellcome Trust"],"retractions":[],"journal":"Journal of immunology (Baltimore, Md. : 1950)","journalShort":"J. Immunol.","day":15,"month":11,"year":2002,"meshHeadings":["Activin Receptors, Type I","Adjuvants, Immunologic","Animals","Antigens, CD44","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Carrier Proteins","Cell Differentiation","Cell Survival","Cells, Cultured","Dose-Response Relationship, Immunologic","Fetus","Gene Expression Regulation","Genes, T-Cell Receptor beta","Genes, T-Cell Receptor delta","Growth Inhibitors","Mice","Mice, Inbred BALB C","Mice, Knockout","Organ Culture Techniques","Protein-Serine-Threonine Kinases","Proteins","Receptors, Growth Factor","Receptors, Interleukin-2","Recombinant Fusion Proteins","Signal Transduction","T-Lymphocytes","Thymus Gland","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein (BMP)2 and BMP4 are involved in the development of many tissues. In this study, we show that BMP2/4 signaling is involved in thymocyte development. Our data suggest that termination of BMP2/4 signaling is necessary for differentiation of CD44(+)CD25(-)CD4(-)CD8(-) double negative (DN) cells along the T cell lineage. BMP2 and BMP4 are produced by the thymic stroma and the requisite BMP receptor molecules (BMPR-1A, BMPR-1B, BMPR-II), and signal transduction molecules (Smad-1, -5, -8, and -4) are expressed by DN thymocytes. BMP4 inhibits thymocyte proliferation, enhances thymocyte survival, and arrests thymocyte differentiation at the CD44(+)CD25(-) DN stage, before T cell lineage commitment. Neutralization of endogenous BMP2 and BMP4 by treatment with the antagonist Noggin promotes and accelerates thymocyte differentiation, increasing the expression of CD2 and the proportion of CD44(-)CD25(-) DN cells and CD4(+)CD8(+) double-positive cells. Our study suggests that the BMP2/4 pathway may function in thymic homeostasis by regulating T cell lineage commitment and differentiation.","affiliation":[]},{"pmid":"12466851","pmcid":null,"title":"Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs.","authors":["Okazaki Y","Furuno M","Kasukawa T","Adachi J","Bono H","Kondo S","Nikaido I","Osato N","Saito R","Suzuki H","Yamanaka I","Kiyosawa H","Yagi K","Tomaru Y","Hasegawa Y","Nogami A","Schnbach C","Gojobori T","Baldarelli R","Hill DP","Bult C","Hume DA","Quackenbush J","Schriml LM","Kanapin A","Matsuda H","Batalov S","Beisel KW","Blake JA","Bradt D","Brusic V","Chothia C","Corbani LE","Cousins S","Dalla E","Dragani TA","Fletcher CF","Forrest A","Frazer KS","Gaasterland T","Gariboldi M","Gissi C","Godzik A","Gough J","Grimmond S","Gustincich S","Hirokawa N","Jackson IJ","Jarvis ED","Kanai A","Kawaji H","Kawasawa Y","Kedzierski RM","King BL","Konagaya A","Kurochkin IV","Lee Y","Lenhard B","Lyons PA","Maglott DR","Maltais L","Marchionni L","McKenzie L","Miki H","Nagashima T","Numata K","Okido T","Pavan WJ","Pertea G","Pesole G","Petrovsky N","Pillai R","Pontius JU","Qi D","Ramachandran S","Ravasi T","Reed JC","Reed DJ","Reid J","Ring BZ","Ringwald M","Sandelin A","Schneider C","Semple CA","Setou M","Shimada K","Sultana R","Takenaka Y","Taylor MS","Teasdale RD","Tomita M","Verardo R","Wagner L","Wahlestedt C","Wang Y","Watanabe Y","Wells C","Wilming LG","Wynshaw-Boris A","Yanagisawa M","Yang I","Yang L","Yuan Z","Zavolan M","Zhu Y","Zimmer A","Carninci P","Hayatsu N","Hirozane-Kishikawa T","Konno H","Nakamura M","Sakazume N","Sato K","Shiraki T","Waki K","Kawai J","Aizawa K","Arakawa T","Fukuda S","Hara A","Hashizume W","Imotani K","Ishii Y","Itoh M","Kagawa I","Miyazaki A","Sakai K","Sasaki D","Shibata K","Shinagawa A","Yasunishi A","Yoshino M","Waterston R","Lander ES","Rogers J","Birney E","Hayashizaki Y","FANTOM Consortium","RIKEN Genome Exploration Research Group Phase I & II Team"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Nature","journalShort":"Nature","day":5,"month":12,"year":2002,"meshHeadings":["Alternative Splicing","Amino Acid Motifs","Animals","Chromosomes, Mammalian","Cloning, Molecular","DNA, Complementary","Databases, Genetic","Expressed Sequence Tags","Genes","Genomics","Humans","Membrane Proteins","Mice","Physical Chromosome Mapping","Protein Structure, Tertiary","Proteome","RNA, Antisense","RNA, Messenger","RNA, Untranslated","Transcription Initiation Site","Transcription, Genetic"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Only a small proportion of the mouse genome is transcribed into mature messenger RNA transcripts. There is an international collaborative effort to identify all full-length mRNA transcripts from the mouse, and to ensure that each is represented in a physical collection of clones. Here we report the manual annotation of 60,770 full-length mouse complementary DNA sequences. These are clustered into 33,409 'transcriptional units', contributing 90.1% of a newly established mouse transcriptome database. Of these transcriptional units, 4,258 are new protein-coding and 11,665 are new non-coding messages, indicating that non-coding RNA is a major component of the transcriptome. 41% of all transcriptional units showed evidence of alternative splicing. In protein-coding transcripts, 79% of splice variations altered the protein product. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs. The present work, completely supported by physical clones, provides the most comprehensive survey of a mammalian transcriptome so far, and is a valuable resource for functional genomics.","affiliation":[]},{"pmid":"12399319","pmcid":null,"title":"Growth arrest specific gene 1 acts as a region-specific mediator of the Fgf10/Fgf8 regulatory loop in the limb.","authors":["Liu Y","Liu C","Yamada Y","Fan CM"],"grantIds":["R01-HD 35596"],"grantAgencies":["NICHD NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":25,"month":11,"year":2002,"meshHeadings":["Animals","Cell Cycle Proteins","Cell Division","Ectoderm","Extremities","Female","Fibroblast Growth Factor 10","Fibroblast Growth Factor 8","Fibroblast Growth Factors","GPI-Linked Proteins","Gene Expression Regulation, Developmental","Limb Deformities, Congenital","Male","Membrane Proteins","Mesoderm","Mice","Mice, Mutant Strains","Microinjections","Mutation"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Proximal-to-distal growth of the embryonic limbs requires Fgf10 in the mesenchyme to activate Fgf8 in the apical ectodermal ridge (AER), which in turn promotes mesenchymal outgrowth. We show here that the growth arrest specific gene 1 (Gas1) is required in the mesenchyme for the normal regulation of Fgf10/Fgf8. Gas1 mutant limbs have defects in the proliferation of the AER and the mesenchyme and develop with small autopods, missing phalanges and anterior digit syndactyly. At the molecular level, Fgf10 expression at the distal tip mesenchyme immediately underneath the AER is preferentially affected in the mutant limb, coinciding with the loss of Fgf8 expression in the AER. To test whether FGF10 deficiency is an underlying cause of the Gas1 mutant phenotype, we employed a limb culture system in conjunction with microinjection of recombinant proteins. In this system, FGF10 but not FGF8 protein injected into the mutant distal tip mesenchyme restores Fgf8 expression in the AER. Our data provide evidence that Gas1 acts to maintain high levels of FGF10 at the tip mesenchyme and support the proposal that Fgf10 expression in this region is crucial for maintaining Fgf8 expression in the AER.","affiliation":[]},{"pmid":"12351174","pmcid":null,"title":"SMAD1 signaling is critical for initial commitment of germ cell lineage from mouse epiblast.","authors":["Hayashi K","Kobayashi T","Umino T","Goitsuka R","Matsui Y","Kitamura D"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Mechanisms of development","journalShort":"Mech. Dev.","day":27,"month":10,"year":2002,"meshHeadings":["Alkaline Phosphatase","Animals","Cell Lineage","Central Nervous System","DNA-Binding Proteins","Dose-Response Relationship, Drug","Exons","Gene Expression Regulation, Developmental","Genotype","Heterozygote","Homozygote","Immunohistochemistry","In Situ Hybridization","Lac Operon","Mesoderm","Mice","Mice, Inbred C57BL","Mice, Inbred DBA","Models, Genetic","Mutagenesis, Site-Directed","Oligonucleotides, Antisense","Phosphoproteins","Phosphorylation","Reverse Transcriptase Polymerase Chain Reaction","Signal Transduction","Smad Proteins","Smad1 Protein","Smad5 Protein","Time Factors","Tissue Distribution","Trans-Activators"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Commitment of the germ cell lineage during embryogenesis depends on zygotic gene expression in mammals, but little is known about the signaling molecules required for germ cell formation. Here we show that the intracellular signaling molecule SMAD1, acting downstream of bone morphogenetic protein (BMP) receptors, is required for the commitment of germ cell lineage from epiblast in early mouse embryos. Smad1 homozygous mutant embryos (Smad1-/-) were generated by in-frame insertion of lacZ gene into an exon of the Smad1 gene. Most of the Smad1-/- embryos contained no primordial germ cells (PGCs) and had short allantois, while histological analysis and in situ hybridization for the mesoderm marker genes revealed that early mesoderm induction was normal in those embryos. Smad1 expression was observed in epiblast and in visceral endoderm during gastrulation, while only a few alkaline phosphatase-positive PGCs at 7.5 and 8.5 days post coitum (E7.5 and E8.5) expressed Smad1. Phosphorylated SMAD proteins were localized in the proximal region of epiblast at E6.0-6.5, where the progenitors of PGCs and of allantois reside. Single-cell reverse transcription-polymerase chain reaction analysis revealed that the expression of Smad1, -5 and -8 were sporadic and mutually independent in proximal epiblast cells. We also found that BMP4-induced differentiation of PGCs from epiblast in vitro was fully dependent on the existence of phosphorylated SMAD1. These results indicate that SMAD1 signaling possesses a critical and non-redundant function in the initial commitment of the germ cell lineage.","affiliation":[]},{"pmid":"12477932","pmcid":null,"title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","authors":["Strausberg RL","Feingold EA","Grouse LH","Derge JG","Klausner RD","Collins FS","Wagner L","Shenmen CM","Schuler GD","Altschul SF","Zeeberg B","Buetow KH","Schaefer CF","Bhat NK","Hopkins RF","Jordan H","Moore T","Max SI","Wang J","Hsieh F","Diatchenko L","Marusina K","Farmer AA","Rubin GM","Hong L","Stapleton M","Soares MB","Bonaldo MF","Casavant TL","Scheetz TE","Brownstein MJ","Usdin TB","Toshiyuki S","Carninci P","Prange C","Raha SS","Loquellano NA","Peters GJ","Abramson RD","Mullahy SJ","Bosak SA","McEwan PJ","McKernan KJ","Malek JA","Gunaratne PH","Richards S","Worley KC","Hale S","Garcia AM","Gay LJ","Hulyk SW","Villalon DK","Muzny DM","Sodergren EJ","Lu X","Gibbs RA","Fahey J","Helton E","Ketteman M","Madan A","Rodrigues S","Sanchez A","Whiting M","Madan A","Young AC","Shevchenko Y","Bouffard GG","Blakesley RW","Touchman JW","Green ED","Dickson MC","Rodriguez AC","Grimwood J","Schmutz J","Myers RM","Butterfield YS","Krzywinski MI","Skalska U","Smailus DE","Schnerch A","Schein JE","Jones SJ","Marra MA","Mammalian Gene Collection Program Team"],"grantIds":["U54 HG003273"],"grantAgencies":["NHGRI NIH HHS"],"retractions":[],"journal":"Proceedings of the National Academy of Sciences of the United States of America","journalShort":"Proc. Natl. Acad. Sci. U.S.A.","day":24,"month":12,"year":2002,"meshHeadings":["Algorithms","Animals","DNA, Complementary","Gene Library","Humans","Mice","Open Reading Frames","Sequence Analysis, DNA"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The National Institutes of Health Mammalian Gene Collection (MGC) Program is a multiinstitutional effort to identify and sequence a cDNA clone containing a complete ORF for each human and mouse gene. ESTs were generated from libraries enriched for full-length cDNAs and analyzed to identify candidate full-ORF clones, which then were sequenced to high accuracy. The MGC has currently sequenced and verified the full ORF for a nonredundant set of >9,000 human and >6,000 mouse genes. Candidate full-ORF clones for an additional 7,800 human and 3,500 mouse genes also have been identified. All MGC sequences and clones are available without restriction through public databases and clone distribution networks (see http:mgc.nci.nih.gov).","affiliation":[]},{"pmid":"12654290","pmcid":null,"title":"BMP receptor 1b is required for axon guidance and cell survival in the developing retina.","authors":["Liu J","Wilson S","Reh T"],"grantIds":["R01 NS28308"],"grantAgencies":["NINDS NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":1,"month":4,"year":2003,"meshHeadings":["Animals","Apoptosis","Axons","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Survival","Gene Expression Regulation, Developmental","In Situ Hybridization","Mice","Mice, Knockout","Optic Nerve","Phenotype","Protein-Serine-Threonine Kinases","Receptors, Cell Surface","Receptors, Growth Factor","Retina","Retinal Ganglion Cells"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Previous work has documented the importance of BMPs in eye development. Loss-of-function studies in mice, with targeted deletions in either the Bmp7 or Bmp4 genes, have shown that these molecules are critical for early eye development. On the basis of the asymmetry in the dorsal-ventral expression patterns of several members of this family, it has been proposed that these molecules are critical for some aspect of dorsal-ventral patterning in the eye; however, it has been difficult to test this hypothesis because of the early requirement for BMPs in eye development. We have therefore examined the effects of loss of one of the BMP receptors, the BmprIb, on the development of the eye by using targeted deletion. We have found that BmprIb is expressed exclusively in the ventral retina during embryonic development and is required for normal ventral ganglion cell axon targeting to the optic nerve head. In mice with a targeted deletion of the BmprIb gene, many axons arising from the ventrally located ganglion cells fail to enter the optic nerve head, and instead, make abrupt turns in this region. A second phenotype in these mice is a significantly elevated inner retinal apoptosis during a distinct phase of postnatal development, at the end of neurogenesis. Our results therefore show two distinct requirements for BmprIb in mammalian retinal development.","affiliation":[]},{"pmid":"14584896","pmcid":null,"title":"Temporal and spatial expression profiles of BMP receptors and noggin during BMP-2-induced ectopic bone formation.","authors":["Nakamura Y","Wakitani S","Nakayama J","Wakabayashi S","Horiuchi H","Takaoka K"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","journalShort":"J. Bone Miner. Res.","day":30,"month":10,"year":2003,"meshHeadings":["Animals","Blotting, Northern","Blotting, Western","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Bone and Bones","Carrier Proteins","Cell Differentiation","Collagen","Feedback, Physiological","Gene Expression Regulation","Immunohistochemistry","In Situ Hybridization","Male","Mice","Muscles","Osteogenesis","Protein Biosynthesis","Protein-Serine-Threonine Kinases","Proteins","RNA","Receptors, Growth Factor","Time Factors","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The mechanism of ectopic bone formation has not been clear. After BMP-2 implantation into the back muscles of 198 mice, expression of BMPR-1A, -2, and Noggin was increased during the early phase of the reaction. The results suggest that positive and negative feedback mechanisms modulate ectopic osteogenesis induced by this growth factor. INTRODUCTION: The expression of bone morphogenetic protein receptors (BMPRs) and Noggin during ectopic bone formation after implantation of BMP-2 into the back muscles of adult mice was investigated in this study. METHODS: One hundred ninety-eight male ddy mice were divided into groups and received either collagen disks containing BMP-2, collagen disks alone, or sham surgery with no disk implantation. Changes in the temporal and spatial expression profiles of BMPRs and Noggin were examined by Northern blotting, in situ hybridization, Western blotting, and immunohistochemistry. RESULTS AND CONCLUSIONS: In the BMP group, expression of BMPR-1A, -2, and Noggin mRNA and protein was enhanced 2-4 days after implantation in undifferentiated mesenchymal cells and regenerating muscle fibers located close to the BMP-retaining implants. On day 7, the expression was also observed in cartilage cells, and after day 14, in the osteoblastic cells around bone tissue. The level of expression peaked at day 4 after implantation and persisted at a much lower level during the bone forming process. No significant expression of BMPR-1B was detected at the mRNA and protein levels during the bone-forming reaction. In the BMP free control groups, a mild enhancement of BMPR-2 expression was also noted around the implant, but this was not observed for BMPR-1A, -1B, or Noggin. Upregulated expression of BMPR-1A, -2, and Noggin in undifferentiated mesenchymal cells and regenerating muscle fibers occurs during the early phase of BMP-2-induced bone formation. The coordinate expression of these positive and negative regulators of BMP signaling points to a potential regulatory mechanism for bone induction.","affiliation":[]},{"pmid":"14610273","pmcid":null,"title":"Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention.","authors":["Zambrowicz BP","Abuin A","Ramirez-Solis R","Richter LJ","Piggott J","BeltrandelRio H","Buxton EC","Edwards J","Finch RA","Friddle CJ","Gupta A","Hansen G","Hu Y","Huang W","Jaing C","Key BW","Kipp P","Kohlhauff B","Ma ZQ","Markesich D","Payne R","Potter DG","Qian N","Shaw J","Schrick J","Shi ZZ","Sparks MJ","Van Sligtenhorst I","Vogel P","Walke W","Xu N","Zhu Q","Person C","Sands AT"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Proceedings of the National Academy of Sciences of the United States of America","journalShort":"Proc. Natl. Acad. Sci. U.S.A.","day":25,"month":11,"year":2003,"meshHeadings":["Animals","Base Sequence","Blood Pressure","DNA, Complementary","Gene Library","Genetic Techniques","Heterozygote","Humans","Hypertension","Intracellular Signaling Peptides and Proteins","Mice","Mice, Inbred C57BL","Mice, Knockout","Mice, Transgenic","Molecular Sequence Data","Mutagenesis, Insertional","Phenotype","Protein-Serine-Threonine Kinases","Sequence Tagged Sites"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The availability of both the mouse and human genome sequences allows for the systematic discovery of human gene function through the use of the mouse as a model system. To accelerate the genetic determination of gene function, we have developed a sequence-tagged gene-trap library of >270,000 mouse embryonic stem cell clones representing mutations in approximately 60% of mammalian genes. Through the generation and phenotypic analysis of knockout mice from this resource, we are undertaking a functional screen to identify genes regulating physiological parameters such as blood pressure. As part of this screen, mice deficient for the Wnk1 kinase gene were generated and analyzed. Genetic studies in humans have shown that large intronic deletions in WNK1 lead to its overexpression and are responsible for pseudohypoaldosteronism type II, an autosomal dominant disorder characterized by hypertension, increased renal salt reabsorption, and impaired K+ and H+ excretion. Consistent with the human genetic studies, Wnk1 heterozygous mice displayed a significant decrease in blood pressure. Mice homozygous for the Wnk1 mutation died during embryonic development before day 13 of gestation. These results demonstrate that Wnk1 is a regulator of blood pressure critical for development and illustrate the utility of a functional screen driven by a sequence-based mutagenesis approach.","affiliation":[]},{"pmid":"14574412","pmcid":null,"title":"Identification of the haematopoietic stem cell niche and control of the niche size.","authors":["Zhang J","Niu C","Ye L","Huang H","He X","Tong WG","Ross J","Haug J","Johnson T","Feng JQ","Harris S","Wiedemann LM","Mishina Y","Li L"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Nature","journalShort":"Nature","day":23,"month":10,"year":2003,"meshHeadings":["Animals","Antigens, CD45","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Bone and Bones","Cadherins","Cell Adhesion","Cell Count","Hematopoietic Stem Cells","Mice","Mutation","Osteoblasts","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Haematopoietic stem cells (HSCs) are a subset of bone marrow cells that are capable of self-renewal and of forming all types of blood cells (multi-potential). However, the HSC 'niche'--the in vivo regulatory microenvironment where HSCs reside--and the mechanisms involved in controlling the number of adult HSCs remain largely unknown. The bone morphogenetic protein (BMP) signal has an essential role in inducing haematopoietic tissue during embryogenesis. We investigated the roles of the BMP signalling pathway in regulating adult HSC development in vivo by analysing mutant mice with conditional inactivation of BMP receptor type IA (BMPRIA). Here we show that an increase in the number of spindle-shaped N-cadherin+CD45- osteoblastic (SNO) cells correlates with an increase in the number of HSCs. The long-term HSCs are found attached to SNO cells. Two adherens junction molecules, N-cadherin and beta-catenin, are asymmetrically localized between the SNO cells and the long-term HSCs. We conclude that SNO cells lining the bone surface function as a key component of the niche to support HSCs, and that BMP signalling through BMPRIA controls the number of HSCs by regulating niche size.","affiliation":[]},{"pmid":"15716346","pmcid":null,"title":"Distinct functions for Bmp signaling in lip and palate fusion in mice.","authors":["Liu W","Sun X","Braut A","Mishina Y","Behringer RR","Mina M","Martin JF"],"grantIds":["2R01DE/HD12324-06","AR42919","DE08682","R01DE013509"],"grantAgencies":["NIDCR NIH HHS","NIAMS NIH HHS","NIDCR NIH HHS","NIDCR NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":7,"month":3,"year":2005,"meshHeadings":["Animals","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cleft Lip","Integrases","Intermediate Filament Proteins","Lip","Mice","Mice, Transgenic","Nerve Tissue Proteins","Nestin","Palate","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Previous work suggested that cleft lip with or without cleft palate (CL/P) is genetically distinct from isolated cleft secondary palate (CP). Mutations in the Bmp target gene Msx1 in families with both forms of orofacial clefting has implicated Bmp signaling in both pathways. To dissect the function of Bmp signaling in orofacial clefting, we conditionally inactivated the type 1 Bmp receptor Bmpr1a in the facial primordia, using the Nestin cre transgenic line. Nestin cre; Bmpr1a mutants had completely penetrant, bilateral CL/P with arrested tooth formation. The cleft secondary palate of Nestin cre; Bmpr1a mutant embryos was associated with diminished cell proliferation in maxillary process mesenchyme and defective anterior posterior patterning. By contrast, we observed elevated apoptosis in the fusing region of the Nestin cre; Bmpr1a mutant medial nasal process. Moreover, conditional inactivation of the Bmp4 gene using the Nestin cre transgenic line resulted in isolated cleft lip. Our data uncover a Bmp4-Bmpr1a genetic pathway that functions in lip fusion, and reveal that Bmp signaling has distinct roles in lip and palate fusion.","affiliation":[]},{"pmid":"12904583","pmcid":null,"title":"A large-scale, gene-driven mutagenesis approach for the functional analysis of the mouse genome.","authors":["Hansen J","Floss T","Van Sloun P","Fchtbauer EM","Vauti F","Arnold HH","Schntgen F","Wurst W","von Melchner H","Ruiz P"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Proceedings of the National Academy of Sciences of the United States of America","journalShort":"Proc. Natl. Acad. Sci. U.S.A.","day":19,"month":8,"year":2003,"meshHeadings":["Animals","Base Sequence","Cell Line","DNA","Genetic Vectors","Genomics","Humans","Mice","Mice, Inbred C57BL","Mice, Transgenic","Mutagenesis, Insertional","Phenotype","Sequence Tagged Sites","Stem Cells"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"A major challenge of the postgenomic era is the functional characterization of every single gene within the mammalian genome. In an effort to address this challenge, we assembled a collection of mutations in mouse embryonic stem (ES) cells, which is the largest publicly accessible collection of such mutations to date. Using four different gene-trap vectors, we generated 5,142 sequences adjacent to the gene-trap integration sites (gene-trap sequence tags; http://genetrap.de) from >11,000 ES cell clones. Although most of the gene-trap vector insertions occurred randomly throughout the genome, we found both vector-independent and vector-specific integration \"hot spots.\" Because >50% of the hot spots were vector-specific, we conclude that the most effective way to saturate the mouse genome with gene-trap insertions is by using a combination of gene-trap vectors. When a random sample of gene-trap integrations was passaged to the germ line, 59% (17 of 29) produced an observable phenotype in transgenic mice, a frequency similar to that achieved by conventional gene targeting. Thus, gene trapping allows a large-scale and cost-effective production of ES cell clones with mutations distributed throughout the genome, a resource likely to accelerate genome annotation and the in vivo modeling of human disease.","affiliation":[]},{"pmid":"14701881","pmcid":null,"title":"Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation.","authors":["Timmerman LA","Grego-Bessa J","Raya A","Bertrn E","Prez-Pomares JM","Dez J","Aranda S","Palomo S","McCormick F","Izpisa-Belmonte JC","de la Pompa JL"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Genes & development","journalShort":"Genes Dev.","day":1,"month":1,"year":2004,"meshHeadings":["Animals","Cell Transformation, Neoplastic","Embryo, Nonmammalian","Embryonic and Fetal Development","Epithelial Cells","Gene Expression Regulation, Developmental","Heart","Membrane Proteins","Mesoderm","Mice","Organ Culture Techniques","Rats","Receptors, Cell Surface","Receptors, Notch","Reverse Transcriptase Polymerase Chain Reaction","Zebrafish"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Epithelial-to-mesenchymal transition (EMT) is fundamental to both embryogenesis and tumor metastasis. The Notch intercellular signaling pathway regulates cell fate determination throughout metazoan evolution, and overexpression of activating alleles is oncogenic in mammals. Here we demonstrate that Notch activity promotes EMT during both cardiac development and oncogenic transformation via transcriptional induction of the Snail repressor, a potent and evolutionarily conserved mediator of EMT in many tissues and tumor types. In the embryonic heart, Notch functions via lateral induction to promote a selective transforming growth factor-beta (TGFbeta)-mediated EMT that leads to cellularization of developing cardiac valvular primordia. Embryos that lack Notch signaling elements exhibit severely attenuated cardiac snail expression, abnormal maintenance of intercellular endocardial adhesion complexes, and abortive endocardial EMT in vivo and in vitro. Accordingly, transient ectopic expression of activated Notch1 (N1IC) in zebrafish embryos leads to hypercellular cardiac valves, whereas Notch inhibition prevents valve development. Overexpression of N1IC in immortalized endothelial cells in vitro induces EMT accompanied by oncogenic transformation, with corresponding induction of snail and repression of VE-cadherin expression. Notch is expressed in embryonic regions where EMT occurs, suggesting an intimate and fundamental role for Notch, which may be reactivated during tumor metastasis.","affiliation":[]},{"pmid":"14633973","pmcid":null,"title":"Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis.","authors":["Xiao C","Shim JH","Klppel M","Zhang SS","Dong C","Flavell RA","Fu XY","Wrana JL","Hogan BL","Ghosh S"],"grantIds":["R37-AI33443"],"grantAgencies":["NIAID NIH HHS"],"retractions":[],"journal":"Genes & development","journalShort":"Genes Dev.","day":1,"month":12,"year":2003,"meshHeadings":["Adaptor Proteins, Signal Transducing","Animals","Base Sequence","Bone Morphogenetic Proteins","Cell Differentiation","Cell Division","DNA Primers","Drosophila Proteins","Embryonic and Fetal Development","Genes, Lethal","Mice","Proteins","Signal Transduction","Smad1 Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (Bmps) are members of the transforming growth factor beta (TGFbeta) superfamily that play critical roles during mouse embryogenesis. Signaling by Bmp receptors is mediated mainly by Smad proteins. In this study, we show that a targeted null mutation of Ecsit, encoding a signaling intermediate of the Toll pathway, leads to reduced cell proliferation, altered epiblast patterning, impairment of mesoderm formation, and embryonic lethality at embryonic day 7.5 (E7.5), phenotypes that mimic the Bmp receptor type1a (Bmpr1a) null mutant. In addition, specific Bmp target gene expression is abolished in the absence of Ecsit. Biochemical analysis demonstrates that Ecsit associates constitutively with Smad4 and associates with Smad1 in a Bmp-inducible manner. Together with Smad1 and Smad4, Ecsit binds to the promoter of specific Bmp target genes. Finally, knock-down of Ecsit with Ecsit-specific short hairpin RNA inhibits both Bmp and Toll signaling. Therefore, these results show that Ecsit functions as an essential component in two important signal transduction pathways and establishes a novel role for Ecsit as a cofactor for Smad proteins in the Bmp signaling pathway.","affiliation":[]},{"pmid":"14610062","pmcid":"2173651","title":"Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA.","authors":["Kobielak K","Pasolli HA","Alonso L","Polak L","Fuchs E"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"The Journal of cell biology","journalShort":"J. Cell Biol.","day":10,"month":11,"year":2003,"meshHeadings":["Animals","Animals, Newborn","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Carrier Proteins","Cell Differentiation","Cytoskeletal Proteins","DNA-Binding Proteins","Down-Regulation","Epidermis","GATA3 Transcription Factor","Gene Expression Regulation, Developmental","Hair Follicle","Lymphoid Enhancer-Binding Factor 1","Mice","Mice, Knockout","Microscopy, Electron","Protein-Serine-Threonine Kinases","Proteins","Proto-Oncogene Proteins","Receptors, Growth Factor","Skin Abnormalities","Stem Cells","Trans-Activators","Transcription Factors","Transplants","Vibrissae","Wnt Proteins","Zebrafish Proteins","beta Catenin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Using conditional gene targeting in mice, we show that BMP receptor IA is essential for the differentiation of progenitor cells of the inner root sheath and hair shaft. Without BMPRIA activation, GATA-3 is down-regulated and its regulated control of IRS differentiation is compromised. In contrast, Lef1 is up-regulated, but its regulated control of hair differentiation is still blocked, and BMPRIA-null follicles fail to activate Lef1/beta-catenin-regulated genes, including keratin genes. Wnt-mediated transcriptional activation can be restored by transfecting BMPRIA-null keratinocytes with a constitutively activated beta-catenin. This places the block downstream from Lef1 expression but upstream from beta-catenin stabilization. Because mice lacking the BMP inhibitor Noggin fail to express Lef1, our findings support a model, whereby a sequential inhibition and then activation of BMPRIA is necessary to define a band of hair progenitor cells, which possess enough Lef1 and stabilized beta-catenin to activate the hair specific keratin genes and generate the hair shaft.","affiliation":[]},{"pmid":"12923052","pmcid":null,"title":"Genetic interaction between Wnt/beta-catenin and BMP receptor signaling during formation of the AER and the dorsal-ventral axis in the limb.","authors":["Soshnikova N","Zechner D","Huelsken J","Mishina Y","Behringer RR","Taketo MM","Crenshaw EB","Birchmeier W"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Genes & development","journalShort":"Genes Dev.","day":15,"month":8,"year":2003,"meshHeadings":["Animals","Body Patterning","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Protein Receptors, Type I","Cytoskeletal Proteins","Ectoderm","Extremities","Fibroblast Growth Factor 8","Fibroblast Growth Factors","Hindlimb","Limb Deformities, Congenital","Mice","Mice, Mutant Strains","Mice, Transgenic","Mutation","Protein-Serine-Threonine Kinases","Proto-Oncogene Proteins","Receptors, Growth Factor","Signal Transduction","Trans-Activators","Wnt Proteins","Zebrafish Proteins","beta Catenin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"By conditional gene ablation in mice, we found that beta-catenin, an essential downstream effector of canonical Wnt signaling, is a key regulator of formation of the apical ectodermal ridge (AER) and of the dorsal-ventral axis of the limbs. By generation of compound mutants, we also show that beta-catenin acts downstream of the BMP receptor IA in AER induction, but upstream or parallel in dorsal-ventral patterning. Thus, AER formation and dorsal-ventral patterning of limbs are tightly controlled by an intricate interplay between Wnt/beta-catenin and BMP receptor signaling.","affiliation":[]},{"pmid":"15090551","pmcid":null,"title":"Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling.","authors":["Mishina Y","Starbuck MW","Gentile MA","Fukuda T","Kasparcova V","Seedor JG","Hanks MC","Amling M","Pinero GJ","Harada S","Behringer RR"],"grantIds":["AR42919"],"grantAgencies":["NIAMS NIH HHS"],"retractions":[],"journal":"The Journal of biological chemistry","journalShort":"J. Biol. Chem.","day":25,"month":6,"year":2004,"meshHeadings":["Alkaline Phosphatase","Animals","Body Weight","Bone Development","Bone Morphogenetic Protein Receptors, Type I","Bone Remodeling","Bone Resorption","Calcification, Physiologic","Cell Differentiation","Female","Integrases","Lysosomes","Male","Mice","Mice, Knockout","Mice, Transgenic","Osteoblasts","Osteoclasts","Ovariectomy","Phenotype","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Signal Transduction","Viral Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (BMPs) function during various aspects of embryonic development including skeletogenesis. However, their biological functions after birth are less understood. To investigate the role of BMPs during bone remodeling, we generated a postnatal osteoblast-specific disruption of Bmpr1a that encodes the type IA receptor for BMPs in mice. Mutant mice were smaller than controls up to 6 months after birth. Irregular calcification and low bone mass were observed, but there were normal numbers of osteoblasts. The ability of the mutant osteoblasts to form mineralized nodules in culture was severely reduced. Interestingly, bone mass was increased in aged mutant mice due to reduced bone resorption evidenced by reduced bone turnover. The mutant mice lost more bone after ovariectomy likely resulting from decreased osteoblast function which could not overcome ovariectomy-induced bone resorption. In organ culture of bones from aged mice, ablation of the Bmpr1a gene by adenoviral Cre recombinase abolished the stimulatory effects of BMP4 on the expression of lysosomal enzymes essential for osteoclastic bone resorption. These results demonstrate essential and age-dependent roles for BMP signaling mediated by BMPRIA (a type IA receptor for BMP) in osteoblasts for bone remodeling.","affiliation":[]},{"pmid":"15084466","pmcid":null,"title":"BMPR1A signaling is necessary for hair follicle cycling and hair shaft differentiation in mice.","authors":["Yuhki M","Yamada M","Kawano M","Iwasato T","Itohara S","Yoshida H","Ogawa M","Mishina Y"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":15,"month":4,"year":2004,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Cell Differentiation","Cytoskeletal Proteins","Hair Follicle","Hedgehog Proteins","Integrases","Mice","Mice, Knockout","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Signal Transduction","Trans-Activators","Viral Proteins","beta Catenin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Interactions between ectodermal and mesenchymal extracellular signaling pathways regulate hair follicle (HF) morphogenesis and hair cycling. Bone morphogenetic proteins (BMPs) are known to be important in hair follicle development by affecting the local cell fate modulation. To study the role of BMP signaling in the HF, we disrupted Bmpr1a, which encodes the BMP receptor type IA (BMPR1A) in an HF cell-specific manner, using the Cre/loxP system. We found that the differentiation of inner root sheath, but not outer root sheath, was severely impaired in mutant mice. The number of HFs was reduced in the dermis and subcutaneous tissue, and cycling epithelial cells were reduced in mutant mice HFs. Our results strongly suggest that BMPR1A signaling is essential for inner root sheath differentiation and is indispensable for HF renewal in adult skin.","affiliation":[]},{"pmid":"15064755","pmcid":null,"title":"Molecular recognition of BMP-2 and BMP receptor IA.","authors":["Keller S","Nickel J","Zhang JL","Sebald W","Mueller TD"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Nature structural & molecular biology","journalShort":"Nat. Struct. Mol. Biol.","day":28,"month":5,"year":2004,"meshHeadings":["Animals","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Carrier Proteins","Cell Line, Tumor","Crystallography, X-Ray","Hydrogen Bonding","Mice","Models, Molecular","Protein Binding","Protein Conformation","Protein-Serine-Threonine Kinases","Proteins","Receptors, Growth Factor","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein-2 (BMP-2) and other members of the TGF-beta superfamily regulate the development, maintenance and regeneration of tissues and organs. Binding epitopes for these extracellular signaling proteins have been defined, but hot spots specifying binding affinity and specificity have so far not been identified. In this study, mutational and structural analyses show that epitopes of BMP-2 and the BRIA receptor form a new type of protein-protein interface. The main chain atoms of Leu 51 and Asp53 of BMP-2 represent a hot spot of binding to BRIA. The BMP-2 variant L51P was deficient in type I receptor binding only, whereas its overall structure and its binding to type II receptors and modulator proteins, such as noggin, were unchanged. Thus, the L51P substitution converts BMP-2 into a receptor-inactive inhibitor of noggin. These results are relevant for other proteins of the TGF-beta superfamily and provide useful clues for structure-based drug design.","affiliation":[]},{"pmid":"15073157","pmcid":null,"title":"BMP receptor IA is required in mammalian neural crest cells for development of the cardiac outflow tract and ventricular myocardium.","authors":["Stottmann RW","Choi M","Mishina Y","Meyers EN","Klingensmith J"],"grantIds":["DE13674","F31 NS042486","F31 NS042486-01","F31 NS042486-02","F31 NS042486-03","HD39948","NS42486"],"grantAgencies":["NIDCR NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NICHD NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":23,"month":5,"year":2004,"meshHeadings":["Animals","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cardiovascular System","Cell Differentiation","Embryo, Mammalian","Gene Expression Regulation, Developmental","Gestational Age","Heart Defects, Congenital","Heart Ventricles","Mice","Mice, Knockout","Morphogenesis","Myocardium","Neural Crest","Pericardium","Protein-Serine-Threonine Kinases","Proto-Oncogene Proteins","Receptors, Growth Factor","Signal Transduction","Somites","Transforming Growth Factor beta","Wnt Proteins","Zebrafish Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The neural crest is a multipotent, migratory cell population arising from the border of the neural and surface ectoderm. In mouse, the initial migratory neural crest cells occur at the five-somite stage. Bone morphogenetic proteins (BMPs), particularly BMP2 and BMP4, have been implicated as regulators of neural crest cell induction, maintenance, migration, differentiation and survival. Mouse has three known BMP2/4 type I receptors, of which Bmpr1a is expressed in the neural tube sufficiently early to be involved in neural crest development from the outset; however, earlier roles in other domains obscure its requirement in the neural crest. We have ablated Bmpr1a specifically in the neural crest, beginning at the five-somite stage. We find that most aspects of neural crest development occur normally; suggesting that BMPRIA is unnecessary for many aspects of early neural crest biology. However, mutant embryos display a shortened cardiac outflow tract with defective septation, a process known to require neural crest cells and to be essential for perinatal viability. Surprisingly, these embryos die in mid-gestation from acute heart failure, with reduced proliferation of ventricular myocardium. The myocardial defect may involve reduced BMP signaling in a novel, minor population of neural crest derivatives in the epicardium, a known source of ventricular myocardial proliferation signals. These results demonstrate that BMP2/4 signaling in mammalian neural crest derivatives is essential for outflow tract development and may regulate a crucial proliferation signal for the ventricular myocardium.","affiliation":[]},{"pmid":"15124223","pmcid":null,"title":"Essential roles of BMPR-IA signaling in differentiation and growth of hair follicles and in skin tumorigenesis.","authors":["Ming Kwan K","Li AG","Wang XJ","Wurst W","Behringer RR"],"grantIds":["AR42919","AR47898","CA16672","HD30284"],"grantAgencies":["NIAMS NIH HHS","NIAMS NIH HHS","NCI NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"Genesis (New York, N.Y. : 2000)","journalShort":"Genesis","day":4,"month":5,"year":2004,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Cell Differentiation","Cell Division","Hair","Mice","Mice, Mutant Strains","Morphogenesis","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Signal Transduction","Skin Neoplasms","Trans-Activators"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Hair differentiation and growth are controlled by complex reciprocal signaling between epithelial and mesenchymal cells. To better understand the requirement and molecular mechanism of BMP signaling in hair follicle development, we performed genetic analyses of bone morphogenetic protein receptor 1A (BMPR-IA) function during hair follicle development by using a conditional knockout approach. The conditional mutation of Bmpr1a in ventral limb ectoderm and its derivatives (epidermis and hair follicles) resulted in a lack of hair outgrowth from the affected skin regions. Mutant hair follicles exhibited abnormal morphology and lacked hair formation and pigment deposition during anagen. The timing of the hair cycle and the proliferation of hair matrix cells were also affected in the mutant follicles. We demonstrate that signaling via epithelial BMPR-IA is required for differentiation of both hair shaft and inner root sheath from hair matrix precursor cells in anagen hair follicles but is dispensable for embryonic hair follicle induction. Surprisingly, aberrant de novo hair follicle morphogenesis together with hair matrix cell hyperplasia was observed in the absence of BMPR-IA signaling within the affected skin of adult mutants. They developed hair follicle tumors from 3 months of age, indicating that inactivation of epidermal BMPR-IA signaling can lead to hair tumor formation. Taken together, our data provide genetic evidence that BMPR-IA signaling plays critical and multiple roles in controlling cell fate decisions or maintenance, proliferation, and differentiation during hair morphogenesis and growth, and implicate Bmpr1a as a tumor suppressor in skin tumorigenesis.","affiliation":[]},{"pmid":"15136140","pmcid":null,"title":"BMP receptor IA is required in the mammalian embryo for endodermal morphogenesis and ectodermal patterning.","authors":["Davis S","Miura S","Hill C","Mishina Y","Klingensmith J"],"grantIds":["P01HD39948","R01DE013674"],"grantAgencies":["NICHD NIH HHS","NIDCR NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":1,"month":6,"year":2004,"meshHeadings":["Animals","Body Patterning","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Central Nervous System","Ectoderm","Embryo, Mammalian","Embryo, Nonmammalian","Endoderm","Gene Expression Regulation, Developmental","Homeodomain Proteins","In Situ Hybridization","Mice","Morphogenesis","Mosaicism","Phenotype","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Signal Transduction","Zebrafish"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BMPRIA is a receptor for bone morphogenetic proteins with high affinity for BMP2 and BMP4. Mouse embryos lacking Bmpr1a fail to gastrulate, complicating studies on the requirements for BMP signaling in germ layer development. Recent work shows that BMP4 produced in extraembryonic tissues initiates gastrulation. Here we use a conditional allele of Bmpr1a to remove BMPRIA only in the epiblast, which gives rise to all embryonic tissues. Resulting embryos are mosaics composed primarily of cells homozygous null for Bmpr1a, interspersed with heterozygous cells. Although mesoderm and endoderm do not form in Bmpr1a null embryos, these tissues are present in the mosaics and are populated with mutant cells. Thus, BMPRIA signaling in the epiblast does not restrict cells to or from any of the germ layers. Cells lacking Bmpr1a also contribute to surface ectoderm; however, from the hindbrain forward, little surface ectoderm forms and the forebrain is enlarged and convoluted. Prechordal plate, early definitive endoderm, and anterior visceral endoderm appear to be expanded, likely due to defective morphogenesis. These data suggest that the enlarged forebrain is caused in part by increased exposure of the ectoderm to signaling sources that promote anterior neural fate. Our results reveal critical roles for BMP signaling in endodermal morphogenesis and ectodermal patterning.","affiliation":[]},{"pmid":"15378062","pmcid":null,"title":"BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling.","authors":["He XC","Zhang J","Tong WG","Tawfik O","Ross J","Scoville DH","Tian Q","Zeng X","He X","Wiedemann LM","Mishina Y","Li L"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Nature genetics","journalShort":"Nat. Genet.","day":29,"month":10,"year":2004,"meshHeadings":["Adenomatous Polyposis Coli","Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cytoskeletal Proteins","Disease Models, Animal","Epithelial Cells","Humans","Intestines","Mice","Mice, Inbred C57BL","Mice, Mutant Strains","Mice, Transgenic","PTEN Phosphohydrolase","Protein Tyrosine Phosphatases","Protein-Serine-Threonine Kinases","Proto-Oncogene Proteins","Proto-Oncogene Proteins c-akt","Receptors, Growth Factor","Signal Transduction","Stem Cells","Trans-Activators","Tumor Suppressor Proteins","Wnt Proteins","beta Catenin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"In humans, mutations in BMPR1A, SMAD4 and PTEN are responsible for juvenile polyposis syndrome, juvenile intestinal polyposis and Cowden disease, respectively. The development of polyposis is a common feature of these diseases, suggesting that there is an association between BMP and PTEN pathways. The mechanistic link between BMP and PTEN pathways and the related etiology of juvenile polyposis is unresolved. Here we show that conditional inactivation of Bmpr1a in mice disturbs homeostasis of intestinal epithelial regeneration with an expansion of the stem and progenitor cell populations, eventually leading to intestinal polyposis resembling human juvenile polyposis syndrome. We show that BMP signaling suppresses Wnt signaling to ensure a balanced control of stem cell self-renewal. Mechanistically, PTEN, through phosphatidylinosital-3 kinase-Akt, mediates the convergence of the BMP and Wnt pathways on control of beta-catenin. Thus, BMP signaling may control the duplication of intestinal stem cells, thereby preventing crypt fission and the subsequent increase in crypt number.","affiliation":[]},{"pmid":"14656471","pmcid":null,"title":"Genetic studies of the AMH/MIS signaling pathway for Mllerian duct regression.","authors":["Jamin SP","Arango NA","Mishina Y","Hanks MC","Behringer RR"],"grantIds":["CA16672","HD30284"],"grantAgencies":["NCI NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"Molecular and cellular endocrinology","journalShort":"Mol. Cell. Endocrinol.","day":15,"month":12,"year":2003,"meshHeadings":["Animals","Anti-Mullerian Hormone","Bone Morphogenetic Protein Receptors, Type I","Crosses, Genetic","Disorders of Sex Development","Female","Gene Expression Regulation, Developmental","Genotype","Glycoproteins","Granulosa Cells","Integrases","Lac Operon","Male","Mice","Mice, Transgenic","Models, Biological","Mullerian Ducts","Ovary","Phenotype","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Receptors, Peptide","Receptors, Transforming Growth Factor beta","Sex Differentiation","Signal Transduction","Testicular Hormones","Time Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Anti-Mllerian hormone (AMH)/Mllerian-inhibiting substance (MIS) is a member of the transforming growth factor-beta (TGF-beta) superfamily. Like other TGF-beta family members, AMH is likely to signal through two transmembrane serine/threonine kinase receptors. Whereas the AMH type II receptor has been clearly defined, only recently has there been evidence about the identity of the AMH type I receptor for Mllerian duct regression in vivo. We generated a new cre mouse line expressing the recombinase in AMH target cells. This line was then used to conditionally inactivate the Bmpr1a gene in the Mllerian duct, resulting in males with a uterus. Thus, Bmpr1a plays an essential role in the process of Mllerian duct regression. To investigate the role of Bmpr1a in granulosa cells, we took advantage of transgenic mice overexpressing human AMH. Surprisingly, these transgenic females that were also conditionally mutant for Bmpr1a in the Mllerian duct had no uterus. These results suggest that when AMH is overexpressed, other TGF-beta family type I receptors can potentially transduce AMH signals.","affiliation":[]},{"pmid":"15342483","pmcid":null,"title":"TGFbeta superfamily signals are required for morphogenesis of the kidney mesenchyme progenitor population.","authors":["Oxburgh L","Chu GC","Michael SK","Robertson EJ"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":2,"month":9,"year":2004,"meshHeadings":["Animals","Bone Morphogenetic Protein 7","Bone Morphogenetic Proteins","Cell Division","Cell Lineage","DNA-Binding Proteins","Gene Deletion","Homeodomain Proteins","Kidney","Mesoderm","Mice","Mice, Transgenic","Morphogenesis","Multigene Family","Nephrosis","Signal Transduction","Smad4 Protein","Stem Cells","Trans-Activators","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The TGFbeta superfamily plays diverse and essential roles in kidney development. Gdf11 and Bmp4 are essential for outgrowth and positioning of the ureteric bud, the inducer of metanephric mesenchyme. During nephrogenesis, Bmp7 is required for renewal of the mesenchyme progenitor population. Additionally, in vitro studies demonstrate inhibitory effects of BMPs and TGFbetas on collecting duct branching and growth. Here, we explore the predicted models of TGFbeta superfamily function by cell-specific inactivation of Smad4, a key mediator of TGFbeta signaling. Using a HoxB7cre transgene expressed in ureteric bud and collecting duct, we find that development of the collecting duct is Smad4 independent. By contrast, removal of Smad4 in nephrogenic mesenchyme using the Bmp7(cre/+) allele leads to disorganization of the nephrogenic mesenchyme and impairment of mesenchyme induction. Smad4-deficient metanephric mesenchyme does not display defects in inducibility in LiCl or spinal cord induction assays. However, in situ hybridization and lineage analysis of Smad4 null mesenchyme cells at E11.5 show that the nephrogenic mesenchyme does not aggregate tightly around the ureteric bud tips, but remains loosely associated, embedded within a population of cells expressing markers of both nephrogenic mesenchyme and peripheral stroma. We conclude that the failure of recruitment of nephrogenic mesenchyme leaves a primitive population of mesenchyme at the periphery of the kidney. This population is gradually depleted, and by E16.5 the periphery is composed of cells of stromal phenotype. This study uncovers a novel role for TGFbeta superfamily signaling in the recruitment and/or organization of the nephrogenic mesenchyme at early time-points of kidney development. Additionally, we present conclusive genetic lineage mapping of the collecting duct and nephrogenic mesenchyme.","affiliation":[]},{"pmid":"15136139","pmcid":null,"title":"A Titin mutation defines roles for circulation in endothelial morphogenesis.","authors":["May SR","Stewart NJ","Chang W","Peterson AS"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":1,"month":6,"year":2004,"meshHeadings":["Animals","Blood Circulation","Cell Death","Cell Size","Chromosome Mapping","Connectin","Endothelial Cells","Endothelium, Vascular","Mesoderm","Mice","Morphogenesis","Muscle Proteins","Mutation","Myocardial Contraction","Myocytes, Cardiac","Neovascularization, Physiologic","Phenotype","Protein Kinases","Vascular Endothelial Growth Factor A","Yolk Sac"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Morphogenesis of the developing vascular network requires coordinated regulation of an extensive array of endothelial cell behaviors. Precisely regulated signaling molecules such as vascular endothelial growth factor (VEGF) direct some of these endothelial behaviors. Newly forming blood vessels also become subjected to novel biomechanical forces upon initiation of cardiac contractions. We report here the identification of a recessive mouse mutation termed shrunken-head (shru) that disrupts function of the Titin gene. Titin was found to be required for the initiation of proper heart contractions as well as for maintaining the correct overall shape and orientation of individual cardiomyocytes. Cardiac dysfunction in shrunken-head mutant embryos provided an opportunity to study the effects of lack of blood circulation on the morphogenesis of endothelial cells. Without blood flow, differentiating endothelial cells display defects in their shapes and patterns of cell-cell contact. These endothelial cells, without exposure to blood circulation, have an abnormal distribution within vasculogenic vessels. Further effects of absent blood flow include abnormal spatial regulation of angiogenesis and elevated VEGF signaling. The shrunken-head mutation has provided an in vivo model to precisely define the roles of circulation on cellular and network aspects of vascular morphogenesis.","affiliation":[]},{"pmid":"14681479","pmcid":null,"title":"GenePaint.org: an atlas of gene expression patterns in the mouse embryo.","authors":["Visel A","Thaller C","Eichele G"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Nucleic acids research","journalShort":"Nucleic Acids Res.","day":1,"month":1,"year":2004,"meshHeadings":["Animals","Brain","Computational Biology","Databases, Genetic","Embryo, Mammalian","Gene Expression Profiling","Gene Expression Regulation, Developmental","In Situ Hybridization","Information Storage and Retrieval","Internet","Mice","RNA Probes","RNA, Messenger","Software"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"High-throughput instruments were recently developed to determine gene expression patterns on tissue sections by RNA in situ hybridization. The resulting images of gene expression patterns, chiefly of E14.5 mouse embryos, are accessible to the public at http://www.genepaint.org. This relational database is searchable for gene identifiers and RNA probe sequences. Moreover, patterns and intensity of expression in approximately 100 different embryonic tissues are annotated and can be searched using a standardized catalog of anatomical structures. A virtual microscope tool, the Zoom Image Server, was implemented in GenePaint.org and permits interactive zooming and panning across approximately 15,000 high-resolution images.","affiliation":[]},{"pmid":"17339028","pmcid":null,"title":"BMP4-BMPR1A signaling in beta cells is required for and augments glucose-stimulated insulin secretion.","authors":["Goulley J","Dahl U","Baeza N","Mishina Y","Edlund H"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Cell metabolism","journalShort":"Cell Metab.","day":6,"month":3,"year":2007,"meshHeadings":["Animals","Autocrine Communication","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Diabetes Mellitus, Type 2","Female","Gene Expression","Glucose","Glucose Intolerance","Homeodomain Proteins","Insulin","Insulin-Secreting Cells","Male","Mice","Mice, Inbred C57BL","Mice, Inbred CBA","Mice, Transgenic","Signal Transduction","Trans-Activators"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Impaired glucose-stimulated insulin secretion (GSIS) and perturbed proinsulin processing are hallmarks of beta cell dysfunction in type 2 diabetes. Signals that can preserve and/or enhance beta cell function are therefore of great therapeutic interest. Here we show that bone morphogenetic protein 4 (Bmp4) and its high-affinity receptor, Bmpr1a, are expressed in beta cells. Mice with attenuated BMPR1A signaling in beta cells show decreased expression of key genes involved in insulin gene expression, proinsulin processing, glucose sensing, secretion stimulus coupling, incretin signaling, and insulin exocytosis and develop diabetes due to impaired insulin secretion. We also show that transgenic expression of Bmp4 in beta cells enhances GSIS and glucose clearance and that systemic administration of BMP4 protein to adult mice significantly stimulates GSIS and ameliorates glucose tolerance in a mouse model of glucose intolerance. Thus, BMP4-BMPR1A signaling in beta cells plays a key role in GSIS.","affiliation":[]},{"pmid":"15469980","pmcid":null,"title":"Signaling through BMP type 1 receptors is required for development of interneuron cell types in the dorsal spinal cord.","authors":["Wine-Lee L","Ahn KJ","Richardson RD","Mishina Y","Lyons KM","Crenshaw EB"],"grantIds":["R01 AR044528"],"grantAgencies":["NIAMS NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":15,"month":11,"year":2004,"meshHeadings":["Animals","Basic Helix-Loop-Helix Transcription Factors","Bone Morphogenetic Protein Receptors, Type I","Cell Differentiation","DNA-Binding Proteins","Down-Regulation","Embryo, Mammalian","Gene Expression Regulation, Developmental","Interneurons","Mice","Mice, Knockout","Mutation","Protein-Serine-Threonine Kinases","Proto-Oncogene Proteins","Receptors, Growth Factor","Signal Transduction","Spinal Cord","Transcription Factors","Wnt Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"During spinal cord development, distinct classes of interneurons arise at stereotypical locations along the dorsoventral axis. In this paper, we demonstrate that signaling through bone morphogenetic protein (BMP) type 1 receptors is required for the formation of two populations of commissural neurons, DI1 and DI2, that arise within the dorsal neural tube. We have generated a double knockout of both BMP type 1 receptors, Bmpr1a and Bmpr1b, in the neural tube. These double knockout mice demonstrate a complete loss of D1 progenitor cells, as evidenced by loss of Math1 expression, and the subsequent failure to form differentiated DI1 interneurons. Furthermore, the DI2 interneuron population is profoundly reduced. The loss of these populations of cells results in a dorsal shift of the dorsal cell populations, DI3 and DI4. Other dorsal interneuron populations, DI5 and DI6, and ventral neurons appear unaffected by the loss of BMP signaling. The Bmpr double knockout animals demonstrate a reduction in the expression of Wnt and Id family members, suggesting that BMP signaling regulates expression of these factors in spinal cord development. These results provide genetic evidence that BMP signaling is crucial for the development of dorsal neuronal cell types.","affiliation":[]},{"pmid":"15556938","pmcid":null,"title":"Identification of FGF10 targets in the embryonic lung epithelium during bud morphogenesis.","authors":["L J","Izvolsky KI","Qian J","Cardoso WV"],"grantIds":["(P01) HL47049"],"grantAgencies":["NHLBI NIH HHS"],"retractions":[],"journal":"The Journal of biological chemistry","journalShort":"J. Biol. Chem.","day":11,"month":2,"year":2005,"meshHeadings":["Animals","Cell Adhesion","Cell Movement","Cell Proliferation","DNA Primers","Embryo, Mammalian","Epithelium","Fibroblast Growth Factor 10","Fibroblast Growth Factors","Gene Expression Regulation, Developmental","In Situ Hybridization","Inflammation","Lung","Mesoderm","Mice","Oligonucleotide Array Sequence Analysis","RNA","Receptor Protein-Tyrosine Kinases","Receptor, Fibroblast Growth Factor, Type 2","Receptors, Fibroblast Growth Factor","Signal Transduction","Time Factors","Transcription, Genetic","Up-Regulation"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Genetic studies implicate Fgf10-Fgfr2 signaling as a critical regulator of bud morphogenesis in the embryo. However, little is known about the transcriptional targets of Fgf10 during this process. Here we identified global changes in gene expression in lung epithelial explants undergoing FGF10-mediated budding in the absence of other growth factors and mesenchyme. Targets were confirmed by their localization at sites where endogenous Fgf10 signaling is active in embryonic lungs and by demonstrating their induction in intact lungs in response to local application of FGF10 protein. We show that the initial stages of budding are characterized by marked up-regulation of genes associated with cell rearrangement and cell migration, inflammatory process, and lipid metabolism but not cell proliferation. We also found that some genes implicated in tumor invasion and metastatic behavior are epithelial targets of Fgf10 in the lung and other developing organs that depend on Fgf10-Fgfr2 signaling to properly form. Our approach identifies Fgf10 targets that are common to multiple biological processes and provides insights into potential mechanisms by which Fgf signaling regulates epithelial cell behavior.","affiliation":[]},{"pmid":"15322331","pmcid":null,"title":"Distinct roles of BMP receptors Type IA and IB in osteo-/chondrogenic differentiation in mesenchymal progenitors (C3H10T1/2).","authors":["Kaps C","Hoffmann A","Zilberman Y","Pelled G","Hupl T","Sittinger M","Burmester G","Gazit D","Gross G"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"BioFactors (Oxford, England)","journalShort":"Biofactors","day":23,"month":8,"year":2004,"meshHeadings":["Animals","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Differentiation","Cell Line","Chondrocytes","Gene Expression","Green Fluorescent Proteins","Humans","Mesenchymal Stromal Cells","Mice","Mice, Inbred C3H","Osteoblasts","Osteogenesis","Protein-Serine-Threonine Kinases","RNA, Messenger","Receptors, Growth Factor","Recombinant Fusion Proteins","Recombinant Proteins","Reverse Transcriptase Polymerase Chain Reaction","Transfection","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The functional roles of BMP type IA and IB receptors mediating differentiation into the osteogenic and chondrogenic lineage were investigated in the mesenchymal progenitor line C3H10T1/2 in vitro. The capacity of type IA and IB BMP receptors was assessed by the forced expression of the wild-type (wtBMPR-IA or IB) and of the kinase-deficient, dominant-negative form (dnBMPR-IA or -IB) in parental C3H10T1/2 progenitors as well as in C3H10T1/2 progenitors which recombinantly express BMP2 (C3H10T1/2-BMP2) or GDF5 (C3H10T1/2-GDF5). Consistent with the higher endogenous expression rate of BMPR-IA in comparison with BMPR-IB, BMPR-IA plays the dominant role in BMP2-mediated osteo-/chondrogenic development. BMPR-IB moderately influences osteogenic and hardly chondrogenic development. BMPR-IB seems to be unable to efficiently activate downstream signaling pathways upon forced expression. However, a mutation conferring constitutive activity to the BMPR-IB receptor indicates that this receptor possesses the capacity to activate downstream signaling cascades. These results suggest that in mesenchymal progenitors C3H10T1/2 BMPR-IA is responsible for the initiation of the osteogenic as well as chondrogenic development and that BMPR-IA and -IB receptor pathways are well separated in this mesenchymal progenitor line and may not substitute each other. In addition this indicates that type IB and IA BMP receptors may transmit different signals during the specification and differentiation of mesenchymal lineages.","affiliation":[]},{"pmid":"15969004","pmcid":null,"title":"[Preliminary study of ALK3 downstream genes related to ventricular septum defect].","authors":["Yang DY","Song HY","Zhang HQ","Huang XY","Guan XQ"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Sheng wu gong cheng xue bao = Chinese journal of biotechnology","journalShort":"Sheng Wu Gong Cheng Xue Bao","day":22,"month":5,"year":2003,"meshHeadings":["1-Alkyl-2-acetylglycerophosphocholine Esterase","14-3-3 Proteins","Animals","Bone Morphogenetic Protein Receptors, Type I","Genotype","Heart Septal Defects, Ventricular","Mice","Mice, Knockout","Oligonucleotide Array Sequence Analysis","Paired Box Transcription Factors","Protein-Tyrosine Kinases","Reverse Transcriptase Polymerase Chain Reaction","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"To investigate the function of ALK3 gene, the gene regulation and the signaling pathway related to ventricular septum defect during heart development. The model mice with ALK3 gene knock-out via alpha-MHC-Cre/lox P system were bred. The mRNA expression level of control group was compared with that of experiment group and ALK3 downstream genes were screened using PCR-select cDNA subtraction microarray. The mRNA of control group was extracted from E11.5 normal mouse hearts, and that of experiment group, from E11.5 hearts of mice with alpha-MHC Cre(+/-) ALK3(F/+) genotype. It was found that the mice with ALK3 gene knock-out produced heart defects involving the interventricular septum. The platelet-activating factors acetylhydrolase and the transcription factor Pax-8 and so on, were down-regulated. However, the Protein Tyrosine Kinase (PTK) of Focal Adhesion Kinase (FAK) subfamily and beta subtype protein 14-3-3 were up-regulated in the alpha-MHC Cre(+/-) ALK3(F/-) mice. These data provide support that ALK3 gene played an important role during heart development. The platelet-activating factors acetylhydrolase and Pax-8 genes could be important ALK3 downstream genes in the BMP signaling pathway during interventricular septum development. PTK and beta subtype protein 14-3-3 might be regulatory factors in this pathway.","affiliation":[]},{"pmid":"15489334","pmcid":null,"title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","authors":["Gerhard DS","Wagner L","Feingold EA","Shenmen CM","Grouse LH","Schuler G","Klein SL","Old S","Rasooly R","Good P","Guyer M","Peck AM","Derge JG","Lipman D","Collins FS","Jang W","Sherry S","Feolo M","Misquitta L","Lee E","Rotmistrovsky K","Greenhut SF","Schaefer CF","Buetow K","Bonner TI","Haussler D","Kent J","Kiekhaus M","Furey T","Brent M","Prange C","Schreiber K","Shapiro N","Bhat NK","Hopkins RF","Hsie F","Driscoll T","Soares MB","Casavant TL","Scheetz TE","Brown-stein MJ","Usdin TB","Toshiyuki S","Carninci P","Piao Y","Dudekula DB","Ko MS","Kawakami K","Suzuki Y","Sugano S","Gruber CE","Smith MR","Simmons B","Moore T","Waterman R","Johnson SL","Ruan Y","Wei CL","Mathavan S","Gunaratne PH","Wu J","Garcia AM","Hulyk SW","Fuh E","Yuan Y","Sneed A","Kowis C","Hodgson A","Muzny DM","McPherson J","Gibbs RA","Fahey J","Helton E","Ketteman M","Madan A","Rodrigues S","Sanchez A","Whiting M","Madari A","Young AC","Wetherby KD","Granite SJ","Kwong PN","Brinkley CP","Pearson RL","Bouffard GG","Blakesly RW","Green ED","Dickson MC","Rodriguez AC","Grimwood J","Schmutz J","Myers RM","Butterfield YS","Griffith M","Griffith OL","Krzywinski MI","Liao N","Morin R","Morrin R","Palmquist D","Petrescu AS","Skalska U","Smailus DE","Stott JM","Schnerch A","Schein JE","Jones SJ","Holt RA","Baross A","Marra MA","Clifton S","Makowski KA","Bosak S","Malek J","MGC Project Team"],"grantIds":["N01-C0-12400"],"grantAgencies":["PHS HHS"],"retractions":[],"journal":"Genome research","journalShort":"Genome Res.","day":18,"month":10,"year":2004,"meshHeadings":["Animals","Cloning, Molecular","Computational Biology","DNA Primers","DNA, Complementary","Gene Library","Humans","Mice","National Institutes of Health (U.S.)","Open Reading Frames","Rats","United States","Xenopus laevis","Zebrafish"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The National Institutes of Health's Mammalian Gene Collection (MGC) project was designed to generate and sequence a publicly accessible cDNA resource containing a complete open reading frame (ORF) for every human and mouse gene. The project initially used a random strategy to select clones from a large number of cDNA libraries from diverse tissues. Candidate clones were chosen based on 5'-EST sequences, and then fully sequenced to high accuracy and analyzed by algorithms developed for this project. Currently, more than 11,000 human and 10,000 mouse genes are represented in MGC by at least one clone with a full ORF. The random selection approach is now reaching a saturation point, and a transition to protocols targeted at the missing transcripts is now required to complete the mouse and human collections. Comparison of the sequence of the MGC clones to reference genome sequences reveals that most cDNA clones are of very high sequence quality, although it is likely that some cDNAs may carry missense variants as a consequence of experimental artifact, such as PCR, cloning, or reverse transcriptase errors. Recently, a rat cDNA component was added to the project, and ongoing frog (Xenopus) and zebrafish (Danio) cDNA projects were expanded to take advantage of the high-throughput MGC pipeline.","affiliation":[]},{"pmid":"15582152","pmcid":null,"title":"A neurogenomics approach to gene expression analysis in the developing brain.","authors":["Jensen P","Magdaleno S","Lehman KM","Rice DS","Lavallie ER","Collins-Racie L","McCoy JM","Curran T"],"grantIds":["R37 NS36558"],"grantAgencies":["NINDS NIH HHS"],"retractions":[],"journal":"Brain research. Molecular brain research","journalShort":"Brain Res. Mol. Brain Res.","day":20,"month":12,"year":2004,"meshHeadings":["Animals","Brain","DNA, Complementary","Female","Gene Expression Regulation, Developmental","Genomics","In Situ Hybridization","Male","Mice","Mice, Inbred C57BL","Pregnancy"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Secreted and transmembrane proteins provide critical functions in the signaling networks essential for neurogenesis. We used a genetic signal sequence gene trap approach to isolate 189 genes expressed during development in e16.5 whole head, e16.5 hippocampus and e14.5 cerebellum. Gene ontology programs were used to classify the genes into respective biological processes. Four major classes of biological processes known to be important during development were identified: cell communication, cell physiology processes, metabolism and morphogenesis. We used in situ hybridization to determine the temporal and spatial patterns of gene expression in the developing brain using this set of probes. The results demonstrate that gene expression patterns can highlight potential gene functions in specific brain regions. We propose that combining bioinformatics with the gene expression pattern is an effective strategy to identify genes that may play critical roles during brain development.","affiliation":[]},{"pmid":"15531373","pmcid":null,"title":"BMP signaling through ACVRI is required for left-right patterning in the early mouse embryo.","authors":["Kishigami S","Yoshikawa S","Castranio T","Okazaki K","Furuta Y","Mishina Y"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":1,"month":12,"year":2004,"meshHeadings":["Animals","Blastocyst","Body Patterning","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Embryonic Development","Female","Gene Expression Regulation, Developmental","Immunohistochemistry","In Situ Hybridization","Mice","Mice, Inbred Strains","Mice, Mutant Strains","Microinjections","Models, Biological","Pregnancy","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Signal Transduction","Stem Cells","beta-Galactosidase"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Vertebrate organisms are characterized by dorsal-ventral and left-right asymmetry. The process that establishes left-right asymmetry during vertebrate development involves bone morphogenetic protein (BMP)-dependent signaling, but the molecular details of this signaling pathway remain poorly defined. This study tests the role of the BMP type I receptor ACVRI in establishing left-right asymmetry in chimeric mouse embryos. Mouse embryonic stem (ES) cells with a homozygous deletion at Acvr1 were used to generate chimeric embryos. Chimeric embryos were rescued from the gastrulation defect of Acvr1 null embryos but exhibited abnormal heart looping and embryonic turning. High mutant contribution chimeras expressed left-side markers such as nodal bilaterally in the lateral plate mesoderm (LPM), indicating that loss of ACVRI signaling leads to left isomerism. Expression of lefty1 was absent in the midline of chimeric embryos, but shh, a midline marker, was expressed normally, suggesting that, despite formation of midline, its barrier function was abolished. High-contribution chimeras also lacked asymmetric expression of nodal in the node. These data suggest that ACVRI signaling negatively regulates left-side determinants such as nodal and positively regulates lefty1. These functions maintain the midline, restrict expression of left-side markers, and are required for left-right pattern formation during embryogenesis in the mouse.","affiliation":[]},{"pmid":"15289457","pmcid":null,"title":"BMP signaling mediated by ALK2 in the visceral endoderm is necessary for the generation of primordial germ cells in the mouse embryo.","authors":["de Sousa Lopes SM","Roelen BA","Monteiro RM","Emmens R","Lin HY","Li E","Lawson KA","Mummery CL"],"grantIds":["DK-19406","DK-D02716","R01 HD35286"],"grantAgencies":["NIDDK NIH HHS","NIDDK NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"Genes & development","journalShort":"Genes Dev.","day":1,"month":8,"year":2004,"meshHeadings":["Activin Receptors, Type I","Adenoviridae","Animals","Bone Morphogenetic Protein 4","Bone Morphogenetic Proteins","Embryo, Mammalian","Endoderm","Fibronectins","Gene Expression Regulation, Developmental","Germ Cells","Heterozygote","Humans","Mice","Mice, Inbred C57BL","Mice, Knockout","Mice, Mutant Strains","Proteins","Reverse Transcriptase Polymerase Chain Reaction","Signal Transduction","Tumor Cells, Cultured"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Deletion of various bone morphogenetic proteins (BMPs) and their downstream Smads in mice have clearly shown that BMP signaling is essential for the formation of primordial germ cells (PGCs). However, the molecular mechanism through which this takes place is still unclear. Here, we demonstrate that BMP4 produced in the extraembryonic ectoderm signals through ALK2, a type I BMP receptor, in the visceral endoderm (VE) to induce formation of PGCs from the epiblast. Firstly, embryonic day 5.5-6.0 (E5.5-E6.0) embryos cultured on fibronectin formed PGCs in the presence of VE, but not in its absence. Secondly, Alk2-deficient embryos completely lacked PGCs and the heterozygotes had reduced numbers, resembling Bmp4-deficient phenotypes. Thirdly, expression of constitutively active ALK2 in the VE, but not in the epiblast, was sufficient to rescue the PGC phenotype in Bmp4-deficient embryos. In addition, we show that the requirement for the VE at E5.5-E6.0 can be replaced by culturing embryos stripped of VE on STO cells, indicating that STO cells provide or transduce signals necessary for PGC formation that are normally transmitted by the VE. We propose a model in which direct signaling to proximal epiblast is supplemented by an obligatory indirect BMP-dependent signal via the VE.","affiliation":[]},{"pmid":"15558476","pmcid":null,"title":"Contributions by members of the TGFbeta superfamily to lens development.","authors":["Beebe D","Garcia C","Wang X","Rajagopal R","Feldmeier M","Kim JY","Chytil A","Moses H","Ashery-Padan R","Rauchman M"],"grantIds":["EY02687","EY04853"],"grantAgencies":["NEI NIH HHS","NEI NIH HHS"],"retractions":[],"journal":"The International journal of developmental biology","journalShort":"Int. J. Dev. Biol.","day":23,"month":11,"year":2004,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Differentiation","Chick Embryo","DNA, Complementary","Endosomes","Gene Deletion","Gene Expression Regulation, Developmental","Lens, Crystalline","Ligands","Mice","Mice, Transgenic","Microscopy, Confocal","Models, Biological","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Signal Transduction","Time Factors","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Members of the TGFbeta superfamily of growth and differentiation factors, including the TGFbeta, BMP, activin and nodal families, play important signaling roles throughout development. This paper summarizes some of the functions of these ligands in lens development. Targeted deletion of the genes encoding one of the BMP receptors, Alk3 (BMP receptor-1A), showed that signaling through this receptor is essential for normal lens development. Lenses lacking Alk3 were smaller than normal, with thin epithelial layers. The fiber cells of Alk3 null lenses became vacuolated and degenerated within the first week after birth. Lenses lacking Alk3 function were surrounded by abnormal mesenchymal cells, suggesting that the lenses provided inappropriate signals to surrounding tissues. Lens epithelial and fiber cells contained endosomes that were associated with activated (phosphorylated) SMAD1 and SMAD2. Endosomal localization of pSMAD1 was reduced in the absence of Alk3 signaling. The presence of pSMAD2 in lens fiber cell nuclei and the observation that the activin antagonist follistatin inhibited lens cell elongation suggested that an activin-like molecule participates in lens fiber cell differentiation. Lenses deficient in type II TGFbeta receptors were clear and had fiber cells of normal morphology. This suggests that TGFbeta signaling is not essential for the normal differentiation of lens fiber cells. The targeted deletion of single or multiple receptors of the TGFbeta superfamily in the lens should further characterize the role of these signaling molecules in lens development. This approach may also provide a useful way to define the downstream pathways that are activated by these receptors during the development of the lens and other tissues.","affiliation":[]},{"pmid":"16141072","pmcid":null,"title":"The transcriptional landscape of the mammalian genome.","authors":["Carninci P","Kasukawa T","Katayama S","Gough J","Frith MC","Maeda N","Oyama R","Ravasi T","Lenhard B","Wells C","Kodzius R","Shimokawa K","Bajic VB","Brenner SE","Batalov S","Forrest AR","Zavolan M","Davis MJ","Wilming LG","Aidinis V","Allen JE","Ambesi-Impiombato A","Apweiler R","Aturaliya RN","Bailey TL","Bansal M","Baxter L","Beisel KW","Bersano T","Bono H","Chalk AM","Chiu KP","Choudhary V","Christoffels A","Clutterbuck DR","Crowe ML","Dalla E","Dalrymple BP","de Bono B","Della Gatta G","di Bernardo D","Down T","Engstrom P","Fagiolini M","Faulkner G","Fletcher CF","Fukushima T","Furuno M","Futaki S","Gariboldi M","Georgii-Hemming P","Gingeras TR","Gojobori T","Green RE","Gustincich S","Harbers M","Hayashi Y","Hensch TK","Hirokawa N","Hill D","Huminiecki L","Iacono M","Ikeo K","Iwama A","Ishikawa T","Jakt M","Kanapin A","Katoh M","Kawasawa Y","Kelso J","Kitamura H","Kitano H","Kollias G","Krishnan SP","Kruger A","Kummerfeld SK","Kurochkin IV","Lareau LF","Lazarevic D","Lipovich L","Liu J","Liuni S","McWilliam S","Madan Babu M","Madera M","Marchionni L","Matsuda H","Matsuzawa S","Miki H","Mignone F","Miyake S","Morris K","Mottagui-Tabar S","Mulder N","Nakano N","Nakauchi H","Ng P","Nilsson R","Nishiguchi S","Nishikawa S","Nori F","Ohara O","Okazaki Y","Orlando V","Pang KC","Pavan WJ","Pavesi G","Pesole G","Petrovsky N","Piazza S","Reed J","Reid JF","Ring BZ","Ringwald M","Rost B","Ruan Y","Salzberg SL","Sandelin A","Schneider C","Schnbach C","Sekiguchi K","Semple CA","Seno S","Sessa L","Sheng Y","Shibata Y","Shimada H","Shimada K","Silva D","Sinclair B","Sperling S","Stupka E","Sugiura K","Sultana R","Takenaka Y","Taki K","Tammoja K","Tan SL","Tang S","Taylor MS","Tegner J","Teichmann SA","Ueda HR","van Nimwegen E","Verardo R","Wei CL","Yagi K","Yamanishi H","Zabarovsky E","Zhu S","Zimmer A","Hide W","Bult C","Grimmond SM","Teasdale RD","Liu ET","Brusic V","Quackenbush J","Wahlestedt C","Mattick JS","Hume DA","Kai C","Sasaki D","Tomaru Y","Fukuda S","Kanamori-Katayama M","Suzuki M","Aoki J","Arakawa T","Iida J","Imamura K","Itoh M","Kato T","Kawaji H","Kawagashira N","Kawashima T","Kojima M","Kondo S","Konno H","Nakano K","Ninomiya N","Nishio T","Okada M","Plessy C","Shibata K","Shiraki T","Suzuki S","Tagami M","Waki K","Watahiki A","Okamura-Oho Y","Suzuki H","Kawai J","Hayashizaki Y","FANTOM Consortium","RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group)"],"grantIds":["TGM03P17","TGM06S01"],"grantAgencies":["Telethon","Telethon"],"retractions":[],"journal":"Science (New York, N.Y.)","journalShort":"Science","day":2,"month":9,"year":2005,"meshHeadings":["3' Untranslated Regions","Animals","Base Sequence","Conserved Sequence","DNA, Complementary","Genome","Genome, Human","Genomics","Humans","Mice","Promoter Regions, Genetic","Proteins","RNA","RNA Splicing","RNA, Untranslated","Regulatory Sequences, Ribonucleic Acid","Terminator Regions, Genetic","Transcription Initiation Site","Transcription, Genetic"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"This study describes comprehensive polling of transcription start and termination sites and analysis of previously unidentified full-length complementary DNAs derived from the mouse genome. We identify the 5' and 3' boundaries of 181,047 transcripts with extensive variation in transcripts arising from alternative promoter usage, splicing, and polyadenylation. There are 16,247 new mouse protein-coding transcripts, including 5154 encoding previously unidentified proteins. Genomic mapping of the transcriptome reveals transcriptional forests, with overlapping transcription on both strands, separated by deserts in which few transcripts are observed. The data provide a comprehensive platform for the comparative analysis of mammalian transcriptional regulation in differentiation and development.","affiliation":[]},{"pmid":"15913604","pmcid":null,"title":"Convergence of bone morphogenetic protein and laminin-1 signaling pathways promotes proliferation and colony formation by fetal mouse pancreatic cells.","authors":["Jiang FX","Harrison LC"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Experimental cell research","journalShort":"Exp. Cell Res.","day":1,"month":8,"year":2005,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Protein Receptors, Type II","Bone Morphogenetic Proteins","Cell Proliferation","Colony-Forming Units Assay","Fetus","Laminin","Mice","Mice, Inbred C57BL","Models, Biological","Pancreas","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Receptors, Laminin","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"We previously reported that bone morphogenetic proteins (BMPs), members of the transforming growth factor superfamily, together with the basement membrane glycoprotein laminin-1 (Ln-1), promote proliferation of fetal pancreatic cells and formation of colonies containing peripheral insulin-positive cells. Here, we further investigate the cross-talk between BMP and Ln-1 signals. By RT-PCR, receptors for BMP (BMPR) (excepting BMPR-1B) and Ln-1 were expressed in the fetal pancreas between E13.5 and E17.5. Specific blocking antibodies to BMP-4 and -6 and selective BMP antagonists partially inhibited colony formation by fetal pancreas cells. Colony formation induced by BMP-6 and Ln-1 was completely abolished in a dose-dependent manner by blocking Ln-1 binding to its alpha(6) integrin and alpha-dystroglycan receptors or by blocking the Ln-1 signaling molecules, phosphatidyl-inositol-3-kinase (P13K) and MAP kinase kinase-1. These results demonstrate a convergence of BMP and Ln-1 signaling through P13K and MAP kinase pathways to induce proliferation and colony formation in E15.5 fetal mouse pancreatic cells.","affiliation":[]},{"pmid":"16314491","pmcid":null,"title":"Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning.","authors":["Ma L","Lu MF","Schwartz RJ","Martin JF"],"grantIds":["2R01DE/HD12324-06","P30 ES9106-07","R01DE013509"],"grantAgencies":["NIDCR NIH HHS","NIEHS NIH HHS","NIDCR NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":29,"month":12,"year":2005,"meshHeadings":["Animals","Body Patterning","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","DNA-Binding Proteins","Endocardium","Epithelium","Glucuronosyltransferase","Heart","Homeodomain Proteins","MSX1 Transcription Factor","Mesoderm","Mice","Morphogenesis","Mutation","Nuclear Proteins","Signal Transduction","Transforming Growth Factor beta","Twist Transcription Factor"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Cardiac cushion development provides a valuable system to investigate epithelial to mesenchymal transition (EMT), a fundamental process in development and tumor progression. In the atrioventricular (AV) canal, endocardial cells lining the heart respond to a myocardial-derived signal, undergo EMT, and contribute to cushion mesenchyme. Here, we inactivated bone morphogenetic protein 2 (Bmp2) in the AV myocardium of mice. We show that Bmp2 has three functions in the AV canal: to enhance formation of the cardiac jelly, to induce endocardial EMT and to pattern the AV myocardium. Bmp2 is required for myocardial expression of Has2, a crucial component of the cardiac jelly matrix. During EMT, Bmp2 promotes expression of the basic helix-loop-helix factor Twist1, previously implicated in EMT in cancer metastases, and the homeobox genes Msx1 and Msx2. Deletion of the Bmp type 1A receptor, Bmpr1a, in endocardium also resulted in failed cushion formation, indicating that Bmp2 signals directly to cushion-forming endocardium to induce EMT. Lastly, we show that Bmp2 mutants failed to specify the AV myocardium with loss of Tbx2 expression uncovering a myocardial, planar signaling function for Bmp2. Our data indicate that Bmp2 has a crucial role in coordinating multiple aspects of AV canal morphogenesis.","affiliation":[]},{"pmid":"15897891","pmcid":null,"title":"Role of type I receptors for anti-Mllerian hormone in the SMAT-1 Sertoli cell line.","authors":["Belville C","Jamin SP","Picard JY","Josso N","di Clemente N"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Oncogene","journalShort":"Oncogene","day":21,"month":7,"year":2005,"meshHeadings":["Animals","Base Sequence","Bone Morphogenetic Protein Receptors, Type I","CHO Cells","Cell Line","Cricetinae","DNA Primers","Gene Expression Regulation","Humans","Male","Polymerase Chain Reaction","Protein-Serine-Threonine Kinases","RNA, Small Interfering","Receptors, Growth Factor","Receptors, Peptide","Receptors, Transforming Growth Factor beta","Recombinant Proteins","Sertoli Cells","Transcription Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Anti-Mllerian hormone (AMH) is a member of the transforming growth factor-beta family responsible for regression of Mllerian ducts during male sexual differentiation and for regulation of gonadal steroidogenesis. AMH is also a gonadal tumor suppressor which mediates its effects through a specific type II receptor and the bone morphogenetic protein (BMP)-specific Smad proteins, suggesting that AMH and BMPs could also share type I receptors, namely activin-like kinases (ALKs)2, 3 or 6. However, attempts to identify a unique AMH type I receptor among them were unsuccessful. Here, using kinase-deficient type I receptors and small interfering RNA technology, we demonstrate that, in an AMH Sertoli target cell line, ALK3 mediates AMH effects on both Smad1 activation and P450 side-chain cleavage enzyme. In addition, transfecting a combination of normal and kinase-deficient receptors, we show that ALK2 can compensate for the absence of ALK3 and probably acts in synergy with ALK3 at high concentrations of AMH to activate Smad1, whereas ALK6 has a competitive inhibitory effect. These results are a first step in understanding how AMH transduces its effects in immature Sertoli cells.","affiliation":[]},{"pmid":"15963767","pmcid":null,"title":"Expression of Fgf and Tgfbeta signaling related genes during embryonic endochondral ossification.","authors":["Minina E","Schneider S","Rosowski M","Lauster R","Vortkamp A"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Gene expression patterns : GEP","journalShort":"Gene Expr. Patterns","day":29,"month":12,"year":2005,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Proteins","Chondrocytes","Embryo, Mammalian","Fibroblast Growth Factors","Forelimb","Gene Expression Regulation, Developmental","Inhibins","Mice","Osteoblasts","Osteogenesis","Receptors, Fibroblast Growth Factor","Receptors, Transforming Growth Factor beta","Signal Transduction","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Disturbed fibroblast growth factor (Fgf) and transforming growth factor beta (Tgfbeta) signaling lead to a variety of human skeletal disorders. To reveal the possible function and interaction of these signaling systems we have started to analyze the expression patterns of signaling factors, antagonists, receptors and transducers of these pathways in forelimbs of mouse embryos and compared them to the expression of established markers including Ihh. In addition to defining their expression domains in the developing bone, our study identified new subpopulations of chondrocytes characterized by the expression of distinct combinations of markers.","affiliation":[]},{"pmid":"16127465","pmcid":null,"title":"Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2.","authors":["Seemann P","Schwappacher R","Kjaer KW","Krakow D","Lehmann K","Dawson K","Stricker S","Pohl J","Plger F","Staub E","Nickel J","Sebald W","Knaus P","Mundlos S"],"grantIds":["HD22567","M01-RR88435","P41 RR-01081"],"grantAgencies":["NICHD NIH HHS","NCRR NIH HHS","NCRR NIH HHS"],"retractions":[],"journal":"The Journal of clinical investigation","journalShort":"J. Clin. Invest.","day":2,"month":9,"year":2005,"meshHeadings":["Amino Acid Sequence","Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Carrier Proteins","Cell Differentiation","Cell Line","Embryonic Structures","Fingers","Growth Differentiation Factor 5","Humans","In Situ Hybridization","Limb Deformities, Congenital","Mice","Molecular Sequence Data","Phenotype","Point Mutation","Protein Binding","Protein Conformation","Recombinant Proteins","Sequence Alignment","Tissue Culture Techniques"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Here we describe 2 mutations in growth and differentiation factor 5 (GDF5) that alter receptor-binding affinities. They cause brachydactyly type A2 (L441P) and symphalangism (R438L), conditions previously associated with mutations in the GDF5 receptor bone morphogenetic protein receptor type 1b (BMPR1B) and the BMP antagonist NOGGIN, respectively. We expressed the mutant proteins in limb bud micromass culture and treated ATDC5 and C2C12 cells with recombinant GDF5. Our results indicated that the L441P mutant is almost inactive. The R438L mutant, in contrast, showed increased biological activity when compared with WT GDF5. Biosensor interaction analyses revealed loss of binding to BMPR1A and BMPR1B ectodomains for the L441P mutant, whereas the R438L mutant showed normal binding to BMPR1B but increased binding to BMPR1A, the receptor normally activated by BMP2. The binding to NOGGIN was normal for both mutants. Thus, the brachydactyly type A2 phenotype (L441P) is caused by inhibition of the ligand-receptor interaction, whereas the symphalangism phenotype (R438L) is caused by a loss of receptor-binding specificity, resulting in a gain of function by the acquisition of BMP2-like properties. The presented experiments have identified some of the main determinants of GDF5 receptor-binding specificity in vivo and open new prospects for generating antagonists and superagonists of GDF5.","affiliation":[]},{"pmid":"16049014","pmcid":null,"title":"Identification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analyses.","authors":["Mazerbourg S","Sangkuhl K","Luo CW","Sudo S","Klein C","Hsueh AJ"],"grantIds":["U54 HD31398"],"grantAgencies":["NICHD NIH HHS"],"retractions":[],"journal":"The Journal of biological chemistry","journalShort":"J. Biol. Chem.","day":16,"month":9,"year":2005,"meshHeadings":["3T3 Cells","Animals","Base Sequence","Blotting, Western","Bone Morphogenetic Proteins","COS Cells","Cell Differentiation","Cell Line","Cell Proliferation","Cysteine","DNA, Complementary","Dimerization","Dose-Response Relationship, Drug","Evolution, Molecular","Genes, Reporter","Genomics","Growth Differentiation Factor 6","Growth Differentiation Factors","Humans","Ligands","Mice","Molecular Sequence Data","Oligonucleotides","Oligonucleotides, Antisense","Peptides","Phylogeny","Plasmids","RNA","RNA Interference","Recombinant Proteins","Reverse Transcriptase Polymerase Chain Reaction","Signal Transduction","Transfection"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"There are more than 30 human transforming growth factor beta/bone morphogenetic protein/growth differentiation factor (TGFbeta/BMP/GDF)-related ligands known to be important during embryonic development, organogenesis, bone formation, reproduction, and other physiological processes. Although select TGFbeta/BMP/GDF proteins were found to interact with type II and type I serine/threonine receptors to activate downstream Smad and other proteins, the receptors and signaling pathways for one-third of these TGFbeta/BMP/GDF paralogs are still unclear. Based on a genomic analysis of the entire repertoire of TGFbeta/BMP/GDF ligands and serine/threonine kinase receptors, we tested the ability of three orphan BMP/GDF ligands to activate a limited number of phylogenetically related receptors. We characterized the dimeric nature of recombinant GDF6 (also known as BMP13), GDF7 (also known as BMP12), and BMP10. We demonstrated their bioactivities based on the activation of Smad1/5/8-, but not Smad2/3-, responsive promoter constructs in the MC3T3 cell line. Furthermore, we showed their ability to induce the phosphorylation of Smad1, but not Smad2, in these cells. In COS7 cells transfected with the seven known type I receptors, overexpression of ALK3 or ALK6 conferred ligand signaling by GDF6, GDF7, and BMP10. In contrast, transfection of MC3T3 cells with ALK3 small hairpin RNA suppressed Smad signaling induced by all three ligands. Based on the coevolution of ligands and receptors, we also tested the role of BMPRII and ActRIIA as the type II receptor candidates for the three orphan ligands. We found that transfection of small hairpin RNA for BMPRII and ActRIIA in MC3T3 cells suppressed the signaling of GDF6, GDF7, and BMP10. Thus, the present approach provides a genomic paradigm for matching paralogous polypeptide ligands with a limited number of evolutionarily related receptors capable of activating specific downstream Smad proteins.","affiliation":[]},{"pmid":"15752764","pmcid":null,"title":"Crystal structure of recombinant human growth and differentiation factor 5: evidence for interaction of the type I and type II receptor-binding sites.","authors":["Schreuder H","Liesum A","Pohl J","Kruse M","Koyama M"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Biochemical and biophysical research communications","journalShort":"Biochem. Biophys. Res. Commun.","day":15,"month":4,"year":2005,"meshHeadings":["Amino Acid Sequence","Animals","Binding Sites","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Protein Receptors, Type II","Bone Morphogenetic Proteins","Computer Simulation","Crystallization","Crystallography","Growth Differentiation Factor 5","Humans","Mice","Models, Molecular","Molecular Sequence Data","Protein Binding","Protein Conformation","Protein-Serine-Threonine Kinases","Receptors, Growth Factor","Sequence Homology, Amino Acid","Stromal Cells","Structure-Activity Relationship"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The crystal structure of human growth differentiation factor 5 (GDF5) was solved at 2.4A resolution. The structure is very similar to the structure of bone morphogenetic factor 7 (BMP7) and consists of two banana-shaped monomers, linked via a disulfide bridge. The crystal packing of GDF5 is the same as the crystal packing of BMP7. This is highly unusual since only 25-30% of the crystal contacts involve identical residues. Analysis of the crystal packing revealed that residues of the type I receptor epitope are binding to residues of the type II receptor-binding epitope. The fact that for both BMP family members the type I and type II receptor-binding sites interact suggests that the complementary sites on the receptors may interact as well, suggesting a way how preformed receptor heterodimers may form, similar to the preformed receptors observed for the erythropoietin receptor and the BMP2 receptors.","affiliation":[]},{"pmid":"16324690","pmcid":null,"title":"BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling.","authors":["Grishina IB","Kim SY","Ferrara C","Makarenkova HP","Walden PD"],"grantIds":["DK056170","DK068007","DK07775","K01 DK068007-01","R01 DK056170-01","R01 DK056170-02"],"grantAgencies":["NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":15,"month":12,"year":2005,"meshHeadings":["Animals","Basic Helix-Loop-Helix Transcription Factors","Bone Morphogenetic Protein 7","Bone Morphogenetic Proteins","Epithelium","Gene Expression Regulation, Developmental","Homeodomain Proteins","Male","Mesoderm","Mice","Mice, Knockout","Morphogenesis","Organ Culture Techniques","Prostate","Receptor, Notch1","Signal Transduction","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The mouse prostate gland develops by branching morphogenesis from the urogenital epithelium and mesenchyme. Androgens and developmental factors, including FGF10 and SHH, promote prostate growth (Berman, D.M., Desai, N., Wang, X., Karhadkar, S.S., Reynon, M., Abate-Shen, C., Beachy, P.A., Shen, M.M., 2004. Roles for Hedgehog signaling in androgen production and prostate ductal morphogenesis. Dev. Biol. 267, 387-398; Donjacour, A.A., Thomson, A.A., Cunha, G.R., 2003. FGF-10 plays an essential role in the growth of the fetal prostate. Dev. Biol. 261, 39-54), while BMP4 signaling from the mesenchyme has been shown to suppresses prostate branching (Lamm, M.L., Podlasek, C.A., Barnett, D.H., Lee, J., Clemens, J.Q., Hebner, C.M., Bushman, W., 2001. Mesenchymal factor bone morphogenetic protein 4 restricts ductal budding and branching morphogenesis in the developing prostate. Dev. Biol. 232, 301-314). Here, we show that Bone Morphogenetic Protein 7 (BMP7) restricts branching of the prostate epithelium. BMP7 is expressed in the periurethral urogenital mesenchyme prior to formation of the prostate buds and, subsequently, in the prostate epithelium. We show that BMP7(lacZ/lacZ) null prostates show a two-fold increase in prostate branching, while recombinant BMP7 inhibits prostate morphogenesis in organ culture in a concentration-dependent manner. We further explore the mechanisms by which the developmental signals may be interpreted in the urogenital epithelium to regulate branching morphogenesis. We show that Notch1 activity is associated with the formation of the prostate buds, and that Notch1 signaling is derepressed in BMP7 null urogenital epithelium. Based on our studies, we propose a model that BMP7 inhibits branching morphogenesis in the prostate and limits the number of domains with high Notch1/Hes1 activity.","affiliation":[]},{"pmid":"15840001","pmcid":null,"title":"Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.","authors":["Taniwaki T","Haruna K","Nakamura H","Sekimoto T","Oike Y","Imaizumi T","Saito F","Muta M","Soejima Y","Utoh A","Nakagata N","Araki M","Yamamura K","Araki K"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Development, growth & differentiation","journalShort":"Dev. Growth Differ.","day":20,"month":4,"year":2005,"meshHeadings":["Animals","Base Sequence","Computational Biology","DNA Mutational Analysis","DNA Primers","DNA, Complementary","Extracellular Matrix Proteins","Genes, Reporter","Genetic Markers","Genetic Vectors","Green Fluorescent Proteins","Histological Techniques","Mice","Molecular Sequence Data","Protein-Lysine 6-Oxidase","RNA Splice Sites","Reverse Transcriptase Polymerase Chain Reaction","Sequence Analysis, RNA","Stem Cells"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"We have developed a new exchangeable gene trap vector, pU-17, carrying the intron-lox71-splicing acceptor (SA)-beta geo-loxP-pA-lox2272-pSP73-lox511. The SA contains three stop codons in-frame with the ATG of beta galactosidase/neomycin-resistance fusion gene (beta geo) that can function in promoter trapping. We found that the trap vector was highly selective for integrations in the introns adjacent to the exon containing the start codon. Furthermore, by using the Cre-mutant lox system, we successfully replaced the beta geo gene with the enhanced green fluorescent protein (EGFP) gene, established mouse lines with the replaced clones, removed the selection marker gene by mating with Flp-deleter mice, and confirmed that the replaced EGFP gene was expressed in the same pattern as the beta geo gene. Thus, using this pU-17 trap vector, we can initially carry out random mutagenesis, and then convert it to a gain-of-function mutation by replacing the beta geo gene with any gene of interest to be expressed under the control of the trapped promoter through Cre-mediated recombination.","affiliation":[]},{"pmid":"16141073","pmcid":null,"title":"Antisense transcription in the mammalian transcriptome.","authors":["Katayama S","Tomaru Y","Kasukawa T","Waki K","Nakanishi M","Nakamura M","Nishida H","Yap CC","Suzuki M","Kawai J","Suzuki H","Carninci P","Hayashizaki Y","Wells C","Frith M","Ravasi T","Pang KC","Hallinan J","Mattick J","Hume DA","Lipovich L","Batalov S","Engstrm PG","Mizuno Y","Faghihi MA","Sandelin A","Chalk AM","Mottagui-Tabar S","Liang Z","Lenhard B","Wahlestedt C","RIKEN Genome Exploration Research Group","Genome Science Group (Genome Network Project Core Group)","FANTOM Consortium"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Science (New York, N.Y.)","journalShort":"Science","day":2,"month":9,"year":2005,"meshHeadings":["Animals","Gene Expression Regulation","Genome","Humans","Mice","RNA Interference","RNA, Antisense","RNA, Messenger","Transcription, Genetic"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Antisense transcription (transcription from the opposite strand to a protein-coding or sense strand) has been ascribed roles in gene regulation involving degradation of the corresponding sense transcripts (RNA interference), as well as gene silencing at the chromatin level. Global transcriptome analysis provides evidence that a large proportion of the genome can produce transcripts from both strands, and that antisense transcripts commonly link neighboring \"genes\" in complex loci into chains of linked transcriptional units. Expression profiling reveals frequent concordant regulation of sense/antisense pairs. We present experimental evidence that perturbation of an antisense RNA can alter the expression of sense messenger RNAs, suggesting that antisense transcription contributes to control of transcriptional outputs in mammals.","affiliation":[]},{"pmid":"16604073","pmcid":null,"title":"Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.","authors":["Babitt JL","Huang FW","Wrighting DM","Xia Y","Sidis Y","Samad TA","Campagna JA","Chung RT","Schneyer AL","Woolf CJ","Andrews NC","Lin HY"],"grantIds":["DK-69533","DK-71837","F32 DK-068997","F32 DK068997","F32 DK068997-02","K08 DK075846","K08 DK075846-01","R01 DK066373","R01 DK066373-03","T32 HL07623"],"grantAgencies":["NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NHLBI NIH HHS"],"retractions":[],"journal":"Nature genetics","journalShort":"Nat. Genet.","day":27,"month":5,"year":2006,"meshHeadings":["Amino Acid Sequence","Animals","Antimicrobial Cationic Peptides","Bone Morphogenetic Protein 2","Bone Morphogenetic Proteins","CHO Cells","Cricetinae","GPI-Linked Proteins","Gene Expression Regulation","Hepcidins","Humans","Liver","Membrane Proteins","Molecular Sequence Data","Mutation","Polymerase Chain Reaction","Signal Transduction","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Hepcidin is a key regulator of systemic iron homeostasis. Hepcidin deficiency induces iron overload, whereas hepcidin excess induces anemia. Mutations in the gene encoding hemojuvelin (HFE2, also known as HJV) cause severe iron overload and correlate with low hepcidin levels, suggesting that hemojuvelin positively regulates hepcidin expression. Hemojuvelin is a member of the repulsive guidance molecule (RGM) family, which also includes the bone morphogenetic protein (BMP) coreceptors RGMA and DRAGON (RGMB). Here, we report that hemojuvelin is a BMP coreceptor and that hemojuvelin mutants associated with hemochromatosis have impaired BMP signaling ability. Furthermore, BMP upregulates hepatocyte hepcidin expression, a process enhanced by hemojuvelin and blunted in Hfe2-/- hepatocytes. Our data suggest a mechanism by which HFE2 mutations cause hemochromatosis: hemojuvelin dysfunction decreases BMP signaling, thereby lowering hepcidin expression.","affiliation":[]},{"pmid":"16481421","pmcid":null,"title":"Genetic analyses demonstrate that bone morphogenetic protein signaling is required for embryonic cerebellar development.","authors":["Qin L","Wine-Lee L","Ahn KJ","Crenshaw EB"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","journalShort":"J. Neurosci.","day":15,"month":2,"year":2006,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cerebellum","Embryonic Development","Gene Expression Regulation, Developmental","Gene Rearrangement","Mice","Mice, Knockout","Neurons","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The cerebellum has been a useful model for studying many aspects of neural development because of its relatively simple cytoarchitecture and developmental program. Yet, the genetic mechanisms underlying early differentiation and patterning of the cerebellum are still poorly characterized. Cell expression studies and culture experiments have suggested the importance of bone morphogenetic proteins (BMPs) in development of specific populations of cerebellar neurons. Here, we examined mice with targeted mutations in the BMP type I receptor genes Bmpr1a and Bmpr1b, to genetically test the hypothesis that BMPs play an inductive role in the embryogenesis of cerebellar granule cells. In Bmpr1a;Bmpr1b double knock-out mice, severe cerebellar patterning defects are observed resulting in smaller cerebella that are devoid of foliation. In mutants containing either single BMP receptor gene mutation alone, cerebellar histogenesis appears normal, thereby demonstrating functional redundancy of type I BMP receptors during cerebellar development. Loss of BMP signaling in double mutant animals leads to a dramatic reduction in the number of cerebellar granule cells and ectopic location of many of those that remain. Molecular markers of granule cell specification, including Math1 and Zic1, are drastically downregulated. In addition, Purkinje cells are disorganized and ectopically located, but they appear to be correctly specified. Consistent with the interpretation that granule cells alone are affected, phosphorylated Smad1/5/8 is immunolocalized predominantly to granule cell precursors and not appreciably detected in Purkinje cell precursors. This study demonstrates that BMP signaling plays a crucial role in the specification of granule cells during cerebellar development.","affiliation":[]},{"pmid":"17301089","pmcid":null,"title":"BMP4 and PTHrP interact to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction.","authors":["Hens JR","Dann P","Zhang JP","Harris S","Robinson GW","Wysolmerski J"],"grantIds":["P30AR46032","P30DK45735","R01DK55501","R01DK69542","T32DK07058"],"grantAgencies":["NIAMS NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","Intramural NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":2,"month":3,"year":2007,"meshHeadings":["Animals","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","DNA-Binding Proteins","Embryo, Mammalian","Gene Expression Regulation, Developmental","Hair Follicle","Homeodomain Proteins","Mammary Glands, Animal","Mesoderm","Mice","Mice, Mutant Strains","Parathyroid Hormone-Related Protein","RNA, Messenger","Signal Transduction","Up-Regulation"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The mammary glands develop initially as buds arising from the ventral embryonic epidermis. Recent work has shed light on signaling pathways leading to the patterning and formation of the mammary placodes and buds in mouse embryos. Relatively little is known of the signaling pathways that initiate branching morphogenesis and the formation of the ducts from the embryonic buds. Previous studies have shown that parathyroid hormone-related protein (PTHrP; also known as parathyroid hormone-like peptide, Pthlh) is produced by mammary epithelial cells and acts on surrounding mesenchymal cells to promote their differentiation into a mammary-specific dense mesenchyme. As a result of PTHrP signaling, the mammary mesenchyme supports mammary epithelial cell fate, initiates ductal development and patterns the overlying nipple sheath. In this report, we demonstrate that PTHrP acts, in part, by sensitizing mesenchymal cells to BMP signaling. PTHrP upregulates BMP receptor 1A expression in the mammary mesenchyme, enabling it to respond to BMP4, which is expressed within mesenchymal cells underlying the ventral epidermis during mammary bud formation. We demonstrate that BMP signaling is important for outgrowth of normal mammary buds and that BMP4 can rescue outgrowth of PTHrP(-/-) mammary buds. In addition, the combination of PTHrP and BMP signaling is responsible for upregulating Msx2 gene expression within the mammary mesenchyme, and disruption of the Msx2 gene rescues the induction of hair follicles on the ventral surface of mice overexpressing PTHrP in keratinocytes (K14-PTHrP). Our data suggest that PTHrP signaling sensitizes the mammary mesenchyme to the actions of BMP4, triggering outgrowth of the mammary buds and inducing MSX2 expression, which, in turn, leads to lateral inhibition of hair follicle formation within the developing nipple sheath.","affiliation":[]},{"pmid":"16809539","pmcid":null,"title":"Lhx2 maintains stem cell character in hair follicles.","authors":["Rhee H","Polak L","Fuchs E"],"grantIds":["R01 AR031737","R01 AR031737-24","R01 AR050452","R01 AR050452-04","R01-AR050452"],"grantAgencies":["NIAMS NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS"],"retractions":[],"journal":"Science (New York, N.Y.)","journalShort":"Science","day":30,"month":6,"year":2006,"meshHeadings":["Animals","Cell Differentiation","Cell Lineage","Cell Proliferation","Epidermis","Female","Gene Expression Profiling","Gene Expression Regulation, Developmental","Hair","Hair Follicle","Homeodomain Proteins","LIM-Homeodomain Proteins","Male","Mice","Mice, Knockout","Mice, Transgenic","Morphogenesis","Oligonucleotide Array Sequence Analysis","Signal Transduction","Skin Transplantation","Stem Cells","Transcription Factors","Up-Regulation"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"During embryogenesis, stem cells are set aside to fuel the postnatal hair cycle and repair the epidermis after injury. To define how hair follicle stem cells are specified and maintained in an undifferentiated state, we developed a strategy to isolate and transcriptionally profile embryonic hair progenitors in mice. We identified Lhx2 as a transcription factor positioned downstream of signals necessary to specify hair follicle stem cells, but upstream from signals required to drive activated stem cells to terminally differentiate. Using gain- and loss-of-function studies, we uncovered a role for Lhx2 in maintaining the growth and undifferentiated properties of hair follicle progenitors.","affiliation":[]},{"pmid":"16622178","pmcid":null,"title":"Upregulation of Id-1 via BMP-2 receptors induces reactive oxygen species in podocytes.","authors":["Pache G","Schfer C","Wiesemann S","Springer E","Liebau M","Reinhardt HC","August C","Pavenstdt H","Bek MJ"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"American journal of physiology. Renal physiology","journalShort":"Am. J. Physiol. Renal Physiol.","day":10,"month":9,"year":2006,"meshHeadings":["Animals","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors, Type II","Bone Morphogenetic Proteins","Humans","Immunohistochemistry","Inhibitor of Differentiation Protein 1","Kidney Glomerulus","Mice","NADP","Oligonucleotides, Antisense","Podocytes","Reactive Oxygen Species","Transforming Growth Factor beta","Up-Regulation"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (BMPs) are secreted signaling molecules, which play a major role in kidney development and disease. Here, we show the existence of mRNA for BMP-2 and for the BMP receptors BMPR1A, BMPR1B, BMPRII, ACVR1A, ACVR2, and ACVR2B in differentiated mouse podocytes and the protein expression of BMPR1A in human glomerular podocytes. BMP-2 dose dependently increases the free cytosolic Ca(2+) concentration in podocytes proving the existence of a functional receptor in these cells. Recent data indicate that in a myoblastic cell line and in a breast cancer cell line, BMP-2 increases the expression of Id-1, a negative regulator of basic helix-loop-helix transcription factors, but the role of BMP-2 stimulated Id-1 expression in the kidney has not been further characterized. Here, we show that BMP-2 increases the expression of Id-1 in differentiated podocytes. To investigate a role of Id-1 for podocyte function, overexpression of Id-1 was induced in differentiated mouse podocytes. Id-1-overexpressing podocytes show an increased NADPH-dependent production of reactive oxygen species (ROS). This effect can be evoked by BMP-2 and can be antagonized by anti-Id-1 antisense oligonucleotides. The data indicate that BMP-2 may, via an increased expression of Id-1 and an increased generation of ROS, contribute to important cellular functions in podocytes. ROS supposedly play a major role in cell adhesion, cell injury, ion transport, fibrogenesis, angiogenesis and are involved in the pathogenesis of membranous nephropathy.","affiliation":[]},{"pmid":"17065231","pmcid":null,"title":"BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways.","authors":["Yoon BS","Pogue R","Ovchinnikov DA","Yoshii I","Mishina Y","Behringer RR","Lyons KM"],"grantIds":["R01 AR044528"],"grantAgencies":["NIAMS NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":8,"month":12,"year":2006,"meshHeadings":["Animals","Apoptosis","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Proliferation","Chondrogenesis","Female","Fibroblast Growth Factors","Growth Plate","Hedgehog Proteins","Intracellular Signaling Peptides and Proteins","Male","Mice","Mice, Knockout","Mice, Mutant Strains","Mutation","Osteochondrodysplasias","Phenotype","Receptor, Fibroblast Growth Factor, Type 1","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein (BMP) signaling pathways are essential regulators of chondrogenesis. However, the roles of these pathways in vivo are not well understood. Limb-culture studies have provided a number of essential insights, including the demonstration that BMP pathways are required for chondrocyte proliferation and differentiation. However, limb-culture studies have yielded contradictory results; some studies indicate that BMPs exert stimulatory effects on differentiation, whereas others support inhibitory effects. Therefore, we characterized the skeletal phenotypes of mice lacking Bmpr1a in chondrocytes (Bmpr1a(CKO)) and Bmpr1a(CKO);Bmpr1b+/- (Bmpr1a(CKO);1b+/-) in order to test the roles of BMP pathways in the growth plate in vivo. These mice reveal requirements for BMP signaling in multiple aspects of chondrogenesis. They also demonstrate that the balance between signaling outputs from BMP and fibroblast growth factor (FGF) pathways plays a crucial role in the growth plate. These studies indicate that BMP signaling is required to promote Ihh expression, and to inhibit activation of STAT and ERK1/2 MAPK, key effectors of FGF signaling. BMP pathways inhibit FGF signaling, at least in part, by inhibiting the expression of FGFR1. These results provide a genetic in vivo demonstration that the progression of chondrocytes through the growth plate is controlled by antagonistic BMP and FGF signaling pathways.","affiliation":[]},{"pmid":"16537572","pmcid":null,"title":"Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects.","authors":["Desai J","Shannon ME","Johnson MD","Ruff DW","Hughes LA","Kerley MK","Carpenter DA","Johnson DK","Rinchik EM","Culiat CT"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Human molecular genetics","journalShort":"Hum. Mol. Genet.","day":15,"month":4,"year":2006,"meshHeadings":["Abnormalities, Drug-Induced","Amino Acid Sequence","Animals","Base Sequence","Calcification, Physiologic","Calcium-Binding Proteins","Cell Adhesion Molecules","Chondrogenesis","Cysteine","Extracellular Matrix Proteins","Female","Glycoproteins","Male","Mice","Mice, Inbred Strains","Molecular Sequence Data","Osteogenesis","Point Mutation","Signal Transduction","Skull","Spine","Tyrosine"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The mammalian Nell1 gene encodes a protein kinase C-beta1 (PKC-beta1) binding protein that belongs to a new class of cell-signaling molecules controlling cell growth and differentiation. Over-expression of Nell1 in the developing cranial sutures in both human and mouse induces craniosynostosis, the premature fusion of the growing cranial bone fronts. Here, we report the generation, positional cloning and characterization of Nell1(6R), a recessive, neonatal-lethal point mutation in the mouse Nell1 gene, induced by N-ethyl-N-nitrosourea. Nell1(6R) has a T-->A base change that converts a codon for cysteine into a premature stop codon [Cys(502)Ter], resulting in severe truncation of the predicted protein product and marked reduction in steady-state levels of the transcript. In addition to the expected alteration of cranial morphology, Nell1(6R) mutants manifest skeletal defects in the vertebral column and ribcage, revealing a hitherto undefined role for Nell1 in signal transduction in endochondral ossification. Real-time quantitative reverse transcription-PCR assays of 219 genes showed an association between the loss of Nell1 function and reduced expression of genes for extracellular matrix (ECM) proteins critical for chondrogenesis and osteogenesis. Several affected genes are involved in the human cartilage disorder Ehlers-Danlos Syndrome and other disorders associated with spinal curvature anomalies. Nell1(6R) mutant mice are a new tool for elucidating basic mechanisms in osteoblast and chrondrocyte differentiation in the developing skull and vertebral column and understanding how perturbations in the production of ECM proteins can lead to anomalies in these structures.","affiliation":[]},{"pmid":"16432712","pmcid":null,"title":"Expression patterns of BMPRs in the developing mouse molar.","authors":["Nadiri A","Kuchler-Bopp S","Perrin-Schmitt F","Lesot H"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Cell and tissue research","journalShort":"Cell Tissue Res.","day":1,"month":4,"year":2006,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Protein Receptors, Type II","Female","Gene Expression Regulation, Developmental","Mice","Mice, Inbred ICR","Molar"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"During development, Bone Morphogenetic Proteins (BMPs) can induce apoptosis, cell growth or differentiation. These different effects are mediated by dimers of two types of BMP-receptors (BMPRs). To identify the responding cells during tooth development and search for possible tissue-or stage-specificities in the receptors involved, the distribution patterns of BMPR-IA, -IB and -II were investigated in the mouse molar, from bud to bell stage. At the bud stage, BMP-2 was suggested to be involved in the formation of an epithelial signaling center, the primary enamel knot (PEK), while BMP-4 would mediate the condensation of the mesenchyme. Immunostaining showed the presence of BMPR-IA and -II in the epithelium instead of BMPR-IB and -II in the mesenchyme. At the cap stage, BMPR-IB was detected in the epithelium but not BMPR-II, suggesting the existence of another type II receptor to form a functional dimer. At the late cap stage in the epithelium, BMP-4, BMPR-IA and -II were restricted to the internal part of the PEK and the stalk: two apoptotic areas. The three proteins were detected in the mesenchyme, showing a strong staining where cusps were about to form. At the late bell stage, BMP-2 or -4 may induce cell differentiation. BMPR-IB and -II were detected in odontoblasts instead of BMPR-IA and -II in ameloblasts. These results provide the first evidence of multiple type I and type II BMP-receptors, expressed in the dental epithelium and mesenchyme at different stages of development, to signal different cellular activities in a time- and tissue-specific way.","affiliation":[]},{"pmid":"16602821","pmcid":"1413568","title":"BGEM: an in situ hybridization database of gene expression in the embryonic and adult mouse nervous system.","authors":["Magdaleno S","Jensen P","Brumwell CL","Seal A","Lehman K","Asbury A","Cheung T","Cornelius T","Batten DM","Eden C","Norland SM","Rice DS","Dosooye N","Shakya S","Mehta P","Curran T"],"grantIds":["5R37NS036558","N01-NS-0-2331"],"grantAgencies":["NINDS NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"PLoS biology","journalShort":"PLoS Biol.","day":10,"month":4,"year":2006,"meshHeadings":["Animals","Brain","Databases, Genetic","Gene Expression Profiling","Humans","In Situ Hybridization","Internet","Mice","Mice, Inbred C57BL","Molecular Sequence Data","Nervous System"],"hasAbstract":false,"score":0,"snippets":[],"abstract":null,"affiliation":[]},{"pmid":"17605791","pmcid":"1949814","title":"Lateral motor column axons execute a ternary trajectory choice between limb and body tissues.","authors":["Luria V","Laufer E"],"grantIds":["R01 NS047510","R01 NS047510-03"],"grantAgencies":["NINDS NIH HHS","NINDS NIH HHS","Howard Hughes Medical Institute"],"retractions":[],"journal":"Neural development","journalShort":"Neural Dev","day":20,"month":8,"year":2007,"meshHeadings":["Animals","Axons","Body Patterning","Bone Morphogenetic Protein Receptors, Type I","Cell Differentiation","Ephrins","Extremities","Gene Expression Regulation, Developmental","Growth Cones","Homeodomain Proteins","Kruppel-Like Transcription Factors","LIM-Homeodomain Proteins","Mesoderm","Mice","Mice, Knockout","Motor Neurons","Muscle, Skeletal","Neuronal Plasticity","Receptors, Eph Family","Spinal Cord","Transcription Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BACKGROUND: Neuronal topographic map formation requires appropriate selection of axonal trajectories at intermediate choice points prior to target innervation. Axons of neurons in the spinal cord lateral motor column (LMC), as defined by a transcription factor code, are thought to innervate limb target tissues exclusively. Axons of the medial and lateral LMC divisions appear to execute a binary decision at the base of the limb as they choose between ventral and dorsal limb trajectories. The cellular logic that guides motor axon trajectory choices into non-limb tissues such as the ventral flank remains unclear. RESULTS: We determined the spinal cord motor column origin of motor nerves that innervate ventral flank tissues at hindlimb level. We found unexpectedly that a subset of medial LMC axons innervates ventral non-limb mesenchyme at hindlimb level, rather than entering ventral limb mesenchyme. We also found that in a conditional BmprIa mutant where all ventral hindlimb mesenchyme is converted to a dorsal identity, all medial LMC axons are redirected into the ventral flank, while lateral LMC axons innervate the bidorsal limb. CONCLUSION: We have found that medial LMC neurons innervate both ventral flank and limb targets. While normally only a subset of medial LMC axons innervate the flank, all are capable of doing so. Furthermore, LMC axons execute a ternary, rather than binary, choice at the base of the limb between ventral flank, ventral limb and dorsal limb trajectories. When making this choice, medial and lateral LMC axons exhibit different and asymmetric relative preferences for these three trajectories. These data redefine the LMC as a motor column that innervates both limb and body tissues.","affiliation":[]},{"pmid":"16943278","pmcid":null,"title":"BMP signaling in the epiblast is required for proper recruitment of the prospective paraxial mesoderm and development of the somites.","authors":["Miura S","Davis S","Klingensmith J","Mishina Y"],"grantIds":["P01HD39948","R01DE013674"],"grantAgencies":["NICHD NIH HHS","NIDCR NIH HHS","Intramural NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":13,"month":10,"year":2006,"meshHeadings":["Animals","Body Patterning","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Embryonic Development","Fibroblast Growth Factors","Mesoderm","Mice","Mice, Mutant Strains","Receptor, Fibroblast Growth Factor, Type 1","Signal Transduction","Somites"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bmpr1a encodes the BMP type IA receptor for bone morphogenetic proteins (BMPs), including 2 and 4. Here, we use mosaic inactivation of Bmpr1a in the epiblast of the mouse embryo (Bmpr-MORE embryos) to assess functions of this gene in mesoderm development. Unlike Bmpr1a-null embryos, which fail to gastrulate, Bmpr-MORE embryos initiate gastrulation, but the recruitment of prospective paraxial mesoderm cells to the primitive streak is delayed. This delay causes a more proximal distribution of cells with paraxial mesoderm character within the primitive streak, resulting in a lateral expansion of somitic mesoderm to form multiple columns. Inhibition of FGF signaling restores the normal timing of recruitment of prospective paraxial mesoderm and partially rescues the development of somites. This suggests that BMP and FGF signaling function antagonistically during paraxial mesoderm development.","affiliation":[]},{"pmid":"17588538","pmcid":null,"title":"Deficient Alk3-mediated BMP signaling causes prenatal omphalocele-like defect.","authors":["Sun J","Liu YH","Chen H","Nguyen MP","Mishina Y","Upperman JS","Ford HR","Shi W"],"grantIds":["EY015417","HL68597","R01 HL068597","R01 HL068597-06"],"grantAgencies":["NEI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS"],"retractions":[],"journal":"Biochemical and biophysical research communications","journalShort":"Biochem. Biophys. Res. Commun.","day":17,"month":8,"year":2007,"meshHeadings":["Animals","Body Patterning","Bone Morphogenetic Protein Receptors, Type I","Hernia, Umbilical","Mice","Mice, Knockout","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BMP signaling plays important roles in many embryonic developmental processes. Alk3 is one of two BMP type I receptors that transduces BMP signal from the cell surface into cell. Conventional knockout of Alk3 resulted in early embryonic lethality around E7.5-E9.5. In this study, we have generated embryonic mesoderm-specific Alk3 conditional knockout by crossing Dermo1-Cre and floxed Alk3 mice. Abrogation of Alk3-mediated BMP signaling in this mouse resulted in severe defect of secondary ventral body wall formation, replicating the omphalocele phenotype in human. Our finding suggests that Alk3 plays an essential role in the formation of embryonic ventral abdominal wall, and abrogation of BMP signaling activity due to gene mutations in its signaling components could be one of the underlying causes of omphalocele at birth.","affiliation":[]},{"pmid":"17537800","pmcid":null,"title":"BMP signals control limb bud interdigital programmed cell death by regulating FGF signaling.","authors":["Pajni-Underwood S","Wilson CP","Elder C","Mishina Y","Lewandoski M"],"grantIds":[],"grantAgencies":["Intramural NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":31,"month":6,"year":2007,"meshHeadings":["Animals","Apoptosis","Bone Morphogenetic Proteins","Fibroblast Growth Factors","Gene Expression Regulation, Developmental","Limb Buds","Mice","Mice, Inbred Strains","Mice, Mutant Strains","Mice, Transgenic","Models, Biological","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"In vertebrate limbs that lack webbing, the embryonic interdigit region is removed by programmed cell death (PCD). Established models suggest that bone morphogenetic proteins (BMPs) directly trigger such PCD, although no direct genetic evidence exists for this. Alternatively, BMPs might indirectly affect PCD by regulating fibroblast growth factors (FGFs), which act as cell survival factors. Here, we inactivated the mouse BMP receptor gene Bmpr1a specifically in the limb bud apical ectodermal ridge (AER), a source of FGF activity. Early inactivation completely prevents AER formation. However, inactivation after limb bud initiation causes an upregulation of two AER-FGFs, Fgf4 and Fgf8, and a loss of interdigital PCD leading to webbed limbs. To determine whether excess FGF signaling inhibits interdigit PCD in these Bmpr1a mutant limbs, we performed double and triple AER-specific inactivations of Bmpr1a, Fgf4 and Fgf8. Webbing persists in AER-specific inactivations of Bmpr1a and Fgf8 owing to elevated Fgf4 expression. Inactivation of Bmpr1a, Fgf8 and one copy of Fgf4 eliminates webbing. We conclude that during normal embryogenesis, BMP signaling to the AER indirectly regulates interdigit PCD by regulating AER-FGFs, which act as survival factors for the interdigit mesenchyme.","affiliation":[]},{"pmid":"16630606","pmcid":null,"title":"BMP receptor type IA in limb bud mesenchyme regulates distal outgrowth and patterning.","authors":["Ovchinnikov DA","Selever J","Wang Y","Chen YT","Mishina Y","Martin JF","Behringer RR"],"grantIds":["AR42919","CA16672"],"grantAgencies":["NIAMS NIH HHS","NCI NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":1,"month":7,"year":2006,"meshHeadings":["Animals","Body Patterning","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Proliferation","Cyclin D1","DNA-Binding Proteins","Gene Expression Regulation, Developmental","Hedgehog Proteins","Homeodomain Proteins","Limb Buds","Limb Deformities, Congenital","MSX1 Transcription Factor","Mesoderm","Mice","Mice, Mutant Strains","Proto-Oncogene Proteins","Trans-Activators","Wnt Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The mesenchyme of the developing vertebrate limb responds to inductive signals, giving rise to skeletal elements that define limb shape and size. Several signals emanate from the limb ectoderm and in particular from the specialized epithelium of the apical ectodermal ridge (AER), including three members of the bone morphogenetic protein (BMP) family of signaling molecules, BMP2, BMP4 and BMP7. Using the Cre/loxP system in mice, we rendered limb bud mesenchyme insensitive to BMP signals through the type I receptor, BMPR-IA. Conditional mutants had shortened limbs and almost complete agenesis of the autopod because of reduced cell proliferation. Reduced expression of downstream BMP signaling targets, Msx1, Msx2 and gremlin in the distal mesenchyme (progress zone) correlated with decreased levels of cyclin D1 and Wnt5a. Ectopic anterior activation of sonic hedgehog (SHH) signaling and Hox expression revealed alterations in anterior-posterior (AP) patterning. Abnormal localization of Lmx1b-expressing cells in the ventral mesenchyme, along with histological alterations and an abnormal melanization pattern of the limb, indicate altered dorsal-ventral (DV) boundaries. These findings suggest that signaling through BMPR-IA in limb mesenchyme is essential for distal outgrowth and also influences AP and DV patterning.","affiliation":[]},{"pmid":"18498827","pmcid":null,"title":"Endothelial expression of bone morphogenetic protein receptor type 1a is required for atrioventricular valve formation.","authors":["Kaneko K","Li X","Zhang X","Lamberti JJ","Jamieson SW","Thistlethwaite PA"],"grantIds":["R01 HL 70852"],"grantAgencies":["NHLBI NIH HHS"],"retractions":[],"journal":"The Annals of thoracic surgery","journalShort":"Ann. Thorac. Surg.","day":23,"month":6,"year":2008,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Endocardial Cushion Defects","Endocardial Cushions","Endocardium","Endothelium, Vascular","Female","Genes, Reporter","Lac Operon","Mice","Mice, Knockout","Pol1 Transcription Initiation Complex Proteins","Pregnancy","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BACKGROUND: Atrioventricular canal defects account for 4% of all congenital heart anomalies. They arise from failure of endocardial cushion formation, a process dependent on transition of endothelial cells into clustered mesenchymal cells in the mid-atrioventricular septum. To date, the genetic signals necessary for atrioventricular canal defects are poorly understood. We hypothesized that bone morphogenetic protein signaling in cardiac endothelial cells may be crucial to this process. METHODS: To study the role of bone morphogenetic protein receptors (Bmpr) in the developing heart, we created knockout mice with inactivation of Bmpr1a selectively in endocardium. Two strains of null mice were created: one with constitutive endothelial-specific knockout of Bmpr1a and one with time-inducible, endothelial-specific knockout of Bmpr1a. Embryos and animals were analyzed by microscopy, RNA in situ hybridization, and microangiography. RESULTS: Animals with null mutation of Bmpr1a in endothelium were embryonic lethal at E11.5 to 12.0 and demonstrated absence of endocardial cushion formation. Embryos failed to form atrioventricular valves and adjacent septa. Endocardial knockout of Bmpr1a did not affect development of the outflow tract or aortic arches. Using time-inducible, cell-specific knockout mice, we show that Bmpr1a has two functions in the developing atrioventricular canal: to induce endocardial endothelial-mesenchymal transition, and to pattern the septal mesenchyme into endocardial cushions. We demonstrate that these processes are temporally linked to expression of the transcription factors Id1 and Id3. CONCLUSIONS: Endocardial cushion formation is dependent on cell-specific expression of Bmpr1a. Our results suggest that Bmpr1a-mediated signaling is a crucial pathway involved in pathogenesis of atrioventricular septal and valve malformations, which are among the most common congenital heart defects in humans.","affiliation":[]},{"pmid":"23197713","pmcid":null,"title":"BMP receptor 1A regulates development of hypothalamic circuits critical for feeding behavior.","authors":["Peng CY","Mukhopadhyay A","Jarrett JC","Yoshikawa K","Kessler JA"],"grantIds":["NS 20013","NS 20778","R01 NS020013","R01 NS020778","U54 CA151880"],"grantAgencies":["NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NCI NIH HHS"],"retractions":[],"journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","journalShort":"J. Neurosci.","day":28,"month":11,"year":2012,"meshHeadings":["Agouti-Related Protein","Animals","Bone Morphogenetic Protein Receptors, Type I","Cell Proliferation","Feeding Behavior","Hypothalamus","Leptin","Mice","Mice, Knockout","Nerve Net","Neural Pathways","Neurons","Neuropeptide Y","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Hypothalamic neural circuits are known to regulate energy homeostasis and feeding behavior, but how these circuits are established during development is not well understood. Here we report that embryonic neural progenitors that express the transcription factor OLIG1 contribute neurons to the ventral hypothalamus including the arcuate nucleus (ARH), a center that regulates feeding behavior. Ablation of bone morphogenetic protein receptor 1a (BMPR1A) in the OLIG1 lineage resulted in hypophagia, hypoglycemia, and weight loss after the second postnatal week with death by week 4. Differentiation and specification of inhibitory hypothalamic neurons contributing to melanocortin and dopaminergic systems were abnormal in the BMPR1A-deficient ARH. Although the hypophagia promoted expression of the orexigenic neuropeptide agouti related protein (AgRP) in the BMPR1A-deficient ARH, there was a profound decrease of AgRP(+) axonal terminals in the mutant ARH targets including dorsomedial and paraventricular hypothalamic nuclei. Projection of AgRP(+) neurons to these nuclei is known to be regulated by leptin. Leptin injection in neonatal mice increased bone morphogenic protein (BMP) signaling in the ventral hypothalamus, and blocking BMP signaling prevented leptin-induced neurite outgrowth in ARH explant cultures. These findings suggest that BMPR1A signaling is critical for postnatal establishment of leptin-responsive orexigenic fibers from ARH to multiple hypothalamic nuclei. More generally these observations indicate that BMPR1A signaling regulates postnatal establishment of OLIG1 lineage-derived ARH neuronal circuits that are critical for leptin-mediated feeding behavior.","affiliation":[]},{"pmid":"16959237","pmcid":null,"title":"Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts.","authors":["Song L","Fssler R","Mishina Y","Jiao K","Baldwin HS"],"grantIds":["5 P50 HL56401-09"],"grantAgencies":["NHLBI NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":1,"month":1,"year":2007,"meshHeadings":["Animals","Atrioventricular Node","Bone Morphogenetic Protein Receptors, Type I","Cell Proliferation","Cell Survival","Female","Fluorescent Antibody Technique","Genes, Lethal","Heart","Male","Mice","Morphogenesis"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Accumulated evidence has suggested that BMP pathways play critical roles during mammalian cardiogenesis and impairment of BMP signaling may contribute to human congenital heart diseases (CHDs), which are the leading cause of infant morbidity and mortality. Alk3 encodes a BMP specific type I receptor expressed in mouse embryonic hearts. To reveal functions of Alk3 during atrioventricular (AV) cushion morphogenesis and to overcome the early lethality of Alk3(-/-) embryos, we applied a Cre/loxp approach to specifically inactivate Alk3 in the endothelium/endocardium. Our studies showed that endocardial depletion of Alk3 severely impairs epithelium-mesenchymal-transformation (EMT) in the atrioventricular canal (AVC) region; the number of mesenchymal cells formed in Tie1-Cre;Alk3(loxp/loxp) embryos was reduced to only approximately 20% of the normal level from both in vivo section studies and in vitro explant assays. We showed, for the first time, that in addition to its functions on mesenchyme formation, Alk3 is also required for the normal growth/survival of AV cushion mesenchymal cells. Functions of Alk3 are accomplished through regulating expression/activation/subcellular localization of multiple downstream genes including Smads and cell-cycle regulators. Taken together, our study supports the notion that Alk3-mediated BMP signaling in AV endocardial/mesenchymal cells plays a central role during cushion morphogenesis.","affiliation":[]},{"pmid":"17967808","pmcid":null,"title":"EUCOMM--the European conditional mouse mutagenesis program.","authors":["Friedel RH","Seisenberger C","Kaloff C","Wurst W"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Briefings in functional genomics & proteomics","journalShort":"Brief Funct Genomic Proteomic","day":6,"month":9,"year":2007,"meshHeadings":["Animals","Europe","Genetic Vectors","Genome","International Cooperation","Mice","Mice, Knockout","Mutagenesis","Mutation"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Functional analysis of the mammalian genome is an enormous challenge for biomedical scientists. To facilitate this endeavour, the European Conditional Mouse Mutagenesis Program (EUCOMM) aims at generating up to 12 000 mutations by gene trapping and up to 8000 mutations by gene targeting in mouse embryonic stem (ES) cells. These mutations can be rendered into conditional alleles, allowing Cre recombinase-mediated disruption of gene function in a time- and tissue-specific manner. Furthermore, the EUCOMM program will generate up to 320 mouse lines from the EUCOMM resource and up to 20 new Cre driver mouse lines. The EUCOMM resource of vectors, mutant ES cell lines and mutant mice will be openly available to the scientific community. EUCOMM will be one of the cornerstones of an international effort to create a global mouse mutant resource.","affiliation":[]},{"pmid":"16783635","pmcid":null,"title":"Quantitative trait loci for body size components in mice.","authors":["Kenney-Hunt JP","Vaughn TT","Pletscher LS","Peripato A","Routman E","Cothran K","Durand D","Norgard E","Perel C","Cheverud JM"],"grantIds":["DK 52514","DK 55736","HL 58427","P30 DK056341","P30 DK056341-05S2","P30 DK056341-06","RR 15116"],"grantAgencies":["NIDDK NIH HHS","NIDDK NIH HHS","NHLBI NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NCRR NIH HHS"],"retractions":[],"journal":"Mammalian genome : official journal of the International Mammalian Genome Society","journalShort":"Mamm. Genome","day":19,"month":6,"year":2006,"meshHeadings":["Animals","Body Size","Bones of Lower Extremity","Bones of Upper Extremity","Female","Male","Mice","Organ Size","Quantitative Trait Loci"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Do body size components, such as weights of internal organs and long bone lengths, with different functions and different developmental histories also have different genetic architectures and pleiotropic patterns? We examine murine quantitative trait loci (QTL) for necropsy weight, four long bone lengths, and four organ weights in the LG/J x SM/J intercross. Differences between trait categories were found in number of QTL, dominance, and pleiotropic patterns. Ninety-seven QTLs for individual traits were identified: 52 for long bone lengths, 30 for organ weights, and 15 for necropsy weight. Results for long bones are typically more highly significant than for organs. Organ weights were more frequently over- or underdominant than long bone lengths or necropsy weight. The single-trait QTLs map to 35 pleiotropic loci. Long bones are much more frequently affected in groups while organs tend to be affected singly or in pairs. Organs and long bones are found at the same locus in only 11 cases, 8 of which also include necropsy weight. Our results suggest mainly separate genetic modules for organ weights and long bone lengths, with a few loci that affect overall body size. Antagonistic pleiotropy, in which a locus has opposite effects on different characteristics, is uncommon.","affiliation":[]},{"pmid":"17913790","pmcid":null,"title":"Mutations in the BMP pathway in mice support the existence of two molecular classes of holoprosencephaly.","authors":["Fernandes M","Gutin G","Alcorn H","McConnell SK","Hbert JM"],"grantIds":["MH075779","MH70596","T32 GM007288"],"grantAgencies":["NIMH NIH HHS","NIMH NIH HHS","NIGMS NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":15,"month":11,"year":2007,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Brain","Embryo, Mammalian","Female","Gene Expression Regulation, Developmental","Hedgehog Proteins","Holoprosencephaly","Male","Mice","Mice, Transgenic","Mutation","Phenotype","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Holoprosencephaly (HPE) is a devastating forebrain abnormality with a range of morphological defects characterized by loss of midline tissue. In the telencephalon, the embryonic precursor of the cerebral hemispheres, specialized cell types form a midline that separates the hemispheres. In the present study, deletion of the BMP receptor genes, Bmpr1b and Bmpr1a, in the mouse telencephalon results in a loss of all dorsal midline cell types without affecting the specification of cortical and ventral precursors. In the holoprosencephalic Shh(-/-) mutant, by contrast, ventral patterning is disrupted, whereas the dorsal midline initially forms. This suggests that two separate developmental mechanisms can underlie the ontogeny of HPE. The Bmpr1a;Bmpr1b mutant provides a model for a subclass of HPE in humans: midline inter-hemispheric HPE.","affiliation":[]},{"pmid":"17626200","pmcid":null,"title":"BMPR1a signaling determines numbers of oligodendrocytes and calbindin-expressing interneurons in the cortex.","authors":["Samanta J","Burke GM","McGuire T","Pisarek AJ","Mukhopadhyay A","Mishina Y","Kessler JA"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","journalShort":"J. Neurosci.","day":11,"month":7,"year":2007,"meshHeadings":["Aging","Animals","Animals, Newborn","Astrocytes","Basic Helix-Loop-Helix Transcription Factors","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Calbindins","Cell Aging","Cell Count","Cell Cycle","Cell Lineage","Cerebral Cortex","Death","Interneurons","Mice","Mice, Inbred C57BL","Mutation","Neurons","Oligodendroglia","S100 Calcium Binding Protein G","Signal Transduction","Smad Proteins","Stem Cells","gamma-Aminobutyric Acid"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Progenitor cells that express the transcription factor olig1 generate several neural cell types including oligodendrocytes and GABAergic interneurons in the dorsal cortex. The fate of these progenitor cells is regulated by a number of signals including bone morphogenetic proteins (BMPs) secreted in the dorsal forebrain. BMPs signal by binding to heteromeric serine-threonine kinase receptors formed by type I (BMPR1a, BMPR1b, Alk2) and type II (BMPRII) subunits. To determine the specific role of the BMPR1a subunit in lineage commitment by olig1-expressing cells, we used a cre/loxP genetic approach to ablate BMPR1a in these cells while leaving signaling from other subunits intact. There was a reduction in numbers of immature oligodendrocytes in the BMPR1a-null mutant brains at birth. However, by postnatal day 20, the BMPR1a-null mice had a significant increase in the number of mature and immature oligodendrocytes compared with wild-type littermates. There was also an increase in the proportion of calbindin-positive interneurons in the dorsomedial cortex of BMPR1a-null mice at birth without any change in the number of parvalbumin- or calretinin-positive cells. These effects were attributable, at least in part, to a decrease in the length of the cell cycle in subventricular zone progenitor cells. Thus, our findings indicate that BMPR1a mediates the suppressive effects of BMP signaling on oligodendrocyte lineage commitment and on the specification of calbindin-positive interneurons in the dorsomedial cortex.","affiliation":[]},{"pmid":"17928452","pmcid":null,"title":"The role of Foxg1 and dorsal midline signaling in the generation of Cajal-Retzius subtypes.","authors":["Hanashima C","Fernandes M","Hebert JM","Fishell G"],"grantIds":["R01MH068469","R01MH070596","R01NS032993"],"grantAgencies":["NIMH NIH HHS","NIMH NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","journalShort":"J. Neurosci.","day":10,"month":10,"year":2007,"meshHeadings":["Animals","Bone Morphogenetic Proteins","Cell Differentiation","Female","Forkhead Transcription Factors","Mice","Mice, Inbred C57BL","Mice, Knockout","Neocortex","Nerve Tissue Proteins","Neurons","Pregnancy","Signal Transduction","Telencephalon","Wnt Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Cajal-Retzius (CR) cells, the earliest-born neurons in the neocortex, arise from discrete sources within the telencephalon, including the dorsal midline and the pallial-subpallial boundary (PSB). In particular, the cortical hem, a region of high bone morphogenetic proteins (BMPs) and Wnt (wingless-type MMTV integration site family) expression but lacking in Foxg1 (forkhead box G1) is a major source of CR neurons. Whether CR cells from distinct origins arise from disparate developmental processes or share a common mechanism is unclear. To elucidate the molecular basis of CR cell development, we assessed the role of both Foxg1 and dorsal midline signaling in the production of cortical hem- and PSB-derived CR cells. We demonstrate that the loss of Foxg1 results in the overproduction of both of these CR populations. However, removal of Foxg1 at embryonic day 13, although expanding the number of CR cells with a PSB phenotype, does not result in an expansion of BMPs or Wnts in the dorsomedial signaling center. Conversely, loss of the dorsal midline ligands as observed in Gli3 (glioma-associated oncogene homolog 3) mutants results in the loss of the cortical hem-derived CR character but does not affect the specification of PSB-derived CR cells. Hence, our findings demonstrate that, although the specification of cortical hem-derived CR cells is dependent on signaling from the dorsal midline, Foxg1 functions to repress the generation of both cortical hem- and PSB-derived CR cells.","affiliation":[]},{"pmid":"17678919","pmcid":null,"title":"Bone morphogenetic protein signaling is essential for terminal differentiation of the intestinal secretory cell lineage.","authors":["Auclair BA","Benoit YD","Rivard N","Mishina Y","Perreault N"],"grantIds":[],"grantAgencies":["Intramural NIH HHS"],"retractions":[],"journal":"Gastroenterology","journalShort":"Gastroenterology","day":14,"month":9,"year":2007,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Differentiation","Cell Proliferation","Intestinal Mucosa","Jejunum","Mice","Mice, Inbred Strains","Mice, Transgenic","Mutation","Signal Transduction","Wnt Proteins","beta Catenin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BACKGROUND & AIMS: Bone morphogenetic proteins (Bmps) are morphogens known to play key roles in gastrointestinal development and pathology. Most Bmps are produced primarily by the mesenchymal compartment and activate their signaling pathways following a paracrine or autocrine route. The aim of this study was to investigate the role of epithelial Bmp signaling in intestinal morphogenesis and maintenance of adult epithelial cell functions. METHODS: With the use of tissue-specific gene ablation, we generated mice lacking the Bmp receptor type IA (Bmpr1a) exclusively in the intestinal epithelium. Bmpr1a mutant and control mice were sacrificed for histology, immunofluorescence, Western blot analysis, electron microscopy, and quantitative polymerase chain reaction. RESULTS: As well as showing increased proliferation and altered intestinal epithelial morphology, Bmpr1a mutant mice revealed that epithelial Bmp signaling is associated with impaired terminal differentiation of cells from the secretory lineage but not with the determination of cell fate. Loss of Bmp signaling exclusively in the epithelial compartment is not sufficient for the initiation of the de novo crypt phenomenon associated with juvenile polyposis syndrome. CONCLUSIONS: Epithelial Bmp signaling plays an important role in the terminal differentiation of the intestinal secretory cell lineage but not in de novo crypt formation. These findings emphasize the importance of delineating the contribution of the stroma vs the epithelium in gastrointestinal physiology and pathology.","affiliation":[]},{"pmid":"18233958","pmcid":null,"title":"Reduced BMP4 abundance in Gata2 hypomorphic mutant mice result in uropathies resembling human CAKUT.","authors":["Hoshino T","Shimizu R","Ohmori S","Nagano M","Pan X","Ohneda O","Khandekar M","Yamamoto M","Lim KC","Engel JD"],"grantIds":["GM28896"],"grantAgencies":["NIGMS NIH HHS"],"retractions":[],"journal":"Genes to cells : devoted to molecular & cellular mechanisms","journalShort":"Genes Cells","day":31,"month":2,"year":2008,"meshHeadings":["Animals","Animals, Newborn","Base Sequence","Bone Morphogenetic Protein 4","Bone Morphogenetic Proteins","DNA Primers","Disease Models, Animal","Female","GATA2 Transcription Factor","Gene Expression Regulation, Developmental","Heterozygote","Humans","Introns","Male","Mice","Mice, Inbred C57BL","Mice, Knockout","Mice, Mutant Strains","Models, Biological","Phenotype","Pregnancy","RNA, Messenger","Transcription, Genetic","Transcriptional Activation","Urogenital Abnormalities","Urogenital System"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Constitutive loss of transcription factor GATA-2 leads to embryonic lethality from primitive erythropoietic failure. We serendipitously discovered an essential contribution of GATA-2 to urogenital development when the hematopoietic deficiency of Gata2 null mutant animals was complemented by a Gata2 yeast artificial chromosome (YAC) transgene; these mice died from a perinatal lethal urogenital abnormality. Here, we report the generation and analysis of Gata2 hypomorphic mutant (Gata2(fGN)/(/fGN)) mice, which suffered from hydronephrosis and megaureter, as do the YAC-rescued Gata2 null mutants. Gata2(fGN)/(/fGN) mutants exhibit anteriorly displaced ureteric budding from the Wolffian duct as well as reduced BMP4 expression in the intermediate mesoderm derivatives in a manner that is temporally coincident with ureteric bud emergence. In Bmp4 mutant heterozygotes, rostral displacement of the initial bud site on the Wolffian duct results in abnormal urogenital development. We show here that Bmp4 mRNA is reduced approximately twofold in Gata2(fGN)/(/fGN) mice (as in Bmp4 null heterozygotes), and that GATA-2 trans-activates a Bmp4 first intron element-directed reporter plasmid in co-transfection assays. These experiments taken together implicate GATA-2 as a direct regulator of Bmp4 transcription. The pathophysiology described in Gata2 hypomorphic mutant animals resembles human congenital anomalies of the kidney and urinary tract.","affiliation":[]},{"pmid":"17823941","pmcid":null,"title":"Temporal and spatial regulation of bone morphogenetic protein signaling in late lung development.","authors":["Alejandre-Alczar MA","Shalamanov PD","Amarie OV","Sevilla-Prez J","Seeger W","Eickelberg O","Morty RE"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Developmental dynamics : an official publication of the American Association of Anatomists","journalShort":"Dev. Dyn.","day":1,"month":10,"year":2007,"meshHeadings":["Animals","Base Sequence","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Proteins","Inhibitor of Differentiation Protein 1","Lung","Mice","Mice, Inbred C57BL","Molecular Sequence Data","Organogenesis","Phosphorylation","Protein Isoforms","Signal Transduction","Smad Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (BMPs) play important roles in early lung development. No study to date has addressed a role for BMP signaling in late lung development. We describe changes in the expression and localization of BMP receptors (Bmpr1a, Bmpr1b, and Bmpr2) and Smad (Smad1, Smad4, Smad5, and Smad8) intracellular signaling proteins during the saccular and alveolarization stages of late lung development. BMP signaling, assessed by Smad1/5 phosphorylation, nuclear translocation, and induction of id1, id2, and id3 gene expression, was evident throughout late lung development. Our data indicate that BMP signaling is active during late lung development, and points to roles for the BMP system in septal and vascular development, and in the homeostasis of the epithelial layer of large conducting airways in the mature lung.","affiliation":[]},{"pmid":"18483623","pmcid":null,"title":"Persistent expression of Pax3 in the neural crest causes cleft palate and defective osteogenesis in mice.","authors":["Wu M","Li J","Engleka KA","Zhou B","Lu MM","Plotkin JB","Epstein JA"],"grantIds":["R01 HL61475"],"grantAgencies":["NHLBI NIH HHS"],"retractions":[],"journal":"The Journal of clinical investigation","journalShort":"J. Clin. Invest.","day":4,"month":6,"year":2008,"meshHeadings":["Animals","Bone Development","Cleft Palate","DNA, Complementary","Dose-Response Relationship, Drug","Gene Expression Regulation, Developmental","Genotype","Mice","Mice, Transgenic","Models, Biological","Models, Genetic","Neural Crest","Osteogenesis","Paired Box Transcription Factors","Proteins","RNA, Untranslated"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Transcription factors regulate tissue patterning and cell fate determination during development; however, expression of early regulators frequently abates upon differentiation, suggesting that they may also play a role in maintaining an undifferentiated phenotype. The transcription factor paired box 3 (Pax3) is expressed by multipotent neural crest precursors and is implicated in neural crest disorders in humans such as Waardenburg syndrome. Pax3 is required for development of multiple neural crest lineages and for activation of lineage-specific programs, yet expression is generally extinguished once neural crest cells migrate from the dorsal neural tube and differentiate. Using a murine Cre-inducible system, we asked whether persistent Pax3 expression in neural crest derivatives would affect development or patterning. We found that persistent expression of Pax3 in cranial neural crest cells resulted in cleft palate, ocular defects, malformation of the sphenoid bone, and perinatal lethality. Furthermore, we demonstrated that Pax3 directly regulates expression of Sostdc1, a soluble inhibitor of bone morphogenetic protein (BMP) signaling. Persistent Pax3 expression renders the cranial crest resistant to BMP-induced osteogenesis. Thus, one mechanism by which Pax3 maintains the undifferentiated state of neural crest mesenchyme may be to block responsiveness to differentiation signals from the environment. These studies provide in vivo evidence for the importance of Pax3 downregulation during differentiation of multipotent neural crest precursors and cranial development.","affiliation":[]},{"pmid":"17553962","pmcid":null,"title":"Loss of a quiescent niche but not follicle stem cells in the absence of bone morphogenetic protein signaling.","authors":["Kobielak K","Stokes N","de la Cruz J","Polak L","Fuchs E"],"grantIds":["R01 AR 050452"],"grantAgencies":["NIAMS NIH HHS"],"retractions":[],"journal":"Proceedings of the National Academy of Sciences of the United States of America","journalShort":"Proc. Natl. Acad. Sci. U.S.A.","day":12,"month":6,"year":2007,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Proliferation","Gene Expression Regulation","Hair Follicle","Hedgehog Proteins","High Mobility Group Proteins","Homeodomain Proteins","LIM-Homeodomain Proteins","Lymphoid Enhancer-Binding Factor 1","Mice","Mice, Transgenic","PTEN Phosphohydrolase","Phosphatidylinositol 3-Kinases","Proto-Oncogene Proteins c-akt","SOXC Transcription Factors","Signal Transduction","Stem Cells","Trans-Activators","Transcription Factors","beta Catenin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"During the hair cycle, follicle stem cells (SCs) residing in a specialized niche called the \"bulge\" undergo bouts of quiescence and activation to cyclically regenerate new hairs. Developmental studies have long implicated the canonical bone morphogenetic protein (BMP) pathway in hair follicle (HF) determination and differentiation, but how BMP signaling functions in the hair follicle SC niche remains unknown. Here, we use loss and gain of function studies to manipulate BMP signaling in the SC niche. We show that when the Bmpr1a gene is conditionally ablated, otherwise quiescent SCs are activated to proliferate, causing an expansion of the niche and loss of slow-cycling cells. Surprisingly, follicle SCs are not lost, however, but rather, they generate long-lived, tumor-like branches that express Sox4, Lhx2, and Sonic Hedgehog but fail to terminally differentiate to make hair. A key component of BMPR1A-deficient SCs is their elevated levels of both Lef1 and beta-catenin, which form a bipartite transcription complex required for initiation of the hair cycle. Although beta-catenin can be stabilized by Wnt signaling, we show that BMPR1A deficiency enhances beta-catenin stabilization in the niche through a pathway involving PTEN inhibition and PI3K/AKT activation. Conversely, sustained BMP signaling in the SC niche blocks activation and promotes premature hair follicle differentiation. Together, these studies reveal the importance of balancing BMP signaling in the SC niche.","affiliation":[]},{"pmid":"17699604","pmcid":null,"title":"BMP signalling inhibits premature neural differentiation in the mouse embryo.","authors":["Di-Gregorio A","Sancho M","Stuckey DW","Crompton LA","Godwin J","Mishina Y","Rodriguez TA"],"grantIds":["MC_U120081320"],"grantAgencies":["Medical Research Council","Intramural NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":27,"month":9,"year":2007,"meshHeadings":["Animals","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein 7","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Differentiation","Embryo, Mammalian","Embryonic Development","Fibroblast Growth Factors","Mice","Mice, Mutant Strains","Nervous System","Pluripotent Stem Cells","Signal Transduction","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The specification of a subset of epiblast cells to acquire a neural fate constitutes the first step in the generation of the nervous system. Little is known about the signals required for neural induction in the mouse. We have analysed the role of BMP signalling in this process. We demonstrate that prior to gastrulation, Bmp2/4 signalling via Bmpr1a maintains epiblast pluripotency and prevents precocious neural differentiation of this tissue, at least in part by maintaining Nodal signalling. We find that during gastrulation, BMPs of the 60A subgroup cooperate with Bmp2/4 to maintain pluripotency. The inhibition of neural fate by BMPs is independent of FGF signalling, as inhibition of FGF signalling between 5.5 and 7.5 days post-coitum does not block neural differentiation in the mouse embryo. Together, our results demonstrate that inhibition of BMP signalling has a central role during neural induction in mammals and suggest that FGFs do not act as neural inducers in the post-implantation mouse embryo.","affiliation":[]},{"pmid":"17804727","pmcid":null,"title":"Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice.","authors":["Bleuming SA","He XC","Kodach LL","Hardwick JC","Koopman FA","Ten Kate FJ","van Deventer SJ","Hommes DW","Peppelenbosch MP","Offerhaus GJ","Li L","van den Brink GR"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Cancer research","journalShort":"Cancer Res.","day":1,"month":9,"year":2007,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Differentiation","Cell Proliferation","Disease Progression","Epithelial Cells","Genes, Tumor Suppressor","Intestinal Mucosa","Intestinal Neoplasms","Mice","Mice, Inbred C57BL","Mice, Knockout","Pyloric Antrum","Signal Transduction","Stomach Neoplasms","beta Catenin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein (BMP) signaling is known to suppress oncogenesis in the small and large intestine of mice and humans. We examined the role of Bmpr1a signaling in the stomach. On conditional inactivation of Bmpr1a, mice developed neoplastic lesions specifically in the squamocolumnar and gastrointestinal transition zones. We hypothesized that the regulation of epithelial cell fate may be less well defined in these junctional zones than in the adjacent epithelium and found that the mucosa at the squamocolumnar junction in mice shows a lack of differentiated fundic gland cell types and that foveolar cells at the gastrointestinal junctional zone lack expression of the foveolar cell marker Muc5ac. Precursor cell proliferation in both transition zones was higher than in the surrounding epithelium. Our data show that BMP signaling through Bmpr1a suppresses tumorigenesis at gastric epithelial junctional zones that are distinct from the adjacent gastric epithelium in both cellular differentiation and proliferation.","affiliation":[]},{"pmid":"18087045","pmcid":null,"title":"Embryonic stromal clones reveal developmental regulators of definitive hematopoietic stem cells.","authors":["Durand C","Robin C","Bollerot K","Baron MH","Ottersbach K","Dzierzak E"],"grantIds":["G0300723","G0800784","R01 DK054077","R01 DK054077-07","R01 DK52191","R37DK51077"],"grantAgencies":["Medical Research Council","Medical Research Council","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS"],"retractions":[],"journal":"Proceedings of the National Academy of Sciences of the United States of America","journalShort":"Proc. Natl. Acad. Sci. U.S.A.","day":26,"month":12,"year":2007,"meshHeadings":["Animals","Aorta","Bone Morphogenetic Protein 4","Bone Morphogenetic Proteins","Cell Culture Techniques","Chemokines, CC","Embryonic Stem Cells","Gene Expression Regulation, Developmental","Gonads","Hematopoietic Stem Cells","Intercellular Signaling Peptides and Proteins","Macrophage Inflammatory Proteins","Mesonephros","Mice","Mice, Inbred C57BL","Mice, Inbred CBA","Mice, Transgenic","Nerve Growth Factor","Recombinant Proteins","Stromal Cells"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Hematopoietic stem cell (HSC) self-renewal and differentiation is regulated by cellular and molecular interactions with the surrounding microenvironment. During ontogeny, the aorta-gonad-mesonephros (AGM) region autonomously generates the first HSCs and serves as the first HSC-supportive microenvironment. Because the molecular identity of the AGM microenvironment is as yet unclear, we examined two closely related AGM stromal clones that differentially support HSCs. Expression analyses identified three putative HSC regulatory factors, beta-NGF (a neurotrophic factor), MIP-1gamma (a C-C chemokine family member) and Bmp4 (a TGF-beta family member). We show here that these three factors, when added to AGM explant cultures, enhance the in vivo repopulating ability of AGM HSCs. The effects of Bmp4 on AGM HSCs were further studied because this factor acts at the mesodermal and primitive erythropoietic stages in the mouse embryo. In this report, we show that enriched E11 AGM HSCs express Bmp receptors and can be inhibited in their activity by gremlin, a Bmp antagonist. Moreover, our results reveal a focal point of Bmp4 expression in the mesenchyme underlying HSC containing aortic clusters at E11. We suggest that Bmp4 plays a relatively late role in the regulation of HSCs as they emerge in the midgestation AGM.","affiliation":[]},{"pmid":"18243104","pmcid":null,"title":"NFATc1 balances quiescence and proliferation of skin stem cells.","authors":["Horsley V","Aliprantis AO","Polak L","Glimcher LH","Fuchs E"],"grantIds":["AI31541","K99-AR054775","R01 AR031737","R01 AR031737-25","R01 AR050452","R01-AR31737"],"grantAgencies":["NIAID NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS"],"retractions":[],"journal":"Cell","journalShort":"Cell","day":25,"month":1,"year":2008,"meshHeadings":["Animals","Antigens, CD34","Biological Markers","Cell Nucleus","Cell Proliferation","Cells, Cultured","Cyclin-Dependent Kinase 4","Cyclosporine","Down-Regulation","Embryo, Mammalian","Gene Deletion","Gene Expression","Gene Expression Regulation, Developmental","Genes, Reporter","Hair Follicle","Immunohistochemistry","Immunosuppressive Agents","Mice","Mice, Knockout","Mice, Nude","Morphogenesis","NFATC Transcription Factors","RNA, Messenger","Retroviridae","Skin","Skin Transplantation","Stem Cells","Transcription Factors","Transgenes","Transplantation, Homologous"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Quiescent adult stem cells reside in specialized niches where they become activated to proliferate and differentiate during tissue homeostasis and injury. How stem cell quiescence is governed is poorly understood. We report here that NFATc1 is preferentially expressed by hair follicle stem cells in their niche, where its expression is activated by BMP signaling upstream and it acts downstream to transcriptionally repress CDK4 and maintain stem cell quiescence. As stem cells become activated during hair growth, NFATc1 is downregulated, relieving CDK4 repression and activating proliferation. When calcineurin/NFATc1 signaling is suppressed, pharmacologically or via complete or conditional NFATc1 gene ablation, stem cells are activated prematurely, resulting in precocious follicular growth. Our findings may explain why patients receiving cyclosporine A for immunosuppressive therapy display excessive hair growth, and unveil a functional role for calcium-NFATc1-CDK4 circuitry in governing stem cell quiescence.","affiliation":[]},{"pmid":"18258849","pmcid":null,"title":"Prenatal lung epithelial cell-specific abrogation of Alk3-bone morphogenetic protein signaling causes neonatal respiratory distress by disrupting distal airway formation.","authors":["Sun J","Chen H","Chen C","Whitsett JA","Mishina Y","Bringas P","Ma JC","Warburton D","Shi W"],"grantIds":["HL44060","HL44977","HL60231","HL68597","HL75773","R01 HL068597","R01 HL068597-07"],"grantAgencies":["NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS"],"retractions":[],"journal":"The American journal of pathology","journalShort":"Am. J. Pathol.","day":29,"month":3,"year":2008,"meshHeadings":["Animals","Animals, Newborn","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Female","Gene Expression Regulation, Developmental","Lung","Mice","Mice, Inbred C57BL","Mice, Knockout","Mice, Transgenic","Organ Specificity","Organogenesis","Respiratory Insufficiency","Respiratory Mucosa","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (BMPs) play important roles in regulating lung development and function although the endogenous regulatory effects of BMP signaling are still controversial. We found that BMP type I receptor Alk3 is expressed predominantly in airway epithelial cells during development. The function of Alk3 in lung development was determined using an inducible knockout mouse model by crossing epithelial cell-specific Cre transgenic mice SPC-rtTA/TetO-Cre and floxed-Alk3 mice. Abrogation of Alk3 in mouse lung epithelia from either early lung organogenesis or late gestation resulted in similar neonatal respiratory distress phenotypes accompanied by collapsed lungs. Early-induction of Alk3 knockout in lung epithelial cells caused retardation of early lung branching morphogenesis, reduced cell proliferation, and differentiation. However, late gestation induction of the knockout caused changes in cell proliferation and survival, as shown by altered cell biology, reduced expression of peripheral epithelial markers (Clara cell-specific protein, surfactant protein C, and aquaporin-5), and lack of surfactant secretion. Furthermore, canonical Wnt signaling was perturbed, possibly through reduced Wnt inhibitory factor-1 expression in Alk3-knockout lungs. Therefore, our data suggest that deficiency of appropriate BMP signaling in lung epithelial cells results in prenatal lung malformation, neonatal atelectasis, and respiratory failure.","affiliation":[]},{"pmid":"18178801","pmcid":null,"title":"BMP receptor ALK3 controls collecting system development.","authors":["Hartwig S","Bridgewater D","Di Giovanni V","Cain J","Mishina Y","Rosenblum ND"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Journal of the American Society of Nephrology : JASN","journalShort":"J. Am. Soc. Nephrol.","day":7,"month":1,"year":2008,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Embryonic Development","Gene Deletion","Gene Expression Regulation, Developmental","Genes, Reporter","Green Fluorescent Proteins","Kidney","Kidney Tubules, Collecting","Mice","Mice, Knockout","Mice, Transgenic","Ureter"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The molecular signals that regulate growth and branching of the ureteric bud during formation of the renal collecting system are largely undefined. Members of the bone morphogenetic protein (BMP) family signal through the type I BMP receptor ALK3 to inhibit ureteric bud and collecting duct cell morphogenesis in vitro. We investigated the function of the BMP signaling pathway in vivo by generating a murine model of ALK3 deficiency restricted to the ureteric bud lineage (Alk3(UB-/-) mice). At the onset of branching morphogenesis, Alk3(UB-/-) kidneys are characterized by an abnormal primary (1 degrees ) ureteric bud branch pattern and an increased number of ureteric bud branches. However, during later stages of renal development, Alk3(UB-/-) kidneys have fewer ureteric bud branches and collecting ducts than wild-type kidneys. Postnatal Alk3(UB-/-) mice exhibit a dysplastic renal phenotype characterized by hypoplasia of the renal medulla, a decreased number of medullary collecting ducts, and abnormal expression of beta-catenin and c-MYC in medullary tubules. In summary, normal kidney development requires ALK3-dependent BMP signaling, which controls ureteric bud branching.","affiliation":[]},{"pmid":"18272594","pmcid":null,"title":"BMP type I receptor complexes have distinct activities mediating cell fate and axon guidance decisions.","authors":["Yamauchi K","Phan KD","Butler SJ"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":25,"month":3,"year":2008,"meshHeadings":["Animals","Axons","Bone Morphogenetic Protein Receptors, Type I","Cell Differentiation","Chick Embryo","Female","Gene Expression Regulation, Developmental","Green Fluorescent Proteins","Humans","Mice","Mice, Mutant Strains","Mice, Transgenic","Models, Neurological","Multiprotein Complexes","Pregnancy","Recombinant Proteins","Signal Transduction","Spinal Cord"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The finding that morphogens, signalling molecules that specify cell identity, also act as axon guidance molecules has raised the possibility that the mechanisms that establish neural cell fate are also used to assemble neuronal circuits. It remains unresolved, however, how cells differentially transduce the cell fate specification and guidance activities of morphogens. To address this question, we have examined the mechanism by which the Bone morphogenetic proteins (BMPs) guide commissural axons in the developing spinal cord. In contrast to studies that have suggested that morphogens direct axon guidance decisions using non-canonical signal transduction factors, our results indicate that canonical components of the BMP signalling pathway, the type I BMP receptors (BMPRs), are both necessary and sufficient to specify the fate of commissural neurons and guide their axonal projections. However, whereas the induction of cell fate is a shared property of both type I BMPRs, axon guidance is chiefly mediated by only one of the type I BMPRs, BMPRIB. Taken together, these results indicate that the diverse activities of BMP morphogens can be accounted for by the differential use of distinct components of the canonical BMPR complex.","affiliation":[]},{"pmid":"17998461","pmcid":null,"title":"Abnormal conduction and morphology in the atrioventricular node of mice with atrioventricular canal targeted deletion of Alk3/Bmpr1a receptor.","authors":["Stroud DM","Gaussin V","Burch JB","Yu C","Mishina Y","Schneider MD","Fishman GI","Morley GE"],"grantIds":["HL59139","HL69020","HL76751","HL79796","R01 HL064757","R01 HL064757-09","R01 HL076751","R01 HL076751-01A1","R01 HL076751-02","R01 HL076751-03","R01 HL076751-04"],"grantAgencies":["NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS"],"retractions":[],"journal":"Circulation","journalShort":"Circulation","day":27,"month":11,"year":2007,"meshHeadings":["Animals","Atrioventricular Node","Body Surface Potential Mapping","Bone Morphogenetic Protein Receptors, Type I","Genotype","Heart Block","Heart Conduction System","Mice","Mice, Mutant Strains","Myocardium"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BACKGROUND: The atrioventricular (AV) node is essential for the sequential excitation and optimized contraction of the adult multichambered heart; however, relatively little is known about its formation from the embryonic AV canal. A recent study demonstrated that signaling by Alk3, the type 1a receptor for bone morphogenetic proteins, in the myocardium of the AV canal was required for the development of both the AV valves and annulus fibrosus. To test the hypothesis that bone morphogenetic protein signaling also plays a role in AV node formation, we investigated conduction system function and AV node morphology in adult mice with conditional deletion of Alk3 in the AV canal. METHODS AND RESULTS: High-resolution optical mapping with correlative histological analysis of 28 mutant hearts revealed 4 basic phenotypic classes based on electrical activation patterns and volume-conducted ECGs. The frequency of AV node conduction and morphological abnormalities increased from no detectable anomalies (class I) to severe defects (class IV), which included the presence of bypass tracts, abnormal ventricular activation patterns, fibrosis of the AV node, and twin AV nodes. CONCLUSIONS: The present findings demonstrate that bone morphogenetic protein signaling is required in the myocardium of the AV canal for proper AV junction development, including the AV node.","affiliation":[]},{"pmid":"18079409","pmcid":null,"title":"Smooth muscle protein 22alpha-mediated patchy deletion of Bmpr1a impairs cardiac contractility but protects against pulmonary vascular remodeling.","authors":["El-Bizri N","Wang L","Merklinger SL","Guignabert C","Desai T","Urashima T","Sheikh AY","Knutsen RH","Mecham RP","Mishina Y","Rabinovitch M"],"grantIds":["R01 HL074186","R01 HL074186","R01 HL074186-01A1","R01 HL074186-02","R01 HL074186-03","R01 HL074186-04"],"grantAgencies":["NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","Intramural NIH HHS"],"retractions":[],"journal":"Circulation research","journalShort":"Circ. Res.","day":15,"month":2,"year":2008,"meshHeadings":["Animals","Anoxia","Aorta","Arteries","Bone Morphogenetic Protein Receptors, Type I","Cells, Cultured","Collagen","Coronary Circulation","Elastin","Humans","Hypertension, Pulmonary","Lung","Mice","Mice, Knockout","Microfilament Proteins","Muscle Proteins","Myocardial Contraction","Myocardium","Myocytes, Smooth Muscle","Neovascularization, Pathologic"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Vascular expression of bone morphogenetic type IA receptor (Bmpr1a) is reduced in lungs of patients with pulmonary arterial hypertension, but the significance of this observation is poorly understood. To elucidate the role of Bmpr1a in the vascular pathology of pulmonary arterial hypertension and associated right ventricular (RV) dysfunction, we deleted Bmpr1a in vascular smooth muscle cells and in cardiac myocytes in mice using the SM22alpha;TRE-Cre/LoxP;R26R system. The LacZ distribution reflected patchy deletion of Bmpr1a in the lung vessels, aorta, and heart of SM22alpha;TRE-Cre;R26R;Bmpr1a(flox/+) and flox/flox mutants. This reduction in BMPR-IA expression was confirmed by Western immunoblot and immunohistochemistry in the flox/flox group. This did not affect pulmonary vasoreactivity to acute hypoxia (10% O2) or the increase in RV systolic pressure and RV hypertrophy following 3 weeks in chronic hypoxia. However, both SM22alpha;TRE-Cre;R26R;Bmpr1a(flox/+) and flox/flox mutant mice had fewer muscularized distal pulmonary arteries and attenuated loss of peripheral pulmonary arteries compared with age-matched control littermates in hypoxia. When Bmpr1a expression was reduced by short interference RNA in cultured pulmonary arterial smooth muscle cells, serum-induced proliferation was attenuated explaining decreased hypoxia-mediated muscularization of distal vessels. When Bmpr1a was reduced in cultured microvascular pericytes by short interference RNA, resistance to apoptosis was observed and this could account for protection against hypoxia-mediated vessel loss. The similar elevation in RV systolic pressure and RV hypertrophy, despite the attenuated remodeling with chronic hypoxia in the flox/flox mutants versus controls, was not a function of elevated left ventricular end diastolic pressure but was associated with increased periadventitial deposition of elastin and collagen, potentially influencing vascular stiffness.","affiliation":[]},{"pmid":"18000065","pmcid":null,"title":"Distinct roles of Wnt/beta-catenin and Bmp signaling during early cardiogenesis.","authors":["Klaus A","Saga Y","Taketo MM","Tzahor E","Birchmeier W"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Proceedings of the National Academy of Sciences of the United States of America","journalShort":"Proc. Natl. Acad. Sci. U.S.A.","day":20,"month":11,"year":2007,"meshHeadings":["Animals","Animals, Genetically Modified","Basic Helix-Loop-Helix Transcription Factors","Bone Morphogenetic Protein 4","Bone Morphogenetic Proteins","Embryo, Nonmammalian","Gene Expression Regulation, Developmental","Heart","Mutation","Myocardium","Signal Transduction","Time Factors","Wnt Proteins","Zebrafish","Zebrafish Proteins","beta Catenin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Heart formation requires the coordinated recruitment of multiple cardiac progenitor cell populations derived from both the first and second heart fields. In this study, we have ablated the Bmp receptor 1a and the Wnt effector beta-catenin in the developing heart of mice by using MesP1-cre, which acts in early mesoderm progenitors that contribute to both first and second heart fields. Remarkably, the entire cardiac crescent and later the primitive ventricle were absent in MesP1-cre; BmpR1a(lox/lox) mutants. Although myocardial progenitor markers such as Nkx2-5 and Isl1 and the differentiation marker MLC2a were detected in the small, remaining cardiac field in these mutants, the first heart field markers, eHand and Tbx-5, were not expressed. We conclude from these results that Bmp receptor signaling is crucial for the specification of the first heart field. In MesP1-cre; beta-catenin(lox/lox) mutants, cardiac crescent formation, as well as first heart field markers, were not affected, although cardiac looping and right ventricle formation were blocked. Expression of Isl1 and Bmp4 in second heart field progenitors was strongly reduced. In contrast, in a gain-of-function mutation of beta-catenin using MesP1-cre, we revealed an expansion of Isl1 and Bmp4 expressing cells, although the heart tube was not formed. We conclude from these results that Wnt/beta-catenin signaling regulates second heart-field development, and that a precise amount and/or timing of Wnt/beta-catenin signaling is required for proper heart tube formation and cardiac looping.","affiliation":[]},{"pmid":"18449905","pmcid":null,"title":"Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.","authors":["Kanzaki S","Takahashi T","Kanno T","Ariyoshi W","Shinmyouzu K","Tujisawa T","Nishihara T"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Journal of cellular physiology","journalShort":"J. Cell. Physiol.","day":23,"month":9,"year":2008,"meshHeadings":["Alkaline Phosphatase","Animals","Anticoagulants","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Proteins","Calcification, Physiologic","Cell Differentiation","Cells, Cultured","Heparin","Mice","Osteoblasts","Osteogenesis","Signal Transduction","Swine","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Heparin demonstrates several kinds of biological activities by binding to various extracellular molecules and plays pivotal roles in bone metabolism. However, the role of heparin in the biological activity of bone morphogenetic protein (BMP) remains unclear. In the present study, we examined whether heparin has the effects on osteoblast differentiation induced by BMP-2 in vitro and also elucidated the precise mechanism by which heparin regulates bone metabolism induced by this molecule. Our results showed that heparin inhibited alkaline phosphatase (ALP) activity and mineralization in osteoblastic cells cultured with BMP-2. Heparin was found to suppress the mRNA expressions of osterix, Runx2, ALP and osteocalcin, as well as phosphorylation of Smad1/5/8 and p38 MAPK. Further, heparin bound to both BMP-2 and BMP receptor (BMPR). These results suggest that heparin suppresses BMP-2-BMPR binding, and inhibits BMP-2 osteogenic activity in vitro.","affiliation":[]},{"pmid":"18159948","pmcid":"2151092","title":"Distinct roles and regulations for HoxD genes in metanephric kidney development.","authors":["Di-Po N","Zkny J","Duboule D"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"PLoS genetics","journalShort":"PLoS Genet.","day":21,"month":12,"year":2007,"meshHeadings":["Animals","Animals, Newborn","Apoptosis","DNA-Binding Proteins","Female","Gene Deletion","Gene Expression Regulation, Developmental","Gene Targeting","Genes, Homeobox","Homeodomain Proteins","Kidney","Kidney Tubules","Lac Operon","Mesoderm","Mice","Mice, Knockout","Mice, Mutant Strains","Mice, Transgenic","Multigene Family","Neoplasm Proteins","Phenotype","Polycystic Kidney Diseases","Pregnancy","Transcription Factors","Ureter"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Hox genes encode homeodomain-containing proteins that control embryonic development in multiple contexts. Up to 30 Hox genes, distributed among all four clusters, are expressed during mammalian kidney morphogenesis, but functional redundancy between them has made a detailed functional account difficult to achieve. We have investigated the role of the HoxD cluster through comparative molecular embryological analysis of a set of mouse strains carrying targeted genomic rearrangements such as deletions, duplications, and inversions. This analysis allowed us to uncover and genetically dissect the complex role of the HoxD cluster. Regulation of metanephric mesenchyme-ureteric bud interactions and maintenance of structural integrity of tubular epithelia are differentially controlled by some Hoxd genes during renal development, consistent with their specific expression profiles. We also provide evidence for a kidney-specific form of colinearity that underlies the differential expression of two distinct sets of genes located on both sides and overlapping at the Hoxd9 locus. These insights further our knowledge of the genetic control of kidney morphogenesis and may contribute to understanding certain congenital kidney malformations, including polycystic kidney disease and renal hypoplasia.","affiliation":[]},{"pmid":"18501628","pmcid":null,"title":"BMP signaling through BMPRIA in astrocytes is essential for proper cerebral angiogenesis and formation of the blood-brain-barrier.","authors":["Araya R","Kudo M","Kawano M","Ishii K","Hashikawa T","Iwasato T","Itohara S","Terasaki T","Oohira A","Mishina Y","Yamada M"],"grantIds":["ES071003-10"],"grantAgencies":["NIEHS NIH HHS"],"retractions":[],"journal":"Molecular and cellular neurosciences","journalShort":"Mol. Cell. Neurosci.","day":30,"month":7,"year":2008,"meshHeadings":["Animals","Astrocytes","Blood-Brain Barrier","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Brain","Cells, Cultured","Mice","Mice, Knockout","Mice, Transgenic","Neovascularization, Physiologic","Signal Transduction","Vascular Endothelial Growth Factor A"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein (BMP) signaling is involved in differentiation of neural precursor cells into astrocytes, but its contribution to angiogenesis is not well characterized. This study examines the role of BMP signaling through BMP type IA receptor (BMPRIA) in early neural development using a conditional knockout mouse model, in which Bmpr1a is selectively disrupted in telencephalic neural stem cells. The conditional mutant mice show a significant increase in the number of cerebral blood vessels and the level of vascular endothelial growth factor (VEGF) is significantly upregulated in the mutant astrocytes. The mutant mice also show leakage of immunoglobulin around cerebral microvessels in neonatal mice, suggesting a defect in formation of the blood-brain-barrier. In addition, astrocytic endfeet fail to encircle cortical blood vessels in the mutant mice. These results suggest that BMPRIA signaling in astrocytes regulates the expression of VEGF for proper cerebrovascular angiogenesis and has a role on in the formation of the blood-brain-barrier.","affiliation":[]},{"pmid":"18543407","pmcid":null,"title":"BMPR IA downstream genes related to VSD.","authors":["Yang D","Zhang J","Chen C","Xie M","Sperling S","Fang F","Chen B","Li X","Zhang H"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Pediatric research","journalShort":"Pediatr. Res.","day":9,"month":6,"year":2008,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Gene Expression Profiling","Gene Expression Regulation, Developmental","Heart","Heart Septal Defects, Ventricular","Heart Septum","In Situ Hybridization","Mice","Mice, Inbred C57BL","Mice, Knockout","Muscle Development","Oligonucleotide Array Sequence Analysis","RNA, Messenger","Reproducibility of Results","Reverse Transcriptase Polymerase Chain Reaction","Time Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Cardiac-specific deletion of the receptor IA of bone morphogenetic protein (BMP) (ALK3) by Cre recombinase driven under the [alpha]-MHC promoter is lethal in mid-gestation with defects in the interventricular septum [ventricular septum defect (VSD)]. Analysis of expression of the ALK3 downstream genes is important to identify the signaling pathway for interventricular septum development. The mRNA expression level of a control group was compared with that of a test group. ALK3 downstream genes were screened using polymerase chain reaction (PCR)-select cDNA subtraction and microarray. It was found that the mice with an ALK3 knockout gene produced a VSD. The expression of some genes such as platelet-activating factor acetylhydrolase (PAF) and Pax-8 was down-regulated in the test group. Pax-8 gene expression was down-regulated by 7.1 times in the test group and expressed specifically in the 11.5-d embryonic (E11.5) heart. Furthermore, the expression of the protein-tyrosine kinase of the focal adhesion kinase subfamily (PTK) and [beta] subtype protein 14-3-3 was up-regulated in the test group. PTK gene expression was up-regulated by 3.7 times in the test group. These data provided support that the ALK3 gene plays an important role during heart development. The PAF and Pax-8 genes could be important ALK3 downstream genes in the BMP signaling pathway during interventricular septum development. PTK and [beta] subtype protein 14-3-3 might be regulatory factors in this pathway.","affiliation":[]},{"pmid":"18322278","pmcid":null,"title":"Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse.","authors":["Orvis GD","Jamin SP","Kwan KM","Mishina Y","Kaartinen VM","Huang S","Roberts AB","Umans L","Huylebroeck D","Zwijsen A","Wang D","Martin JF","Behringer RR"],"grantIds":["CA09299","DE/HD12324","DEO13085","HD30284","R01 HD030284"],"grantAgencies":["NCI NIH HHS","NIDCR NIH HHS","PHS HHS","NICHD NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"Biology of reproduction","journalShort":"Biol. Reprod.","day":22,"month":6,"year":2008,"meshHeadings":["Activin Receptors, Type I","Animals","Anti-Mullerian Hormone","Bone Morphogenetic Protein Receptors, Type I","Female","Infertility, Male","Male","Mice","Mice, Inbred C57BL","Mice, Knockout","Mice, Mutant Strains","Models, Biological","Mullerian Ducts","Pregnancy","Signal Transduction","Smad1 Protein","Smad5 Protein","Smad8 Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Amniotes, regardless of genetic sex, develop two sets of genital ducts: the Wolffian and Mllerian ducts. For normal sexual development to occur, one duct must differentiate into its corresponding organs, and the other must regress. In mammals, the Wolffian duct differentiates into the male reproductive tract, mainly the vasa deferentia, epididymides, and seminal vesicles, whereas the Mllerian duct develops into the four components of the female reproductive tract, the oviducts, uterus, cervix, and upper third of the vagina. In males, the fetal Leydig cells produce testosterone, which stimulates the differentiation of the Wolffian duct, whereas the Sertoli cells of the fetal testes express anti-Mllerian hormone, which activates the regression of the Mllerian duct. Anti-Mllerian hormone is a member of the transforming growth factor-beta (TGF-beta) family of secreted signaling molecules and has been shown to signal through the BMP pathway. It binds to its type II receptor, anti-Mllerian hormone receptor 2 (AMHR2), in the Mllerian duct mesenchyme and through an unknown mechanism(s); the mesenchyme induces the regression of the Mllerian duct mesoepithelium. Using tissue-specific gene inactivation with an Amhr2-Cre allele, we have determined that two TGF-beta type I receptors (Acvr1 and Bmpr1a) and all three BMP receptor-Smads (Smad1, Smad5, and Smad8) function redundantly in transducing the anti-Mllerian hormone signal required for Mllerian duct regression. Loss of these genes in the Mllerian duct mesenchyme results in male infertility due to retention of Mllerian duct derivatives in an otherwise virilized male.","affiliation":[]},{"pmid":"19246680","pmcid":null,"title":"Activation of the bone morphogenetic protein receptor by H11kinase/Hsp22 promotes cardiac cell growth and survival.","authors":["Sui X","Li D","Qiu H","Gaussin V","Depre C"],"grantIds":["HL 072863"],"grantAgencies":["NHLBI NIH HHS"],"retractions":[],"journal":"Circulation research","journalShort":"Circ. Res.","day":10,"month":4,"year":2009,"meshHeadings":["Animals","Animals, Newborn","Apoptosis","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Protein Receptors, Type II","Carrier Proteins","Cell Proliferation","Cell Survival","Cells, Cultured","Heat-Shock Proteins","Humans","MAP Kinase Kinase Kinases","Male","Mice","Mice, Transgenic","Myocytes, Cardiac","Phosphatidylinositol 3-Kinases","Phosphorylation","Protein-Serine-Threonine Kinases","Proto-Oncogene Proteins c-akt","Rats","Signal Transduction","Smad Proteins, Receptor-Regulated","Transduction, Genetic"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"H11 kinase/Hsp22 (H11K) is a chaperone promoting cardiac cell growth and survival through the activation of Akt, a downstream effector of phosphatidylinositol 3-kinase (PI3K). In this study, we tested whether H11K-induced activation of the PI3K/Akt pathway is mediated by the bone morphogenetic protein (BMP) signaling, both in a transgenic mouse model with cardiac-specific overexpression of H11K and in isolated cardiac myocytes. Microarrays in hearts from transgenic compared to wild-type mice showed an upregulation of the BMP receptors Alk3 and BMPR-II, and of their ligand BMP4 (P<0.01 versus wild type). Activation of the BMP pathway in transgenic mice was confirmed by increased phosphorylation of the \"canonical\" BMP effectors Smad 1/5/8 (P<0.01 versus wild type). In isolated myocytes, adenovirus-mediated overexpression of H11K was accompanied by a significant (P<0.01) increase in PI3K activity, phospho-Akt, Smad 1/5/8 phosphorylation and [(3)H]phenylalanine incorporation, and by a 70% reduction in H(2)O(2)-mediated apoptosis. All these effects were abolished by the BMP antagonist noggin. In presence of BMP4, Smad 1/5/8 phosphorylation was enhanced by 5-fold on H11K overexpression but decreased by 3-fold on H11K knockdown (P<0.01 versus control), showing that H11K potentiates the BMP signaling. In pull-down experiments, H11K increased both the association of Alk3 and BMPR-II together, and their interaction with the transforming growth factor-beta-activated kinase (TAK)1, a \"noncanonical\" mediator of the BMP receptor signaling. TAK1 inhibition prevented H11K-mediated activation of Akt. Therefore, potentiation of the BMP receptor by H11K promotes an activation of the PI3K/Akt pathway mediated by TAK1, which dictates the physiological effects of H11K on cardiac cell growth and survival.","affiliation":[]},{"pmid":"18287559","pmcid":null,"title":"GUDMAP: the genitourinary developmental molecular anatomy project.","authors":["McMahon AP","Aronow BJ","Davidson DR","Davies JA","Gaido KW","Grimmond S","Lessard JL","Little MH","Potter SS","Wilder EL","Zhang P","GUDMAP project"],"grantIds":["MC_U127527203"],"grantAgencies":["Medical Research Council"],"retractions":[],"journal":"Journal of the American Society of Nephrology : JASN","journalShort":"J. Am. Soc. Nephrol.","day":28,"month":4,"year":2008,"meshHeadings":["Animals","Databases, Genetic","Mice","Molecular Biology","Urogenital System"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"In late 2004, an International Consortium of research groups were charged with the task of producing a high-quality molecular anatomy of the developing mammalian urogenital tract (UGT). Given the importance of these organ systems for human health and reproduction, the need for a systematic molecular and cellular description of their developmental programs was deemed a high priority. The information obtained through this initiative is anticipated to enable the highest level of basic and clinical research grounded on a 21st-century view of the developing anatomy. There are three components to the Genitourinary Developmental Molecular Anatomy Project GUDMAP; all of these are intended to provide resources that support research on the kidney and UGT. The first provides ontology of the cell types during UGT development and the molecular hallmarks of those cells as discerned by a variety of procedures, including in situ hybridization, transcriptional profiling, and immunostaining. The second generates novel mouse strains. In these strains, cell types of particular interest within an organ are labeled through the introduction of a specific marker into the context of a gene that exhibits appropriate cell type or structure-specific expression. In addition, the targeting construct enables genetic manipulation within the cell of interest in many of the strains. Finally, the information is annotated, collated, and promptly released at regular intervals, before publication, through a database that is accessed through a Web portal. Presented here is a brief overview of the Genitourinary Developmental Molecular Anatomy Project effort.","affiliation":[]},{"pmid":"18579678","pmcid":null,"title":"Hes genes and neurogenin regulate non-neural versus neural fate specification in the dorsal telencephalic midline.","authors":["Imayoshi I","Shimogori T","Ohtsuka T","Kageyama R"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":14,"month":8,"year":2008,"meshHeadings":["Animals","Basic Helix-Loop-Helix Transcription Factors","Bone Morphogenetic Proteins","Cell Differentiation","Cell Lineage","Gene Expression Regulation, Developmental","Mice","Mice, Knockout","Signal Transduction","Telencephalon","Up-Regulation"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The choroid plexus in the brain is unique because it is a non-neural secretory tissue. It secretes the cerebrospinal fluid and functions as a blood-brain barrier, but the precise mechanism of specification of this non-neural tissue has not yet been determined. Using mouse embryos and lineage-tracing analysis, we found that the prospective choroid plexus region initially gives rise to Cajal-Retzius cells, specialized neurons that guide neuronal migration. Inactivation of the bHLH repressor genes Hes1, Hes3 and Hes5 upregulated expression of the proneural gene neurogenin 2 (Ngn2) and prematurely depleted Bmp-expressing progenitor cells, leading to enhanced formation of Cajal-Retzius cells and complete loss of choroid plexus epithelial cells. Overexpression of Ngn2 had similar effects. These data indicate that Hes genes promote specification of the fate of choroid plexus epithelial cells rather than the fate of Cajal-Retzius cells by antagonizing Ngn2 in the dorsal telencephalic midline region, and thus this study has identified a novel role for bHLH genes in the process of deciding which cells will have a non-neural versus a neural fate.","affiliation":[]},{"pmid":"18684091","pmcid":null,"title":"Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass.","authors":["Kamiya N","Ye L","Kobayashi T","Lucas DJ","Mochida Y","Yamauchi M","Kronenberg HM","Feng JQ","Mishina Y"],"grantIds":["K22 DE016977","P01 DK56246","R01 AR051587","R21 AR052824"],"grantAgencies":["NIDCR NIH HHS","NIDDK NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS","Intramural NIH HHS"],"retractions":[],"journal":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","journalShort":"J. Bone Miner. Res.","day":25,"month":12,"year":2008,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Bone Remodeling","Bone Resorption","Bone and Bones","Collagen","Female","Mice","Mice, Knockout","Mice, Transgenic","Osteoblasts","Osteoclasts","Signal Transduction","Time Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (BMPs) are known as ectopic bone inducers. The FDA approved BMPs (BMP2 and BMP7) for clinical use. However, direct effects of BMPs on endogenous bone metabolism are not yet well known. We conditionally disrupted BMP receptor type IA (BMPRIA) in osteoblasts during weanling and adult stages to show the impact of BMP signaling on endogenous bone modeling and remodeling. Cre recombination was detected in immature osteoblasts in the periosteum, osteoblasts, and osteocytes but not in chondrocytes and osteoclasts after tamoxifen administration. Bmpr1a conditional knockout mice (cKO) showed increased bone mass primarily in trabecular bone at P21 and 22 wk as determined by H&E staining. Vertebrae, tails, and ribs showed increased radiodensity at 22 wk, consistent with a significant increase in BMD. Both muCT and histomorphometry showed an increase in trabecular BV/TV and thickness of cKO adult bones, whereas osteoclast number, bone formation rate, and mineral apposition rate were decreased. Expression levels of bone formation markers (Runx2 and Bsp), resorption markers (Mmp9, Ctsk, and Tracp), and Rankl were decreased, and Opg was increased in adult bones, resulting in a reduction in the ratio of Rankl to osteoprotegerin (Opg). The reduction in osteoclastogenesis through the RANKL-OPG pathway was also observed in weanling stages and reproduced in newborn calvaria culture. These results suggest that Bmpr1a cKO increased endogenous bone mass primarily in trabecular bone with decreased osteoclastogenesis through the RANKL-OPG pathway. We conclude that BMPRIA signaling in osteoblasts affects both bone formation and resorption to reduce endogenous bone mass in vivo.","affiliation":[]},{"pmid":"19874086","pmcid":"3153381","title":"Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts.","authors":["Kamiya N","Kobayashi T","Mochida Y","Yu PB","Yamauchi M","Kronenberg HM","Mishina Y"],"grantIds":["ES071003-11","K08 HL079943","K08 HL079943-04","P01 DK56246","R01 AR057374"],"grantAgencies":["NIEHS NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NIDDK NIH HHS","NIAMS NIH HHS","Intramural NIH HHS"],"retractions":[],"journal":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","journalShort":"J. Bone Miner. Res.","day":24,"month":2,"year":2010,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Genetic Markers","Glycoproteins","Intercellular Signaling Peptides and Proteins","Mice","Mice, Knockout","Osteoblasts","Signal Transduction","Wnt Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The bone morphogenetic protein (BMP) and Wnt signaling pathways both contribute essential roles in regulating bone mass. However, the molecular interactions between these pathways in osteoblasts are poorly understood. We recently reported that osteoblast-targeted conditional knockout (cKO) of BMP receptor type IA (BMPRIA) resulted in increased bone mass during embryonic development, where diminished expression of Sost as a downstream effector of BMPRIA resulted in increased Wnt/beta-catenin signaling. Here, we report that Bmpr1a cKO mice exhibit increased bone mass during weanling stages, again with evidence of enhanced Wnt/beta-catenin signaling as assessed by Wnt reporter TOPGAL mice and TOPFLASH luciferase. Consistent with negative regulation of the Wnt pathway by BMPRIA signaling, treatment of osteoblasts with dorsomorphin, an inhibitor of Smad-dependent BMP signaling, enhanced Wnt signaling. In addition to Sost, Wnt inhibitor Dkk1 also was downregulated in cKO bone. Expression levels of Dkk1and Sost were upregulated by BMP2 treatment and downregulated by Noggin. Moreover, expression of a constitutively active Bmpr1a transgene in mice resulted in the upregulation of both Dkk1 and Sost and partially rescued the Bmpr1a cKO bone phenotype. These effectors are differentially regulated by mitogen-activated protein kinase (MAPK) p38 because pretreatment of osteoblasts with SB202190 blocked BMP2-induced Dkk1 expression but not Sost. These results demonstrate that BMPRIA in osteoblasts negatively regulates endogenous bone mass and Wnt/beta-catenin signaling and that this regulation may be mediated by the activities of Sost and Dkk1. This study highlights several interactions between BMP and Wnt signaling cascades in osteoblasts that may be amenable to therapeutic intervention for the modification of bone mass density.","affiliation":[]},{"pmid":"18667463","pmcid":null,"title":"SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis.","authors":["El-Bizri N","Guignabert C","Wang L","Cheng A","Stankunas K","Chang CP","Mishina Y","Rabinovitch M"],"grantIds":["HL085345","R01 HL074186","R01 HL074186","R01 HL074186-01A1","R01 HL074186-02","R01 HL074186-03","R01 HL074186-04","R01 HL074186-05","R01 HL087118","R01 HL087118-01A1"],"grantAgencies":["NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","Intramural NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":13,"month":9,"year":2008,"meshHeadings":["Animals","Apoptosis","Blood Vessels","Bone Morphogenetic Protein Receptors, Type I","Brain","Cell Movement","Cell Proliferation","Embryo Loss","Embryo, Mammalian","Gene Deletion","Heart","Humans","Hypertension, Pulmonary","Integrases","Matrix Metalloproteinase 2","Matrix Metalloproteinase 9","Mice","Mice, Transgenic","Microfilament Proteins","Muscle Proteins","Muscle, Smooth, Vascular","Myocytes, Smooth Muscle","Organogenesis","Pericytes"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Expression of bone morphogenetic protein receptor 1A (BMPR1A) is attenuated in the lung vessels of patients with pulmonary arterial hypertension, but the functional impact of this abnormality is unknown. We ablated Bmpr1a in cardiomyocytes and vascular smooth muscle cells (VSMCs) by breeding mice possessing a loxP allele of Bmpr1a (Bmpr1aflox) expressing R26R with SM22alpha-Cre mice. SM22alpha-Cre;R26R;Bmpr1aflox/flox mice died soon after embryonic day 11 (E11) with massive vascular and pericardial hemorrhage and impaired brain development. At E10.5, SM22alpha-Cre;R26R;Bmpr1aflox/flox embryos showed thinning of the myocardium associated with reduced cell proliferation. These embryos also had severe dilatation of the aorta and large vessels with impaired investment of SMCs that was also related to reduced proliferation. SM22alpha-Cre;R26R;Bmpr1aflox/flox mice showed collapsed telencephalon in association with impaired clearing of brain microvessels in areas where reduced apoptosis was observed. Transcript and protein levels of matrix metalloproteinase (MMP) 2 and 9 were reduced in E9.5 and E10.5 SM22alpha-Cre;R26R;Bmpr1aflox/flox embryos, respectively. Knock-down of BMPR1A by RNA interference in human pulmonary artery SMCs reduced MMP2 and MMP9 activity, attenuated serum-induced proliferation, and impaired PDGF-BB-directed migration. RNA interference of MMP2 or MMP9 recapitulated these abnormalities, supporting a functional interaction between BMP signaling and MMP expression. In human brain microvascular pericytes, knock-down of BMPR1A reduced MMP2 activity and knock-down of either BMPR1A or MMP2 caused resistance to apoptosis. Thus, loss of Bmpr1a, by decreasing MMP2 and/or MMP9 activity, can account for vascular dilatation and persistence of brain microvessels, leading to the impaired organogenesis documented in the brain.","affiliation":[]},{"pmid":"18272846","pmcid":null,"title":"Bmp in podocytes is essential for normal glomerular capillary formation.","authors":["Ueda H","Miyazaki Y","Matsusaka T","Utsunomiya Y","Kawamura T","Hosoya T","Ichikawa I"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Journal of the American Society of Nephrology : JASN","journalShort":"J. Am. Soc. Nephrol.","day":28,"month":4,"year":2008,"meshHeadings":["Animals","Bone Morphogenetic Proteins","Capillaries","Kidney Glomerulus","Mice","Mice, Transgenic","Podocytes"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein (BMP) 4 exerts multiple biological effects on kidney and ureter development. To examine the role of BMP4 in glomerular morphogenesis, we generated transgenic mice with altered BMP4 function in podocytes by conferring tissue-specificity with the nephrin (Nphs1) promoter. At birth, Tg(Nphs1-Nog) mice, which had loss of BMP4 function in podocytes, were found to have glomerular microaneurysms, collapsed glomerular capillary tufts, enlarged Bowman's capsules, and fewer normal proximal tubules. Conversely, Tg(Nphs1-Bmp4) mice, which had increased BMP4 function in podocytes, demonstrated defects in glomerular capillary formation, but podocytes were not appreciably affected. The Tg(Nphs1-Nog) and Tg(Nphs1-Bmp4) mice shared morphological characteristics with the previously reported podocyte-specific Vegf-A over-expressing and knockout mice, respectively. Consistent with the morphological similarity, in situ hybridization revealed an intense signal for podocyte expression of Vegf in Tg(Nphs1-Nog) mice, whereas the signal was markedly suppressed in Tg(Nphs1-Bmp4) mice. However, in vitro studies with metanephroi failed to demonstrate a direct interaction between BMP4 or Noggin and VEGF in podocytes. Instead, immunostaining showed that phosphorylated Smads, the mediators of BMP signaling, are present in endothelial and/or mesangial cells, but not in podocytes, within the developing glomeruli. Therefore, this study suggests that podocyte-derived BMP plays an important role in glomerular capillary formation, perhaps by acting on non-podocyte glomerular cells in a paracrine fashion.","affiliation":[]},{"pmid":"19224984","pmcid":null,"title":"BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation.","authors":["Retting KN","Song B","Yoon BS","Lyons KM"],"grantIds":["AR44528","R01 AR044528","R01 AR044528-10"],"grantAgencies":["NIAMS NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":9,"month":4,"year":2009,"meshHeadings":["Animals","Bone Morphogenetic Proteins","Cell Differentiation","Cell Proliferation","Cell Survival","Chondrocytes","Chondrogenesis","Extremities","Female","Fibroblast Growth Factors","Hedgehog Proteins","Male","Mice","Mice, Knockout","Mice, Mutant Strains","Osteogenesis","Parathyroid Hormone-Related Protein","Phosphorylation","Signal Transduction","Smad1 Protein","Smad4 Protein","Smad5 Protein","Smad8 Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein (BMP) signaling is required for endochondral bone formation. However, whether or not the effects of BMPs are mediated via canonical Smad pathways or through noncanonical pathways is unknown. In this study we have determined the role of receptor Smads 1, 5 and 8 in chondrogenesis. Deletion of individual Smads results in viable and fertile mice. Combined loss of Smads 1, 5 and 8, however, results in severe chondrodysplasia. Smad1/5(CKO) (cartilage-specific knockout) mutant mice are nearly identical to Smad1/5(CKO);Smad8(-/-) mutants, indicating that Smads 1 and 5 have overlapping functions and are more important than Smad8 in cartilage. The Smad1/5(CKO) phenotype is more severe than that of Smad4(CKO) mice, challenging the dogma, at least in chondrocytes, that Smad4 is required to mediate Smad signaling through BMP pathways. The chondrodysplasia in Smad1/5(CKO) mice is accompanied by imbalances in cross-talk between the BMP, FGF and Ihh/PTHrP pathways. We show that Ihh is a direct target of BMP pathways in chondrocytes, and that FGF exerts antagonistic effects on Ihh expression. Finally, we tested whether FGF exerts its antagonistic effects directly through Smad linker phosphorylation. The results support the alternative conclusion that the effects of FGFs on BMP signaling are indirect in vivo.","affiliation":[]},{"pmid":"19211807","pmcid":null,"title":"Bone morphogenetic protein 2 signals via BMPR1A to regulate murine follicle-stimulating hormone beta subunit transcription.","authors":["Ho CC","Bernard DJ"],"grantIds":["HD047794"],"grantAgencies":["NICHD NIH HHS"],"retractions":[],"journal":"Biology of reproduction","journalShort":"Biol. Reprod.","day":26,"month":7,"year":2009,"meshHeadings":["Animals","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors, Type I","CHO Cells","Cells, Cultured","Cricetinae","Cricetulus","Follicle Stimulating Hormone, beta Subunit","Gene Expression Regulation","Gonadotrophs","Humans","Mice","Mutation, Missense","Signal Transduction","Transcription, Genetic","Transfection"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Follicle-stimulating hormone beta subunit (Fshb) expression is regulated by transforming growth factor beta superfamily ligands. Recently, we demonstrated that bone morphogenetic proteins (BMPs) stimulate Fshb transcription alone and in synergy with activins. Also, transfection of the BMP type II receptor (BMPR2) and constitutively active forms of the type I receptors (activin A receptor type I [ACVR1] or BMP receptor type IA [BMPR1A]) in immortalized gonadotroph cells (LbetaT2) stimulated murine Fshb promoter-reporter activity. A third type I receptor (BMP receptor type IB [BMPR1B]) is also expressed in LbetaT2 cells, but we did not previously assess its functional role. A point mutation in BMPR1B (Q249R) is associated with increased ovulation rates and elevated FSH levels in Booroola (FecB) sheep. Herein, we assessed whether BMPR1B can regulate Fshb transcription in LbetaT2 cells and whether its ability to do so is altered by the Q249R mutation. As with ACVR1 and BMPR1A, coexpression of BMPR1B with BMPR2 increased Fshb promoter-reporter activity in BMP2-dependent and BMP2-independent fashions. Unexpectedly, the BMPR1B-Q249R mutant was equivalent to the wild type in its ability to stimulate SMAD1/5 phosphorylation and Fshb transcription. Pharmacological inhibition of ACVR1, BMPR1A, and BMPR1B confirmed that one or more of these receptors are required for BMP2-stimulated SMAD1/5 phosphorylation and Fshb reporter activity. Knockdown of endogenous BMPR1A, but not ACVR1 or BMPR1B, significantly impaired the synergism of BMP2 with activin A. Collectively, these data suggest that BMPR1A is the preferred BMP2 type I receptor in LbetaT2 cells and that neither ACVR1 nor BMPR1B compensates for its loss. The specific mechanism(s) through which the Booroola FecB mutation alters BMPR1B function remains to be determined.","affiliation":[]},{"pmid":"18614674","pmcid":null,"title":"Bone morphogenetic proteins, eye patterning, and retinocollicular map formation in the mouse.","authors":["Plas DT","Dhande OS","Lopez JE","Murali D","Thaller C","Henkemeyer M","Furuta Y","Overbeek P","Crair MC"],"grantIds":["P30 EY000785","P30 EY000785","P30 EY000785-36","P30 EY000785-367521","P30 EY000785-369006","P30 EY000785-37","P30 EY000785-379006","R01 EY015788","R01 EY015788","R01 EY015788-01A1","R01 EY015788-02","R01 EY015788-03","R01 EY015788-04","R01 EY015788-05","R01 MH62639","R01EY017434"],"grantAgencies":["NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NIMH NIH HHS","NEI NIH HHS"],"retractions":[],"journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","journalShort":"J. Neurosci.","day":9,"month":7,"year":2008,"meshHeadings":["Animals","Animals, Newborn","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Carrier Proteins","Eye","Humans","In Vitro Techniques","Mice","Mice, Transgenic","Mutation","Retina","Superior Colliculi","Transforming Growth Factor beta","Visual Pathways","Xenopus"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Patterning events during early eye formation determine retinal cell fate and can dictate the behavior of retinal ganglion cell (RGC) axons as they navigate toward central brain targets. The temporally and spatially regulated expression of bone morphogenetic proteins (BMPs) and their receptors in the retina are thought to play a key role in this process, initiating gene expression cascades that distinguish different regions of the retina, particularly along the dorsoventral axis. Here, we examine the role of BMP and a potential downstream effector, EphB, in retinotopic map formation in the lateral geniculate nucleus (LGN) and superior colliculus (SC). RGC axon behaviors during retinotopic map formation in wild-type mice are compared with those in several strains of mice with engineered defects of BMP and EphB signaling. Normal RGC axon sorting produces axon order in the optic tract that reflects the dorsoventral position of the parent RGCs in the eye. A dramatic consequence of disrupting BMP signaling is a missorting of RGC axons as they exit the optic chiasm. This sorting is not dependent on EphB. When BMP signaling in the developing eye is genetically modified, RGC order in the optic tract and targeting in the LGN and SC are correspondingly disrupted. These experiments show that BMP signaling regulates dorsoventral RGC cell fate, RGC axon behavior in the ascending optic tract, and retinotopic map formation in the LGN and SC through mechanisms that are in part distinct from EphB signaling in the LGN and SC.","affiliation":[]},{"pmid":"19153163","pmcid":null,"title":"Consequences of axon guidance defects on the development of retinotopic receptive fields in the mouse colliculus.","authors":["Chandrasekaran AR","Furuta Y","Crair MC"],"grantIds":["P30 EY000785","R01 EY015788","R01 EY015788","R01 MH062639"],"grantAgencies":["NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NIMH NIH HHS"],"retractions":[],"journal":"The Journal of physiology","journalShort":"J. Physiol. (Lond.)","day":1,"month":3,"year":2009,"meshHeadings":["Animals","Axons","Bone Morphogenetic Protein Receptors","Mice","Mice, Knockout","Mice, Transgenic","Neurogenesis","Photic Stimulation","Retina","Retinal Ganglion Cells","Superior Colliculi","Visual Fields","Visual Pathways"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Gradients of molecular factors pattern the developing retina and superior colliculus (SC) and guide retinal ganglion cell (RGC) axons to their appropriate central target perinatally. During and subsequent to this period, spontaneous waves of action potentials sweep across the retina, providing an instructive topographic signal based on the correlations of firing patterns of neighbouring RGCs. How these activity-independent and activity-dependent factors interact during retinotopic map formation remains unclear. A typical phenotype of mutant mice lacking genes for one or more RGC axon guidance molecules is the presence of topographically inappropriate projections or 'ectopic spots'. Here, we examine mice that lack functional bone morphogenetic protein receptors (BMPRs) in the retina. Retinal BMP controls the graded expression of RGC axon guidance molecules, resulting in some dorsal RGCs projecting ectopically to locations in the SC that normally receive input from ventral retina. We examine the consequences of this anatomical phenotype in vivo by studying the receptive field (RF) properties of neurons in the superficial SC. We observe a mixture of physiological phenotypes in BMPR mutant mice; notably we find some neurons with ectopic RFs displaced in elevation, corresponding to the observed anatomical defect. However, in a result not necessarily congruent with the presence of focal ectopic projections, some neurons have split, enlarged and patchy/distorted RFs. These results are consistent with the effects of spontaneous retinal waves acting upon a disrupted molecular template, and they place significant limits on the form of an activity-dependent learning rule for the development of retinocollicular projections.","affiliation":[]},{"pmid":"19442313","pmcid":"2685768","title":"Myoblast sensitivity and fibroblast insensitivity to osteogenic conversion by BMP-2 correlates with the expression of Bmpr-1a.","authors":["Liu R","Ginn SL","Lek M","North KN","Alexander IE","Little DG","Schindeler A"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"BMC musculoskeletal disorders","journalShort":"BMC Musculoskelet Disord","day":25,"month":5,"year":2009,"meshHeadings":["Animals","Biological Markers","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Protein Receptors, Type I","Calcification, Physiologic","Cell Differentiation","Cell Lineage","Cell Proliferation","Cells, Cultured","Feedback, Physiological","Fibroblasts","Mice","Mice, Inbred C57BL","MyoD Protein","Myoblasts","NIH 3T3 Cells","Osteogenesis","Stem Cells","Transduction, Genetic","Up-Regulation"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BACKGROUND: Osteoblasts are considered to primarily arise from osseous progenitors within the periosteum or bone marrow. We have speculated that cells from local soft tissues may also take on an osteogenic phenotype. Myoblasts are known to adopt a bone gene program upon treatment with the osteogenic bone morphogenetic proteins (BMP-2,-4,-6,-7,-9), but their osteogenic capacity relative to other progenitor types is unclear. We further hypothesized that the sensitivity of cells to BMP-2 would correlate with BMP receptor expression. METHODS: We directly compared the BMP-2 sensitivity of myoblastic murine cell lines and primary cells with osteoprogenitors from osseous tissues and fibroblasts. Fibroblasts forced to undergo myogenic conversion by transduction with a MyoD-expressing lentiviral vector (LV-MyoD) were also examined. Outcome measures included alkaline phosphatase expression, matrix mineralization, and expression of osteogenic genes (alkaline phosphatase, osteocalcin and bone morphogenetic protein receptor-1A) as measured by quantitative PCR. RESULTS: BMP-2 induced a rapid and robust osteogenic response in myoblasts and osteoprogenitors, but not in fibroblasts. Myoblasts and osteoprogenitors grown in osteogenic media rapidly upregulated Bmpr-1a expression. Chronic BMP-2 treatment resulted in peak Bmpr-1a expression at day 6 before declining, suggestive of a negative feedback mechanism. In contrast, fibroblasts expressed low levels of Bmpr-1a that was only weakly up-regulated by BMP-2 treatment. Bioinformatics analysis confirmed the presence of myogenic responsive elements in the proximal promoter region of human and murine BMPR-1A/Bmpr-1a. Forced myogenic gene expression in fibroblasts was associated with a significant increase in Bmpr-1a expression and a synergistic increase in the osteogenic response to BMP-2. CONCLUSION: These data demonstrate the osteogenic sensitivity of muscle progenitors and provide a mechanistic insight into the variable response of different cell lineages to BMP-2.","affiliation":[]},{"pmid":"19141668","pmcid":null,"title":"Embryonic hair follicle fate change by augmented beta-catenin through Shh and Bmp signaling.","authors":["Suzuki K","Yamaguchi Y","Villacorte M","Mihara K","Akiyama M","Shimizu H","Taketo MM","Nakagata N","Tsukiyama T","Yamaguchi TP","Birchmeier W","Kato S","Yamada G"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":14,"month":2,"year":2009,"meshHeadings":["Animals","Bone Morphogenetic Protein 2","Cell Differentiation","Epidermis","Gene Expression Regulation, Developmental","Hair Follicle","Hedgehog Proteins","Keratinocytes","Keratins, Hair-Specific","Mice","Mice, Mutant Strains","Mutation","Signal Transduction","beta Catenin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"beta-catenin signaling is one of the key factors regulating the fate of hair follicles (HFs). To elucidate the regulatory mechanism of embryonic HF fate determination during epidermal development/differentiation, we analyzed conditional mutant mice with keratinocytes expressing constitutively active beta-catenin (K5-Cre Catnb(ex3)fl/+). The mutant mice developed scaly skin with a thickened epidermis and showed impaired epidermal stratification. The hair shaft keratins were broadly expressed in the epidermis but there was no expression of the terminal differentiation markers K1 and loricrin. Hair placode markers (Bmp2 and Shh) and follicular dermal condensate markers (noggin, patched 1 and Pdgfra) were expressed throughout the epidermis and the upper dermis, respectively. These results indicate that the embryonic epidermal keratinocytes have switched extensively to the HF fate. A series of genetic studies demonstrated that the epidermal switching to HF fate was suppressed by introducing the conditional mutation K5-Cre Catnb(ex3)fl/+Shhfl/- (with additional mutation of Shh signaling) or K5-Cre Catnb(ex3)fl/+BmprIAfl/fl (with additional mutation of Bmp signaling). These results demonstrate that Wnt/beta-catenin signaling relayed through Shh and Bmp signals is the principal regulatory mechanism underlying the HF cell fate change. Assessment of Bmp2 promoter activities suggested a putative regulation by beta-catenin signaling relayed by Shh signaling towards Bmp2. We also found that Shh protein expression was increased and expanded in the epidermis of K5-Cre Catnb(ex3)fl/+BmprIAfl/fl mice. These results indicate the presence of growth factor signal cross-talk involving beta-catenin signaling, which regulates the HF fate.","affiliation":[]},{"pmid":"18799693","pmcid":null,"title":"Large-scale gene trapping in C57BL/6N mouse embryonic stem cells.","authors":["Hansen GM","Markesich DC","Burnett MB","Zhu Q","Dionne KM","Richter LJ","Finnell RH","Sands AT","Zambrowicz BP","Abuin A"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Genome research","journalShort":"Genome Res.","day":3,"month":10,"year":2008,"meshHeadings":["Animals","Blastocyst","Cell Line","Chimera","Clone Cells","Embryo, Mammalian","Embryonic Stem Cells","Introns","Mice","Mice, Inbred C57BL","Mice, Knockout","Mice, Transgenic","MicroRNAs","Mutagenesis, Insertional"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"We report the construction and analysis of a mouse gene trap mutant resource created in the C57BL/6N genetic background containing more than 350,000 sequence-tagged embryonic stem (ES) cell clones. We also demonstrate the ability of these ES cell clones to contribute to the germline and produce knockout mice. Each mutant clone is identified by a genomic sequence tag representing the exact insertion location, allowing accurate prediction of mutagenicity and enabling direct genotyping of mutant alleles. Mutations have been identified in more than 10,000 genes and show a bias toward the first intron. The trapped ES cell lines, which can be requested from the Texas A&M Institute for Genomic Medicine, are readily available to the scientific community.","affiliation":[]},{"pmid":"18974875","pmcid":"2570622","title":"Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.","authors":["Landry J","Sharov AA","Piao Y","Sharova LV","Xiao H","Southon E","Matta J","Tessarollo L","Zhang YE","Ko MS","Kuehn MR","Yamaguchi TP","Wu C"],"grantIds":["N01-CO-12400","Z01 BC010419-08"],"grantAgencies":["NCI NIH HHS","Intramural NIH HHS"],"retractions":[],"journal":"PLoS genetics","journalShort":"PLoS Genet.","day":31,"month":10,"year":2008,"meshHeadings":["Adenosine Triphosphatases","Animals","Antigens, Nuclear","Cell Differentiation","Chromatin Assembly and Disassembly","Chromosomal Proteins, Non-Histone","DNA Helicases","DNA-Binding Proteins","Embryo, Mammalian","Embryonic Development","Embryonic Stem Cells","Endoderm","Left-Right Determination Factors","Mice","Mice, Knockout","Mutation","Nerve Tissue Proteins","Oligonucleotide Array Sequence Analysis","Smad Proteins","Transcription Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"We have characterized the biological functions of the chromatin remodeling protein Bptf (Bromodomain PHD-finger Transcription Factor), the largest subunit of NURF (Nucleosome Remodeling Factor) in a mammal. Bptf mutants manifest growth defects at the post-implantation stage and are reabsorbed by E8.5. Histological analyses of lineage markers show that Bptf(-/-) embryos implant but fail to establish a functional distal visceral endoderm. Microarray analysis at early stages of differentiation has identified Bptf-dependent gene targets including homeobox transcriptions factors and genes essential for the development of ectoderm, mesoderm, and both definitive and visceral endoderm. Differentiation of Bptf(-/-) embryonic stem cell lines into embryoid bodies revealed its requirement for development of mesoderm, endoderm, and ectoderm tissue lineages, and uncovered many genes whose activation or repression are Bptf-dependent. We also provide functional and physical links between the Bptf-containing NURF complex and the Smad transcription factors. These results suggest that Bptf may co-regulate some gene targets of this pathway, which is essential for establishment of the visceral endoderm. We conclude that Bptf likely regulates genes and signaling pathways essential for the development of key tissues of the early mouse embryo.","affiliation":[]},{"pmid":"18594511","pmcid":null,"title":"An Fgf/Gremlin inhibitory feedback loop triggers termination of limb bud outgrowth.","authors":["Verheyden JM","Sun X"],"grantIds":["5T32GM07133","R01 HD045522","R01 HD045522","R01 HD045522-01A1","R01 HD045522-02","R01 HD045522-03","R01 HD045522-04","R01 HD045522-05","R01 HD045522-05S1","T32 GM007133","T32 GM007133-24","T32 GM007133-25","T32 GM007133-26","T32 GM007133-27"],"grantAgencies":["NIGMS NIH HHS","NICHD NIH HHS","NICHD NIH HHS","NICHD NIH HHS","NICHD NIH HHS","NICHD NIH HHS","NICHD NIH HHS","NICHD NIH HHS","NICHD NIH HHS","NIGMS NIH HHS","NIGMS NIH HHS","NIGMS NIH HHS","NIGMS NIH HHS","NIGMS NIH HHS"],"retractions":[],"journal":"Nature","journalShort":"Nature","day":31,"month":7,"year":2008,"meshHeadings":["Animals","Chick Embryo","Feedback, Physiological","Fibroblast Growth Factor 2","Fibroblast Growth Factor 4","Fibroblast Growth Factor 8","Gene Expression Regulation, Developmental","Hedgehog Proteins","Intercellular Signaling Peptides and Proteins","Limb Buds","Mice","Mice, Knockout","Mutation","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"During organ formation and regeneration a proper balance between promoting and restricting growth is critical to achieve stereotypical size. Limb bud outgrowth is driven by signals in a positive feedback loop involving fibroblast growth factor (Fgf) genes, sonic hedgehog (Shh) and Gremlin1 (Grem1). Precise termination of these signals is essential to restrict limb bud size. The current model predicts a sequence of signal termination consistent with that in chick limb buds. Our finding that the sequence in mouse limb buds is different led us to explore alternative mechanisms. Here we show, by analysing compound mouse mutants defective in genes comprising the positive loop, genetic evidence that FGF signalling can repress Grem1 expression, revealing a novel Fgf/Grem1 inhibitory loop. This repression occurs both in mouse and chick limb buds, and is dependent on high FGF activity. These data support a mechanism where the positive Fgf/Shh loop drives outgrowth and an increase in FGF signalling, which triggers the Fgf/Grem1 inhibitory loop. The inhibitory loop then operates to terminate outgrowth signals in the order observed in either mouse or chick limb buds. Our study unveils the concept of a self-promoting and self-terminating circuit that may be used to attain proper tissue size in a broad spectrum of developmental and regenerative settings.","affiliation":[]},{"pmid":"19812316","pmcid":null,"title":"The spatial patterning of mouse cone opsin expression is regulated by bone morphogenetic protein signaling through downstream effector COUP-TF nuclear receptors.","authors":["Satoh S","Tang K","Iida A","Inoue M","Kodama T","Tsai SY","Tsai MJ","Furuta Y","Watanabe S"],"grantIds":["DK045641","EY013128","HL076448","R01 EY013128-08","R01 HL076448","R01 HL076448-05","R37 DK045641","R37 DK045641-17"],"grantAgencies":["NIDDK NIH HHS","NEI NIH HHS","NHLBI NIH HHS","NEI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS"],"retractions":[],"journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","journalShort":"J. Neurosci.","day":7,"month":10,"year":2009,"meshHeadings":["Animals","Body Patterning","Bone Morphogenetic Proteins","COUP Transcription Factors","Cone Opsins","Mice","Mice, Inbred ICR","Mice, Knockout","Rats","Rats, Wistar","Retina","Retinal Cone Photoreceptor Cells","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Cone photopigments, known as opsins, are pivotal elements and the first detection module used in color vision. In mice, cone photoreceptors are distributed throughout the retina, and short-wavelength (S) and medium-wavelength (M) opsins have unique expression patterns in the retina with a gradient along the dorsoventral axis; however, the mechanisms regulating the spatial patterning of cone opsin expression have not been well documented. The purpose of this study was to define the mechanisms regulating the spatial patterning of cone opsin expression. By analyzing knock-outs for bone morphogenetic protein (BMP) signaling, we found an essential role for BMP in forming cone opsin expression patterns in the retina; however, BMP signaling is activated only transiently in the dorsal half of the retina during early retinal development. Thus, BMP is not likely to play a direct role in opsin gene expression, which starts at a later stage of retinal development. We identified the chicken ovalbumin upstream promoter-transcription factor (COUP-TF) nuclear receptor as a link between BMP and opsin expression. BMP signaling is essential for the correct dorsoventral spatial expression of COUP-TFI and COUP-TFII. Through gain- and loss-of-function analyses, we found that both COUP-TFI and COUP-TFII are required to suppress S-opsin expression in the dorsal retina but that only COUP-TFI plays an essential role in suppressing M-opsin expression in the ventral retina. Based on these findings, we propose a new molecular cascade involving BMP and COUP-TFs that conveys dorsoventral information to direct the expression of cone opsins during retinal development.","affiliation":[]},{"pmid":"19272526","pmcid":null,"title":"The expression and crucial roles of BMP signaling in development of smooth muscle progenitor cells in the mouse embryonic gut.","authors":["Torihashi S","Hattori T","Hasegawa H","Kurahashi M","Ogaeri T","Fujimoto T"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Differentiation; research in biological diversity","journalShort":"Differentiation","day":10,"month":3,"year":2009,"meshHeadings":["Animals","Bone Morphogenetic Proteins","Cell Differentiation","Embryo, Mammalian","Gene Expression Regulation, Developmental","Immunohistochemistry","Intestines","Mice","Myocytes, Smooth Muscle","RNA, Messenger","Reverse Transcriptase Polymerase Chain Reaction","Signal Transduction","Stem Cells"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein (BMP) signaling is essential for normal development of the gastrointestinal (GI) tract. BMPs also play multiple roles in vascular smooth muscle cells; however, the BMP signaling in the development of the GI musculature remains to be clarified. We investigated the expression of BMPs and their receptors in mouse embryonic GI tracts by immunohistochemistry and in situ hybridization. We demonstrated that BMP2, BMP receptor Ib and BMP receptor II were expressed in the smooth muscle progenitors from E12 to E13 for the first time. BMP signaling on smooth muscle differentiation was examined by implantation of agarose beads soaked with BMPs in the in vitro developmental model that is gut-like structures from mouse embryonic stem (ES) cells. BMP2 rather than BMP4 beads enhanced smooth muscle differentiation, and increased gut-like structures showing spontaneous contractions and expressing intensive alpha-smooth muscle actin immunoreactivity. This increase was confirmed by up-regulation of SM22 mRNA shown by real-time PCR. By addition of noggin beads or noggin to the medium at BMP2 bead implantation, the ratio of contractive gut-like structures decreased. Implantation of BMP2 beads at EB7 (EB--embryoid bodies) (corresponding to E12 or E13 of mouse embryo) showed the highest effects and up-regulation of transcription factors msx-1 after 24h. This increase was blocked by noggin, and msx-1 decreased to almost the control level after 60 h. BMP2 beads at EB7 increased platelet-derived growth factor-A (PDGF-A) in the differentiating smooth muscle cells. We have recently reported that PDGF-A is expressed in the developing inner circular smooth muscle and is crucial for the longitudinal smooth muscle differentiation. Taken together, BMP signaling was expressed for a short window in the smooth muscle progenitors and the signal, especially BMP2, plays an essential role in smooth muscle differentiation in cooperation with PDGF signaling.","affiliation":[]},{"pmid":"19327734","pmcid":null,"title":"Duplications involving a conserved regulatory element downstream of BMP2 are associated with brachydactyly type A2.","authors":["Dathe K","Kjaer KW","Brehm A","Meinecke P","Nrnberg P","Neto JC","Brunoni D","Tommerup N","Ott CE","Klopocki E","Seemann P","Mundlos S"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"American journal of human genetics","journalShort":"Am. J. Hum. Genet.","day":13,"month":4,"year":2009,"meshHeadings":["Adult","Animals","Base Sequence","Bone Morphogenetic Protein 2","Chromosomes, Human, Pair 20","Comparative Genomic Hybridization","Conserved Sequence","DNA","DNA Primers","Female","Fingers","Gene Duplication","Gene Expression Regulation, Developmental","Humans","Infant","Limb Deformities, Congenital","Male","Mice","Mice, Inbred C57BL","Mice, Transgenic","Pedigree","Phenotype","Regulatory Elements, Transcriptional","Tandem Repeat Sequences"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Autosomal-dominant brachydactyly type A2 (BDA2), a limb malformation characterized by hypoplastic middle phalanges of the second and fifth fingers, has been shown to be due to mutations in the Bone morphogenetic protein receptor 1B (BMPR1B) or in its ligand Growth and differentiation factor 5 (GDF5). A linkage analysis performed in a mutation-negative family identified a novel locus for BDA2 on chromosome 20p12.3 that incorporates the gene for Bone morphogenetic protein 2 (BMP2). No point mutation was identified in BMP2, so a high-density array CGH analysis covering the critical interval of approximately 1.3 Mb was performed. A microduplication of approximately 5.5 kb in a noncoding sequence approximately 110 kb downstream of BMP2 was detected. Screening of other patients by qPCR revealed a similar duplication in a second family. The duplicated region contains evolutionary highly conserved sequences suggestive of a long-range regulator. By using a transgenic mouse model we can show that this sequence is able to drive expression of a X-Gal reporter construct in the limbs. The almost complete overlap with endogenous Bmp2 expression indicates that a limb-specific enhancer of Bmp2 is located within the identified duplication. Our results reveal an additional functional mechanism for the pathogenesis of BDA2, which is duplication of a regulatory element that affects the expression of BMP2 in the developing limb.","affiliation":[]},{"pmid":"19369394","pmcid":null,"title":"FGF-regulated BMP signaling is required for eyelid closure and to specify conjunctival epithelial cell fate.","authors":["Huang J","Dattilo LK","Rajagopal R","Liu Y","Kaartinen V","Mishina Y","Deng CX","Umans L","Zwijsen A","Roberts AB","Beebe DC"],"grantIds":["EY04853","P30 EY02687","R01 EY004853","R01 EY004853-26"],"grantAgencies":["NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":27,"month":5,"year":2009,"meshHeadings":["Animals","Animals, Newborn","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Differentiation","Conjunctiva","Epithelial Cells","Eyelids","Fibroblast Growth Factors","Forkhead Transcription Factors","Hair Follicle","Hedgehog Proteins","JNK Mitogen-Activated Protein Kinases","Mice","Mice, Knockout","Receptor, Fibroblast Growth Factor, Type 2","Signal Transduction","Smad Proteins, Receptor-Regulated","Smad4 Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"There are conflicting reports about whether BMP signaling is required for eyelid closure during fetal development. This question was addressed using mice deficient in BMP or TGFbeta signaling in prospective eyelid and conjunctival epithelial cells. Genes encoding two type I BMP receptors, the type II TGFbeta receptor, two BMP- or two TGFbeta-activated R-Smads or the co-Smad Smad4 were deleted from the ocular surface ectoderm using Cre recombinase. Only mice with deletion of components of the BMP pathway had an 'eyelid open at birth' phenotype. Mice lacking Fgf10 or Fgfr2 also have open eyelids at birth. To better understand the pathways that regulate BMP expression and function during eyelid development, we localized BMPs and BMP signaling intermediates in Fgfr2 and Smad4 conditional knockout (CKO) mice. We found that Fgfr2 was required for the expression of Bmp4, the normal distribution of Shh signaling and for preserving the differentiation of the conjunctival epithelium. FGF signaling also promoted the expression of the Wnt antagonist Sfrp1 and suppressed Wnt signaling in the prospective eyelid epithelial cells, independently of BMP function. Transcripts encoding Foxc1 and Foxc2, which were previously shown to be necessary for eyelid closure, were not detectable in Smad4(CKO) animals. c-Jun, another key regulator of eyelid closure, was present and phosphorylated in eyelid periderm cells at the time of fusion, but failed to translocate to the nucleus in the absence of BMP function. Smad4(CKO) mice also showed premature differentiation of the conjunctival epithelium, conjunctival hyperplasia and the acquisition of epidermal characteristics, including formation of an ectopic row of hair follicles in place of the Meibomian glands. A second row of eyelashes is a feature of human lymphedema-distichiasis syndrome, which is associated with mutations in FOXC2.","affiliation":[]},{"pmid":"19358156","pmcid":null,"title":"Abnormal glucose metabolism in heterozygous mutant mice for a type I receptor required for BMP signaling.","authors":["Scott GJ","Ray MK","Ward T","McCann K","Peddada S","Jiang FX","Mishina Y"],"grantIds":["Z99 ES999999"],"grantAgencies":["Intramural NIH HHS"],"retractions":[],"journal":"Genesis (New York, N.Y. : 2000)","journalShort":"Genesis","day":30,"month":6,"year":2009,"meshHeadings":["Animals","Blood Glucose","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Female","Gene Expression","Glucose","Glucose Tolerance Test","Heterozygote","Insulin","Male","Mice","Mice, Inbred C57BL","Mice, Inbred Strains","Mice, Mutant Strains","Proinsulin","RNA, Messenger","Reverse Transcriptase Polymerase Chain Reaction","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BMPRIA and its high-affinity ligand BMP4 have recently been shown to be expressed in the beta-cells of the pancreas. Here, we report the abnormalities of heterozygous mice for Bmpr1a in glucose metabolism during the course of intraperitoneal glucose tolerance test. The heterozygous mice had increased blood glucose levels throughout the first 2.5 h after the administration of glucose. Analysis of glucose-stimulated insulin secretion (GSIS) indicates that insulin secretion in the heterozygous mice is compromised, and induction of secreted insulin by stimulation is substantially lower compared with the wild-type controls. No apparent abnormalities in pancreas, thyroid, and liver were seen upon histological examination. Real-time PCR results of selected genes showed an increase in the mRNA level of Ins1 and Ins2 in the heterozygous group. These results indicate that the glucose-sensing pathway in these heterozygous mice is altered because of the heterozygosity in Bmpr1a. Together, our data suggest that BMP signaling through BMPRIA plays an important role in glucose metabolism and possibly working through the GSIS pathway.","affiliation":[]},{"pmid":"19592576","pmcid":null,"title":"Differential effects of BMP signaling on parvalbumin and somatostatin interneuron differentiation.","authors":["Mukhopadhyay A","McGuire T","Peng CY","Kessler JA"],"grantIds":["NS 20013","NS 20778","R01 NS020013","R01 NS020013-26","R01 NS020778","R01 NS020778-26"],"grantAgencies":["NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":13,"month":8,"year":2009,"meshHeadings":["Animals","Animals, Newborn","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors, Type I","Cell Differentiation","Cell Movement","Cells, Cultured","Cerebral Cortex","Interneurons","Mice","Models, Biological","Parvalbumins","Signal Transduction","Somatostatin","Stem Cells","Time Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Several different populations of interneurons in the murine cortex, including somatostatin (SST)- or parvalbumin (PV)-expressing cells, are born in the ventral ganglionic eminences during mid-gestation and then migrate tangentially to the cortex. SST is expressed by some interneuron progenitors in the cerebral cortex and in migrating populations in the ventrolateral cortex at birth. However, PV (also known as PVALB) is not expressed by interneurons until the second postnatal week after reaching the cortex, suggesting that molecular cues in the cerebral cortex might be involved in the differentiation process. BMP4 is expressed at high levels in the somatosensory cortex at the time when the PV(+) interneurons differentiate. Treatment of cortical cultures containing interneuron precursors is sufficient to generate PV(+) interneurons prematurely and inhibit SST differentiation. Furthermore, overexpression of BMP4 in vivo increases the number of interneurons expressing PV, with a reduction in the number of SST(+) interneurons. PV(+) interneurons in the cortex express BMP type I receptors and a subpopulation displays activated BMP signaling, assessed by downstream molecules including phosphorylated SMAD1/5/8. Conditional mutation of BMP type I receptors in interneuron precursors significantly reduces the number of cortical PV(+) interneurons in the adult brain. Thus, BMP4 signaling through type I receptors regulates the differentiation of two major medial ganglionic eminence-derived interneuron populations and defines their relative numbers in the cortex.","affiliation":[]},{"pmid":"19726563","pmcid":null,"title":"The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors.","authors":["Lee NY","Kirkbride KC","Sheu RD","Blobe GC"],"grantIds":["R01-CA106307","R01-CA136786"],"grantAgencies":["NCI NIH HHS","NCI NIH HHS"],"retractions":[],"journal":"Molecular biology of the cell","journalShort":"Mol. Biol. Cell","day":15,"month":10,"year":2009,"meshHeadings":["Animals","Arrestins","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","COS Cells","Cell Line","Cell Line, Tumor","Cercopithecus aethiops","Gene Expression Regulation","Humans","Kidney","Mice","Multiprotein Complexes","Protein Interaction Mapping","Protein Structure, Tertiary","Protein Transport","Proteoglycans","Receptors, Transforming Growth Factor beta","Signal Transduction","Structure-Activity Relationship","Subcellular Fractions","Teratocarcinoma"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (BMPs) signal through the BMP type I and type II receptors to regulate cellular processes, including embryonic development. The type I BMP receptors activin-like kinase (ALK)3 and ALK6 share a high degree of homology, yet possess distinct signaling roles. Here, we report that although the transforming growth factor (TGF)-beta type III receptor (TbetaRIII) enhanced both ALK3 and ALK6 signaling, TbetaRIII more potently enhanced ALK6-mediated stimulation of the BMP-responsive promoters XVent2 and 3GC2, and up-regulation of the early response gene Smad6. In contrast, TbetaRIII specifically enhanced ALK3-mediated up-regulation of the early response gene ID-1. TbetaRIII associated with ALK3 primarily through their extracellular domains, whereas its interaction with ALK6 required both the extracellular and cytoplasmic domains. TbetaRIII, along with its interacting scaffolding protein beta-arrestin2, induced the internalization of ALK6. In contrast, TbetaRIII colocalized with and resulted in the cell surface retention of ALK3, independently of beta-arrestin2. Although complex formation between TbetaRIII, ALK6, and beta-arrestin2 and TbetaRIII/ALK6 internalization resulted in maximal BMP signaling, the TbetaRIII mutant unable to interact with beta-arrestin2, TbetaRIII-T841A, was unable to do so. These studies support a novel role for TbetaRIII in mediating differential ALK3 and ALK6 subcellular trafficking resulting in distinct signaling downstream of ALK3 and ALK6.","affiliation":[]},{"pmid":"19717734","pmcid":null,"title":"Outflow tract cushions perform a critical valve-like function in the early embryonic heart requiring BMPRIA-mediated signaling in cardiac neural crest.","authors":["Nomura-Kitabayashi A","Phoon CK","Kishigami S","Rosenthal J","Yamauchi Y","Abe K","Yamamura K","Samtani R","Lo CW","Mishina Y"],"grantIds":["ES071003-10","K08-HL-04414","Z01-HL-005701"],"grantAgencies":["NIEHS NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","Intramural NIH HHS"],"retractions":[],"journal":"American journal of physiology. Heart and circulatory physiology","journalShort":"Am. J. Physiol. Heart Circ. Physiol.","day":27,"month":11,"year":2009,"meshHeadings":["Animals","Arrhythmias, Cardiac","Arteries","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cardiac Output","Cell Movement","Cell Proliferation","Embryo Loss","Genotype","Gestational Age","Heart","Heart Defects, Congenital","Heart Failure","Heart Rate","Heart Valves","Mice","Mice, Inbred C57BL","Mice, Knockout","Microscopy, Acoustic","Myocardial Contraction","Myocardium","Neural Crest","Phenotype","Regional Blood Flow","Signal Transduction","Tomography, X-Ray Computed","Truncus Arteriosus, Persistent","Ultrasonography, Doppler"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Neural crest-specific ablation of BMP type IA receptor (BMPRIA) causes embryonic lethality by embryonic day (E) 12.5, and this was previously postulated to arise from a myocardial defect related to signaling by a small population of cardiac neural crest cells (cNCC) in the epicardium. However, as BMP signaling via cNCC is also required for proper development of the outflow tract cushions, precursors to the semilunar valves, a plausible alternate or additional hypothesis is that heart failure may result from an outflow tract cushion defect. To investigate whether the outflow tract cushions may serve as dynamic valves in regulating hemodynamic function in the early embryo, in this study we used noninvasive ultrasound biomicroscopy-Doppler imaging to quantitatively assess hemodynamic function in mouse embryos with P0-Cre transgene mediated neural crest ablation of Bmpr1a (P0 mutants). Similar to previous studies, the neural crest-deleted Bmpr1a P0 mutants died at approximately E12.5, exhibiting persistent truncus arteriosus, thinned myocardium, and congestive heart failure. Surprisingly, our ultrasound analyses showed normal contractile indices, heart rate, and atrioventricular conduction in the P0 mutants. However, reversed diastolic arterial blood flow was detected as early as E11.5, with cardiovascular insufficiency and death rapidly ensuing by E12.5. Quantitative computed tomography showed thinning of the outflow cushions, and this was associated with a marked reduction in cell proliferation. These results suggest BMP signaling to cNCC is required for growth of the outflow tract cushions. This study provides definitive evidence that the outflow cushions perform a valve-like function critical for survival of the early mouse embryo.","affiliation":[]},{"pmid":"19393343","pmcid":null,"title":"BMP and BMP receptor expression during murine organogenesis.","authors":["Danesh SM","Villasenor A","Chong D","Soukup C","Cleaver O"],"grantIds":["R01 DK079862","R01 DK079862-01","R01 DK079862-01"],"grantAgencies":["NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS"],"retractions":[],"journal":"Gene expression patterns : GEP","journalShort":"Gene Expr. Patterns","day":3,"month":6,"year":2009,"meshHeadings":["Animals","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein 7","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Protein Receptors, Type II","Bone Morphogenetic Proteins","Carrier Proteins","Embryo, Mammalian","Female","Gene Expression Profiling","Gene Expression Regulation, Developmental","Heart","In Situ Hybridization","Liver","Lung","Mice","Organogenesis","Pregnancy","Time Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Cell-cell communication is critical for regulating embryonic organ growth and differentiation. The Bone Morphogenetic Protein (BMP) family of transforming growth factor beta (TGFbeta) molecules represents one class of such cell-cell signaling molecules that regulate the morphogenesis of several organs. Due to high redundancy between the myriad BMP ligands and receptors in certain tissues, it has been challenging to address the role of BMP signaling using targeting of single Bmp genes in mouse models. Here, we present a detailed study of the developmental expression profiles of three BMP ligands (Bmp2, Bmp4, Bmp7) and three BMP receptors (Bmpr1a, Bmpr1b, and BmprII), as well as their molecular antagonist (noggin), in the early embryo during the initial steps of murine organogenesis. In particular, we focus on the expression of Bmp family members in the first organs and tissues that take shape during embryogenesis, such as the heart, vascular system, lungs, liver, stomach, nervous system, somites and limbs. Using in situ hybridization, we identify domains where ligand(s) and receptor(s) are either singly or co-expressed in specific tissues. In addition, we identify a previously unnoticed asymmetric expression of Bmp4 in the gut mesogastrium, which initiates just prior to gut turning and the establishment of organ asymmetry in the gastrointestinal tract. Our studies will aid in the future design and/or interpretation of targeted deletion of individual Bmp or Bmpr genes, since this study identifies organs and tissues where redundant BMP signaling pathways are likely to occur.","affiliation":[]},{"pmid":"19416967","pmcid":null,"title":"SUMO interaction motifs in Sizn1 are required for promyelocytic leukemia protein nuclear body localization and for transcriptional activation.","authors":["Cho G","Lim Y","Golden JA"],"grantIds":["NS45034","R01 NS045034","R01 NS046616"],"grantAgencies":["NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"The Journal of biological chemistry","journalShort":"J. Biol. Chem.","day":17,"month":7,"year":2009,"meshHeadings":["Animals","Binding Sites","Blotting, Western","Cell Line","Glutathione Transferase","Green Fluorescent Proteins","Humans","Immunohistochemistry","Intranuclear Inclusion Bodies","Leukemia, Promyelocytic, Acute","Luciferases","Microscopy, Fluorescence","Mutation","Nuclear Proteins","Recombinant Fusion Proteins","SUMO-1 Protein","Smad1 Protein","Transcription Factors","Transcriptional Activation","Transfection","Zinc Fingers"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Mutations in Sizn1 (Zcchc12), a novel transcriptional co-activator in the BMP signaling pathway, are associated with X-linked mental retardation. Previously, we demonstrated that Sizn1 positively modulates the BMP signal by interacting with Smad family members and cAMP-responsive element-binding protein-binding protein. To further define the molecular basis of Sizn1 function, we have explored its subcellular localization and generated various deletion mutants to carry out domain analyses. Here, we report that Sizn1 localizes to promyelocytic leukemia protein nuclear bodies (PML-NBs). Sizn1 deletion mutants that disrupt the MA homologous domain or the middle region fail to target to the PML-NB. We show that two SUMO interaction motifs (SIMs) in Sizn1 can bind to SUMO and govern SUMO conjugation to Sizn1 in the absence of the consensus motif for SUMO attachment. Interestingly, the SIM mutant Sizn1 localizes to nuclear bodies, but not to PML-NBs. Thus, SIMs mediate the localization of Sizn1 to PML-NB. Interestingly, mutations in SIM sequences and deletion of the MA homologous domain also affected the transcriptional co-activation function of a Sizn1. Taken together, our data indicate that the SIMs in Sizn1 are required for its PML-NB localization and for the full transcriptional co-activation function in BMP signaling.","affiliation":[]},{"pmid":"19804412","pmcid":null,"title":"The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding.","authors":["Hauburger A","von Einem S","Schwaerzer GK","Buttstedt A","Zebisch M","Schrml M","Hortschansky P","Knaus P","Schwarz E"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"The FEBS journal","journalShort":"FEBS J.","day":14,"month":11,"year":2009,"meshHeadings":["Alkaline Phosphatase","Animals","Binding, Competitive","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Protein Receptors, Type II","COS Cells","Cell Line","Cercopithecus aethiops","Mice","Phosphorylation","Protein Precursors","Signal Transduction","Smad Proteins","p38 Mitogen-Activated Protein Kinases"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Pro-forms of growth factors have received increasing attention since it was shown that they can affect both the maturation and functions of mature growth factors. Here, we assessed the biological function of the pro-form of bone morphogenetic protein-2 (BMP-2), a member of the transforming growth factor beta (TGFbeta)/BMP superfamily. The role of the 263 amino acids of the pro-peptide is currently unclear. In order to obtain an insight into the function of the pro-form (proBMP-2), the ability of proBMP-2 to induce alkaline phosphatase (AP), a marker enzyme for cells differentiating into osteoblasts, was tested. Interestingly, in contrast to mature BMP-2, proBMP-2 did not lead to induction of AP. Instead, proBMP-2 inhibited the induction of AP by BMP-2. This result raised the question of whether proBMP-2 may compete with mature BMP-2 for receptor binding. ProBMP-2 was found to bind to the purified extracellular ligand binding domain (ECD) of BMPR-IA, a high-affinity receptor for mature BMP-2, with a similar affinity as mature BMP-2. Binding of proBMP-2 to BMPR-IA was confirmed in cell culture by cross-linking proBMP-2 to BMPR-IA presented on the cell surface. In contrast to this finding, proBMP-2 did not bind to the ECD of BMPR-II. ProBMP-2 also differed from BMP-2 in its capacity to induce p38 and Smad phosphorylation. The data presented here suggest that the pro-domain of BMP-2 can alter the signalling properties of the growth factor by modulating the ability of the mature part to interact with the receptors.","affiliation":[]},{"pmid":"21194568","pmcid":null,"title":"Transcription factors expressed in olfactory bulb local progenitor cells revealed by genome-wide transcriptome profiling.","authors":["Campbell GR","Baudhuin A","Vranizan K","Ngai J"],"grantIds":["R01 DC007235","R01 DC007235-04S1","R01 DC007235-05"],"grantAgencies":["NIDCD NIH HHS","NIDCD NIH HHS","NIDCD NIH HHS"],"retractions":[],"journal":"Molecular and cellular neurosciences","journalShort":"Mol. Cell. Neurosci.","day":28,"month":2,"year":2011,"meshHeadings":["Animals","Cell Differentiation","Cluster Analysis","Gene Expression Profiling","Genome-Wide Association Study","In Situ Hybridization","Mice","Neural Stem Cells","Olfactory Bulb","Olfactory Receptor Neurons","Transcription Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The local progenitor population in the olfactory bulb (OB) gives rise to mitral and tufted projection neurons during embryonic development. In contrast, OB interneurons are derived from sources outside the bulb where neurogenesis continues throughout life. While many of the genes involved in OB interneuron development have been characterized, the genetic pathways driving local progenitor cell differentiation in this tissue are largely unknown. To better understand this process, we used transcriptional profiling to monitor gene expression of whole OB at daily intervals from embryonic day 11 through birth, generating a compendium of gene expression encompassing the major developmental events of this tissue. Through hierarchical clustering, bioinformatics analysis, and validation by RNA in situ hybridizations, we identified a large number of transcription factors, DNA binding proteins, and cell cycle-related genes expressed by the local neural progenitor cells (NPCs) of the embryonic OB. Further in silico analysis of transcription factor binding sites identified an enrichment of genes regulated by the E2F-Rb pathway among those expressed in the local NPC population. Together these results provide initial insights into the molecular identity of the OB local NPC population and the transcription factor networks that may regulate their function.","affiliation":[]},{"pmid":"19793887","pmcid":null,"title":"BMP signaling regulates sympathetic nervous system development through Smad4-dependent and -independent pathways.","authors":["Morikawa Y","Zehir A","Maska E","Deng C","Schneider MD","Mishina Y","Cserjesi P"],"grantIds":["R01-NS015547"],"grantAgencies":["NINDS NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":12,"month":11,"year":2009,"meshHeadings":["Bone Morphogenetic Proteins","Cell Survival","Embryo, Mammalian","Neurogenesis","Norepinephrine","Signal Transduction","Smad4 Protein","Sympathetic Nervous System"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Induction of the sympathetic nervous system (SNS) from its neural crest (NC) precursors is dependent on BMP signaling from the dorsal aorta. To determine the roles of BMP signaling and the pathways involved in SNS development, we conditionally knocked out components of the BMP pathways. To determine if BMP signaling is a cell-autonomous requirement of SNS development, the Alk3 (BMP receptor IA) was deleted in the NC lineage. The loss of Alk3 does not prevent NC cell migration, but the cells die immediately after reaching the dorsal aorta. The paired homeodomain factor Phox2b, known to be essential for survival of SNS precursors, is downregulated, suggesting that Phox2b is a target of BMP signaling. To determine if Alk3 signals through the canonical BMP pathway, Smad4 was deleted in the NC lineage. Loss of Smad4 does not affect neurogenesis and ganglia formation; however, proliferation and noradrenergic differentiation are reduced. Analysis of transcription factors regulating SNS development shows that the basic helix-loop-helix factor Ascl1 is downregulated by loss of Smad4 and that Ascl1 regulates SNS proliferation but not noradrenergic differentiation. To determine if the BMP-activated Tak1 (Map3k7) pathway plays a role in SNS development, Tak1 was deleted in the NC lineage. We show that Tak1 is not involved in SNS development. Taken together, our results suggest multiple roles for BMP signaling during SNS development. The Smad4-independent pathway acts through the activation of Phox2b to regulate survival of SNS precursors, whereas the Smad4-dependent pathway controls noradrenergic differentiation and regulates proliferation by maintaining Ascl1 expression.","affiliation":[]},{"pmid":"20059955","pmcid":null,"title":"Bone ridge patterning during musculoskeletal assembly is mediated through SCX regulation of Bmp4 at the tendon-skeleton junction.","authors":["Blitz E","Viukov S","Sharir A","Shwartz Y","Galloway JL","Pryce BA","Johnson RL","Tabin CJ","Schweitzer R","Zelzer E"],"grantIds":["F32HD057701","P01 DK056246","P01 DK056246-10","P01 DK56246","R01 AR055640"],"grantAgencies":["NICHD NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIAMS NIH HHS"],"retractions":[],"journal":"Developmental cell","journalShort":"Dev. Cell","day":11,"month":12,"year":2009,"meshHeadings":["Animals","Basic Helix-Loop-Helix Transcription Factors","Bone Morphogenetic Protein 4","Embryo, Mammalian","Gene Expression Regulation, Developmental","Mice","Osteogenesis","Tendons"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"During the assembly of the musculoskeletal system, bone ridges provide a stable anchoring point and stress dissipation for the attachment of muscles via tendons to the skeleton. In this study, we investigate the development of the deltoid tuberosity as a model for bone ridge formation. We show that the deltoid tuberosity develops through endochondral ossification in a two-phase process: initiation is regulated by a signal from the tendons, whereas the subsequent growth phase is muscle dependent. We then show that the transcription factor scleraxis (SCX) regulates Bmp4 in tendon cells at their insertion site. The inhibition of deltoid tuberosity formation and several other bone ridges in embryos in which Bmp4 expression was blocked specifically in Scx-expressing cells implicates BMP4 as a key mediator of tendon effects on bone ridge formation. This study establishes a mechanistic basis for tendon-skeleton regulatory interactions during musculoskeletal assembly and bone secondary patterning.","affiliation":[]},{"pmid":"23103586","pmcid":null,"title":"BMP-binding protein twisted gastrulation is required in mammary gland epithelium for normal ductal elongation and myoepithelial compartmentalization.","authors":["Forsman CL","Ng BC","Heinze RK","Kuo C","Sergi C","Gopalakrishnan R","Yee D","Graf D","Schwertfeger KL","Petryk A"],"grantIds":["R01 DE016601","R01DE016601"],"grantAgencies":["NIDCR NIH HHS","NIDCR NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":1,"month":1,"year":2013,"meshHeadings":["Animals","Apoptosis","Blotting, Western","Bone Morphogenetic Proteins","Bromodeoxyuridine","Cell Line","Cell Proliferation","Epithelium","Female","Galactosides","Gene Expression Regulation, Developmental","Gene Knock-In Techniques","Hematoxylin","Immunohistochemistry","Indoles","Mammary Glands, Animal","Mice","Mice, Knockout","Proteins","Real-Time Polymerase Chain Reaction","Reverse Transcriptase Polymerase Chain Reaction","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (BMPs) are involved in embryonic mammary gland (MG) development and can be dysregulated in breast cancer. However, the role BMPs play in the postnatal MG remains virtually unknown. BMPs are potent morphogens that are involved in cell fate determination, proliferation, apoptosis and adult tissue homeostasis. Twisted gastrulation (TWSG1) is a secreted BMP binding protein that modulates BMP ligand availability in the extracellular space. Here we investigate the consequences of TWSG1 deletion on development of the postnatal MG. At puberty, Twsg1 is expressed in the myoepithelium and in a subset of body cells of the terminal end buds. In the mature duct, Twsg1 expression is primarily restricted to the myoepithelial layer. Global deletion of Twsg1 leads to a delay in ductal elongation, reduced secondary branching, enlarged terminal end buds, and occluded lumens. This is associated with an increase in luminal epithelial cell number and a decrease in apoptosis. In the MG, pSMAD1/5/8 level and the expression of BMP target genes are reduced, consistent with a decrease in BMP signaling. GATA-3, which is required for luminal identity, is reduced in Twsg1(-/-) MGs, which may explain why K14 positive cells, which are normally restricted to the myoepithelial layer, are found within the luminal compartment and shed into the lumen. In summary, regulation of BMP signaling by TWSG1 is required for normal ductal elongation, branching of the ductal tree, lumen formation, and myoepithelial compartmentalization in the postnatal MG.","affiliation":[]},{"pmid":"19793892","pmcid":null,"title":"Talin 1 and 2 are required for myoblast fusion, sarcomere assembly and the maintenance of myotendinous junctions.","authors":["Conti FJ","Monkley SJ","Wood MR","Critchley DR","Mller U"],"grantIds":["MH078833","NS046456"],"grantAgencies":["NIMH NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":12,"month":11,"year":2009,"meshHeadings":["Animals","Cell Fusion","Cytoskeleton","Integrins","Mice","Mice, Knockout","Muscle, Skeletal","Muscular Diseases","Sarcomeres","Talin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Talin 1 and 2 connect integrins to the actin cytoskeleton and regulate the affinity of integrins for ligands. In skeletal muscle, talin 1 regulates the stability of myotendinous junctions (MTJs), but the function of talin 2 in skeletal muscle is not known. Here we show that MTJ integrity is affected in talin 2-deficient mice. Concomitant ablation of talin 1 and 2 leads to defects in myoblast fusion and sarcomere assembly, resembling defects in muscle lacking beta1 integrins. Talin 1/2-deficient myoblasts express functionally active beta1 integrins, suggesting that defects in muscle development are not primarily caused by defects in ligand binding, but rather by disruptions of the interaction of integrins with the cytoskeleton. Consistent with this finding, assembly of integrin adhesion complexes is perturbed in the remaining muscle fibers of talin 1/2-deficient mice. We conclude that talin 1 and 2 are crucial for skeletal muscle development, where they regulate myoblast fusion, sarcomere assembly and the maintenance of MTJs.","affiliation":[]},{"pmid":"20211162","pmcid":null,"title":"Bmpr1a is required for proper migration of the AVE through regulation of Dkk1 expression in the pre-streak mouse embryo.","authors":["Miura S","Singh AP","Mishina Y"],"grantIds":["ES071003-11","Z01 ES071003-11"],"grantAgencies":["NIEHS NIH HHS","Intramural NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":1,"month":5,"year":2010,"meshHeadings":["Animals","Body Patterning","Bone Morphogenetic Protein Receptors, Type I","Embryo, Mammalian","Endoderm","Intercellular Signaling Peptides and Proteins","Mice","Wnt Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Here, we report a novel mechanism regulating migration of the anterior visceral endoderm (AVE) by BMP signaling through BMPRIA. In Bmpr1a-deficient (Bmpr-null) embryos, the AVE does not migrate at all. In embryos with an epiblast-specific deletion of Bmpr1a (Bmpr1a(null/flox); Sox2Cre embryos), the AVE cells migrate randomly from the distal end of embryos, resulting in an expansion of the AVE. Dkk1, which is normally expressed in the anterior proximal visceral endoderm (PxVE), is downregulated in Bmpr-null embryos, whereas it is circumferentially expressed in Bmpr1a(null/flox); Sox2Cre embryos at E5.75-6.5. These results demonstrate an association of the position of Dkk1 expressing cells with direction of the migration of AVE. In Bmpr1a(null/flox); Sox2Cre embryos, a drastic decrease of WNT signaling is observed at E6.0. Addition of WNT3A to the culture of Bmpr1a(null/flox); Sox2Cre embryos at E5.5 restores expression patterns of Dkk1 and Cer1. These data indicate that BMP signaling in the epiblast induces Wnt3 and Wnt3a expression to maintain WNT signaling in the VE, resulting in downregulation of Dkk1 to establish the anterior expression domain. Thus, our results suggest that BMP signaling regulates the expression patterns of Dkk1 for anterior migration of the AVE.","affiliation":[]},{"pmid":"20130285","pmcid":null,"title":"Regulation of retinal progenitor cell differentiation by bone morphogenetic protein 4 is mediated by the smad/id cascade.","authors":["Du Y","Xiao Q","Yip HK"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Investigative ophthalmology & visual science","journalShort":"Invest. Ophthalmol. Vis. Sci.","day":23,"month":7,"year":2010,"meshHeadings":["Animals","Animals, Newborn","Blotting, Western","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors, Type I","Cell Death","Cell Differentiation","Cell Proliferation","Female","Fluorescent Antibody Technique, Indirect","Inhibitor of Differentiation Proteins","Mice","Mice, Inbred ICR","Phosphorylation","Pregnancy","RNA, Messenger","Retinal Ganglion Cells","Reverse Transcriptase Polymerase Chain Reaction","Smad Proteins","Stem Cells"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"PURPOSE. Bone morphogenetic proteins (BMPs) are secreted signaling molecules that are implicated in the control of multiple events during mouse eye development. However, little is known about the mechanisms by which BMP signaling regulates these retinal developmental processes. METHODS. Real-time PCR, Western blot, and immunohistochemistry were used to investigate the expression of components of BMP signaling in the mouse retina. Retinal progenitor cells (RPCs) were used to study the effects of BMP4 on retinal cell differentiation and regulation of Id protein expression. RESULTS. Results showed that BMP2, -4, and -7; BMP receptor (BMPRIb) mRNAs; and proteins and downstream signaling molecule Smad1/5/8 proteins were all highly expressed in the mouse retina during the embryonic (E13.5-E18.5) and early postnatal (P)1 stage and that the expression was downregulated in the adult. On stimulation with BMP4, cultured mouse RPCs differentiated into neuronal lineage whereas astrocyte cell differentiation was inhibited. BMP4 mainly stimulated production of retinal ganglion cells (RGCs). Results also revealed that BMPs and BMPRIb were co-localized with inhibitors of differentiation (Id) (mainly Id1 and -3) in RGCs in the adult mouse retina. Exposure of RPCs to BMP4 upregulated Id1-3 expression levels, mediated through the phosphorylation of Smad1/5/8 proteins. CONCLUSIONS. These results suggest that Id genes are one of the potential targets of BMP signaling in the differentiation of RPCs.","affiliation":[]},{"pmid":"20522595","pmcid":"2911072","title":"Mesenchymal bone morphogenetic protein signaling is required for normal pancreas development.","authors":["Ahnfelt-Rnne J","Ravassard P","Pardanaud-Glavieux C","Scharfmann R","Serup P"],"grantIds":["U19 DK072495"],"grantAgencies":["NIDDK NIH HHS"],"retractions":[],"journal":"Diabetes","journalShort":"Diabetes","day":29,"month":8,"year":2010,"meshHeadings":["Animals","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein 5","Bone Morphogenetic Proteins","Cell Differentiation","Chick Embryo","Embryo, Mammalian","Mesenteric Veins","Mesoderm","Mice","Neovascularization, Physiologic","Pancreas","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"OBJECTIVE: Pancreas organogenesis is orchestrated by interactions between the epithelium and the mesenchyme, but these interactions are not completely understood. Here we investigated a role for bone morphogenetic protein (BMP) signaling within the pancreas mesenchyme and found it to be required for the normal development of the mesenchyme as well as for the pancreatic epithelium. RESEARCH DESIGN AND METHODS: We analyzed active BMP signaling by immunostaining for phospho-Smad1,5,8 and tested whether pancreas development was affected by BMP inhibition after expression of Noggin and dominant negative BMP receptors in chicken and mouse pancreas. RESULTS: Endogenous BMP signaling is confined to the mesenchyme in the early pancreas and inhibition of BMP signaling results in severe pancreatic hypoplasia with reduced epithelial branching. Notably, we also observed an excessive endocrine differentiation when mesenchymal BMP signaling is blocked, presumably secondary to defective mesenchyme to epithelium signaling. CONCLUSIONS: We conclude that BMP signaling plays a previously unsuspected role in the mesenchyme, required for normal development of the mesenchyme as well as for the epithelium.","affiliation":[]},{"pmid":"20130193","pmcid":null,"title":"BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury.","authors":["Sahni V","Mukhopadhyay A","Tysseling V","Hebert A","Birch D","Mcguire TL","Stupp SI","Kessler JA"],"grantIds":["NS20013","R01 NS020013","R01 NS020013-25A2","R01 NS020013-26","R01 NS020013-27","R01 NS020778","R01 NS020778-25","R01 NS020778-26","R01 NS20778"],"grantAgencies":["NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","journalShort":"J. Neurosci.","day":3,"month":2,"year":2010,"meshHeadings":["Animals","Astrocytes","Axons","Bone Morphogenetic Protein Receptors, Type I","Cells, Cultured","Female","Gliosis","Hyperplasia","Mice","Mice, Knockout","Mice, Transgenic","MicroRNAs","STAT3 Transcription Factor","Smad Proteins","Spinal Cord Injuries","Up-Regulation"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Astrogliosis following spinal cord injury (SCI) involves an early hypertrophic response that is beneficial and a subsequent formation of a dense scar. We investigated the role of bone morphogenetic protein (BMP) signaling in gliosis after SCI and find that BMPR1a and BMPR1b signaling exerts opposing effects on hypertrophy. Conditional ablation of BMPR1a from glial fibrillary acidic protein (GFAP)-expressing cells leads to defective astrocytic hypertrophy, increased infiltration by inflammatory cells, and reduced axon density. BMPR1b-null mice conversely develop \"hyperactive\" reactive astrocytes and consequently have smaller lesion volumes. The effects of ablation of either receptor are reversed in the double knock-out animals. These findings indicate that BMPR1a and BMPR1b exert directly opposing effects on the initial reactive astrocytic hypertrophy. Also, BMPR1b knock-out mice have an attenuated glial scar in the chronic stages following injury, suggesting that it has a greater role in glial scar progression. To elucidate the differing roles of the two receptors in astrocytes, we examined the effects of ablation of either receptor in serum-derived astrocytes in vitro. We find that the two receptors exert opposing effects on the posttranscriptional regulation of astrocytic microRNA-21. Further, overexpression of microRNA-21 in wild-type serum-derived astrocytes causes a dramatic reduction in cell size accompanied by reduction in GFAP levels. Hence, regulation of microRNA-21 by BMP signaling provides a novel mechanism for regulation of astrocytic size. Targeting specific BMPR subunits for therapeutic purposes may thus provide an approach for manipulating gliosis and enhancing functional outcomes after SCI.","affiliation":[]},{"pmid":"19733164","pmcid":null,"title":"The type I BMP receptors, Bmpr1a and Acvr1, activate multiple signaling pathways to regulate lens formation.","authors":["Rajagopal R","Huang J","Dattilo LK","Kaartinen V","Mishina Y","Deng CX","Umans L","Zwijsen A","Roberts AB","Beebe DC"],"grantIds":["5R01DE013085","5R01HL074862","EY02687","EY04853","R01 EY004853","R01 EY004853-26"],"grantAgencies":["NIDCR NIH HHS","NHLBI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":15,"month":11,"year":2009,"meshHeadings":["Activin Receptors, Type I","Animals","Bone Morphogenetic Protein Receptors, Type I","Cell Proliferation","Cell Survival","Lens, Crystalline","Mice","Mice, Transgenic","Signal Transduction","Smad Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BMPs play multiple roles in development and BMP signaling is essential for lens formation. However, the mechanisms by which BMP receptors function in vertebrate development are incompletely understood. To determine the downstream effectors of BMP signaling and their functions in the ectoderm that will form the lens, we deleted the genes encoding the type I BMP receptors, Bmpr1a and Acvr1, and the canonical transducers of BMP signaling, Smad4, Smad1 and Smad5. Bmpr1a and Acvr1 regulated cell survival and proliferation, respectively. Absence of both receptors interfered with the expression of proteins involved in normal lens development and prevented lens formation, demonstrating that BMPs induce lens formation by acting directly on the prospective lens ectoderm. Remarkably, the canonical Smad signaling pathway was not needed for most of these processes. Lens formation, placode cell proliferation, the expression of FoxE3, a lens-specific transcription factor, and the lens protein, alphaA-crystallin were regulated by BMP receptors in a Smad-independent manner. Placode cell survival was promoted by R-Smad signaling, but in a manner that did not involve Smad4. Of the responses tested, only maintaining a high level of Sox2 protein, a transcription factor expressed early in placode formation, required the canonical Smad pathway. A key function of Smad-independent BMP receptor signaling may be reorganization of actin cytoskeleton to drive lens invagination.","affiliation":[]},{"pmid":"20406889","pmcid":null,"title":"BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo.","authors":["Suzuki Y","Ohga N","Morishita Y","Hida K","Miyazono K","Watabe T"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Journal of cell science","journalShort":"J. Cell. Sci.","day":15,"month":5,"year":2010,"meshHeadings":["Activin Receptors, Type II","Adenocarcinoma","Allantois","Animals","Blood Vessels","Cell Line, Tumor","Cell Proliferation","Embryo, Mammalian","Endothelial Cells","Gene Expression Regulation, Developmental","Growth Differentiation Factor 2","Humans","Mice","Mice, Inbred BALB C","Mice, Inbred ICR","Neoplasm Transplantation","Neovascularization, Physiologic","Pancreatic Neoplasms","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Members of the bone morphogenetic protein (BMP) family have been implicated in the development and maintenance of vascular systems. Whereas members of the BMP-2/4 and osteogenic protein-1 groups signal via activin receptor-like kinase (ALK)-2, ALK-3 and ALK-6, BMP-9 and BMP-10 have been reported to bind to ALK-1 in endothelial cells. However, the roles of BMP-9-ALK-1 signaling in the regulation of endothelial cells have not yet been fully elucidated. Here, using various systems, we examined the effects of BMP-9 on the proliferation of endothelial cells. Vascular-tube formation from ex vivo allantoic explants of mouse embryos was promoted by BMP-9. BMP-9, as well as BMP-4 and BMP-6, also induced the proliferation of in-vitro-cultured mouse embryonic-stem-cell-derived endothelial cells (MESECs) by inducing the expression of vascular endothelial growth factor receptor 2 and Tie2, a receptor for angiopoietin-1. A decrease in ALK-1 expression or expression of constitutively active ALK-1 in MESECs abrogated and mimicked the effects of BMP-9 on the proliferation of MESECs, respectively, suggesting that BMP-9 promotes the proliferation of these cells via ALK-1. Furthermore, in vivo angiogenesis was promoted by BMP-9 in a Matrigel plug assay and in a BxPC3 xenograft model of human pancreatic cancer. Consistent with these in vivo findings, BMP-9 enhanced the proliferation of in-vitro-cultured normal endothelial cells from dermal tissues of adult mice and of tumor-associated endothelial cells isolated from tumor xenografts in host mice. These findings suggest that BMP-9 signaling activates the endothelium tested in the present study via ALK-1.","affiliation":[]},{"pmid":"21185278","pmcid":null,"title":"Bmpr1a signaling plays critical roles in palatal shelf growth and palatal bone formation.","authors":["Baek JA","Lan Y","Liu H","Maltby KM","Mishina Y","Jiang R"],"grantIds":["R01 DE013681","R01 DE013681-09","R01 DE013681-10","R01 DE013681-11","R01 DE015207","R01 DE015207-06","R01 DE015207-07","R01DE013681","R01DE015207"],"grantAgencies":["NIDCR NIH HHS","NIDCR NIH HHS","NIDCR NIH HHS","NIDCR NIH HHS","NIDCR NIH HHS","NIDCR NIH HHS","NIDCR NIH HHS","NIDCR NIH HHS","NIDCR NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":15,"month":2,"year":2011,"meshHeadings":["Animals","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors, Type I","Cell Differentiation","Female","Hedgehog Proteins","Male","Mice","Osteoblasts","Osteogenesis","Palate","RNA, Messenger","Signal Transduction","Transcription Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Cleft palate, including submucous cleft palate, is among the most common birth defects in humans. While overt cleft palate results from defects in growth or fusion of the developing palatal shelves, submucous cleft palate is characterized by defects in palatal bones. In this report, we show that the Bmpr1a gene, encoding a type I receptor for bone morphogenetic proteins (Bmp), is preferentially expressed in the primary palate and anterior secondary palate during palatal outgrowth. Following palatal fusion, Bmpr1a mRNA expression was upregulated in the condensed mesenchyme progenitors of palatal bone. Tissue-specific inactivation of Bmpr1a in the developing palatal mesenchyme in mice caused reduced cell proliferation in the primary and anterior secondary palate, resulting in partial cleft of the anterior palate at birth. Expression of Msx1 and Fgf10 was downregulated in the anterior palate mesenchyme and expression of Shh was downregulated in the anterior palatal epithelium in the Bmpr1a conditional mutant embryos, indicating that Bmp signaling regulates mesenchymal-epithelial interactions during palatal outgrowth. In addition, formation of the palatal processes of the maxilla was blocked while formation of the palatal processes of the palatine was significantly delayed, resulting in submucous cleft of the hard palate in the mutant mice. Our data indicate that Bmp signaling plays critical roles in the regulation of palatal mesenchyme condensation and osteoblast differentiation during palatal bone formation.","affiliation":[]},{"pmid":"20445055","pmcid":null,"title":"Bone morphogenetic protein signaling in the developing telencephalon controls formation of the hippocampal dentate gyrus and modifies fear-related behavior.","authors":["Caronia G","Wilcoxon J","Feldman P","Grove EA"],"grantIds":["R37 H059962","R37 MH059962","R37 MH059962-13"],"grantAgencies":["PHS HHS","NIMH NIH HHS","NIMH NIH HHS"],"retractions":[],"journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","journalShort":"J. Neurosci.","day":5,"month":5,"year":2010,"meshHeadings":["Animals","Animals, Newborn","Behavior, Animal","Bone Morphogenetic Protein 1","Dentate Gyrus","Fear","Gene Expression Regulation, Developmental","Maze Learning","Mice","Mice, Knockout","Mossy Fibers, Hippocampal","Neurogenesis","Signal Transduction","Telencephalon","Wnt Proteins","Wnt3 Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The cortical hem is an embryonic signaling center that generates bone morphogenetic proteins (BMPs) and acts as an organizer for the hippocampus. The role of BMP signaling in hippocampal neurogenesis, however, has not been established. We therefore generated mice that were deficient in Bmpr1b constitutively, and deficient in Bmpr1a conditionally in the dorsal telencephalon. In double mutant male and female mice, the dentate gyrus (DG) was dramatically smaller than in control mice, reflecting decreased production of granule neurons at the peak period of DG neurogenesis. Additionally, the pool of cells that generates new DG neurons throughout life was reduced, commensurate with the smaller size of the DG. Effects of diminished BMP signaling on the cortical hem were at least partly responsible for these defects in DG development. Reduction of the DG and its major extrinsic output to CA3 raised the possibility that the DG was functionally compromised. We therefore looked for behavioral deficits in double mutants and found that the mice were less responsive to fear- or anxiety-provoking stimuli, whether the association of the stimulus with fear or anxiety was learned or innate. Given that no anatomical defects appeared in the double mutant telencephalon outside the DG, our observations support a growing literature that implicates the hippocampus in circuitry mediating fear and anxiety. Our results additionally indicate a requirement for BMP signaling in generating the dorsalmost neuronal lineage of the telencephalon, DG granule neurons, and in the development of the stem cell niche that makes neurons in the adult hippocampus.","affiliation":[]},{"pmid":"20392740","pmcid":null,"title":"Opposing Fgf and Bmp activities regulate the specification of olfactory sensory and respiratory epithelial cell fates.","authors":["Maier E","von Hofsten J","Nord H","Fernandes M","Paek H","Hbert JM","Gunhaga L"],"grantIds":["070596"],"grantAgencies":["PHS HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":30,"month":5,"year":2010,"meshHeadings":["Animals","Bone Morphogenetic Proteins","CHO Cells","Cell Differentiation","Cells, Cultured","Chick Embryo","Cricetinae","Cricetulus","Drug Antagonism","Embryo, Mammalian","Embryo, Nonmammalian","Fibroblast Growth Factors","Gene Expression Regulation, Developmental","Mice","Models, Biological","Olfactory Mucosa","Olfactory Pathways","Quail","Respiratory Mucosa","Sensory Receptor Cells","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The olfactory sensory epithelium and the respiratory epithelium are derived from the olfactory placode. However, the molecular mechanisms regulating the differential specification of the sensory and the respiratory epithelium have remained undefined. To address this issue, we first identified Msx1/2 and Id3 as markers for respiratory epithelial cells by performing quail chick transplantation studies. Next, we established chick explant and intact chick embryo assays of sensory/respiratory epithelial cell differentiation and analyzed two mice mutants deleted of Bmpr1a;Bmpr1b or Fgfr1;Fgfr2 in the olfactory placode. In this study, we provide evidence that in both chick and mouse, Bmp signals promote respiratory epithelial character, whereas Fgf signals are required for the generation of sensory epithelial cells. Moreover, olfactory placodal cells can switch between sensory and respiratory epithelial cell fates in response to Fgf and Bmp activity, respectively. Our results provide evidence that Fgf activity suppresses and restricts the ability of Bmp signals to induce respiratory cell fate in the nasal epithelium. In addition, we show that in both chick and mouse the lack of Bmp or Fgf activity results in disturbed placodal invagination; however, the fate of cells in the remaining olfactory epithelium is independent of morphological movements related to invagination. In summary, we present a conserved mechanism in amniotes in which Bmp and Fgf signals act in an opposing manner to regulate the respiratory versus sensory epithelial cell fate decision.","affiliation":[]},{"pmid":"20417197","pmcid":null,"title":"BMP signaling controls formation of a primordial germ cell niche within the early genital ridges.","authors":["Dudley B","Palumbo C","Nalepka J","Molyneaux K"],"grantIds":["1S10RR017980","1S10RR021228","R01 HD053900","R01 HD053900-05","R01HD053900"],"grantAgencies":["NCRR NIH HHS","NCRR NIH HHS","NICHD NIH HHS","NICHD NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":1,"month":7,"year":2010,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Cell Differentiation","Cell Movement","Embryo, Mammalian","Germ Cells","Mice","Mice, Knockout","PAX2 Transcription Factor","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Stem cells are necessary to maintain tissue homeostasis and the microenvironment (a.k.a. the niche) surrounding these cells controls their ability to self-renew or differentiate. For many stem cell populations it remains unclear precisely what cells and signals comprise a niche. Here we identify a possible PGC niche in the mouse genital ridges. Conditional ablation of Bmpr1a was used to demonstrate that BMP signaling is required for PGC survival and migration as these cells colonize the genital ridges. Reduced BMP signaling within the genital ridges led to increased somatic cell death within the mesonephric mesenchyme. Loss of these supporting cells correlated with decreased levels of the mesonephric marker, Pax2, as well as a reduction in genes expressed in the coelomic epithelium including the putative PGC chemo-attractants Kitl and Sdf1a. We propose that BMP signaling promotes mesonephric cell survival within the genital ridges and that these cells support correct development of the coelomic epithelium, the target of PGC migration. Loss of BMP signaling leads to the loss of the PGC target resulting in reduced PGC numbers and disrupted PGC migration.","affiliation":[]},{"pmid":"20534673","pmcid":null,"title":"N-cadherin can structurally substitute for E-cadherin during intestinal development but leads to polyp formation.","authors":["Libusova L","Stemmler MP","Hierholzer A","Schwarz H","Kemler R"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":23,"month":7,"year":2010,"meshHeadings":["Animals","Cadherins","DNA, Complementary","Epithelial Cells","Intestinal Mucosa","Mice","Mice, Transgenic","Polyps","Signal Transduction","beta Catenin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"We conditionally substituted E-cadherin (E-cad; cadherin 1) with N-cadherin (N-cad; cadherin 2) during intestine development by generating mice in which an Ncad cDNA was knocked into the Ecad locus. Mutant mice were born, demonstrating that N-cad can structurally replace E-cad and establish proper organ architecture. After birth, mutant mice gradually developed a mutant phenotype in both the small and large intestine and died at ~2-3 weeks of age, probably due to malnutrition during the transition to solid food. Molecular analysis revealed an extended domain of cells from the crypt into the villus region, with nuclear localization of beta-catenin (beta-cat; Ctnnb1) and enhanced expression of several beta-cat target genes. In addition, the BMP signaling pathway was suppressed in the intestinal epithelium of the villi, suggesting that N-cad might interfere with BMP signaling in the intestinal epithelial cell layer. Interestingly, mutant mice developed severe dysplasia and clusters of cells with neoplastic features scattered along the crypt-villus axis in the small and large intestine. Our experimental model indicates that, in the absence of E-cad, the sole expression of N-cad in an epithelial environment is sufficient to induce neoplastic transformations.","affiliation":[]},{"pmid":"20413717","pmcid":null,"title":"Inducible activation of Cre recombinase in adult mice causes gastric epithelial atrophy, metaplasia, and regenerative changes in the absence of \"floxed\" alleles.","authors":["Huh WJ","Mysorekar IU","Mills JC"],"grantIds":["K99-DK080643","R01 DK-079798-01","R01 DK079798","R01 DK079798-01A2","R01 DK079798-02"],"grantAgencies":["NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS"],"retractions":[],"journal":"American journal of physiology. Gastrointestinal and liver physiology","journalShort":"Am. J. Physiol. Gastrointest. Liver Physiol.","day":29,"month":8,"year":2010,"meshHeadings":["Alleles","Animals","Apoptosis","Atrophy","Bone Morphogenetic Protein Receptors, Type I","DNA Damage","Dose-Response Relationship, Drug","Enzyme Activation","Gastric Mucosa","Gene Deletion","Gene Expression","Hyperplasia","Integrases","Metaplasia","Mice","Mice, Knockout","Mice, Transgenic","Phenotype","Regeneration","Tamoxifen","Transgenes"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The epithelium of the mammalian gastric body comprises multiple cell types replenished by a single stem cell. The adult conformation of cell lineages occurs well after birth; hence, study of genes regulating stem cell activity is facilitated by inducible systems for gene deletion. However, there is a potential pitfall involving the commonly used inducible Cre recombinase system to delete genes: we report here that induction of Cre using standard doses of tamoxifen led to marked spasmolytic polypeptide-expressing metaplasia of the stomach within days and profound atrophy of the entire epithelium with foci of hyperplasia by 2 wk even in the absence of loxP-flanked alleles. Cre induction caused genotoxicity with TdT-mediated dUTP nick-end labeling (TUNEL)-positive apoptosis (TUNEL-positive cells) and increased levels of DNA damage markers (gammaH2AX, p53, DDIT3, GADD45A). Although Cre was expressed globally by use of a chicken actin promoter, the effects were almost entirely stomach specific. Despite severe injury, a subset of mice showed near complete healing of the gastric mucosa 11-12 wk after Cre induction, suggesting substantial gastric regenerative capacity. Finally, we show that nongenotoxic doses of tamoxifen could be used to specifically delete loxP-flanked Bmpr1a, the receptor for bone morphogenetic protein 2, 4, and 7, causing antral polyps and marked antral-pyloric hyperplasia, consistent with previous reports on Bmpr1a. Together, the results show dose-dependent, potentially reversible sensitivity of the gastric mucosa to Cre genotoxicity. Thus we propose that tamoxifen induction of Cre could be used to induce genotoxic injury to study the regenerative capacity of the gastric epithelial stem cell.","affiliation":[]},{"pmid":"20493948","pmcid":null,"title":"Bmp5/7 in concert with the mid-hindbrain organizer control development of noradrenergic locus coeruleus neurons.","authors":["Tilleman H","Hakim V","Novikov O","Liser K","Nashelsky L","Di Salvio M","Krauthammer M","Scheffner O","Maor I","Mayseless O","Meir I","Kayam G","Sela-Donenfeld D","Simeone A","Brodski C"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Molecular and cellular neurosciences","journalShort":"Mol. Cell. Neurosci.","day":26,"month":9,"year":2010,"meshHeadings":["Animals","Apoptosis","Bone Morphogenetic Protein 5","Bone Morphogenetic Protein 7","Fibroblast Growth Factor 8","Homeodomain Proteins","Locus Coeruleus","Mesencephalon","Mice","Mice, Knockout","Neurons","Norepinephrine","Otx Transcription Factors","Rhombencephalon","Stem Cells"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The locus coeruleus (LC) which is the major noradrenergic nucleus in the brain develops under the influence of Bmps secreted by the roof plate and Fgf8 emitted from the mid-hindbrain organizer. We studied the development of the LC in different Bmp mouse mutants and report the absence of this nucleus in Bmp5(-/-);Bmp7(-/-) double knockouts. Notably, genes marking organizers and neuronal populations adjacent to the LC precursor field are unperturbed in Bmp5(-/-);Bmp7(-/-) animals. In addition, we found that in En1(+/Otx2) mutants in which the caudal Otx2 expression domain and thereby the mid-hindbrain organizer are shifted caudally, LC neurons are concomitantly reduced along with Bmp5/7. Complementing these results, Otx1(-/-);Otx2(+/-) mutants, in which the mid-hinbrain organizer is shifted rostrally, show a rostrally extended Bmp5 expression area and an increase in LC neurons. Taken together, our data indicate that LC development requires either Bmp5 or Bmp7, and one is able to compensate for the loss of the other. In addition, we conclude that the position of the mid-hindbrain organizer determines the size of the LC and propose that Bmp5/7 play an important role in mediating this organizer function.","affiliation":[]},{"pmid":"20621052","pmcid":null,"title":"Signaling through BMPR-IA regulates quiescence and long-term activity of neural stem cells in the adult hippocampus.","authors":["Mira H","Andreu Z","Suh H","Lie DC","Jessberger S","Consiglio A","San Emeterio J","Hortigela R","Marqus-Torrejn MA","Nakashima K","Colak D","Gtz M","Farias I","Gage FH"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Cell stem cell","journalShort":"Cell Stem Cell","day":2,"month":7,"year":2010,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Carrier Proteins","Cell Cycle","Cell Line","Cells, Cultured","Flow Cytometry","Genetic Vectors","Hippocampus","Humans","Lentivirus","Mice","Models, Biological","Neurons","Rats","Rats, Inbred F344","Reverse Transcriptase Polymerase Chain Reaction","Signal Transduction","Smad4 Protein","Stem Cells"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Neural stem cells (NSCs) in the adult hippocampus divide infrequently, and the molecules that modulate their quiescence are largely unknown. Here, we show that bone morphogenetic protein (BMP) signaling is active in hippocampal NSCs, downstream of BMPR-IA. BMPs reversibly diminish proliferation of cultured NSCs while maintaining their undifferentiated state. In vivo, acute blockade of BMP signaling in the hippocampus by intracerebral infusion of Noggin first recruits quiescent NSCs into the cycle and increases neurogenesis; subsequently, it leads to decreased stem cell division and depletion of precursors and newborn neurons. Consistently, selective ablation of Bmpr1a in hippocampal NSCs, or inactivation of BMP canonical signaling in conditional Smad4 knockout mice, transiently enhances proliferation but later leads to a reduced number of precursors, thereby limiting neuronal birth. BMPs are therefore required to balance NSC quiescence/proliferation and to prevent loss of the stem cell activity that supports continuous neurogenesis in the mature hippocampus.","affiliation":[]},{"pmid":"20363875","pmcid":null,"title":"Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development.","authors":["Edson MA","Nalam RL","Clementi C","Franco HL","Demayo FJ","Lyons KM","Pangas SA","Matzuk MM"],"grantIds":["AR44528","HD32067","R01 AR044528","R01 HD032067","T32GM07730","T32HD007165","U54 HD28934"],"grantAgencies":["NIAMS NIH HHS","NICHD NIH HHS","NIAMS NIH HHS","NICHD NIH HHS","NIGMS NIH HHS","NICHD NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"Molecular endocrinology (Baltimore, Md.)","journalShort":"Mol. Endocrinol.","day":26,"month":6,"year":2010,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cumulus Cells","Estrous Cycle","Female","Fertility","Gene Expression Regulation, Neoplastic","Granulosa Cells","Hedgehog Proteins","Hormones","Mice","Mice, Knockout","Ovarian Neoplasms","Precancerous Conditions","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (BMPs) have diverse roles in development and reproduction. Although several BMPs are produced by oocytes, thecal cells, and granulosa cells of developing follicles, the in vivo functions of most of these ligands are unknown. BMP signals are transduced by multiple type I and type II TGFbeta family receptors, and of the type I receptors, BMP receptor 1A (BMPR1A) and BMP receptor 1B (BMPR1B) are known to be expressed in rodent granulosa cells. Female mice homozygous null for Bmpr1b are sterile due to compromised cumulus expansion, but the function of BMPR1A in the ovary is unknown. To further decipher a role for BMP signaling in mouse granulosa cells, we deleted Bmpr1a in the granulosa cells of the ovary and found Bmpr1a conditional knockout females to be subfertile with reduced spontaneous ovulation. To explore the redundant functions of BMP receptor signaling in the ovary, we generated Bmpr1a Bmpr1b double-mutant mice, which developed granulosa cell tumors that have evidence of increased TGFbeta and hedgehog signaling. Thus, similar to SMAD1 and SMAD5, which have redundant roles in suppressing granulosa cell tumor development in mice, two type I BMP receptors, BMPR1A and BMPR1B, function together to prevent ovarian tumorigenesis. These studies support a role for a functional BMP signaling axis as a tumor suppressor pathway in the ovary, with BMPR1A and BMPR1B acting downstream of BMP ligands and upstream of BMP receptor SMADs.","affiliation":[]},{"pmid":"20837004","pmcid":null,"title":"BMP/SMAD signaling regulates the cell behaviors that drive the initial dorsal-specific regional morphogenesis of the otocyst.","authors":["Ohta S","Mansour SL","Schoenwolf GC"],"grantIds":["DC004185","R01 DC004185-10","R01 DC011819"],"grantAgencies":["NIDCD NIH HHS","NIDCD NIH HHS","NIDCD NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":15,"month":11,"year":2010,"meshHeadings":["Animals","Base Sequence","Body Patterning","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Proteins","Cadherins","Cell Proliferation","Cell Shape","DNA Primers","Ear, Inner","Female","Gene Expression Regulation, Developmental","Guinea Pigs","Mice","Morphogenesis","Pregnancy","Signal Transduction","Smad Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"During development of the otocyst, regional morphogenesis establishes a dorsal vestibular chamber and a ventral auditory chamber, which collectively constitute the membranous labyrinth of the inner ear. We identified the earliest morphogenetic event heralding the formation of the vestibular chamber, a rapid thinning and expansion of the dorsolateral wall of the otocyst, and showed that this process is generated by changes in otocyst cell shape from columnar to squamous, as opposed to changes in other cell behaviors, such as localized changes in cell proliferation or cell death. Moreover, we showed that thinning and expansion of the dorsolateral otocyst is regulated by BMP/SMAD signaling, which is both sufficient and necessary for localized thinning and expansion. Finally, we showed that BMP/SMAD signaling causes fragmentation of E-cadherin in the dorsolateral otocyst, occurring concomitantly with cell shape change, suggesting that BMP/SMAD signaling regulates cell-cell adhesion during the initial morphogenesis of the otocyst epithelium. Collectively, our results show that BMP signaling via SMADs regulates the cell behaviors that drive the initial dorsal-specific morphogenesis of the otocyst, providing new information about how regional morphogenesis of a complex organ rudiment, the developing membranous labyrinth, is initiated.","affiliation":[]},{"pmid":"21034733","pmcid":null,"title":"BmprIa is required in mesenchymal tissue and has limited redundant function with BmprIb in tooth and palate development.","authors":["Li L","Lin M","Wang Y","Cserjesi P","Chen Z","Chen Y"],"grantIds":["R01 DE014044","R01 DE014044-09","R01DE14044"],"grantAgencies":["NIDCR NIH HHS","NIDCR NIH HHS","NIDCR NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":15,"month":1,"year":2011,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Gene Silencing","Histological Techniques","In Situ Hybridization","In Situ Nick-End Labeling","Mesoderm","Mice","Neural Crest","Palate, Hard","Signal Transduction","Tooth"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The BMP signaling plays a pivotal role in the development of craniofacial organs, including the tooth and palate. BmprIa and BmprIb encode two type I BMP receptors that are primarily responsible for BMP signaling transduction. We investigated mesenchymal tissue-specific requirement of BmprIa and its functional redundancy with BmprIb during the development of mouse tooth and palate. BmprIa and BmprIb exhibit partially overlapping and distinct expression patterns in the developing tooth and palatal shelf. Neural crest-specific inactivation of BmprIa leads to formation of an unusual type of anterior clefting of the secondary palate, an arrest of tooth development at the bud/early cap stages, and severe hypoplasia of the mandible. Defective tooth and palate development is accompanied by the down-regulation of BMP-responsive genes and reduced cell proliferation levels in the palatal and dental mesenchyme. To determine if BmprIb could substitute for BmprIa during tooth and palate development, we expressed a constitutively active form of BmprIb (caBmprIb) in the neural crest cells in which BmprIa was simultaneously inactivated. We found that substitution of BmprIa by caBmprIb in neural rest cells rescues the development of molars and maxillary incisor, but the rescued teeth exhibit a delayed odontoblast and ameloblast differentiation. In contrast, caBmprIb fails to rescue the palatal and mandibular defects including the lack of lower incisors. Our results demonstrate an essential role for BmprIa in the mesenchymal component and a limited functional redundancy between BmprIa and BmprIb in a tissue-specific manner during tooth and palate development.","affiliation":[]},{"pmid":"21068310","pmcid":null,"title":"BMP signaling is necessary for patterning the sensory and nonsensory regions of the developing mammalian cochlea.","authors":["Ohyama T","Basch ML","Mishina Y","Lyons KM","Segil N","Groves AK"],"grantIds":["DC006185","DC006276","R01 AR044528","R01 DC004189","R01 DC006185","R01 DC006185-06"],"grantAgencies":["NIDCD NIH HHS","NIDCD NIH HHS","NIAMS NIH HHS","NIDCD NIH HHS","NIDCD NIH HHS","NIDCD NIH HHS"],"retractions":[],"journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","journalShort":"J. Neurosci.","day":10,"month":11,"year":2010,"meshHeadings":["Animals","Bone Morphogenetic Proteins","Cochlea","Hair Cells, Auditory","Immunohistochemistry","In Situ Hybridization","Mice","Mice, Transgenic","Organ Culture Techniques","Reverse Transcriptase Polymerase Chain Reaction","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The mammalian inner ear detects sound with the organ of Corti, an intricately patterned region of the cochlea in which one row of inner hair cells and three rows of outer hair cells are surrounded by specialized supporting cells. The organ of Corti derives from a prosensory domain that runs the length of the cochlear duct and is bounded by two nonsensory domains, Klliker's organ on the neural side and the outer sulcus on the abneural side. Although much progress has been made in identifying the signals regulating organ of Corti induction and differentiation, less is known about the mechanisms that establish sensory and nonsensory territories in the cochlear duct. Here, we show that a gradient of bone morphogenetic protein (BMP) signaling is established in the abneural-neural axis of the cochlea. Analysis of compound mutants of Alk3/6 type I BMP receptors shows that BMP signaling is necessary for specification of the prosensory domain destined to form the organ of Corti. Reduction of BMP signaling in Alk3/6 compound mutants eliminates both the future outer sulcus and the prosensory domain, with all cells expressing markers of Klliker's organ. BMP4 upregulates markers of the future outer sulcus and downregulates marker genes of Klliker's organ in cochlear organ cultures in a dose-dependent manner. Our results suggest BMP signaling is required for patterning sensory and nonsensory tissue in the mammalian cochlea.","affiliation":[]},{"pmid":"20875817","pmcid":null,"title":"DCC is specifically required for the survival of retinal ganglion and displaced amacrine cells in the developing mouse retina.","authors":["Shi M","Zheng MH","Liu ZR","Hu ZL","Huang Y","Chen JY","Zhao G","Han H","Ding YQ"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":1,"month":12,"year":2010,"meshHeadings":["Amacrine Cells","Animals","Apoptosis","Cell Survival","Eye Abnormalities","Eye Proteins","Gene Expression Regulation, Developmental","Genes, DCC","Mice","Mice, Knockout","Mice, Mutant Strains","Neurogenesis","Protein Structure, Tertiary","RNA, Messenger","Receptors, Cell Surface","Retina","Retinal Ganglion Cells","Sequence Deletion","Tumor Suppressor Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Netrin-1 and DCC are well known for their roles in neurite growth, axonal guidance, and neuronal migration. Recently, a number of studies showed that DCC is involved in the induction of apoptosis, and this proapoptotic activity can be blocked in the presence of Netrin-1. However, here, we found that DCC is required for the survival of two types of neurons selectively in the developing mouse retina where DCC is abundantly expressed. Our results showed that the DCC(-/-) retina displayed a reduced ganglion cell layer with relatively normal neuroblastic layer. Immunostaining assays revealed that in DCC(-/-) mice, initial neurogenesis within retina was unchanged while the numbers of differentiated retinal ganglion cells and displaced amacrine cells in ganglion cell layer were greatly reduced due to increased apoptosis. By contrast, other neuronal types including horizontal cells, bipolar cells, amacrine cells, photoreceptors, and Mller cells appeared normal in DCC mutant retinas. Moreover, DCC(kanga) mice that lack the intracellular P3 domain of DCC receptor displayed the same defects as DCC(-/-) mice. Thus, our findings suggest that DCC is a key regulator for the survival of specific types of neurons during retinal development and that DCC-P3 domain is essential for this developing event.","affiliation":[]},{"pmid":"21056086","pmcid":null,"title":"Mechanisms of bone morphogenetic protein 2 (BMP2) stimulated inhibitor of DNA binding 3 (Id3) transcription.","authors":["Ho CC","Zhou X","Mishina Y","Bernard DJ"],"grantIds":["MOP-86626","R01 DE020843"],"grantAgencies":["Canadian Institutes of Health Research","NIDCR NIH HHS"],"retractions":[],"journal":"Molecular and cellular endocrinology","journalShort":"Mol. Cell. Endocrinol.","day":30,"month":1,"year":2011,"meshHeadings":["Animals","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors, Type I","CHO Cells","Cell Line","Cricetinae","Cricetulus","Humans","Inhibitor of Differentiation Protein 2","Inhibitor of Differentiation Proteins","Male","Mice","Mice, Transgenic","Neoplasm Proteins","Promoter Regions, Genetic","RNA, Small Interfering","Signal Transduction","Smad1 Protein","Smad5 Protein","Transcription, Genetic"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein 2 (BMP2) stimulates expression of the inhibitors of DNA binding (Id) 1, 2, and 3 in a variety of cell types. Here, we examined mechanisms mediating BMP2-stimulated Id3 transcription in murine gonadotropes. Using a combination of quantitative RT-PCR, promoter-reporter analyses, over-expression, and RNA interference approaches, we demonstrate that BMP2 signals via the BMPR2 and BMPR1A (ALK3) receptors and intracellular signaling proteins SMADs 1 and 5 to stimulate Id3 transcription. We further define a novel 6-bp cis-element mediating BMP2- and SMAD-dependent transcription, though this site does not appear to bind SMADs directly. A specific DNA binding protein complex binds to this element, but its constituent protein(s) remain undetermined. Recently, a more distal enhancer was shown to mediate BMP4-induction of the human ID3 gene in ovarian cancer cells. This enhancer is conserved in the murine gene and we demonstrate its role in BMP2-induced Id3 promoter activity in gonadotropes. Conversely, the proximal cis-element defined here is also conserved in human ID3 and we demonstrate its functional role in BMP2-induction of ID3 transcription. Finally, we show that the two regulatory elements also mediate BMP2-induction of Id3 promoter activity in murine fibroblasts. Collectively, we have defined a general mechanism whereby BMP2 regulates Id3/ID3 transcription in different cell types and in different species.","affiliation":[]},{"pmid":"21084449","pmcid":null,"title":"FOXL2 and BMP2 act cooperatively to regulate follistatin gene expression during ovarian development.","authors":["Kashimada K","Pelosi E","Chen H","Schlessinger D","Wilhelm D","Koopman P"],"grantIds":[],"grantAgencies":["Intramural NIH HHS"],"retractions":[],"journal":"Endocrinology","journalShort":"Endocrinology","day":24,"month":1,"year":2011,"meshHeadings":["Animals","Bone Morphogenetic Protein 2","Cell Line, Tumor","Female","Fetal Development","Follistatin","Forkhead Transcription Factors","Gene Expression Regulation, Developmental","Genetic Markers","Mice","Ovary"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Follistatin is a secreted glycoprotein required for female sex determination and early ovarian development, but the precise mechanisms regulating follistatin (Fst) gene expression are not known. Here, we investigate the roles of bone morphogenetic protein 2 (BMP2) and forkhead-domain transcription factor L2 (FOXL2) in the regulation of Fst expression in the developing mouse ovary. Bmp2 and Fst showed similar temporal profiles of mRNA expression, whereas FOXL2 protein and Fst mRNA were coexpressed in the same ovarian cells. In a cell culture model, both FOXL2 and BMP2 up-regulated Fst expression. In ex vivo mouse fetal gonad culture, exogenous BMP2 increased Fst expression, but this effect was counteracted by the BMP antagonist Noggin. Moreover, in Foxl2-null mice, Fst expression was reduced throughout fetal ovarian development, and Bmp2 expression was also reduced. Our data support a model in which FOXL2 and BMP2 cooperate to ensure correct expression of Fst in the developing ovary. Further, Wnt4-knockout mice showed reduced expression of Fst limited to early ovarian development, suggesting a role for WNT4 in the initiation, but not the maintenance, of Fst expression.","affiliation":[]},{"pmid":"20724449","pmcid":null,"title":"Inhibition of Wnt signaling by Wise (Sostdc1) and negative feedback from Shh controls tooth number and patterning.","authors":["Ahn Y","Sanderson BW","Klein OD","Krumlauf R"],"grantIds":["R00 DE022059","R01 DE021420"],"grantAgencies":["NIDCR NIH HHS","NIDCR NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":8,"month":10,"year":2010,"meshHeadings":["Animals","Body Patterning","Bone Morphogenetic Proteins","Fibroblast Growth Factors","Gene Expression Regulation, Developmental","Hedgehog Proteins","Humans","LDL-Receptor Related Proteins","Low Density Lipoprotein Receptor-Related Protein-5","Low Density Lipoprotein Receptor-Related Protein-6","Mice","Mice, Transgenic","Signal Transduction","Tooth","Wnt Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Mice carrying mutations in Wise (Sostdc1) display defects in many aspects of tooth development, including tooth number, size and cusp pattern. To understand the basis of these defects, we have investigated the pathways modulated by Wise in tooth development. We present evidence that, in tooth development, Wise suppresses survival of the diastema or incisor vestigial buds by serving as an inhibitor of Lrp5- and Lrp6-dependent Wnt signaling. Reducing the dosage of the Wnt co-receptor genes Lrp5 and Lrp6 rescues the Wise-null tooth phenotypes. Inactivation of Wise leads to elevated Wnt signaling and, as a consequence, vestigial tooth buds in the normally toothless diastema region display increased proliferation and continuous development to form supernumerary teeth. Conversely, gain-of-function studies show that ectopic Wise reduces Wnt signaling and tooth number. Our analyses demonstrate that the Fgf and Shh pathways are major downstream targets of Wise-regulated Wnt signaling. Furthermore, our experiments revealed that Shh acts as a negative-feedback regulator of Wnt signaling and thus determines the fate of the vestigial buds and later tooth patterning. These data provide insight into the mechanisms that control Wnt signaling in tooth development and into how crosstalk among signaling pathways controls tooth number and morphogenesis.","affiliation":[]},{"pmid":"20689554","pmcid":null,"title":"BMP signalling permits population expansion by preventing premature myogenic differentiation in muscle satellite cells.","authors":["Ono Y","Calhabeu F","Morgan JE","Katagiri T","Amthor H","Zammit PS"],"grantIds":["084241","G0601943"],"grantAgencies":["Wellcome Trust","Medical Research Council","Medical Research Council","Wellcome Trust"],"retractions":[],"journal":"Cell death and differentiation","journalShort":"Cell Death Differ.","day":10,"month":2,"year":2011,"meshHeadings":["Animals","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Carrier Proteins","Cell Differentiation","Cell Proliferation","Mice","Phosphorylation","Pyrazoles","Pyrimidines","RNA Interference","RNA, Small Interfering","Recombinant Proteins","Satellite Cells, Skeletal Muscle","Signal Transduction","Smad Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Satellite cells are the resident stem cells of adult skeletal muscle, supplying myonuclei for homoeostasis, hypertrophy and repair. In this study, we have examined the role of bone morphogenetic protein (BMP) signalling in regulating satellite cell function. Activated satellite cells expressed BMP receptor type 1A (BMPR-1A/Alk-3) and contained phosphorylated Smad proteins, indicating that BMP signalling is operating during proliferation. Indeed, exogenous BMP4 stimulated satellite cell division and inhibited myogenic differentiation. Conversely, interfering with the interactions between BMPs and their receptors by the addition of either the BMP antagonist Noggin or soluble BMPR-1A fragments, induced precocious differentiation. Similarly, blockade of BMP signalling by siRNA-mediated knockdown of BMPR-1A, disruption of the intracellular pathway by either Smad5 or Smad4 knockdown or inhibition of Smad1/5/8 phosphorylation with Dorsomorphin, also caused premature myogenic differentiation. BMP signalling acted to inhibit the upregulation of genes associated with differentiation, in part, through regulating Id1. As satellite cells differentiated, Noggin levels increased to antagonise BMP signalling, since Noggin knockdown enhanced proliferation and impeded myoblast fusion into large multinucleated myotubes. Finally, interference of normal BMP signalling after muscle damage in vivo perturbed the regenerative process, and resulted in smaller regenerated myofibres. In conclusion, BMP signalling operates during routine satellite cell function to help coordinate the balance between proliferation and differentiation, before Noggin is activated to antagonise BMPs and facilitate terminal differentiation.","affiliation":[]},{"pmid":"20554972","pmcid":null,"title":"Vegf regulates embryonic erythroid development through Gata1 modulation.","authors":["Drogat B","Kalucka J","Gutirrez L","Hammad H","Goossens S","Farhang Ghahremani M","Bartunkova S","Haigh K","Deswarte K","Nyabi O","Naessens M","Ferrara N","Klingmller U","Lambrecht BN","Nagy A","Philipsen S","Haigh JJ"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Blood","journalShort":"Blood","day":23,"month":9,"year":2010,"meshHeadings":["Cell Differentiation","Cell Line","Cell Lineage","Down-Regulation","Erythroid Cells","Erythropoiesis","GATA1 Transcription Factor","GATA2 Transcription Factor","RNA, Messenger","Transgenes","Vascular Endothelial Growth Factor A"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"To determine the role of vascular endothelial growth factor (Vegf) in embryonic erythroid development we have deleted or overexpressed Vegf specifically in the erythroid lineage using the EpoR-iCre transgenic line in combination with Cre/loxP conditional gain and loss of function Vegf alleles. ROSA26 promoter-based expression of the Vegf(164) isoform in the early erythroid lineage resulted in a differentiation block of primitive erythroid progenitor (EryP) development and a partial block in definitive erythropoiesis between the erythroid burst-forming unit and erythroid colony-forming unit stages. Decreased mRNA expression levels of the key erythroid transcription factor Gata1 were causally linked to this phenotype. Conditional deletion of Vegf within the erythroid lineage was associated with increased Gata1 levels and increased erythroid differentiation. Expression of a ROSA26-based GATA2 transgene rescued Gata1 mRNA levels and target genes and restored erythroid differentiation in our Vegf gain of function model. These results demonstrate that Vegf modulates Gata1 expression levels in vivo and provides new molecular insight into Vegf's ability to modulate erythropoiesis.","affiliation":[]},{"pmid":"23077214","pmcid":null,"title":"22q11 Gene dosage establishes an adaptive range for sonic hedgehog and retinoic acid signaling during early development.","authors":["Maynard TM","Gopalakrishna D","Meechan DW","Paronett EM","Newbern JM","LaMantia AS"],"grantIds":["K99 NS076661","NICHD042182","NS031768","S10RR025565"],"grantAgencies":["NINDS NIH HHS","PHS HHS","NINDS NIH HHS","NCRR NIH HHS"],"retractions":[],"journal":"Human molecular genetics","journalShort":"Hum. Mol. Genet.","day":15,"month":1,"year":2013,"meshHeadings":["Adaptation, Biological","Animals","Bone Morphogenetic Proteins","DiGeorge Syndrome","Female","Fibroblast Growth Factors","Gene Dosage","Gene Expression Regulation, Developmental","Hedgehog Proteins","Humans","Mice","Mice, Knockout","Morphogenesis","Neural Tube","Phenotype","Signal Transduction","Tretinoin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"We asked whether key morphogenetic signaling pathways interact with 22q11 gene dosage to modulate the severity of cranial or cardiac anomalies in DiGeorge/22q1 deletion syndrome (22q11DS). Sonic hedgehog (Shh) and retinoic acid (RA) signaling is altered in the brain and heart-clinically significant 22q11DS phenotypic sites-in LgDel mouse embryos, an established 22q11DS model. LgDel embryos treated with cyclopamine, an Shh inhibitor, or carrying mutations in Gli3(Xtj), an Shh-signaling effector, have morphogenetic anomalies that are either not seen, or seen at significantly lower frequencies in control or single-mutant embryos. Similarly, RA exposure or genetic loss of RA function via heterozygous mutation of the RA synthetic enzyme Raldh2 induces novel cranial anomalies and enhances cardiovascular phenotypes in LgDel but not other genotypes. These changes are not seen in heterozygous Tbx1 mutant embryos-a 22q11 gene thought to explain much of 22q11DS pathogenesis-in which Shh or RA signaling has been similarly modified. Our results suggest that full dosage of 22q11 genes beyond Tbx1 establish an adaptive range for morphogenetic signaling via Shh and RA. When this adaptive range is constricted by diminished dosage of 22q11 genes, embryos are sensitized to otherwise benign changes in Shh and RA signaling. Such sensitization, in the face of environmental or genetic factors that modify Shh or RA signaling, may explain variability in 22q11DS morphogenetic phenotypes.","affiliation":[]},{"pmid":"21273545","pmcid":null,"title":"Smad4 is required predominantly in the developmental processes dependent on the BMP branch of the TGF- signaling system in the embryonic mouse retina.","authors":["Murali D","Kawaguchi-Niida M","Deng CX","Furuta Y"],"grantIds":["CA16672","EY010608","EY013128"],"grantAgencies":["NCI NIH HHS","NEI NIH HHS","NEI NIH HHS"],"retractions":[],"journal":"Investigative ophthalmology & visual science","journalShort":"Invest. Ophthalmol. Vis. Sci.","day":3,"month":5,"year":2011,"meshHeadings":["Animals","Apoptosis","Axons","Bone Morphogenetic Proteins","Female","Fluorescent Antibody Technique, Indirect","Gene Deletion","Gene Expression Regulation, Developmental","Genotype","In Situ Hybridization","In Situ Nick-End Labeling","Male","Mice","Mice, Knockout","Microphthalmos","Polymerase Chain Reaction","Retina","Retinal Ganglion Cells","Signal Transduction","Smad4 Protein","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"PURPOSE: The present study was aimed at defining developmental roles of Smad4, a key mediator of the TGF- superfamily signaling system, in the embryonic mouse retina. METHODS: Using a Cre/loxP-mediated conditional gene targeting approach, Smad4 gene function was deleted from the embryonic mouse retina. Mutant phenotypes were morphologically and molecularly examined. RESULTS: Loss of Smad4 in the developing retina led to varying degrees of microphthalmia at birth, presumably because of elevated apoptosis observed transiently at embryonic day 12.5 in the developing retina. This was also associated with an apparent delay in accumulation of retinal ganglion cells. Smad4 conditional mutants also exhibited alterations of retinal spatial patterning along the dorsal-ventral axis, consistent with a known function of BMP signaling in the embryonic retina. However, despite a known role for BMP signaling in retinal cell survival, proliferation, and differentiation, Smad4 mutant retinal progenitor cells were capable of maintaining growth and neurogenesis throughout embryonic development. We also found that the loss of Smad4 led to abnormal targeting of retinal ganglion cell axons to the optic nerve head, a phenotype consistent with reduced BMP signaling in the developing retina. CONCLUSIONS: These results suggest that Smad4 is essential for a subset of, but not all, TGF-/BMP-dependent developmental processes in the embryonic retina. In addition, genetic requirements for Smad4 in the embryonic retina are evident predominantly in the developmental events regulated by the BMP branch of the TGF- signaling pathway.","affiliation":[]},{"pmid":"21571225","pmcid":null,"title":"-Catenin-dependent FGF signaling sustains cell survival in the anterior embryonic head by countering Smad4.","authors":["Paek H","Hwang JY","Zukin RS","Hbert JM"],"grantIds":["MH083804","R01 MH083804","R01 MH083804-02","R01 MH083804-03","R01 MH083804-04"],"grantAgencies":["NIMH NIH HHS","NIMH NIH HHS","NIMH NIH HHS","NIMH NIH HHS","NIMH NIH HHS"],"retractions":[],"journal":"Developmental cell","journalShort":"Dev. Cell","day":17,"month":5,"year":2011,"meshHeadings":["Animals","Cell Survival","Fibroblast Growth Factors","Head","Mice","Signal Transduction","Smad4 Protein","beta Catenin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Growing evidence suggests that FGFs secreted from embryonic signaling centers are key mediators of cell survival. However, the mechanisms regulating FGF-dependent cell survival remain obscure. At the rostral end of the embryo, for example, ablation of FGF signaling leads to the rapid death of the precursor cells that form the anterior head, including the telencephalon. Here, we outline a core genetic circuit that regulates survival in the embryonic mouse head: WNT signaling through -catenin directly maintains FGF expression and requires FGF function in vivo to oppose proapoptotic TGF- signaling through SMAD4. Moreover, these antagonistic pathways converge on the transcriptional regulation of apoptosis, and genes such as Cdkn1a, suggesting a mechanism for how signaling centers in the embryonic head regulate cell survival.","affiliation":[]},{"pmid":"21303850","pmcid":null,"title":"Signaling through BMP receptors promotes respiratory identity in the foregut via repression of Sox2.","authors":["Domyan ET","Ferretti E","Throckmorton K","Mishina Y","Nicolis SK","Sun X"],"grantIds":["T32 GM007133"],"grantAgencies":["NIGMS NIH HHS"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":9,"month":3,"year":2011,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Protein Receptors, Type I","Bronchi","Constriction, Pathologic","Digestive System","Mice","Respiratory System","SOXB1 Transcription Factors","Trachea"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The mammalian foregut gives rise to the dorsally located esophagus and stomach and the ventrally located trachea and lung. Proper patterning and morphogenesis of the common foregut tube and its derived organs is essential for viability of the organism at birth. Here, we show that conditional inactivation of BMP type I receptor genes Bmpr1a and Bmpr1b (Bmpr1a;b) in the ventral endoderm leads to tracheal agenesis and ectopic primary bronchi. Molecular analyses of these mutants reveal a reduction of ventral endoderm marker NKX2-1 and an expansion of dorsal markers SOX2 and P63 into the prospective trachea and primary bronchi. Subsequent genetic experiments show that activation of canonical WNT signaling, previously shown to induce ectopic respiratory fate in otherwise wild-type mice, is incapable of promoting respiratory fate in the absence of Bmpr1a;b. Furthermore, we find that inactivation of Sox2 in Bmpr1a;b mutants does not suppress ectopic lung budding but does rescue trachea formation and NKX2-1 expression. Together, our data suggest that signaling through BMPR1A;B performs at least two roles in early respiratory development: first, it promotes tracheal formation through repression of Sox2; and second, it restricts the site of lung bud initiation.","affiliation":[]},{"pmid":"21571370","pmcid":null,"title":"Bone morphogenetic protein 6-induced interleukin-1 expression in macrophages requires PU.1/Smad1 interaction.","authors":["Lee GT","Jung YS","Lee JH","Kim WJ","Kim IY"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Molecular immunology","journalShort":"Mol. Immunol.","day":6,"month":7,"year":2011,"meshHeadings":["Animals","Bone Morphogenetic Protein 6","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Protein Receptors, Type II","Cells, Cultured","Extracellular Signal-Regulated MAP Kinases","Fluorescent Antibody Technique","Immunoblotting","Immunoprecipitation","Interleukin-1beta","JNK Mitogen-Activated Protein Kinases","Macrophages","Mice","Nitric Oxide Synthase Type II","Proto-Oncogene Proteins","Reverse Transcriptase Polymerase Chain Reaction","Signal Transduction","Smad1 Protein","Trans-Activators"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Interleukin 1 (IL-1) is a pro-inflammatory cytokine secreted by activated macrophages and monocytes. Previously, we have reported that bone morphogenetic protein-6 (BMP-6) induces inducible nitric oxide synthase (iNOS) expression via IL-1 in macrophages. In the present study, we demonstrate that BMP-6 increases IL-1 expression in macrophages via the receptors ALK3 and BMPRII as well as the downstream signaling protein Smad1. Surprisingly though, inhibition of the ERK and JNK non-Smad pathways also completely blocked the induction of IL-1 by BMP-6 in macrophages. Further analysis revealed that a physical interaction between the transcription factor PU.1 and Smad 1 is necessary for the upregulation of IL-1 expression by BMP-6 in macrophages. Taken together, these results demonstrate that BMP-6-induced IL-1 expression in macrophages is mediated via a cross-talk between the Smad and the non-Smad pathways through Smad1 and PU.1.","affiliation":[]},{"pmid":"21763800","pmcid":null,"title":"Casein kinase 2 regulates in vivo bone formation through its interaction with bone morphogenetic protein receptor type Ia.","authors":["Bragdon B","Thinakaran S","Moseychuk O","Gurski L","Bonor J","Price C","Wang L","Beamer WG","Nohe A"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Bone","journalShort":"Bone","day":24,"month":11,"year":2011,"meshHeadings":["Absorptiometry, Photon","Animals","Bone Density","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors, Type I","Casein Kinase II","Cell Line","Mice","Mice, Inbred C57BL","Mice, Knockout","Microscopy, Confocal","NFATC Transcription Factors","Osteogenesis","Point Mutation","Recombinant Proteins","Signal Transduction","Wnt Signaling Pathway"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Approximately 7.9 million fractures occur annually in the United States with 5-10% of these resulting in delayed or impaired healing. Nearly half of the trauma cost of $56 billion per year is used for the treatment of fractures. More importantly, fracture results in a substantial reduction in the quality of life. New approaches and therapies are needed to enhance fracture healing. Only a limited number of treatments are available including bone grafting, allogeneic and autologous bone marrow transplantation, and bone morphogenetic protein (BMP). We previously identified Protein Kinase CK2 to interact with BMP receptor type Ia (BMPRIa) and as a key protein for signal activation. Peptides approximately 30 AA were developed that mimicked BMP2 action in vitro by blocking this interaction. In this paper we extended our studies to investigate if the most promising peptide could induce in vivo bone formation in mice and to elucidate this mechanism of action. The CK2 blocking peptide activated the Wnt pathway. To identify the optimal peptide concentration and peptide concentration curves for mineralization studies were performed. We designed BMPRIa mutants with a point mutation in the CK2 phosphorylation site to establish a specific effect. Mineralization was initiated with the overexpression of the BMPRIa mutants indicating CK2 is a negative regulatory protein for osteoblast differentiation. Osteoclast differentiation and activity was decreased with the CK2 blocking peptide. Further, subcutaneous calvarial bone injections of a CK2 blocking peptide increased bone area, areal bone mineral density, and bone growth. These results indicate CK2 is crucial for osteoblast differentiation and could be a target for future therapeutics of fracture healing.","affiliation":[]},{"pmid":"21786321","pmcid":null,"title":"Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice.","authors":["Okamoto M","Murai J","Imai Y","Ikegami D","Kamiya N","Kato S","Mishina Y","Yoshikawa H","Tsumaki N"],"grantIds":["DE020843"],"grantAgencies":["NIDCR NIH HHS"],"retractions":[],"journal":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","journalShort":"J. Bone Miner. Res.","day":28,"month":10,"year":2011,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Remodeling","Cell Differentiation","Cells, Cultured","Gene Deletion","Mice","Osteoblasts","Osteoclasts","Real-Time Polymerase Chain Reaction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone undergoes remodeling consisting of osteoclastic bone resorption followed by osteoblastic bone formation throughout life. Although the effects of bone morphogenetic protein (BMP) signals on osteoblasts have been studied extensively, the function of BMP signals in osteoclasts has not been fully elucidated. To delineate the function of BMP signals in osteoclasts during bone remodeling, we deleted BMP receptor type IA (Bmpr1a) in an osteoclast-specific manner using a knock-in Cre mouse line to the cathepsin K locus (Ctsk(Cre/+);Bmpr1a(flox/flox), designated as Bmpr1a(Oc/Oc)). Cre was specifically expressed in multinucleated osteoclasts in vivo. Cre-dependent deletion of the Bmpr1a gene occurred at 4 days after cultivation of bone marrow macrophages obtained from Bmpr1a(Oc/Oc) with RANKL. These results suggested that Bmpr1a was deleted after formation of osteoclasts in Bmpr1a(Oc/Oc) mice. Expression of bone-resorption markers increased, thus suggesting that BMPRIA signaling negatively regulates osteoclast differentiation. Trabeculae in tibia and femurs were thickened in 3.5-, 8-, and 12-week-old Bmpr1a(Oc/Oc) mice. Bone histomorphometry revealed increased bone volume associated with increased osteoblastic bone-formation rates (BFR) in the remodeling bone of the secondary spongiosa in Bmpr1a(Oc/Oc) tibias at 8 weeks of age. For comparison, we also induced an osteoblast-specific deletion of Bmpr1a using Col1a1-Cre. The resulting mice showed increased bone volume with marked decreases in BFR in tibias at 8 weeks of age. These results indicate that deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, thus suggesting that BMPR1A signaling in osteoclasts regulates coupling to osteoblasts by reducing bone-formation activity during bone remodeling.","affiliation":[]},{"pmid":"21415412","pmcid":null,"title":"Epithelial BMP signaling is required for proper specification of epithelial cell lineages and gastric endocrine cells.","authors":["Maloum F","Allaire JM","Gagn-Sansfaon J","Roy E","Belleville K","Sarret P","Morisset J","Carrier JC","Mishina Y","Kaestner KH","Perreault N"],"grantIds":["MOP-111104","R01-DK053839"],"grantAgencies":["Canadian Institutes of Health Research","NIDDK NIH HHS"],"retractions":[],"journal":"American journal of physiology. Gastrointestinal and liver physiology","journalShort":"Am. J. Physiol. Gastrointest. Liver Physiol.","day":2,"month":6,"year":2011,"meshHeadings":["Aging","Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Differentiation","Cell Lineage","Cell Proliferation","Duodenum","Enteroendocrine Cells","Epithelial Cells","Gastric Mucosa","Hepatocyte Nuclear Factor 3-gamma","Hyperplasia","Integrases","Mice","Mice, 129 Strain","Mice, Inbred C57BL","Mice, Knockout","Mice, Transgenic","Morphogenesis","Signal Transduction","Stomach Neoplasms"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein (BMP) signaling within the gastrointestinal tract is complex. BMP ligands and their receptors are expressed in both epithelial and mesenchymal compartments, suggesting bidirectional signaling between these two entities. Despite an increasing interest in BMP signaling in gut physiology and pathologies, the distinct contribution of BMP signaling in the epithelium vs. the mesenchyme in gastrointestinal homeostasis remains to be established. We aimed to investigate the role of epithelial BMP signaling in gastric organogenesis, gland morphogenesis, and maintenance of epithelial cell functions. Using the Cre/loxP system, we generated a mouse model with an early deletion during development of BMP receptor 1A (Bmpr1a) exclusively in the foregut endoderm. Bmpr1a(GEC) mice showed no severe abnormalities in gastric organogenesis, gland epithelial proliferation, or morphogenesis, suggesting only a minor role for epithelial BMP signaling in these processes. However, early loss of BMP signaling in foregut endoderm did impact on gastric patterning, leading to an anteriorization of the stomach. In addition, numbers of parietal cells were reduced in Bmpr1a(GEC) mice. Epithelial BMP deletion significantly increased the numbers of chromogranin A-, ghrelin-, somatostatin-, gastrin-, and serotonin-expressing gastric endocrine cells. Cancer never developed in young adult (<100 days) Bmpr1a-inactivated mice although a marker of spasmolytic polypeptide-expressing metaplasia was upregulated. Using this model, we have uncovered that BMP signaling negatively regulates the proliferation and commitment of endocrine precursor cells. Our data also indicate that loss of BMP signaling in epithelial gastric cells alone is not sufficient to induce gastric neoplasia.","affiliation":[]},{"pmid":"21542012","pmcid":null,"title":"Activation of c-Jun NH(2)-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor.","authors":["Liu H","Liu Y","Viggeswarapu M","Zheng Z","Titus L","Boden SD"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","journalShort":"J. Bone Miner. Res.","day":4,"month":5,"year":2011,"meshHeadings":["Animals","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors, Type I","Calcification, Physiologic","Cell Differentiation","Cell Line","Cell Nucleus","Enzyme Activation","JNK Mitogen-Activated Protein Kinases","Mice","Osteoblasts","Phosphorylation","Protein Binding","Rats","Rats, Sprague-Dawley","Smad1 Protein","Smad6 Protein","Transcription, Genetic"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein 2 (BMP-2) plays a critical role in the differentiation of precursor cells and has been approved for clinical application to induce new bone formation. To date, unexpectedly high doses of recombinant BMP-2 have been required to induce bone healing in humans. Thus, enhancing cellular responsiveness to BMP-2 potentially has critically important clinical implications. BMP responsiveness may be modulated in part by cross-talk with other signaling pathways, including mitogen-activated protein kinases (MAPKs). c-Jun NH(2)-terminal kinase (JNK) is a MAPK that has been reported to be required for late-stage differentiation of preosteoblasts and BMP-2-induced differentiation of preosteoblasts and pleuripotent cells. In this study we determined that MC3T3-E1-clone 24cells (MC-24) can be induced by BMP-2 to differentiate into mineralizing osteoblast cultures. Using this inducible system, we employed both JNK loss-of-function and gain-of-function reagents to make three key observations: (1) JNK is required for phosphorylation of Smad1 by BMP-2 and subsequent activation of Smad1 signaling and osteoblast differentiation, (2) JNK1, but not JNK2, is required for BMP-2-induced formation of mineralized nodules, and (3) JNK1 activation decreases binding of inhibitory Smad6 to the type I BMP receptor (BMPR-I) and reciprocally increases binding of Smad1, both observations that would increase responsiveness to BMP-2. Understanding this and other pathways that lead to increased cellular responsiveness to BMPs could greatly aid more cost-effective and safe clinical delivery of these important molecules.","affiliation":[]},{"pmid":"21394823","pmcid":null,"title":"Bone morphogenetic protein signaling is required in the dorsal neural folds before neurulation for the induction of spinal neural crest cells and dorsal neurons.","authors":["Stottmann RW","Klingensmith J"],"grantIds":["F31-NS42486","R01-DE13674","R56 DE013674","R56 DE013674-07A1","RC1 NS068932","RC1 NS068932-01","RC1-NS068932"],"grantAgencies":["NINDS NIH HHS","NIDCR NIH HHS","NIDCR NIH HHS","NIDCR NIH HHS","NINDS NIH HHS","NINDS NIH HHS","NINDS NIH HHS"],"retractions":[],"journal":"Developmental dynamics : an official publication of the American Association of Anatomists","journalShort":"Dev. Dyn.","day":15,"month":4,"year":2011,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Embryo, Mammalian","Gene Deletion","Mice","Mice, Inbred C57BL","Mice, Transgenic","Neural Crest","Neurulation","Posterior Horn Cells","Signal Transduction","Spinal Cord"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone Morphogenetic Protein (BMP) activity has been implicated as a key regulator of multiple aspects of dorsal neural tube development. BMP signaling in the dorsal-most neuroepithelial cells presumably plays a critical role. We use tissue-specific gene ablation to probe the roles of BMPR1A, the type 1 BMP receptor that is seemingly the best candidate to mediate the activities of BMPs on early dorsal neural development. We use two different Cre lines expressed in the dorsal neural folds, one prior to spinal neurulation and one shortly afterward, together with a Bmpr1a conditional null mutation. Our findings indicate that BMPR1A signaling in the dorsal neural folds is important for hindbrain neural tube closure, but suggest it is dispensable for spinal neurulation. Our results also demonstrate a requirement for BMP signaling in patterning of dorsal neural tube cell fate and in neural crest cell formation, and imply a critical period shortly before neural tube closure.","affiliation":[]},{"pmid":"21223962","pmcid":null,"title":"The function of FGF signaling in the lens placode.","authors":["Garcia CM","Huang J","Madakashira BP","Liu Y","Rajagopal R","Dattilo L","Robinson ML","Beebe DC"],"grantIds":["E012995","EY02687","EY04853","P30 EY002687","P30 EY002687-33","R01 EY004853","R01 EY004853-27","R01 EY012995","R01 EY012995-10"],"grantAgencies":["PHS HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS","NEI NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":1,"month":3,"year":2011,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors","Ectoderm","Eye Proteins","Fibroblast Growth Factors","Germ-Line Mutation","Homeodomain Proteins","Lens, Crystalline","Mice","Paired Box Transcription Factors","Receptors, Fibroblast Growth Factor","Repressor Proteins","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Previous studies suggested that FGF signaling is important for lens formation. However, the times at which FGFs act to promote lens formation, the FGFs that are involved, the cells that secrete them and the mechanisms by which FGF signaling may promote lens formation are not known. We found that transcripts encoding several FGF ligands and the four classical FGF receptors are detectable in the lens-forming ectoderm at the time of lens induction. Conditional deletion of Fgfr1 and Fgfr2 from this tissue resulted in the formation of small lens rudiments that soon degenerated. Lens placodes lacking Fgfr1 and 2 were thinner than in wild-type embryos. Deletion of Fgfr2 increased cell death from the initiation of placode formation and concurrent deletion of Fgfr1 enhanced this phenotype. Fgfr1/2 conditional knockout placode cells expressed lower levels of proteins known to be regulated by FGF receptor signaling, but proteins known to be important for lens formation were present at normal levels in the remaining placode cells, including the transcription factors Pax6, Sox2 and FoxE3 and the lens-preferred protein A-crystallin. Previous studies identified a genetic interaction between BMP and FGF signaling in lens formation and conditional deletion of Bmpr1a caused increased cell death in the lens placode, resulting in the formation of smaller lenses. In the present study, conditional deletion of both Bmpr1a and Fgfr2 increased cell death beyond that seen in Fgfr2(CKO) placodes and prevented lens formation. These results suggest that the primary role of autocrine or paracrine FGF signaling is to provide essential survival signals to lens placode cells. Because apoptosis was already increased at the onset of placode formation in Fgfr1/2 conditional knockout placode cells, FGF signaling was functionally absent during the period of lens induction by the optic vesicle. Since the expression of proteins required for lens formation was not altered in the knockout placode cells, we can conclude that FGF signaling from the optic vesicle is not required for lens induction.","affiliation":[]},{"pmid":"22485132","pmcid":"3317656","title":"Fstl1 antagonizes BMP signaling and regulates ureter development.","authors":["Xu J","Qi X","Gong J","Yu M","Zhang F","Sha H","Gao X"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"PloS one","journalShort":"PLoS ONE","day":9,"month":4,"year":2012,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Differentiation","Cell Proliferation","Epithelial Cells","Female","Follistatin-Related Proteins","Gene Expression","HEK293 Cells","Hedgehog Proteins","Humans","Male","Mice","Mice, 129 Strain","Mice, Inbred C57BL","Mice, Knockout","Signal Transduction","Ureter","Urinary Tract"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein (BMP) signaling pathway plays important roles in urinary tract development although the detailed regulation of its activity in this process remains unclear. Here we report that follistatin-like 1 (Fstl1), encoding a secreted extracellular glycoprotein, is expressed in developing ureter and antagonizes BMP signaling activity. Mouse embryos carrying disrupted Fstl1 gene displayed prominent hydroureter arising from proximal segment and ureterovesical junction defects. These defects were associated with significant reduction in ureteric epithelial cell proliferation at E15.5 and E16.5 as well as absence of subepithelial ureteral mesenchymal cells in the urinary tract at E16.5 and E18.5. At the molecular level, increased BMP signaling was found in Fstl1 deficient ureters, indicated by elevated pSmad1/5/8 activity. In vitro study also indicated that Fstl1 can directly bind to ALK6 which is specifically expressed in ureteric epithelial cells in developing ureter. Furthermore, Sonic hedgehog (SHH) signaling, which is crucial for differentiation of ureteral subepithelial cell proliferation, was also impaired in Fstl1(-/-) ureter. Altogether, our data suggest that Fstl1 is essential in maintaining normal ureter development by antagonizing BMP signaling.","affiliation":[]},{"pmid":"21841161","pmcid":null,"title":"Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice.","authors":["Steinbicker AU","Bartnikas TB","Lohmeyer LK","Leyton P","Mayeur C","Kao SM","Pappas AE","Peterson RT","Bloch DB","Yu PB","Fleming MD","Bloch KD"],"grantIds":["K08 HL079943","K99DK084122","R01 AR057374","R01DK082971"],"grantAgencies":["NHLBI NIH HHS","NIDDK NIH HHS","NIAMS NIH HHS","NIDDK NIH HHS"],"retractions":[],"journal":"Blood","journalShort":"Blood","day":13,"month":10,"year":2011,"meshHeadings":["Activin Receptors, Type I","Animals","Antimicrobial Cationic Peptides","Bone Morphogenetic Protein Receptors, Type I","Cells, Cultured","Gene Deletion","Gene Expression Regulation","Hepatocytes","Hepcidins","Iron Overload","Mice","Mice, Mutant Strains","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein (BMP) signaling induces hepatic expression of the peptide hormone hepcidin. Hepcidin reduces serum iron levels by promoting degradation of the iron exporter ferroportin. A relative deficiency of hepcidin underlies the pathophysiology of many of the genetically distinct iron overload disorders, collectively termed hereditary hemochromatosis. Conversely, chronic inflammatory conditions and neoplastic diseases can induce high hepcidin levels, leading to impaired mobilization of iron stores and the anemia of chronic disease. Two BMP type I receptors, Alk2 (Acvr1) and Alk3 (Bmpr1a), are expressed in murine hepatocytes. We report that liver-specific deletion of either Alk2 or Alk3 causes iron overload in mice. The iron overload phenotype was more marked in Alk3- than in Alk2-deficient mice, and Alk3 deficiency was associated with a nearly complete ablation of basal BMP signaling and hepcidin expression. Both Alk2 and Alk3 were required for induction of hepcidin gene expression by BMP2 in cultured hepatocytes or by iron challenge in vivo. These observations demonstrate that one type I BMP receptor, Alk3, is critically responsible for basal hepcidin expression, whereas 2 type I BMP receptors, Alk2 and Alk3, are required for regulation of hepcidin gene expression in response to iron and BMP signaling.","affiliation":[]},{"pmid":"21731673","pmcid":"3121735","title":"Deterministic and stochastic allele specific gene expression in single mouse blastomeres.","authors":["Tang F","Barbacioru C","Nordman E","Bao S","Lee C","Wang X","Tuch BB","Heard E","Lao K","Surani MA"],"grantIds":["G0800784"],"grantAgencies":["Medical Research Council","Wellcome Trust"],"retractions":[],"journal":"PloS one","journalShort":"PLoS ONE","day":6,"month":7,"year":2011,"meshHeadings":["3' Untranslated Regions","Alleles","Allelic Imbalance","Alternative Splicing","Animals","Blastocyst","Blastomeres","Embryonic Development","Gene Expression Profiling","Gene Expression Regulation, Developmental","Mice","MicroRNAs","Polymorphism, Single Nucleotide","Principal Component Analysis","Protein Isoforms","RNA, Untranslated","Stochastic Processes"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Stochastic and deterministic allele specific gene expression (ASE) might influence single cell phenotype, but the extent and nature of the phenomenon at the onset of early mouse development is unknown. Here we performed single cell RNA-Seq analysis of single blastomeres of mouse embryos, which revealed significant changes in the transcriptome. Importantly, over half of the transcripts with detectable genetic polymorphisms exhibit ASE, most notably, individual blastomeres from the same two-cell embryo show similar pattern of ASE. However, about 6% of them exhibit stochastic expression, indicated by altered expression ratio between the two alleles. Thus, we demonstrate that ASE is both deterministic and stochastic in early blastomeres. Furthermore, we also found that 1,718 genes express two isoforms with different lengths of 3'UTRs, with the shorter one on average 5-6 times more abundant in early blastomeres compared to the transcripts in epiblast cells, suggesting that microRNA mediated regulation of gene expression acquires increasing importance as development progresses.","affiliation":[]},{"pmid":"22872577","pmcid":null,"title":"Mullerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation.","authors":["Wu X","Zhang N","Lee MM"],"grantIds":["HD01367","HD36768","P3DK032520","U54-HD28934"],"grantAgencies":["NICHD NIH HHS","NICHD NIH HHS","NIDDK NIH HHS","NICHD NIH HHS"],"retractions":[],"journal":"Endocrinology","journalShort":"Endocrinology","day":24,"month":10,"year":2012,"meshHeadings":["Activin Receptors, Type I","Androstenedione","Animals","Anti-Mullerian Hormone","Bone Morphogenetic Protein Receptors, Type I","Cell Count","Cell Differentiation","Down-Regulation","Leydig Cells","Luteinizing Hormone","Male","Mice","Mice, Knockout","Phosphoproteins","Receptors, Peptide","Receptors, Transforming Growth Factor beta","Steroid 17-alpha-Hydroxylase","Testis","Testosterone"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Mllerian inhibiting substance (MIS) not only induces Mllerian duct regression during male sexual differentiation but also modulates Leydig cell steroidogenic capacity and differentiation. MIS actions are mediated through a complex of homologous receptors: a type II ligand-binding receptor [MIS type II receptor (MISRII)] and a tissue-specific type I receptor that initiates downstream signaling. The putative MIS type I receptors responsible for Mllerian duct regression are activin A type II receptor, type I [Acvr1/activin receptor-like kinase 2 (ALK2)], ALK3, and ALK6, but the one recruited by MIS in Leydig cells is unknown. To identify whether ALK3 is the specific type I receptor partner for MISRII in Leydig cells, we generated Leydig cell-specific ALK3 conditional knockout mice using a Cre-lox system and compared gene expression and steroidogenic capacity in Leydig cells of ALK3(fx/fx)Cyp17(cre+) and control mice (ALK3(fx/fx)Cyp17(cre-) or ALK3(fx/wt)Cyp17(cre-) littermates). We found reduced mRNA expression of the genes encoding P450c17, StAR, and two enzymes (17HSD-III and 3HSD-VI) that are expressed in differentiated adult Leydig cells and increased expression of androgen-metabolizing enzymes (3-HSD and SRD5A2) and proliferating cell nuclear antigen (PCNA) in Leydig cells of ALK3(fx/fx)Cyp17(cre+) mice. Despite down-regulation of steroidogenic capacity in ALK3(fx/fx)Cyp17(cre+) mice, the loss of MIS signaling also stimulates Leydig cell proliferation such that plasma testosterone and androstenedione concentrations are comparable to that of control mice. Collectively, these results indicate that the phenotype in ALK3 conditional knockout mice is similar to that of the MIS-knockout mice, confirming that ALK3 is the primary type I receptor recruited by the MIS-MISRII complex during Leydig cell differentiation.","affiliation":[]},{"pmid":"22036911","pmcid":null,"title":"Altered plasma membrane dynamics of bone morphogenetic protein receptor type Ia in a low bone mass mouse model.","authors":["Bragdon B","D'Angelo A","Gurski L","Bonor J","Schultz KL","Beamer WG","Rosen CJ","Nohe A"],"grantIds":["AR043618","AR045433","R01 AR045433"],"grantAgencies":["NIAMS NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS"],"retractions":[],"journal":"Bone","journalShort":"Bone","day":27,"month":1,"year":2012,"meshHeadings":["Animals","Bone Density","Bone Marrow Cells","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors, Type I","Bone and Bones","Calcification, Physiologic","Caveolae","Caveolins","Cell Membrane","Disease Models, Animal","Female","Humans","Male","Mice","Mice, Congenic","Mice, Inbred C3H","Mice, Inbred C57BL","Osteoporosis","Protein Isoforms","Signal Transduction","Smad Proteins","Stromal Cells"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (BMPs) are growth factors that initiate differentiation of bone marrow stromal cells to osteoblasts and adipocytes, yet the mechanism that decides which lineage the cell will follow is unknown. BMP2 is linked to the development of osteoporosis and variants of BMP2 gene have been reported to increase the development of osteoporosis. Intracellular signaling is transduced by BMP receptors (BMPRs) of type I and type II that are serine/threonine kinase receptors. The BMP type I a receptor (BMPRIa) is linked to osteogenesis and bone mineral density (BMD). BMPRs are localized to caveolae enriched with Caveolin1 alpha/beta and Caveolin beta isoforms to facilitate signaling. BMP2 binding to caveolae was recently found to be crucial for the initiation of the Smad signaling pathway. Here we determined the role of BMP receptor localization within caveolae isoforms and aggregation of caveolae as well as BMPRIa in bone marrow stromal cells (BMSCs) on bone mineral density using the B6.C3H-6T as a model system. The B6.C3H-6T is a congenic mouse with decreased bone mineral density (BMD) with increased marrow adipocytes and decreased osteoprogenitor proliferation. C57BL/6J mice served as controls since only a segment of Chr6 from the C3H/HeJ mouse was backcrossed to a C57BL/6J background. Family of image correlation spectroscopy was used to analyze receptor cluster density and co-localization of BMPRIa and caveolae. It was previously shown that BMP2 stimulation results in an aggregation of caveolae and BMPRIa. Additionally, BMSCs isolated from the B6.C3H-6T mice showed a dispersion of caveolae domains compared to C57BL/6J. The aggregation of BMPRIa that is necessary for signaling to occur was inhibited in BMSCs isolated from B6.C3H-6T. Additionally, we analyzed the co-localization of BMPRIa with caveolin-1 isoforms. There was increased percentage of BMPRIa co-localization with caveolae compared to C57BL/6J. BMP2 stimulation had no effect on the colocalization of BMPRIa with caveolin-1. Disrupting caveolae initiated Smad signaling in the isolated BMSCs from B6.C3H-6T. These data suggest that in congenic 6T mice BMP receptors aggregation is inhibited causing an inhibition of signaling and reduced bone mass.","affiliation":[]},{"pmid":"22076636","pmcid":null,"title":"Integration of repulsive guidance cues generates avascular zones that shape mammalian blood vessels.","authors":["Meadows SM","Fletcher PJ","Moran C","Xu K","Neufeld G","Chauvet S","Mann F","Krieg PA","Cleaver O"],"grantIds":["DK079862","HL007360-32","HL074184-02","R01 DK079862","R01 DK079862-04","R01 HL113498"],"grantAgencies":["NIDDK NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NHLBI NIH HHS"],"retractions":[],"journal":"Circulation research","journalShort":"Circ. Res.","day":6,"month":1,"year":2012,"meshHeadings":["Animals","Aorta","Blood Vessels","Cells, Cultured","Embryo, Mammalian","Endothelium, Vascular","Forkhead Transcription Factors","Glycoproteins","Hepatocyte Nuclear Factor 3-beta","In Vitro Techniques","Membrane Proteins","Mesoderm","Mice","Mice, Knockout","Models, Animal","Neovascularization, Physiologic","Notochord","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"RATIONALE: Positive signals, such as vascular endothelial growth factor, direct endothelial cells (ECs) to specific locations during blood vessel formation. Less is known about repulsive signal contribution to shaping vessels. Recently, \"neuronal guidance cues\" have been shown to influence EC behavior, particularly in directing sprouting angiogenesis by repelling ECs. However, their role during de novo blood vessel formation remains unexplored. OBJECTIVE: To identify signals that guide and pattern the first mammalian blood vessels. METHODS AND RESULTS: Using genetic mouse models, we show that blood vessels are sculpted through the generation of stereotyped avascular zones by EC-repulsive cues. We demonstrate that Semaphorin3E (Sema3E) is a key factor that shapes the paired dorsal aortae in mouse, as sema3E(-/-) embryos develop an abnormally branched aortic plexus with a markedly narrowed avascular midline. In vitro cultures and avian grafting experiments show strong repulsion of ECs by Sema3E-expressing cells. We further identify the mouse notochord as a rich source of multiple redundant neuronal guidance cues. Mouse embryos that lack notochords fail to form cohesive aortic vessels because of loss of the avascular midline, yet maintain lateral avascular zones. We demonstrate that lateral avascular zones are directly generated by the lateral plate mesoderm, a critical source of Sema3E. CONCLUSIONS: These findings demonstrate that Sema3E-generated avascular zones are critical regulators of mammalian cardiovascular patterning and are the first to identify a repulsive role for the lateral plate mesoderm. Integration of multiple, and in some cases redundant, repulsive cues from various tissues is critical to patterning the first embryonic blood vessels.","affiliation":[]},{"pmid":"22306733","pmcid":"3998727","title":"Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis.","authors":["Sugimoto H","LeBleu VS","Bosukonda D","Keck P","Taduri G","Bechtel W","Okada H","Carlson W","Bey P","Rusckowski M","Tampe B","Tampe D","Kanasaki K","Zeisberg M","Kalluri R"],"grantIds":["2T32DK007760-11","5T32HL007374-30","CA125550","CA151925","CA155370","CA163191","DK061688","DK074558","DK081576","DK55001","U54 CA163191"],"grantAgencies":["NIDDK NIH HHS","NHLBI NIH HHS","NCI NIH HHS","NCI NIH HHS","NCI NIH HHS","NCI NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NCI NIH HHS"],"retractions":[],"journal":"Nature medicine","journalShort":"Nat. Med.","day":7,"month":3,"year":2012,"meshHeadings":["Angiotensin-Converting Enzyme Inhibitors","Animals","Apoptosis","Bone Morphogenetic Protein Receptors","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Protein Receptors, Type II","Bone Morphogenetic Proteins","Captopril","Diabetic Nephropathies","Epithelial-Mesenchymal Transition","Fibrosis","Inflammation","Kidney","Kidney Tubules","Mice","Peptide Library","Peptides","Rats","Rats, Sprague-Dawley","Regeneration","Signal Transduction","Smad3 Protein","Structure-Activity Relationship","Transforming Growth Factor beta"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Molecules associated with the transforming growth factor  (TGF-) superfamily, such as bone morphogenic proteins (BMPs) and TGF-, are key regulators of inflammation, apoptosis and cellular transitions. Here we show that the BMP receptor activin-like kinase 3 (Alk3) is elevated early in diseased kidneys after injury. We also found that its deletion in the tubular epithelium leads to enhanced TGF-1-Smad family member 3 (Smad3) signaling, epithelial damage and fibrosis, suggesting a protective role for Alk3-mediated signaling in the kidney. A structure-function analysis of the BMP-Alk3-BMP receptor, type 2 (BMPR2) ligand-receptor complex, along with synthetic organic chemistry, led us to construct a library of small peptide agonists of BMP signaling that function through the Alk3 receptor. One such peptide agonist, THR-123, suppressed inflammation, apoptosis and the epithelial-to-mesenchymal transition program and reversed established fibrosis in five mouse models of acute and chronic renal injury. THR-123 acts specifically through Alk3 signaling, as mice with a targeted deletion for Alk3 in their tubular epithelium did not respond to therapy with THR-123. Combining THR-123 and the angiotensin-converting enzyme inhibitor captopril had an additive therapeutic benefit in controlling renal fibrosis. Our studies show that BMP signaling agonists constitute a new line of therapeutic agents with potential utility in the clinic to induce regeneration, repair and reverse established fibrosis.","affiliation":[]},{"pmid":"21677750","pmcid":null,"title":"A conditional knockout resource for the genome-wide study of mouse gene function.","authors":["Skarnes WC","Rosen B","West AP","Koutsourakis M","Bushell W","Iyer V","Mujica AO","Thomas M","Harrow J","Cox T","Jackson D","Severin J","Biggs P","Fu J","Nefedov M","de Jong PJ","Stewart AF","Bradley A"],"grantIds":["077188","U01-HG004080"],"grantAgencies":["Wellcome Trust","NHGRI NIH HHS","Wellcome Trust"],"retractions":[],"journal":"Nature","journalShort":"Nature","day":16,"month":6,"year":2011,"meshHeadings":["Alleles","Animals","Computational Biology","Embryonic Stem Cells","Gene Deletion","Gene Knockout Techniques","Genes","Genes, Lethal","Genetic Association Studies","Genetic Vectors","Genome","Genomics","Genotype","Humans","Mice","Mice, Inbred C57BL","Mice, Knockout","Mutagenesis, Insertional","Phenotype","Polymerase Chain Reaction","Rats"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Gene targeting in embryonic stem cells has become the principal technology for manipulation of the mouse genome, offering unrivalled accuracy in allele design and access to conditional mutagenesis. To bring these advantages to the wider research community, large-scale mouse knockout programmes are producing a permanent resource of targeted mutations in all protein-coding genes. Here we report the establishment of a high-throughput gene-targeting pipeline for the generation of reporter-tagged, conditional alleles. Computational allele design, 96-well modular vector construction and high-efficiency gene-targeting strategies have been combined to mutate genes on an unprecedented scale. So far, more than 12,000 vectors and 9,000 conditional targeted alleles have been produced in highly germline-competent C57BL/6N embryonic stem cells. High-throughput genome engineering highlighted by this study is broadly applicable to rat and human stem cells and provides a foundation for future genome-wide efforts aimed at deciphering the function of all genes encoded by the mammalian genome.","affiliation":[]},{"pmid":"21613322","pmcid":null,"title":"Alk3 controls nephron number and androgen production via lineage-specific effects in intermediate mesoderm.","authors":["Di Giovanni V","Alday A","Chi L","Mishina Y","Rosenblum ND"],"grantIds":[],"grantAgencies":["Canadian Institutes of Health Research"],"retractions":[],"journal":"Development (Cambridge, England)","journalShort":"Development","day":9,"month":7,"year":2011,"meshHeadings":["Androgens","Animals","Apoptosis","Bone Morphogenetic Protein Receptors, Type I","Cell Proliferation","Fluorescent Antibody Technique","Immunoblotting","Immunohistochemistry","In Situ Hybridization","Kidney","Male","Mesoderm","Mice","Mice, Mutant Strains","Models, Biological","Nephrons","Signal Transduction","beta-Galactosidase"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The mammalian kidney and male reproductive system are both derived from the intermediate mesoderm. The spatial and temporal expression of bone morphogenetic protein (BMP) 2 and BMP4 and their cognate receptor, activin like kinase 3 (ALK3), suggests a functional role for BMP-ALK3 signaling during formation of intermediate mesoderm-derivative organs. Here, we define cell autonomous functions for Alk3 in the kidney and male gonad in mice with CRE-mediated Alk3 inactivation targeted to intermediate mesoderm progenitors (Alk3(IMP null)). Alk3-deficient mice exhibit simple renal hypoplasia characterized by decreases in both kidney size and nephron number but normal tissue architecture. These defects are preceded by a decreased contribution of Alk3-deleted cells to the metanephric blastema and reduced expression of Osr1 and SIX2, which mark nephron progenitor cells. Mutant mice are also characterized by defects in intermediate mesoderm-derived genital tissues with fewer mesonephric tubules and testicular Leydig cells, epithelial vacuolization in the postnatal corpus epididymis, and decreased serum testosterone levels and reduced fertility. Analysis of ALK3-dependent signaling effectors revealed lineage-specific reduction of phospho-p38 MAPK in metanephric mesenchyme and phospho-SMAD1/5/8 in the testis. Together, these results demonstrate a requirement for Alk3 in distinct progenitor cell populations derived from the intermediate mesoderm.","affiliation":[]},{"pmid":"21848994","pmcid":null,"title":"Epithelial Bmp (Bone morphogenetic protein) signaling for bulbourethral gland development: a mouse model for congenital cystic dilation.","authors":["Omori A","Harada M","Ohta S","Villacorte M","Sugimura Y","Shiraishi T","Suzuki K","Nakagata N","Ito T","Yamada G"],"grantIds":["R01ES016597"],"grantAgencies":["NIEHS NIH HHS"],"retractions":[],"journal":"Congenital anomalies","journalShort":"Congenit Anom (Kyoto)","day":18,"month":9,"year":2011,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Bulbourethral Glands","Dilatation, Pathologic","Disease Models, Animal","Epithelium","Humans","Hyperplasia","Integrases","Male","Mice","Mice, Knockout","Mutation","Pelvic Floor Disorders","Signal Transduction","Smad1 Protein","Tamoxifen"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The bulbourethral gland (BUG) is a male-specific organ, which secretes part of the semen fluid. As the BUG is located in the deep pelvic floor, its developmental process is still unclear. Bone morphogenetic protein (Bmp) signaling plays pivotal roles in various organs. However, the function of Bmp signaling for BUG development is still unclear. The present study aimed to elucidate the role of Bmp signaling in the development of the BUG. We observed the prominent nuclear accumulation of phosphorylated (p) SMAD1/5/8, the downstream molecules of Bmp signaling, during BUG epithelial development. These results suggest that Bmp signaling contributes to BUG development. Bmp receptor1a (Bmpr1a) is known as the major type 1 signal transducer in some organogeneses. To analyze the Bmp signaling function for BUG development, we examined epithelial cell-specific Bmpr1a gene conditional mutant mice utilizing the tamoxifen-inducible Cre recombinase system. We observed cystic dilation and epithelial hyperplasia of the BUG in the Bmpr1a conditional knockout mice. The mutant cystic BUG specimens also showed inflammatory lesions. These BUG abnormalities resembled some of the BUG malformations observed in human congenital syndromes. The current study suggests that Bmp signaling possesses an essential role in BUG development and homeostasis. This would be the first report showing that the mutation of the Bmpr1a gene in the BUG epithelia phenocopied some abnormalities of human congenital syndromes affecting the BUG duct.","affiliation":[]},{"pmid":"22773757","pmcid":"3484876","title":"Reduced bone morphogenetic protein receptor type 1A signaling in neural-crest-derived cells causes facial dysmorphism.","authors":["Saito H","Yamamura K","Suzuki N"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Disease models & mechanisms","journalShort":"Dis Model Mech","day":1,"month":11,"year":2012,"meshHeadings":["Animals","Animals, Newborn","Bone Morphogenetic Protein Receptors, Type I","Cell Survival","Embryo, Mammalian","Face","Female","Frontal Bone","Genes, Dominant","Heart Septal Defects","Humans","Mesoderm","Mice","Mice, Inbred C57BL","Mice, Transgenic","Mutation","Neural Crest","Nose","Pigmentation","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein (BMP) receptor type 1A (BMPR1A) mutations are associated with facial dysmorphism, which is one of the main clinical signs in both juvenile polyposis and chromosome 10q23 deletion syndromes. Craniofacial development requires reciprocal epithelial/neural crest (NC)-derived mesenchymal interactions mediated by signaling factors, such as BMP, in both cell populations. To address the role of mesenchymal BMP signaling in craniofacial development, we generated a conditional knockdown mouse by expressing the dominant-negative Bmpr1a in NC-derived cells expressing the myelin protein zero(Mpz)-Cre transgene. At birth, 100% of the conditional mutant mice had wide-open anterior fontanelles, and 80% of them died because of cleft face and cleft palate soon after birth. The other 20% survived and developed short faces, hypertelorism and calvarial foramina. Analysis of the NC-derived craniofacial mesenchyme of mutant embryos revealed an activation of the P53 apoptosis pathway, downregulation of both c-Myc and Bcl-XL, a normal growth rate but an incomplete expansion of mesenchymal cells. These findings provide genetic evidence indicating that optimal Bmpr1a-mediated signaling is essential for NC-derived mesenchymal cell survival in both normal nasal and frontal bone development and suggest that our model is useful for studying some aspects of the molecular etiology of human craniofacial dysmorphism.","affiliation":[]},{"pmid":"22729085","pmcid":null,"title":"c-Abl promotes osteoblast expansion by differentially regulating canonical and non-canonical BMP pathways and p16INK4a expression.","authors":["Kua HY","Liu H","Leong WF","Li L","Jia D","Ma G","Hu Y","Wang X","Chau JF","Chen YG","Mishina Y","Boast S","Yeh J","Xia L","Chen GQ","He L","Goff SP","Li B"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Nature cell biology","journalShort":"Nat. Cell Biol.","day":3,"month":7,"year":2012,"meshHeadings":["Adaptor Proteins, Signal Transducing","Amino Acid Sequence","Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Protein Receptors, Type II","Bone Morphogenetic Proteins","Cell Aging","Cell Proliferation","Cells, Cultured","Cyclin-Dependent Kinase Inhibitor p16","Enzyme Activation","Genotype","Inhibitor of Differentiation Protein 1","MAP Kinase Kinase Kinases","Mesenchymal Stromal Cells","Mice","Mice, Inbred C57BL","Mice, Knockout","Mitogen-Activated Protein Kinase 1","Mitogen-Activated Protein Kinase 3","Molecular Sequence Data","Osteoblasts","Phenotype","Phosphorylation","Proto-Oncogene Proteins c-abl","Signal Transduction","Smad1 Protein","Smad5 Protein","Smad8 Protein","Time Factors","Transfection","Tumor Suppressor Protein p53"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Defects in stem cell renewal or progenitor cell expansion underlie ageing-related diseases such as osteoporosis. Yet much remains unclear about the mechanisms regulating progenitor expansion. Here we show that the tyrosine kinase c-Abl plays an important role in osteoprogenitor expansion. c-Abl interacts with and phosphorylates BMPRIA and the phosphorylation differentially influences the interaction of BMPRIA with BMPRII and the Tab1-Tak1 complex, leading to uneven activation of Smad1/5/8 and Erk1/2, the canonical and non-canonical BMP pathways that direct the expression of p16(INK4a). c-Abl deficiency shunts BMP signalling from Smad1/5/8 to Erk1/2, leading to p16(INK4a) upregulation and osteoblast senescence. Mouse genetic studies revealed that p16(INK4a) controls mesenchymal stem cell maintenance and osteoblast expansion and mediates the effects of c-Abl deficiency on osteoblast expansion and bone formation. These findings identify c-Abl as a regulator of BMP signalling pathways and uncover a role for c-Abl in p16(INK4a) expression and osteoprogenitor expansion.","affiliation":[]},{"pmid":"22698281","pmcid":null,"title":"Spatial restriction of bone morphogenetic protein signaling in mouse gastrula through the mVam2-dependent endocytic pathway.","authors":["Aoyama M","Sun-Wada GH","Yamamoto A","Yamamoto M","Hamada H","Wada Y"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Developmental cell","journalShort":"Dev. Cell","day":12,"month":6,"year":2012,"meshHeadings":["Animals","Body Patterning","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Endocytosis","Endosomes","Epidermal Growth Factor","Gastrula","Gene Expression Regulation, Developmental","Genetic Loci","Mice","Signal Transduction","Smad1 Protein","Smad5 Protein","Transforming Growth Factor beta","Vesicular Transport Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The embryonic body plan is established through positive and negative control of various signaling cascades. Late endosomes and lysosomes are thought to terminate signal transduction by compartmentalizing the signaling molecules; however, their roles in embryogenesis remain poorly understood. We showed here that the endocytic pathway participates in the developmental program by regulating the signaling activity. We modified the mouse Vam2 (mVam2) locus encoding a regulator of membrane trafficking. mVam2-deficient cells exhibited abnormally fragmented late endosomal compartments. The mutant cells could terminate signaling after theremoval of the growth factors including TGF- and EGF, except BMP-Smad1/Smad5 signaling. mVam2-deficient embryos exhibited ectopic activation of BMP signaling and disorganization of embryo patterning. We found that mVam2, which interacts with BMP type I receptor, is required for the spatiotemporal modulation of BMP signaling, via sequestration of the receptor complex in the late stages of the endocytic pathway.","affiliation":[]},{"pmid":"24680892","pmcid":null,"title":"AcvR1-mediated BMP signaling in second heart field is required for arterial pole development: implications for myocardial differentiation and regional identity.","authors":["Thomas PS","Rajderkar S","Lane J","Mishina Y","Kaartinen V"],"grantIds":["HL074862","R01 HL074862","T32 GM007315"],"grantAgencies":["NHLBI NIH HHS","NHLBI NIH HHS","NIGMS NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":15,"month":6,"year":2014,"meshHeadings":["Activin Receptors, Type I","Animals","Arteries","Body Patterning","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Differentiation","Gene Expression Regulation, Developmental","Gene Knock-In Techniques","Genetic Vectors","Heart","Immunohistochemistry","In Situ Hybridization","In Situ Nick-End Labeling","Mice","Mice, Transgenic","Morphogenesis","Myocardium","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BMP signaling plays an essential role in second heart field-derived heart and arterial trunk development, including myocardial differentiation, right ventricular growth, and interventricular, outflow tract and aortico-pulmonary septation. It is mediated by a number of different BMP ligands, and receptors, many of which are present simultaneously. The mechanisms by which they regulate morphogenetic events and degree of redundancy amongst them have still to be elucidated. We therefore assessed the role of BMP Type I receptor AcvR1 in anterior second heart field-derived cell development, and compared it with that of BmpR1a. By removing Acvr1 using the driver Mef2c[AHF]-Cre, we show that AcvR1 plays an essential role in arterial pole morphogenesis, identifying defects in outflow tract wall and cushion morphology that preceded a spectrum of septation defects from double outlet right ventricle to common arterial trunk in mutants. Its absence caused dysregulation in gene expression important for myocardial differentiation (Isl1, Fgf8) and regional identity (Tbx2, Tbx3, Tbx20, Tgfb2). Although these defects resemble to some degree those in the equivalent Bmpr1a mutant, a novel gene knock-in model in which Bmpr1a was expressed in the Acvr1 locus only partially restored septation in Acvr1 mutants. These data show that both BmpR1a and AcvR1 are needed for normal heart development, in which they play some non-redundant roles, and refine our understanding of the genetic and morphogenetic processes underlying Bmp-mediated heart development important in human congenital heart disease.","affiliation":[]},{"pmid":"22761317","pmcid":null,"title":"A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength.","authors":["Baud'huin M","Solban N","Cornwall-Brady M","Sako D","Kawamoto Y","Liharska K","Lath D","Bouxsein ML","Underwood KW","Ucran J","Kumar R","Pobre E","Grinberg A","Seehra J","Canalis E","Pearsall RS","Croucher PI"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Proceedings of the National Academy of Sciences of the United States of America","journalShort":"Proc. Natl. Acad. Sci. U.S.A.","day":24,"month":7,"year":2012,"meshHeadings":["Analysis of Variance","Animals","Blotting, Western","Bone Density","Bone Diseases, Metabolic","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors, Type I","Bone Resorption","Bone and Bones","Chromatography, Gel","Cloning, Molecular","Densitometry","Electrophoresis, Polyacrylamide Gel","Intercellular Signaling Peptides and Proteins","Luciferases","Mice","Mice, Inbred C57BL","Osteoclasts","Osteogenesis","Osteoprotegerin","Polymerase Chain Reaction","RANK Ligand","Real-Time Polymerase Chain Reaction","Recombinant Fusion Proteins","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Diseases such as osteoporosis are associated with reduced bone mass. Therapies to prevent bone loss exist, but there are few that stimulate bone formation and restore bone mass. Bone morphogenetic proteins (BMPs) are members of the TGF superfamily, which act as pleiotropic regulators of skeletal organogenesis and bone homeostasis. Ablation of the BMPR1A receptor in osteoblasts increases bone mass, suggesting that inhibition of BMPR1A signaling may have therapeutic benefit. The aim of this study was to determine the skeletal effects of systemic administration of a soluble BMPR1A fusion protein (mBMPR1A-mFc) in vivo. mBMPR1A-mFc was shown to bind BMP2/4 specifically and with high affinity and prevent downstream signaling. mBMPR1A-mFc treatment of immature and mature mice increased bone mineral density, cortical thickness, trabecular bone volume, thickness and number, and decreased trabecular separation. The increase in bone mass was due to an early increase in osteoblast number and bone formation rate, mediated by a suppression of Dickkopf-1 expression. This was followed by a decrease in osteoclast number and eroded surface, which was associated with a decrease in receptor activator of NF-B ligand (RANKL) production, an increase in osteoprotegerin expression, and a decrease in serum tartrate-resistant acid phosphatase (TRAP5b) concentration. mBMPR1A treatment also increased bone mass and strength in mice with bone loss due to estrogen deficiency. In conclusion, mBMPR1A-mFc stimulates osteoblastic bone formation and decreases bone resorption, which leads to an increase in bone mass, and offers a promising unique alternative for the treatment of bone-related disorders.","affiliation":[]},{"pmid":"22560297","pmcid":null,"title":"Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module.","authors":["Koss M","Bolze A","Brendolan A","Saggese M","Capellini TD","Bojilova E","Boisson B","Prall OW","Elliott DA","Solloway M","Lenti E","Hidaka C","Chang CP","Mahlaoui N","Harvey RP","Casanova JL","Selleri L"],"grantIds":["DE18031","HD061403","HD43997","HL085345","R01 HD061403","R01 HD061403-03","UL1RR024143"],"grantAgencies":["NIDCR NIH HHS","NICHD NIH HHS","NICHD NIH HHS","NHLBI NIH HHS","NICHD NIH HHS","NICHD NIH HHS","NCRR NIH HHS"],"retractions":[],"journal":"Developmental cell","journalShort":"Dev. Cell","day":15,"month":5,"year":2012,"meshHeadings":["Adolescent","Amino Acid Sequence","Animals","Cells, Cultured","Cyclin-Dependent Kinase Inhibitor p15","DNA-Binding Proteins","Exome","Female","Gene Expression Profiling","Gene Expression Regulation, Developmental","Homeodomain Proteins","Humans","Infant","Male","Mice","Mice, Transgenic","Molecular Sequence Data","Mutation, Missense","Pedigree","Proto-Oncogene Proteins","Spleen","Splenic Diseases","Transcription Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The molecular determinants of spleen organogenesis and the etiology of isolated congenital asplenia (ICA), a life-threatening human condition, are unknown. We previously reported that Pbx1 deficiency causes organ growth defects including asplenia. Here, we show that mice with splenic mesenchyme-specific Pbx1 inactivation exhibit hyposplenia. Moreover, the loss of Pbx causes downregulation of Nkx2-5 and derepression of p15Ink4b in spleen mesenchymal progenitors, perturbing the cell cycle. Removal of p15Ink4b in Pbx1 spleen-specific mutants partially rescues spleen growth. By whole-exome sequencing of a multiplex kindred with ICA, we identify a heterozygous missense mutation (P236H) in NKX2-5 showing reduced transactivation in vitro. This study establishes that a Pbx/Nkx2-5/p15 regulatory module is essential for spleen development.","affiliation":[]},{"pmid":"22170575","pmcid":null,"title":"Bone morphogenetic protein receptor type Ia localization causes increased BMP2 signaling in mice exhibiting increased peak bone mass phenotype.","authors":["Bragdon B","Bonor J","Shultz KL","Beamer WG","Rosen CJ","Nohe A"],"grantIds":["R01 AR043618","R01 AR043618","R01 AR043618-09"],"grantAgencies":["NIAMS NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS"],"retractions":[],"journal":"Journal of cellular physiology","journalShort":"J. Cell. Physiol.","day":21,"month":7,"year":2012,"meshHeadings":["Animals","Bone Density","Bone Marrow","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors, Type I","Bone and Bones","Calcification, Physiologic","Caveolae","Caveolin 1","Cell Membrane","Female","Mice","Mice, Congenic","Mice, Inbred C3H","Mice, Inbred C57BL","Osteogenesis","Phenotype","Protein Isoforms","Protein Structure, Tertiary","Signal Transduction","Smad Proteins","Stromal Cells"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic protein 2 (BMP2) is a growth factor that initiates osteoblast differentiation. Recent studies show that BMP2 signaling regulates bone mineral density (BMD). BMP2 interacts with BMP receptor type Ia (BMPRIa) and type II receptor leading to the activation of the Smad signaling pathway. BMPRIa must shuttle between distinct plasma membrane domains, enriched of Caveolin-1 alpha and Caveolin-1 beta isoforms, and receptor activation occurs in these domains. Yet it remains unknown whether the molecular mechanism that regulates BMP2 signaling is driving mineralization and BMD. Therefore, the B6.C3H-1-12 congenic mouse model with increased BMD and osteoblast mineralization was utilized in this study. Using the family image correlation spectroscopy, we determined if BMP2 led to a significant re-localization of BMPRIa to caveolae of the alpha/beta isoforms in bone marrow stromal cells (BMSCs) isolated from B6.C3H-1-12 mice compared to the C57BL/6J mice, which served as controls. The control, C57BL/6J mice, was selected due to only 4Mb of chromosome 1 from the C3H/HeJ mouse was backcrossed to a C57BL/6J background. Using reporter gene assays, the B6.C3H-1-12 BMSCs responded to BMP2 with increased Smad activation. Furthermore, disrupting caveolae reduced the BMP2-induced Smad signaling in BMSCs isolated from B6.C3H-1-12 and C57BL/6J. This study suggests for the first time a regulatory mechanism of BMPRIa signaling at the plasma membrane of BMSCs that (i) associated with genetic differences in the distal Chromosome 1 segment carried by the B6.C3H-1-12 congenic and (ii) contributes to increase BMD of the B6.C3H-1-12 compared to the C57BL/6J control mice.","affiliation":[]},{"pmid":"23708139","pmcid":null,"title":"BMP signaling specifies the development of a large and fast CNS synapse.","authors":["Xiao L","Michalski N","Kronander E","Gjoni E","Genoud C","Knott G","Schneggenburger R"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Nature neuroscience","journalShort":"Nat. Neurosci.","day":26,"month":7,"year":2013,"meshHeadings":["Age Factors","Animals","Animals, Newborn","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Calcium-Binding Proteins","Central Nervous System","Cerebellum","Early Growth Response Protein 2","Electric Stimulation","Gene Expression Regulation, Developmental","In Vitro Techniques","Inhibitory Postsynaptic Potentials","Membrane Potentials","Mice","Mice, Inbred C57BL","Mice, Transgenic","Nerve Tissue Proteins","Neurons","Rhombencephalon","Signal Transduction","Synapses"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Large excitatory synapses with multiple active zones ensure reliable and fast information transfer at specific points in neuronal circuits. However, the mechanisms that determine synapse size in CNS circuits are largely unknown. Here we use the calyx of Held synapse, a major relay in the auditory system, to identify and study signaling pathways that specify large nerve terminal size and fast synaptic transmission. Using genome-wide screening, we identified bone morphogenetic proteins (BMPs) as candidate signaling molecules in the area of calyx synapses. Conditional deletion of BMP receptors in the auditory system of mice led to aberrations of synapse morphology and function specifically at the calyx of Held, with impaired nerve terminal growth, loss of monoinnervation and less mature transmitter release properties. Thus, BMP signaling specifies large and fast-transmitting synapses in the auditory system in a process that shares homologies with, but also extends beyond, retrograde BMP signaling at Drosophila neuromuscular synapses.","affiliation":[]},{"pmid":"22729646","pmcid":"3404688","title":"The bone morphogenetic protein receptor-1A pathway is required for lactogenic differentiation of mammary epithelial cells in vitro.","authors":["Perotti C","Karayazi O","Moffat S","Shemanko CS"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"In vitro cellular & developmental biology. Animal","journalShort":"In Vitro Cell. Dev. Biol. Anim.","day":29,"month":6,"year":2012,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Carrier Proteins","Caseins","Cell Differentiation","Cell Line","Epithelial Cells","Female","Lactation","Mammary Glands, Animal","Mice","RNA Interference","RNA, Small Interfering","Signal Transduction","Smad1 Protein","Smad5 Protein","Smad8 Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenetic proteins (BMPs) have been implicated in the control of proliferation, tissue formation, and differentiation. BMPs regulate the biology of stem and progenitor cells and can promote cellular differentiation, depending on the cell type and context. Although the BMP pathway is known to be involved in early embryonic development of the mammary gland via mesenchymal cells, its role in later epithelial cellular differentiation has not been examined. The majority of the mammary gland development occurs post-natal, and its final functional differentiation is characterized by the emergence of alveolar cells that produce milk proteins. Here, we tested the hypothesis that bone morphogenetic protein receptor 1A (BMPR1A) function was required for mammary epithelial cell differentiation. We found that the BMPR1A-SMAD1/5/8 pathway was predominantly active in undifferentiated mammary epithelial cells, compared with differentiated cells. Reduction of BMPR1A mRNA and protein, using short hairpin RNA, resulted in a reduction of SMAD1/5/8 phosphorylation in undifferentiated cells, indicating an impact on this pathway. When the expression of the BMPR1A gene knocked down in undifferentiated cells, this also prevented beta-casein production during differentiation of the mammary epithelial cells by lactogenic hormone stimulation. Addition of Noggin, a BMP antagonist, also prevented beta-casein expression. Together, this demonstrated that BMP-BMPR1A-SMAD1/5/8 signal transduction is required for beta-casein production, a marker of alveolar cell differentiation. This evidence functionally identifies BMPR1A as a potential new regulator of mammary epithelial alveolar cell differentiation.","affiliation":[]},{"pmid":"22860096","pmcid":"3408458","title":"The hedgehog signal induced modulation of bone morphogenetic protein signaling: an essential signaling relay for urinary tract morphogenesis.","authors":["Haraguchi R","Matsumaru D","Nakagata N","Miyagawa S","Suzuki K","Kitazawa S","Yamada G"],"grantIds":["R01ES016597"],"grantAgencies":["NIEHS NIH HHS"],"retractions":[],"journal":"PloS one","journalShort":"PLoS ONE","day":3,"month":8,"year":2012,"meshHeadings":["Animals","Bone Morphogenetic Proteins","Hedgehog Proteins","In Situ Hybridization","Mice","Mice, Knockout","Signal Transduction","Urinary Tract"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"BACKGROUND: Congenital diseases of the urinary tract are frequently observed in infants. Such diseases present a number of developmental anomalies such as hydroureter and hydronephrosis. Although some genetically-modified mouse models of growth factor signaling genes reproduce urinary phenotypes, the pathogenic mechanisms remain obscure. Previous studies suggest that a portion of the cells in the external genitalia and bladder are derived from peri-cloacal mesenchymal cells that receive Hedgehog (Hh) signaling in the early developmental stages. We hypothesized that defects in such progenitor cells, which give rise to urinary tract tissues, may be a cause of such diseases. METHODOLOGY/PRINCIPAL FINDINGS: To elucidate the pathogenic mechanisms of upper urinary tract malformations, we analyzed a series of Sonic hedgehog (Shh) deficient mice. Shh(-/-) displayed hydroureter and hydronephrosis phenotypes and reduced expression of several developmental markers. In addition, we suggested that Shh modulation at an early embryonic stage is responsible for such phenotypes by analyzing the Shh conditional mutants. Tissue contribution assays of Hh-responsive cells revealed that peri-cloacal mesenchymal cells, which received Hh signal secreted from cloacal epithelium, could contribute to the ureteral mesenchyme. Gain- and loss-of-functional mutants for Hh signaling revealed a correlation between Hh signaling and Bone morphogenetic protein (Bmp) signaling. Finally, a conditional ablation of Bmp receptor type IA (BmprIA) gene was examined in Hh-responsive cell lineages. This system thus made it possible to analyze the primary functions of the growth factor signaling relay. The defective Hh-to-Bmp signaling relay resulted in severe urinary tract phenotypes with a decrease in the number of Hh-responsive cells. CONCLUSIONS/SIGNIFICANCE: This study identified the essential embryonic stages for the pathogenesis of urinary tract phenotypes. These results suggested that Hh-responsive mesenchymal Bmp signaling maintains the population of peri-cloacal mesenchyme cells, which is essential for the development of the ureter and the upper urinary tract.","affiliation":[]},{"pmid":"24098149","pmcid":"3789827","title":"A GDF5 point mutation strikes twice--causing BDA1 and SYNS2.","authors":["Degenkolbe E","Knig J","Zimmer J","Walther M","Reiner C","Nickel J","Plger F","Raspopovic J","Sharpe J","Dathe K","Hecht JT","Mundlos S","Doelken SC","Seemann P"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"PLoS genetics","journalShort":"PLoS Genet.","day":7,"month":10,"year":2013,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Brachydactyly","Chickens","Growth Differentiation Factor 5","Humans","Mice","Osteoarthritis","Pedigree","Point Mutation","Protein Binding","Signal Transduction","Synostosis"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Growth and Differentiation Factor 5 (GDF5) is a secreted growth factor that belongs to the Bone Morphogenetic Protein (BMP) family and plays a pivotal role during limb development. GDF5 is a susceptibility gene for osteoarthritis (OA) and mutations in GDF5 are associated with a wide variety of skeletal malformations ranging from complex syndromes such as acromesomelic chondrodysplasias to isolated forms of brachydactylies or multiple synostoses syndrome 2 (SYNS2). Here, we report on a family with an autosomal dominant inherited combination of SYNS2 and additional brachydactyly type A1 (BDA1) caused by a single point mutation in GDF5 (p.W414R). Functional studies, including chondrogenesis assays with primary mesenchymal cells, luciferase reporter gene assays and Surface Plasmon Resonance analysis, of the GDF5(W414R) variant in comparison to other GDF5 mutations associated with isolated BDA1 (p.R399C) or SYNS2 (p.E491K) revealed a dual pathomechanism characterized by a gain- and loss-of-function at the same time. On the one hand insensitivity to the main GDF5 antagonist NOGGIN (NOG) leads to a GDF5 gain of function and subsequent SYNS2 phenotype. Whereas on the other hand, a reduced signaling activity, specifically via the BMP receptor type IA (BMPR1A), is likely responsible for the BDA1 phenotype. These results demonstrate that one mutation in the overlapping interface of antagonist and receptor binding site in GDF5 can lead to a GDF5 variant with pathophysiological relevance for both, BDA1 and SYNS2 development. Consequently, our study assembles another part of the molecular puzzle of how loss and gain of function mutations in GDF5 affect bone development in hands and feet resulting in specific types of brachydactyly and SYNS2. These novel insights into the biology of GDF5 might also provide further clues on the pathophysiology of OA.","affiliation":[]},{"pmid":"23676271","pmcid":null,"title":"Notch2 regulates BMP signaling and epithelial morphogenesis in the ciliary body of the mouse eye.","authors":["Zhou Y","Tanzie C","Yan Z","Chen S","Duncan M","Gaudenz K","Li H","Seidel C","Lewis B","Moran A","Libby RT","Kiernan AE","Xie T"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Proceedings of the National Academy of Sciences of the United States of America","journalShort":"Proc. Natl. Acad. Sci. U.S.A.","day":28,"month":5,"year":2013,"meshHeadings":["Animals","Bone Morphogenetic Proteins","Calcium-Binding Proteins","Cell Proliferation","Ciliary Body","DNA Primers","Epithelium","In Situ Hybridization","Intercellular Signaling Peptides and Proteins","Membrane Proteins","Mice","Microarray Analysis","Morphogenesis","Receptor, Notch2","Signal Transduction"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The ciliary body (CB) of the mammalian eye is responsible for secreting aqueous humor to maintain intraocular pressure, which is elevated in the eyes of glaucoma patients. It contains a folded two-layered epithelial structure comprising the nonpigmented inner ciliary epithelium (ICE), the pigmented outer ciliary epithelium (OCE), and the underlying stroma. Although the CB has an important function in the eye, its morphogenesis remains poorly studied. In this study, we show that conditional inactivation of the Jagged 1 (Jag1)-Notch2 signaling pathway in the developing CB abolishes its morphogenesis. Notch2 is expressed in the OCE of the CB, whereas Jag1 is expressed in the ICE. Conditional inactivation of Jag1 in the ICE or Notch2 in the OCE disrupts CB morphogenesis, but neither affects the specification of the CB region. Notch2 signaling in the OCE is required for promoting cell proliferation and maintaining bone morphogenetic protein (BMP) signaling, both of which have been suggested to be important for CB morphogenesis. Although Notch and BMP signaling pathways are known to cross-talk via the interaction between their downstream transcriptional factors, this study suggests that Notch2 maintains BMP signaling in the OCE possibly by repressing expression of secreted BMP inhibitors. Based on our findings, we propose that Jag1-Notch2 signaling controls CB morphogenesis at least in part by regulating cell proliferation and BMP signaling.","affiliation":[]},{"pmid":"23584254","pmcid":null,"title":"Expression of the BMP receptor Alk3 in the second heart field is essential for development of the dorsal mesenchymal protrusion and atrioventricular septation.","authors":["Briggs LE","Phelps AL","Brown E","Kakarla J","Anderson RH","van den Hoff MJ","Wessels A"],"grantIds":["5T32-GM008716-12","C06 RR015455","C06 RR018823","C06-RR018823","CO0-RR015455","P30 GM103342","P30 GM103342-01","R01 HL033756","R01 HL084285","R01HL084285","R25 HL092611","T32 GM008716","UL1 RR029882","UL1 TR000062","UL1RR029882","UL1TR000062"],"grantAgencies":["NIGMS NIH HHS","NCRR NIH HHS","NCRR NIH HHS","NCRR NIH HHS","NCI NIH HHS","NIGMS NIH HHS","NIGMS NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NIGMS NIH HHS","NCRR NIH HHS","NCATS NIH HHS","NCRR NIH HHS","NCATS NIH HHS"],"retractions":[],"journal":"Circulation research","journalShort":"Circ. Res.","day":24,"month":5,"year":2013,"meshHeadings":["Animals","Atrial Septum","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Female","Gene Expression Regulation, Developmental","Green Fluorescent Proteins","Heart Septal Defects","Heart Septal Defects, Atrial","Male","Mesoderm","Mice","Mice, 129 Strain","Mice, Knockout","Myocardium","Pregnancy","Signal Transduction","Ventricular Septum"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"RATIONALE: The dorsal mesenchymal protrusion (DMP) is a prong of mesenchyme derived from the second heart field (SHF) located at the venous pole of the developing heart. Recent studies have shown that perturbation of its development is associated with the pathogenesis of atrioventricular (AV) septal defect. Although the importance of the DMP to AV septation is now established, the molecular and cellular mechanisms underlying its development are far from fully understood. Prior studies have demonstrated that bone morphogenetic protein (BMP) signaling is essential for proper formation of the AV endocardial cushions and the cardiac outflow tract. A role for BMP signaling in regulation of DMP development remained to be elucidated. OBJECTIVE: To determine the role of BMP signaling in DMP development. METHODS AND RESULTS: Conditional deletion of the BMP receptor Alk3 from venous pole SHF cells leads to impaired formation of the DMP and a completely penetrant phenotype of ostium primum defect, a hallmark feature of AV septal defects. Analysis of mutants revealed decreased proliferative index of SHF cells and, consequently, reduced number of SHF cells at the cardiac venous pole. In contrast, volume and expression of markers associated with proliferation and active BMP/transforming growth factor  signaling were not significantly altered in the AV cushions of SHF-Alk3 mutants. CONCLUSIONS: BMP signaling is required for expansion of the SHF-derived DMP progenitor population at the cardiac venous pole. Perturbation of Alk3-mediated BMP signaling from the SHF results in impaired development of the DMP and ostium primum defects.","affiliation":[]},{"pmid":"23560082","pmcid":"3613384","title":"Endocardial to myocardial notch-wnt-bmp axis regulates early heart valve development.","authors":["Wang Y","Wu B","Chamberlain AA","Lui W","Koirala P","Susztak K","Klein D","Taylor V","Zhou B"],"grantIds":["R01 DK076077","R01DK076077","R01HL078881","R01HL111770","T32 GM007288"],"grantAgencies":["NIDDK NIH HHS","NIDDK NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS","NIGMS NIH HHS"],"retractions":[],"journal":"PloS one","journalShort":"PLoS ONE","day":5,"month":4,"year":2013,"meshHeadings":["Animals","Bone Morphogenetic Protein 2","Calcium-Binding Proteins","Embryo, Mammalian","Endocardium","Epithelial-Mesenchymal Transition","Extracellular Matrix Proteins","Gene Expression Regulation, Developmental","Heart Valves","Intercellular Signaling Peptides and Proteins","Membrane Proteins","Mice","Mice, Transgenic","Myocardium","Organogenesis","Receptor, Notch1","Signal Transduction","Wnt4 Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Endocardial to mesenchymal transformation (EMT) is a fundamental cellular process required for heart valve formation. Notch, Wnt and Bmp pathways are known to regulate this process. To further address how these pathways coordinate in the process, we specifically disrupted Notch1 or Jagged1 in the endocardium of mouse embryonic hearts and showed that Jagged1-Notch1 signaling in the endocardium is essential for EMT and early valvular cushion formation. qPCR and RNA in situ hybridization assays reveal that endocardial Jagged1-Notch1 signaling regulates Wnt4 expression in the atrioventricular canal (AVC) endocardium and Bmp2 in the AVC myocardium. Whole embryo cultures treated with Wnt4 or Wnt inhibitory factor 1 (Wif1) show that Bmp2 expression in the AVC myocardium is dependent on Wnt activity; Wnt4 also reinstates Bmp2 expression in the AVC myocardium of endocardial Notch1 null embryos. Furthermore, while both Wnt4 and Bmp2 rescue the defective EMT resulting from Notch inhibition, Wnt4 requires Bmp for its action. These results demonstrate that Jagged1-Notch1 signaling in endocardial cells induces the expression of Wnt4, which subsequently acts as a paracrine factor to upregulate Bmp2 expression in the adjacent AVC myocardium to signal EMT.","affiliation":[]},{"pmid":"23341776","pmcid":"3547831","title":"Tbx2 controls lung growth by direct repression of the cell cycle inhibitor genes Cdkn1a and Cdkn1b.","authors":["Ldtke TH","Farin HF","Rudat C","Schuster-Gossler K","Petry M","Barnett P","Christoffels VM","Kispert A"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"PLoS genetics","journalShort":"PLoS Genet.","day":23,"month":1,"year":2013,"meshHeadings":["Animals","Cell Cycle Proteins","Cell Differentiation","Cyclin-Dependent Kinase Inhibitor p21","Cyclin-Dependent Kinase Inhibitor p27","Epithelial Cells","Gene Expression Regulation, Developmental","Lung","Mesoderm","Mice","Morphogenesis","Signal Transduction","T-Box Domain Proteins"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Vertebrate organ development relies on the precise spatiotemporal orchestration of proliferation rates and differentiation patterns in adjacent tissue compartments. The underlying integration of patterning and cell cycle control during organogenesis is insufficiently understood. Here, we have investigated the function of the patterning T-box transcription factor gene Tbx2 in lung development. We show that lungs of Tbx2-deficient mice are markedly hypoplastic and exhibit reduced branching morphogenesis. Mesenchymal proliferation was severely decreased, while mesenchymal differentiation into fibrocytes was prematurely induced. In the epithelial compartment, proliferation was reduced and differentiation of alveolar epithelial cells type 1 was compromised. Prior to the observed cellular changes, canonical Wnt signaling was downregulated, and Cdkn1a (p21) and Cdkn1b (p27) (two members of the Cip/Kip family of cell cycle inhibitors) were strongly induced in the Tbx2-deficient lung mesenchyme. Deletion of both Cdkn1a and Cdkn1b rescued, to a large degree, the growth deficits of Tbx2-deficient lungs. Prolongation of Tbx2 expression into adulthood led to hyperproliferation and maintenance of mesenchymal progenitor cells, with branching morphogenesis remaining unaffected. Expression of Cdkn1a and Cdkn1b was ablated from the lung mesenchyme in this gain-of-function setting. We further show by ChIP experiments that Tbx2 directly binds to Cdkn1a and Cdkn1b loci in vivo, defining these two genes as direct targets of Tbx2 repressive activity in the lung mesenchyme. We conclude that Tbx2-mediated regulation of Cdkn1a and Cdkn1b represents a crucial node in the network integrating patterning information and cell cycle regulation that underlies growth, differentiation, and branching morphogenesis of this organ.","affiliation":[]},{"pmid":"24657641","pmcid":null,"title":"FGFR3 induces degradation of BMP type I receptor to regulate skeletal development.","authors":["Qi H","Jin M","Duan Y","Du X","Zhang Y","Ren F","Wang Y","Tian Q","Wang X","Wang Q","Zhu Y","Xie Y","Liu C","Cao X","Mishina Y","Chen D","Deng CX","Chang Z","Chen L"],"grantIds":["P30 DK079637","R01 AR054465","R01 AR055915"],"grantAgencies":["NIDDK NIH HHS","NIAMS NIH HHS","NIAMS NIH HHS"],"retractions":[],"journal":"Biochimica et biophysica acta","journalShort":"Biochim. Biophys. Acta","day":7,"month":7,"year":2014,"meshHeadings":["Achondroplasia","Animals","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors, Type I","Cell Differentiation","Chondrocytes","Embryo, Mammalian","Fibroblast Growth Factor 2","Gene Expression Regulation, Developmental","Growth Plate","Humans","Mice","Mice, Knockout","Morphogenesis","Phosphorylation","Pyrazoles","Pyrimidines","Receptor, Fibroblast Growth Factor, Type 3","Signal Transduction","Smad Proteins","Ubiquitin-Protein Ligases","Ubiquitination"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Fibroblast growth factors (FGFs) and their receptors (FGFRs) play significant roles in vertebrate organogenesis and morphogenesis. FGFR3 is a negative regulator of chondrogenesis and multiple mutations with constitutive activity of FGFR3 result in achondroplasia, one of the most common dwarfisms in humans, but the molecular mechanism remains elusive. In this study, we found that chondrocyte-specific deletion of BMP type I receptor a (Bmpr1a) rescued the bone overgrowth phenotype observed in Fgfr3 deficient mice by reducing chondrocyte differentiation. Consistently, using in vitro chondrogenic differentiation assay system, we demonstrated that FGFR3 inhibited BMPR1a-mediated chondrogenic differentiation. Furthermore, we showed that FGFR3 hyper-activation resulted in impaired BMP signaling in chondrocytes of mouse growth plates. We also found that FGFR3 inhibited BMP-2- or constitutively activated BMPR1-induced phosphorylation of Smads through a mechanism independent of its tyrosine kinase activity. We found that FGFR3 facilitates BMPR1a to degradation through Smurf1-mediated ubiquitination pathway. We demonstrated that down-regulation of BMP signaling by BMPR1 inhibitor dorsomorphin led to the retardation of chondrogenic differentiation, which mimics the effect of FGF-2 on chondrocytes and BMP-2 treatment partially rescued the retarded growth of cultured bone rudiments from thanatophoric dysplasia type II mice. Our findings reveal that FGFR3 promotes the degradation of BMPR1a, which plays an important role in the pathogenesis of FGFR3-related skeletal dysplasia.","affiliation":[]},{"pmid":"23604909","pmcid":null,"title":"Gene-trap mutagenesis using Mol/MSM-1 embryonic stem cells from MSM/Ms mice.","authors":["Nakahara M","Tateyama H","Araki M","Nakagata N","Yamamura K","Araki K"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Mammalian genome : official journal of the International Mammalian Genome Society","journalShort":"Mamm. Genome","day":19,"month":6,"year":2013,"meshHeadings":["Animals","Crosses, Genetic","Embryonic Stem Cells","Female","Humans","Mice","Mice, Inbred C57BL","Mice, Inbred CBA","Mutagenesis, Insertional"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The MSM/Ms strain is derived from the Japanese wild mouse Mus musculus molossinus and displays characteristics not observed in common laboratory strains. Functional genomic analyses using genetically engineered MSM/Ms mice will reveal novel phenotypes and gene functions/interactions. We previously reported the establishment of a germline-competent embryonic stem (ES) cell line, Mol/MSM-1, from the MSM/Ms strain. To analyze its usefulness for insertional mutagenesis, we performed gene-trapping using these cells. In the present study, we compared the gene-trap events between Mol/MSM-1 and a conventional ES cell line, KTPU8, derived from the F1 progeny of a C57BL/6CBA cross. We introduced a promoter-trap vector carrying the promoterless -galactosidase/neomycin-resistance fusion gene into Mol/MSM-1 and KTPU8 cells, isolated clones, and identified the trapped genes by rapid amplification of cDNA 5'-ends (5'-RACE), inverse PCR, or plasmid rescue. Unexpectedly, the success rate of 5'-RACE in Mol/MSM trap clones was 47%, lower than the 87% observed in KTPU8 clones. Genomic analysis of the 5'-RACE-failed clones revealed that most had trapped ribosomal RNA gene regions. The percentage of ribosomal RNA region trap clones was 41% in Mol/MSM-1 cells, but less than 10% in KTPU8 cells. However, within the Mol/MSM-1 5'-RACE-successful clones, the trapping frequency of annotated genes, the chromosomal distribution of vector insertions, the frequency of integration into an intron around the start codon-containing exon, and the functional spectrum of trapped genes were comparable to those in KTPU8 cells. By selecting 5'-RACE-successful clones, it is possible to perform gene-trapping efficiently using Mol/MSM-1 ES cells and promoter-trap vectors.","affiliation":[]},{"pmid":"23360989","pmcid":null,"title":"The phosphatase Dullard negatively regulates BMP signalling and is essential for nephron maintenance after birth.","authors":["Sakaguchi M","Sharmin S","Taguchi A","Ohmori T","Fujimura S","Abe T","Kiyonari H","Komatsu Y","Mishina Y","Asashima M","Araki E","Nishinakamura R"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Nature communications","journalShort":"Nat Commun","day":30,"month":1,"year":2013,"meshHeadings":["Aging","Animals","Animals, Newborn","Apoptosis","Blotting, Western","Bone Morphogenetic Proteins","Cell Line","Mice","Mice, Mutant Strains","Nephrons","Phosphoprotein Phosphatases","Signal Transduction","Staining and Labeling"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Most kidney nephron components, including glomeruli and renal tubules, derive from the metanephric mesenchyme. The overall differentiation into each component finishes at birth, but the molecular events linking the perinatal and adult kidneys remain elusive. Dullard was cloned from Xenopus kidneys, and encodes a phosphatase that negatively regulates BMP signalling. Here we report that Dullard deletion in the murine metanephric mesenchyme leads to failure of nephron maintenance after birth, resulting in lethality before adulthood. The nephron components are lost by massive apoptosis within 3 weeks after birth, leading to formation of a large hollow with a thin-layered cortex and medulla. Phosphorylated Smad1/5/8 is upregulated in the mutant nephrons, probably through cell-autonomous inhibitory effects of Dullard on BMP signalling. Importantly, administration of the BMP receptor kinase inhibitor LDN-193189 partially rescued the defects caused by Dullard deletion. Thus, Dullard keeps BMP signalling at an appropriate level, which is required for nephron maintenance in the postnatal period.","affiliation":[]},{"pmid":"23776616","pmcid":"3680418","title":"Augmented BMPRIA-mediated BMP signaling in cranial neural crest lineage leads to cleft palate formation and delayed tooth differentiation.","authors":["Li L","Wang Y","Lin M","Yuan G","Yang G","Zheng Y","Chen Y"],"grantIds":["R01DE14044"],"grantAgencies":["NIDCR NIH HHS"],"retractions":[],"journal":"PloS one","journalShort":"PLoS ONE","day":18,"month":6,"year":2013,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Bromodeoxyuridine","Cell Differentiation","Cleft Palate","Immunohistochemistry","In Situ Hybridization","Mesoderm","Mice","Mice, Transgenic","Neural Crest","Signal Transduction","Tooth"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The importance of BMP receptor Ia (BMPRIa) mediated signaling in the development of craniofacial organs, including the tooth and palate, has been well illuminated in several mouse models of loss of function, and by its mutations associated with juvenile polyposis syndrome and facial defects in humans. In this study, we took a gain-of-function approach to further address the role of BMPR-IA-mediated signaling in the mesenchymal compartment during tooth and palate development. We generated transgenic mice expressing a constitutively active form of BmprIa (caBmprIa) in cranial neural crest (CNC) cells that contributes to the dental and palatal mesenchyme. Mice bearing enhanced BMPRIa-mediated signaling in CNC cells exhibit complete cleft palate and delayed odontogenic differentiation. We showed that the cleft palate defect in the transgenic animals is attributed to an altered cell proliferation rate in the anterior palatal mesenchyme and to the delayed palatal elevation in the posterior portion associated with ectopic cartilage formation. Despite enhanced activity of BMP signaling in the dental mesenchyme, tooth development and patterning in transgenic mice appeared normal except delayed odontogenic differentiation. These data support the hypothesis that a finely tuned level of BMPRIa-mediated signaling is essential for normal palate and tooth development.","affiliation":[]},{"pmid":"23485971","pmcid":"3623555","title":"Brown-fat paucity due to impaired BMP signalling induces compensatory browning of white fat.","authors":["Schulz TJ","Huang P","Huang TL","Xue R","McDougall LE","Townsend KL","Cypess AM","Mishina Y","Gussoni E","Tseng YH"],"grantIds":["F32 DK091996","F32 DK091996","K23 DK081604","P30 DK036836","R01 DK077097","R01 NS047727","T32 DK007260"],"grantAgencies":["NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NIDDK NIH HHS","NINDS NIH HHS","NIDDK NIH HHS"],"retractions":[],"journal":"Nature","journalShort":"Nature","day":21,"month":3,"year":2013,"meshHeadings":["Adipose Tissue, Brown","Adipose Tissue, White","Animals","Body Temperature","Body Temperature Regulation","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cell Differentiation","Cell Proliferation","Cells, Cultured","Energy Metabolism","Mice","Signal Transduction","Stem Cells"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Maintenance of body temperature is essential for the survival of homeotherms. Brown adipose tissue (BAT) is a specialized fat tissue that is dedicated to thermoregulation. Owing to its remarkable capacity to dissipate stored energy and its demonstrated presence in adult humans, BAT holds great promise for the treatment of obesity and metabolic syndrome. Rodent data suggest the existence of two types of brown fat cells: constitutive BAT (cBAT), which is of embryonic origin and anatomically located in the interscapular region of mice; and recruitable BAT (rBAT), which resides within white adipose tissue (WAT) and skeletal muscle, and has alternatively been called beige, brite or inducible BAT. Bone morphogenetic proteins (BMPs) regulate the formation and thermogenic activity of BAT. Here we use mouse models to provide evidence for a systemically active regulatory mechanism that controls whole-body BAT activity for thermoregulation and energy homeostasis. Genetic ablation of the type 1A BMP receptor (Bmpr1a) in brown adipogenic progenitor cells leads to a severe paucity of cBAT. This in turn increases sympathetic input to WAT, thereby promoting the formation of rBAT within white fat depots. This previously unknown compensatory mechanism, aimed at restoring total brown-fat-mediated thermogenic capacity in the body, is sufficient to maintain normal temperature homeostasis and resistance to diet-induced obesity. These data suggest an important physiological cross-talk between constitutive and recruitable brown fat cells. This sophisticated regulatory mechanism of body temperature may participate in the control of energy balance and metabolic disease.","affiliation":[]},{"pmid":"24632946","pmcid":"4013517","title":"Disruption of the temporally regulated cloaca endodermal -catenin signaling causes anorectal malformations.","authors":["Miyagawa S","Harada M","Matsumaru D","Tanaka K","Inoue C","Nakahara C","Haraguchi R","Matsushita S","Suzuki K","Nakagata N","Ng RC","Akita K","Lui VC","Yamada G"],"grantIds":["R01ES016597"],"grantAgencies":["NIEHS NIH HHS"],"retractions":[],"journal":"Cell death and differentiation","journalShort":"Cell Death Differ.","day":6,"month":6,"year":2014,"meshHeadings":["Animals","Anus, Imperforate","Cloaca","Endoderm","Gene Expression Regulation, Neoplastic","Homeodomain Proteins","Humans","Mice","Wnt Signaling Pathway","beta Catenin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The cloaca is temporally formed and eventually divided by the urorectal septum (URS) during urogenital and anorectal organ development. Although congenital malformations, such as anorectal malformations (ARMs), are frequently observed during this process, the underlying pathogenic mechanisms remain unclear. -Catenin is a critical component of canonical Wnt signaling and is essential for the regulation of cell differentiation and morphogenesis during embryogenesis. The expression of -catenin is observed in endodermal epithelia, including URS epithelia. We modulated the -catenin gene conditionally in endodermal epithelia by utilizing tamoxifen-inducible Cre driver line (Shh(CreERT2)). Both -catenin loss- and gain-of-function (LOF and GOF) mutants displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS. The mutants also displayed reduced cell proliferation in the URS mesenchyme. In addition, the -catenin GOF mutants displayed reduced apoptosis and subsequently increased apoptosis in the URS epithelium. This instability possibly resulted in reduced expression levels of differentiation markers, such as keratin 1 and filaggrin, in the perineal epithelia. The expression of bone morphogenetic protein (Bmp) genes, such as Bmp4 and Bmp7, was also ectopically induced in the epithelia of the URS in the -catenin GOF mutants. The expression of the Msx2 gene and phosphorylated-Smad1/5/8, possible readouts of Bmp signaling, was also increased in the mutants. Moreover, we introduced an additional mutation for a Bmp receptor gene: BmprIA. The Shh(CreERT2/+); -catenin(flox(ex3)/+); BmprIA(flox/-) mutants displayed partial restoration of URS elongation compared with the -catenin GOF mutants. These results indicate that some ARM phenotypes in the -catenin GOF mutants were caused by abnormal Bmp signaling. The current analysis revealed the close relation of endodermal -catenin signaling to the ARM phenotypes. These results are considered to shed light on the pathogenic mechanisms of human ARMs.","affiliation":[]},{"pmid":"24163588","pmcid":"3807016","title":"BMP receptor 1A determines the cell fate of the postnatal growth plate.","authors":["Jing J","Ren Y","Zong Z","Liu C","Kamiya N","Mishina Y","Liu Y","Zhou X","Feng JQ"],"grantIds":["DE018486","R01 DE020843"],"grantAgencies":["NIDCR NIH HHS","NIDCR NIH HHS"],"retractions":[],"journal":"International journal of biological sciences","journalShort":"Int. J. Biol. Sci.","day":28,"month":10,"year":2013,"meshHeadings":["Animals","Bone Development","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cartilage","Cell Differentiation","Chondrogenesis","Gene Expression Regulation, Developmental","Growth Plate","Mice","Mice, Knockout","Microscopy, Electron, Scanning","Tamoxifen"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Bone morphogenic proteins (BMPs) are critical for both chondrogenesis and osteogenesis. Previous studies reported that embryos deficient in Bmp receptor (Bmpr)1a or Bmpr1b in cartilage display subtle skeletal defects; however, double mutant embryos develop severe skeletal defects, suggesting a functional redundancy that is essential for early chondrogenesis. In this study, we examined the postnatal role of Bmpr1a in cartilage. In the Bmpr1a conditional knockout (cKO, a cross between Bmpr1a flox and aggrecan-CreER (T2) induced by a one-time-tamoxifen injection at birth and harvested at ages of 2, 4, 8 and 20 weeks), there was essentially no long bone growth with little expression of cartilage markers such as SOX9, IHH and glycoproteins. Unexpectedly, the null growth plate was replaced by bone-like tissues, supporting the notions that the progenitor cells in the growth plate, which normally form cartilage, can form other tissues such as bone and fibrous; and that BMPR1A determines the cell fate. A working hypothesis is proposed to explain the vital role of BMPR1A in postnatal chondrogenesis.","affiliation":[]},{"pmid":"24601881","pmcid":null,"title":"Bone morphogenetic protein 2 stimulates noncanonical SMAD2/3 signaling via the BMP type 1A receptor in gonadotrope-like cells: implications for FSH synthesis.","authors":["Wang Y","Ho CC","Bang E","Rejon CA","Libasci V","Pertchenko P","Hbert TE","Bernard DJ"],"grantIds":["MOP-123447","MOP-86626","MOP-89991"],"grantAgencies":["Canadian Institutes of Health Research","Canadian Institutes of Health Research","Canadian Institutes of Health Research"],"retractions":[],"journal":"Endocrinology","journalShort":"Endocrinology","day":21,"month":5,"year":2014,"meshHeadings":["Activins","Animals","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein Receptors, Type I","Cell Line","Follicle Stimulating Hormone, beta Subunit","Gene Silencing","Genes, Reporter","Gonadotrophs","Humans","Mice","Phosphorylation","Protein Processing, Post-Translational","RNA, Small Interfering","Recombinant Proteins","Signal Transduction","Smad2 Protein","Smad3 Protein","Transcription, Genetic"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"FSH is an essential regulator of mammalian reproduction. Its synthesis by pituitary gonadotrope cells is regulated by multiple endocrine and paracrine factors, including TGF superfamily ligands, such as the activins and inhibins. Activins stimulate FSH synthesis via transcriptional regulation of its -subunit gene (Fshb). More recently, bone morphogenetic proteins (BMPs) were shown to stimulate murine Fshb transcription alone and in synergy with activins. BMP2 signals via its canonical type I receptor, BMPR1A (or activin receptor-like kinase 3 [ALK3]), and SMAD1 and SMAD5 to stimulate transcription of inhibitor of DNA binding proteins. Inhibitor of DNA binding proteins then potentiate the actions of activin-stimulated SMAD3 to regulate the Fshb gene in the gonadotrope-like LT2 cell line. Here, we report the unexpected observation that BMP2 also stimulates the SMAD2/3 pathway in these cells and that it does so directly via ALK3. Indeed, this novel, noncanonical ALK3 activity is completely independent of ALK4, ALK5, and ALK7, the type I receptors most often associated with SMAD2/3 pathway activation. Induction of the SMAD2/3 pathway by ALK3 is dependent upon its own previous activation by associated type II receptors, which phosphorylate conserved serine and threonine residues in the ALK3 juxtamembrane glycine-serine-rich domain. ALK3 signaling via SMAD3 is necessary for the receptor to stimulate Fshb transcription, whereas its activation of the SMAD1/5/8 pathway alone is insufficient. These data challenge current dogma that ALK3 and other BMP type I receptors signal via SMAD1, SMAD5, and SMAD8 and not SMAD2 or SMAD3. Moreover, they suggest that BMPs and activins may use similar intracellular signaling mechanisms to activate the murine Fshb promoter in immortalized gonadotrope-like cells.","affiliation":[]},{"pmid":"23891934","pmcid":null,"title":"Enhanced BMP signaling prevents degeneration and leads to endochondral ossification of Meckel's cartilage in mice.","authors":["Wang Y","Zheng Y","Chen D","Chen Y"],"grantIds":["R01 DE014044","R01DE14044","R01DE17792"],"grantAgencies":["NIDCR NIH HHS","NIDCR NIH HHS","NIDCR NIH HHS"],"retractions":[],"journal":"Developmental biology","journalShort":"Dev. Biol.","day":15,"month":9,"year":2013,"meshHeadings":["Animals","Bone Morphogenetic Protein 2","Bone Morphogenetic Protein 7","Bone Morphogenetic Protein Receptors, Type I","Carrier Proteins","Cartilage","Cell Proliferation","Chondrocytes","Chondrogenesis","Embryo, Mammalian","Female","Gene Expression Regulation, Developmental","Male","Mandible","Mesoderm","Mice","Ossification, Heterotopic","Osteogenesis","Phosphorylation","Pregnancy","Signal Transduction","Smad1 Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Meckel's cartilage is a transient supporting tissue of the embryonic mandible in mammals, and disappears by taking different ultimate cell fate along the distal-proximal axis, with the majority (middle portion) undergoing degeneration and chondroclastic resorption. While a number of factors have been implicated in the degeneration and resorption processes, signaling pathways that trigger this degradation are currently unknown. BMP signaling has been implicated in almost every step of chondrogenesis. In this study, we used Noggin mutant mice as a model for gain-of-BMP signaling function to investigate the function of BMP signaling in Meckel's cartilage development, with a focus on the middle portion. We showed that Bmp2 and Bmp7 are expressed in early developing Meckels' cartilage, but their expression disappears thereafter. In contrast, Noggin is expressed constantly in Meckel's cartilage throughout the entire gestation period. In the absence of Noggin, Meckel's cartilage is significantly thickened attributing to dramatically elevated cell proliferation rate associated with enhanced phosphorylated Smad1/5/8 expression. Interestingly, instead of taking a degeneration fate, the middle portion of Meckel's cartilage in Noggin mutants undergoes chondrogenic differentiation and endochondral ossification contributing to the forming mandible. Chondrocyte-specific expression of a constitutively active form of BMPRIa but not BMPRIb leads to enlargement of Meckel's cartilage, phenocopying the consequence of Noggin deficiency. Our results demonstrate that elevated BMP signaling prevents degeneration and leads to endochondral ossification of Meckel's cartilage, and support the idea that withdrawal of BMP signaling is required for normal Meckel's cartilage development and ultimate cell fate.","affiliation":[]},{"pmid":"24048844","pmcid":null,"title":"Dendrite complexity of sympathetic neurons is controlled during postnatal development by BMP signaling.","authors":["Majdazari A","Stubbusch J","Mller CM","Hennchen M","Weber M","Deng CX","Mishina Y","Schtz G","Deller T","Rohrer H"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","journalShort":"J. Neurosci.","day":18,"month":9,"year":2013,"meshHeadings":["Age Factors","Analysis of Variance","Animals","Animals, Newborn","Archaeal Proteins","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Proteins","Cells, Cultured","DNA-Directed DNA Polymerase","Dendrites","Embryo, Mammalian","Fluorescent Dyes","Ganglia, Sympathetic","Gene Expression Regulation, Developmental","Homeodomain Proteins","Imaging, Three-Dimensional","Mice","Mice, Inbred C57BL","Mice, Transgenic","Microtubule-Associated Proteins","Models, Neurological","Nerve Tissue Proteins","Sensory Receptor Cells","Signal Transduction","Smad4 Protein","Statistics, Nonparametric","Transcription Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Dendrite development is controlled by the interplay of intrinsic and extrinsic signals affecting initiation, growth, and maintenance of complex dendrites. Bone morphogenetic proteins (BMPs) stimulate dendrite growth in cultures of sympathetic, cortical, and hippocampal neurons but it was unclear whether BMPs control dendrite morphology in vivo. Using a conditional knock-out strategy to eliminate Bmpr1a and Smad4 in immature noradrenergic sympathetic neurons we now show that dendrite length, complexity, and neuron cell body size are reduced in adult mice deficient of Bmpr1a. The combined deletion of Bmpr1a and Bmpr1b causes no further decrease in dendritic features. Sympathetic neurons devoid of Bmpr1a/1b display normal Smad1/5/8 phosphorylation, which suggests that Smad-independent signaling paths are involved in dendritic growth control downstream of BMPR1A/B. Indeed, in the Smad4 conditional knock-out dendrite and cell body size are not affected and dendrite complexity and number are increased. Together, these results demonstrate an in vivo function for BMPs in the generation of mature sympathetic neuron dendrites. BMPR1 signaling controls dendrite complexity postnatally during the major dendritic growth period of sympathetic neurons.","affiliation":[]},{"pmid":"24081330","pmcid":null,"title":"Cessation of epithelial Bmp signaling switches the differentiation of crown epithelia to the root lineage in a -catenin-dependent manner.","authors":["Yang Z","Hai B","Qin L","Ti X","Shangguan L","Zhao Y","Wiggins L","Liu Y","Feng JQ","Chang JY","Wang F","Liu F"],"grantIds":["K08 DE020883","R01 CA096824","R56 DE023106","T32 DE018380"],"grantAgencies":["NIDCR NIH HHS","NCI NIH HHS","NIDCR NIH HHS","NIDCR NIH HHS"],"retractions":[],"journal":"Molecular and cellular biology","journalShort":"Mol. Cell. Biol.","day":11,"month":12,"year":2013,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Cell Differentiation","Cell Lineage","Cells, Cultured","Cementogenesis","Dental Cementum","Epithelial Cells","Epithelial-Mesenchymal Transition","Gene Knockout Techniques","Incisor","Mice","Mice, Transgenic","Tooth Crown","Tooth Root","Wnt Signaling Pathway","beta Catenin"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The differentiation of dental epithelia into enamel-producing ameloblasts or the root epithelial lineage compartmentalizes teeth into crowns and roots. Bmp signaling has been linked to enamel formation, but its role in root epithelial lineage differentiation is unclear. Here we show that cessation of epithelial Bmp signaling by Bmpr1a depletion during the differentiation stage switched differentiation of crown epithelia into the root lineage and led to formation of ectopic cementum-like structures. This phenotype is related to the upregulation of Wnt/-catenin signaling and epithelial-mesenchymal transition (EMT). Although epithelial -catenin depletion during the differentiation stage also led to variable enamel defect and precocious/ectopic formation of fragmented root epithelia in some teeth, it did not cause ectopic cementogenesis and inhibited EMT in cultured dental epithelia. Concomitant epithelial -catenin depletion rescued EMT and ectopic cementogenesis caused by Bmpr1a depletion. These data suggested that Bmp and Wnt/-catenin pathways interact antagonistically in dental epithelia to regulate the root lineage differentiation and EMT. These findings will aid in the design of new strategies to promote functional differentiation in the regeneration and tissue engineering of teeth and will provide new insights into the dynamic interactions between the Bmp and Wnt/-catenin pathways during cell fate decisions.","affiliation":[]},{"pmid":"24398041","pmcid":null,"title":"Expression of bone morphogenetic protein 4 and its receptors in the remodeling heart.","authors":["Wu X","Sagave J","Rutkovskiy A","Haugen F","Baysa A","Nygrd S","Czibik G","Dahl CP","Gullestad L","Vaage J","Valen G"],"grantIds":[],"grantAgencies":[],"retractions":[],"journal":"Life sciences","journalShort":"Life Sci.","day":3,"month":3,"year":2014,"meshHeadings":["Adult","Aged","Animals","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein Receptors, Type I","Bone Morphogenetic Protein Receptors, Type II","Cardiomyopathy, Dilated","Coronary Artery Disease","Disease Models, Animal","Down-Regulation","Female","Heart Failure","Humans","Male","Mice","Mice, Inbred C57BL","Middle Aged","Myocardial Infarction","Myocardial Ischemia","Myocytes, Cardiac","RNA, Messenger","Time Factors","Ventricular Remodeling","Young Adult"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"AIMS: Heart failure is associated with activation of fetal gene programs. Bone morphogenetic proteins (BMPs) regulate embryonic development through interaction with BMP receptors (BMPRs) on the cell surface. We investigated if the expression of BMP4 and its receptors BMPR1a and BMPR2 were activated in post-infarction remodeling and heart failure. MAIN METHODS: Left ventricular biopsies were taken from explanted hearts of patients with end-stage heart failure due to dilated cardiomyopathy (CMP; n=15) or ischemic heart disease (CAD; n=9), and compared with homograft control preparations from organ donors deceased due to non-cardiac causes (n=7). Other samples were taken from patients undergoing coronary artery bypass grafting (CABG; n=11). Mice were subjected to induced infarction by permanent coronary artery ligation or sham operation, and hearts were sampled serially thereafter (n=7 at each time point). KEY FINDINGS: Human and mouse hearts expressed BMP4 and both receptor subtypes. CABG and CMP patients had increased expression of mRNA encoding for BMP4, but unchanged protein. Mouse hearts had increased BMP4 precursor protein 24h after infarction. BMPR1a protein decreased in CAD patients and initially in postinfarcted mouse hearts, but increased again in the latter after two weeks. Human recombinant BMP4 promoted survival after H2O2 injury in HL-1 cells, and also protected adult mouse cardiomyocytes against hypoxia-reoxygenation injury. SIGNIFICANCE: Adult hearts express BMP4, the mRNA increasingly so in patients with coronary artery disease with good cardiac function. BMPRs are downregulated in cardiac remodeling and failure. Recombinant BMP4 has protective effects on cultured cardiomyocytes.","affiliation":[]},{"pmid":"23712751","pmcid":null,"title":"Expression levels of endoglin distinctively identify hematopoietic and endothelial progeny at different stages of yolk sac hematopoiesis.","authors":["Borges L","Iacovino M","Koyano-Nakagawa N","Baik J","Garry DJ","Kyba M","Perlingeiro RC"],"grantIds":["R01 HL085840","R01 HL085840-01","T32 AR007612","U01 HL100407","U01 HL100407"],"grantAgencies":["NHLBI NIH HHS","NHLBI NIH HHS","NIAMS NIH HHS","NHLBI NIH HHS","NHLBI NIH HHS"],"retractions":[],"journal":"Stem cells (Dayton, Ohio)","journalShort":"Stem Cells","day":7,"month":9,"year":2013,"meshHeadings":["Animals","Bone Morphogenetic Proteins","Endothelial Cells","Gene Expression Regulation, Developmental","Hematopoiesis","Hematopoietic Stem Cells","Intracellular Signaling Peptides and Proteins","Mice","Models, Biological","Signal Transduction","Subcellular Fractions","Transforming Growth Factor beta","Vascular Endothelial Growth Factor Receptor-2","Yolk Sac"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Endoglin (Eng), an ancillary receptor of the transforming growth factor beta (TGF) signaling pathway superfamily, has been well recognized for its important function in vascular development and angiogenesis since its discovery more than a decade ago. Recent studies show that this receptor is also critical for the emergence of blood during embryonic development, and that at E7.5, endoglin together with Flk-1 identifies early mesoderm progenitors that are endowed with hematopoietic and endothelial potential. These two lineages emerge in very close association during embryogenesis, and because they share the expression of the same surface markers, it has been difficult to distinguish the earliest hematopoietic from endothelial cells. Here, we evaluated the function of endoglin in hematopoiesis as development progresses past E7.5, and found that the hematopoietic and endothelial progenitors can be distinguished by the levels of endoglin in E9.5 yolk sacs. Whereas endothelial cells are Eng(bright), hematopoietic activity is primarily restricted to a subset of cells that display dim expression of endoglin (Eng(dim)). Molecular characterization of these subfractions showed that endoglin-mediated induction of hematopoiesis occurs in concert with BMP2/BMP4 signaling. This pathway is highly active in Eng(dim) cells but significantly downregulated in the Eng knockout. Taken together, our findings show an important function for endoglin in mediating BMP2/BMP4 signaling during yolk sac hematopoietic development and suggest that the levels of this receptor modulate TGF versus bone morphogenetic protein (BMP) signaling.","affiliation":[]},{"pmid":"24491691","pmcid":null,"title":"Jagged1 is essential for osteoblast development during maxillary ossification.","authors":["Hill CR","Yuasa M","Schoenecker J","Goudy SL"],"grantIds":["5K08DE17953-5","K08 DE017953","S10 RR027631"],"grantAgencies":["NIDCR NIH HHS","NIDCR NIH HHS","NCRR NIH HHS"],"retractions":[],"journal":"Bone","journalShort":"Bone","day":17,"month":5,"year":2014,"meshHeadings":["Animals","Bone Density","Bone Morphogenetic Proteins","Calcification, Physiologic","Calcium","Calcium-Binding Proteins","Cell Differentiation","Embryo, Mammalian","Intercellular Signaling Peptides and Proteins","Maxilla","Membrane Proteins","Mesoderm","Mice, Knockout","Organ Size","Osteoblasts","Osteogenesis","Palate","Receptors, Fc","Receptors, Notch","Signal Transduction","X-Ray Microtomography"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Maxillary hypoplasia occurs due to insufficient maxillary intramembranous ossification, leading to poor dental occlusion, respiratory obstruction and cosmetic deformities. Conditional deletion of Jagged1 (Jag1) in cranial neural crest (CNC) cells using Wnt1-cre; Jagged1(f/f) (Jag1CKO) led to maxillary hypoplasia characterized by intrinsic differences in bone morphology and density using CT evaluation. Jag1CKO maxillas revealed altered collagen deposition, delayed ossification, and reduced expression of early and late determinants of osteoblast development during maxillary ossification. In vitro bone cultures on Jag1CKO mouse embryonic maxillary mesenchymal (MEMM) cells demonstrated decreased mineralization that was also associated with diminished induction of osteoblast determinants. BMP receptor expression was dysregulated in the Jag1CKO MEMM cells suggesting that these cells were unable to respond to BMP-induced differentiation. JAG1-Fc rescued in vitro mineralization and osteoblast gene expression changes. These data suggest that JAG1 signaling in CNC-derived MEMM cells is required for osteoblast development and differentiation during maxillary ossification.","affiliation":[]},{"pmid":"24116187","pmcid":"3792867","title":"Deletion of the sequence encoding the tail domain of the bone morphogenetic protein type 2 receptor reveals a bone morphogenetic protein 7-specific gain of function.","authors":["Leyton PA","Beppu H","Pappas A","Martyn TM","Derwall M","Baron DM","Galdos R","Bloch DB","Bloch KD"],"grantIds":["HL074352"],"grantAgencies":["NHLBI NIH HHS"],"retractions":[],"journal":"PloS one","journalShort":"PLoS ONE","day":11,"month":10,"year":2013,"meshHeadings":["Activin Receptors, Type I","Activin Receptors, Type II","Animals","Binding Sites","Bone Morphogenetic Protein 4","Bone Morphogenetic Protein 7","Bone Morphogenetic Protein Receptors, Type II","Cells, Cultured","Familial Primary Pulmonary Hypertension","Gene Expression","Genotype","Hypertension, Pulmonary","Immunoblotting","Mice","Mice, Inbred C57BL","Mice, Knockout","Microscopy, Confocal","Muscle, Smooth, Vascular","Myocytes, Smooth Muscle","Pulmonary Artery","RNA Interference","Reverse Transcriptase Polymerase Chain Reaction","Sequence Deletion","Smad6 Protein"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"The bone morphogenetic protein (BMP) type II receptor (BMPR2) has a long cytoplasmic tail domain whose function is incompletely elucidated. Mutations in the tail domain of BMPR2 are found in familial cases of pulmonary arterial hypertension. To investigate the role of the tail domain of BMPR2 in BMP signaling, we generated a mouse carrying a Bmpr2 allele encoding a non-sense mediated decay-resistant mutant receptor lacking the tail domain of Bmpr2. We found that homozygous mutant mice died during gastrulation, whereas heterozygous mice grew normally without developing pulmonary arterial hypertension. Using pulmonary artery smooth muscle cells (PaSMC) from heterozygous mice, we determined that the mutant receptor was expressed and retained its ability to transduce BMP signaling. Heterozygous PaSMCs exhibited a BMP7specific gain of function, which was transduced via the mutant receptor. Using siRNA knockdown and cells from conditional knockout mice to selectively deplete BMP receptors, we observed that the tail domain of Bmpr2 inhibits Alk2mediated BMP7 signaling. These findings suggest that the tail domain of Bmpr2 is essential for normal embryogenesis and inhibits Alk2mediated BMP7 signaling in PaSMCs.","affiliation":[]},{"pmid":"24501215","pmcid":null,"title":"The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6.","authors":["Mayeur C","Lohmeyer LK","Leyton P","Kao SM","Pappas AE","Kolodziej SA","Spagnolli E","Yu B","Galdos RL","Yu PB","Peterson RT","Bloch DB","Bloch KD","Steinbicker AU"],"grantIds":["K08 HL079943","R01 AR057374","R01DK082971"],"grantAgencies":["NHLBI NIH HHS","NIAMS NIH HHS","NIDDK NIH HHS"],"retractions":[],"journal":"Blood","journalShort":"Blood","day":3,"month":4,"year":2014,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Gene Expression Regulation","Hep G2 Cells","Hepcidins","Humans","Interleukin-6","Iron","Liver","Male","Mice","Mice, Inbred C57BL","Mice, Transgenic"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Increased IL-6 production induces, via STAT3 phosphorylation, hepatic transcription of the gene encoding the iron-regulatory hormone, hepcidin, leading to development of anemia of chronic disease (ACD). Inhibition of bone morphogenetic protein (BMP) signaling prevents the induction of hepcidin gene expression by IL-6 and ameliorates ACD. Using mice with hepatocyte-specific deficiency of Alk2 or Alk3, we sought to identify the BMP type I receptor that participates in IL-6-mediated induction of hepcidin gene expression. Mice were injected with adenovirus specifying IL-6 (Ad.IL-6) or control adenovirus. Seventy-two hours later, serum iron concentrations and hepatic levels of STAT3 phosphorylation and hepcidin messenger RNA were measured. Additional mice were injected with recombinant murine IL-6 (mIL-6) or vehicle, and hepatic hepcidin gene expression was measured 4 hours later. Deficiency of Alk2 or Alk3 did not alter the ability of Ad.IL-6 injection to induce hepatic STAT3 phosphorylation. Ad.IL-6 increased hepatic hepcidin messenger RNA levels and decreased serum iron concentrations in Alk2- but not Alk3-deficient mice. Similarly, administration of mIL-6 induced hepatic hepcidin gene expression in Alk2- but not Alk3-deficient mice. These results demonstrate that the ability of IL-6 to induce hepatic hepcidin gene expression and reduce serum iron concentrations is dependent on the BMP type I receptor Alk3.","affiliation":[]},{"pmid":"24731097","pmcid":"4060178","title":"Essential roles of epithelial bone morphogenetic protein signaling during prostatic development.","authors":["Omori A","Miyagawa S","Ogino Y","Harada M","Ishii K","Sugimura Y","Ogino H","Nakagata N","Yamada G"],"grantIds":["R01ES016597-01A1"],"grantAgencies":["NIEHS NIH HHS"],"retractions":[],"journal":"Endocrinology","journalShort":"Endocrinology","day":21,"month":7,"year":2014,"meshHeadings":["Animals","Bone Morphogenetic Protein Receptors, Type I","Cell Differentiation","Cell Line, Tumor","Cell Proliferation","Epithelium","Female","Fluorescent Antibody Technique","Gene Expression Regulation, Developmental","Homeodomain Proteins","Humans","Hyperplasia","Male","Mice","Mice, Inbred C57BL","Mice, Inbred ICR","Mice, Knockout","Mice, Transgenic","Mutation","Phosphorylation","Prostate","Receptors, Androgen","Reverse Transcriptase Polymerase Chain Reaction","Signal Transduction","Smad Proteins","Transcription Factors"],"hasAbstract":true,"score":0,"snippets":[],"abstract":"Prostate is a male sex-accessory organ. The prostatic epithelia consist primarily of basal and luminal cells that differentiate from embryonic urogenital sinus epithelia. Prostate tumors are believed to originate in the basal and luminal cells. However, factors that promote normal epithelial differentiation have not been well elucidated, particularly for bone morphogenetic protein (Bmp) signaling. This study shows that Bmp signaling prominently increases during prostatic differentiation in the luminal epithelia, which is monitored by the expression of phosphorylated Smad1/5/8. To elucidate the mechanism of epithelial differentiation and the function of Bmp signaling during prostatic development, conditional male mutant mouse analysis for the epithelial-specific Bmp receptor 1a (Bmpr1a) was performed. We demonstrate that Bmp signaling is indispensable for luminal cell maturation, which regulates basal cell proliferation. Expression of the prostatic epithelial regulatory gene Nkx3.1 was significantly reduced in the Bmpr1a mutants. These results indicate that Bmp signaling is a key factor for prostatic epithelial differentiation, possibly by controlling the prostatic regulatory gene Nkx3.1.","affiliation":[]}]}